<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="review-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">53839</article-id><article-id pub-id-type="doi">10.7554/eLife.53839</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Cancer systems immunology</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-165965"><name><surname>Reticker-Flynn</surname><given-names>Nathan E</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9963-039X</contrib-id><email>retickerflynn@stanford.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-60584"><name><surname>Engleman</surname><given-names>Edgar G</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2096-9279</contrib-id><email>edgareng@stanford.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Pathology, Stanford University School of Medicine</institution><addr-line><named-content content-type="city">Stanford</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine</institution><addr-line><named-content content-type="city">Stanford</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Stanford Cancer Institute, Stanford University</institution><addr-line><named-content content-type="city">Stanford</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="senior_editor"><name><surname>Settleman</surname><given-names>Jeffrey</given-names></name><role>Senior Editor</role><aff><institution>Pfizer</institution><country>United States</country></aff></contrib><contrib contrib-type="editor"><name><surname>Kawakami</surname><given-names>Yutaka</given-names></name><role>Reviewing Editor</role><aff><institution>Keio University School of Medicine</institution><country>Japan</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>13</day><month>07</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e53839</elocation-id><history><date date-type="received" iso-8601-date="2019-11-25"><day>25</day><month>11</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2020-06-26"><day>26</day><month>06</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Reticker-Flynn and Engleman</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Reticker-Flynn and Engleman</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-53839-v1.pdf"/><abstract><p>Tumor immunology is undergoing a renaissance due to the recent profound clinical successes of tumor immunotherapy. These advances have coincided with an exponential growth in the development of –omics technologies. Armed with these technologies and their associated computational and modeling toolsets, systems biologists have turned their attention to tumor immunology in an effort to understand the precise nature and consequences of interactions between tumors and the immune system. Such interactions are inherently multivariate, spanning multiple time and size scales, cell types, and organ systems, rendering systems biology approaches particularly amenable to their interrogation. While in its infancy, the field of ‘Cancer Systems Immunology’ has already influenced our understanding of tumor immunology and immunotherapy. As the field matures, studies will move beyond descriptive characterizations toward functional investigations of the emergent behavior that govern tumor-immune responses. Thus, Cancer Systems Immunology holds incredible promise to advance our ability to fight this disease.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>systems biology</kwd><kwd>tumor immunology</kwd><kwd>cancer systems biology</kwd><kwd>systems immunology</kwd><kwd>tumor immunotherapy</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>U54 CA209971</award-id><principal-award-recipient><name><surname>Engleman</surname><given-names>Edgar G</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Cancer systems immunology is a highly interdisciplinary field that is advancing our ability to understand and predict the complex behavior that orchestrates the interplay between tumors and the immune system.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Systems Biology is an interdisciplinary field that aims to interrogate and predict complex behaviors of multivariate biological systems. It employs quantitative approaches to understand the integrated behaviors of multiple biological components. In contrast to reductionist approaches, which seek to identify how individual components affect particular phenotypes, systems biology attempts to query the simultaneous responses of many elements to uncover how they work in concert to elicit a given response. It is predicated upon the belief that many biological processes cannot be comprehensively understood by analyses of individual components alone (e.g. a single molecule, cell, etc.), but rather require a holistic appreciation of entire networks and systems (e.g. signaling networks, heterotypic cell-cell interactions, physiologic interplay between organs, etc.). By combining mathematical modeling and computation with experimental and clinical data, systems biologists can construct a framework for understanding the multiscale and temporal elements regulating biological responses and elucidate emergent behaviors.</p><p>While the discipline of systems biology became well established around 2000 (<xref ref-type="bibr" rid="bib269">Ideker et al., 2001</xref>), its underlying concepts have been appreciated for over half a century (<xref ref-type="bibr" rid="bib631">Waterman and Theory, 1968</xref>; <xref ref-type="bibr" rid="bib307">Kitano, 2002</xref>). Indeed, some have suggested that the study of medicine, which requires an understanding of the complex interactions between multiple molecules, cell types, and organ systems in response to different treatments over time, represents an original implementation of Systems Biology (<xref ref-type="bibr" rid="bib201">Germain, 2018</xref>). Nonetheless, recent advances in technologies and computational approaches have enabled researchers to query systems-level dynamics at scales not possible in previous decades (<xref ref-type="bibr" rid="bib258">Hood et al., 2004</xref>).</p><p>Recently, researchers in the fields of both cancer biology and immunology have embraced systems approaches to advance their disciplines. In cancer biology, genomics and proteomics approaches have been implemented to identify the effects of defects in signaling networks on malignant transformation and progression (<xref ref-type="bibr" rid="bib513">Sanchez-Vega et al., 2018</xref>; <xref ref-type="bibr" rid="bib389">Mertins et al., 2016</xref>). Next-generation sequencing (NGS) has enabled studies of tumor heterogeneity and clonal evolution (<xref ref-type="bibr" rid="bib278">Jacoby et al., 2015</xref>). In the United States, the National Cancer Institute formed the Cancer Systems Biology Consortium to promote applications of systems approaches to cancer.</p><p>Immunology represents a field that is readily amenable to systems level approaches. Deciphering the immune system requires an understanding of the interactions between numerous cell types, immune receptors, and cytokines as they traverse multiple anatomical locations and organ systems in order to orchestrate effective immune responses. While the multivariate components governing an immune response have been slowly elucidated through reductionist approaches, they have recently become subject to a much more comprehensive characterization through advances in modeling and high-throughput technologies (<xref ref-type="bibr" rid="bib133">Davis et al., 2017</xref>).</p><p>Although the study of tumor immunology can be traced back at least to the advent of Coley’s toxins at the turn of the twentieth century (<xref ref-type="bibr" rid="bib566">Starnes, 1992</xref>), the recent clinical successes of immunotherapies in the treatment of advanced stage cancers have catalyzed renewed interest in the field. Consequently, cancer systems immunology represents a new avenue of interrogation for understanding how the immune system interacts with tumors during tumorigenesis, progression, and treatment. Cancer systems biology and systems immunology have been reviewed elsewhere (<xref ref-type="bibr" rid="bib133">Davis et al., 2017</xref>; <xref ref-type="bibr" rid="bib171">Faratian, 2010</xref>; <xref ref-type="bibr" rid="bib577">Suhail et al., 2019</xref>; <xref ref-type="bibr" rid="bib199">Germain et al., 2011</xref>; <xref ref-type="bibr" rid="bib618">Vera, 2015</xref>; <xref ref-type="bibr" rid="bib633">Werner et al., 2014</xref>; <xref ref-type="bibr" rid="bib314">Korsunsky et al., 2014</xref>; <xref ref-type="bibr" rid="bib316">Kreeger and Lauffenburger, 2010</xref>; <xref ref-type="bibr" rid="bib105">Chuang et al., 2010</xref>). In this review, we will discuss approaches to the nascent field of cancer systems immunology as well as their potential applications and current limitations.</p></sec><sec id="s2"><title>Applying systems biology to overcome challenges and discrepancies with animal models</title><p>Traditionally, animal models have served as critical tools to cancer biologists and immunologists as they try to decipher how tumors affect the host organism or how the immune response is orchestrated across multiple tissues, respectively. Nonetheless, animal models are frequently imperfect surrogates for human biology. While orthologous genes typically elicit similar functions across species, there are many instances where there exists a stark divergence in phenotypes for orthologs of different species (<xref ref-type="bibr" rid="bib206">Gharib and Robinson-Rechavi, 2011</xref>; <xref ref-type="bibr" rid="bib313">Koonin, 2005</xref>). Furthermore, there are even greater discrepancies between gene products that elicit the same functions, often reflecting a high degree of convergent evolution (<xref ref-type="bibr" rid="bib312">Koonin, 2003</xref>). For example, inhibitory signaling in natural killer (NK) cells following recognition of major histocompatibility (MHC) class Ia molecules is achieved by Ly49 family members in mice but killer immunoglobulin-like receptors (KIRs) in humans (<xref ref-type="bibr" rid="bib324">Lanier, 2005</xref>; <xref ref-type="bibr" rid="bib293">Karlhofer et al., 1992</xref>; <xref ref-type="bibr" rid="bib399">Moretta et al., 1990</xref>). In addition to differences in orthology, the cellular immune repertoires and the very existence of their associated effector molecules can vary significantly between species (<xref ref-type="bibr" rid="bib390">Mestas and Hughes, 2004</xref>). All these factors frequently conspire to yield failed translation of therapeutic approaches when moving from preclinical models to human clinical trials (<xref ref-type="bibr" rid="bib139">Denayer et al., 2014</xref>). As discussed throughout our report, systems biology offers potential solutions to this otherwise vexing problem through its ability to bridge data sets and models across species. Indeed, systems biology approaches have already provided predictive insights into human responses where preclinical models alone may be insufficient or inaccurate.</p><p>Computational biologists have developed a variety of tools to translate findings from preclinical models to humans when simple matching of orthologs is insufficient for predicting responses (<xref ref-type="bibr" rid="bib74">Brubaker and Lauffenburger, 2020</xref>). To overcome differences in gene-to-function relationships and predict human responses from rodent data, researchers used Bayesian analysis of gene expression to define ‘functional orthologs’ across species (<xref ref-type="bibr" rid="bib104">Chikina and Troyanskaya, 2011</xref>), and others have applied unsupervised and semi-supervised machine learning approaches to transcriptomic and proteomic data generated in rodent models to predict human responses (<xref ref-type="bibr" rid="bib73">Brubaker et al., 2019</xref>). On collaborative initiatiative, termed SBV-IMPROVER (Systems Biology Verification for Industrial Methodology for PROcess VErification in Research), sought to develop computational methods capable of cross-species translation using multimodal datasets including transcriptomics, phosphoproteomics, and cytokine data (<xref ref-type="bibr" rid="bib467">Poussin et al., 2014</xref>; <xref ref-type="bibr" rid="bib489">Rhrissorrakrai et al., 2015</xref>). Solutions ranged from approaches using support vector machines, neural networks, random forest trees, and more, with no one algorithm outperforming the others across all datasets. These types of cross-species comparisons have been extended to single-cell analyses, wherein cell types can be defined separately in the different organisms and matched manually, through correlation analyses, or through the use of random forest machine learning (<xref ref-type="bibr" rid="bib601">Tosches et al., 2018</xref>; <xref ref-type="bibr" rid="bib85">Butler et al., 2018</xref>; <xref ref-type="bibr" rid="bib538">Shafer, 2019</xref>; <xref ref-type="bibr" rid="bib162">Elyada et al., 2019</xref>). Nonetheless, the choice of preclinical model is critical as a given model may not be as informative as another (<xref ref-type="bibr" rid="bib436">Olson et al., 2018</xref>). For example, transplantable pancreatic cancer models did not predict the limited efficacy of gemcitabine as accurately as autochthonous models due to a lack of desmoplastic stroma in the transplantable setting (<xref ref-type="bibr" rid="bib434">Olive et al., 2009</xref>).</p><p>Even with improved animal models, however, there are many instances where they fail to predict clinical responses, and only 8% of drugs entering clinical trials succeed in Phase I (<xref ref-type="bibr" rid="bib366">Mak et al., 2014</xref>). Thus, the use of systems approaches, informed by existing data sets, to accurately predict human responses in the absence of accurate animal models represents an important opportunity to improve translation. Mathematical models have proven effective at accurately predicting many aspects of cancer biology ranging from growth kinetics and tumor evolution to responses to therapy (<xref ref-type="bibr" rid="bib11">Altrock et al., 2015</xref>). For example, such models have tracked the development of resistance in CML (<xref ref-type="bibr" rid="bib392">Michor et al., 2005</xref>) or have served as the basis for clinical trials altering dosing strategies (<xref ref-type="bibr" rid="bib427">Norton and Simon, 1977</xref>; <xref ref-type="bibr" rid="bib106">Citron et al., 2003</xref>). Critically, mathematical models have been used to inform clinical decisions. In an approach they term ‘adaptive therapy’, one group used an evolutionary game theory model to predict patient-specific treatment responses in patients with castration-resistant prostate cancer, modifying their treatment accordingly, and in doing so, extended the time to progression in these patients (<xref ref-type="bibr" rid="bib665">Zhang et al., 2017a</xref>). This study highlights the profound impact systems-level mathematical modeling can impart on clinical decision-making. Systems immunology has been applied particularly in the field of vaccinology to reduce the reliance upon animal models (<xref ref-type="bibr" rid="bib133">Davis et al., 2017</xref>), and these types of modeling approaches have recently been extended to cancer immunology to understand how treatment regimens can be tailored to improve immune responses (<xref ref-type="bibr" rid="bib446">Park et al., 2019</xref>). By extending these approaches further, cancer systems immunology holds the potential to inform clinical approaches when animal models are insufficient.</p></sec><sec id="s3"><title>Technologies</title><p>The multivariate nature of systems biology has rendered it particularly applicable to comprehensive datasets derived from quantification of systems-level parameters (e.g. genomics, transcriptomics, metabolomics, proteomics, etc.). Indeed, the beginning of modern-era systems biology largely coincides with the Human Genome Project (<xref ref-type="bibr" rid="bib323">Lander et al., 2001</xref>; <xref ref-type="bibr" rid="bib617">Venter et al., 2001</xref>; <xref ref-type="bibr" rid="bib273">International Human Genome Sequencing Consortium, 2004</xref>), which enabled researchers to interrogate the genome-wide contributions of mutations to diseases. It is worth noting that systems biology does not require the use of any of these advanced technologies, and many mathematical and computational models were derived from experimental evidence collected with conventional assays. Similarly, the use of these next-generation technologies for a particular study does not, in and of itself, constitute a systems biology approach. Frequently, such technologies are used to screen for targets that are subsequently subjected to conventional reductionist analyses (e.g. differential gene expression (DGE) analyses of RNA-seq data to identify a gene of interest). Such approaches alone do not provide a systems-level understanding of a particular phenomenon, as they do not describe emergent behavior that could not be uncovered with reductionist approaches. Nonetheless, a wide range of new technologies has enabled researchers to examine the breath and dynamics of entire systems in order to better understand the interplay of multiple elements and networks (<xref ref-type="fig" rid="fig1">Figure 1</xref>; <xref ref-type="bibr" rid="bib258">Hood et al., 2004</xref>; <xref ref-type="bibr" rid="bib270">Ideker, 2001</xref>). Here, we describe some of the major technologies adopted by cancer systems immunologists to uncover new biology. Strengths and weaknesses for the various genomic and epigenomic profiling technologies are highlighted in <xref ref-type="table" rid="table1">Tables 1</xref>–<xref ref-type="table" rid="table3">3</xref>.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Technologies for cancer systems immunology.</title><p>Technologies used in cancer systems immunology operate either on bulk tissue samples or single-cell suspensions. Conventional MS, NGS, and imaging platforms do not require tissue dissociation (although histology provides single-cell resolution). Droplet-based microfluidics and mass cytometry, in contrast, require cell suspensions, but generate high-dimensional data for individual cells.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-53839-fig1-v1.tif"/></fig><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Genomic and transcriptomic profiling technologies.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Measurement</th><th valign="top">DNA</th><th valign="top">DNA</th><th valign="top">DRNA/RNA</th><th valign="top">RNA</th><th valign="top">RNA</th></tr></thead><tbody><tr><td valign="top">Technology</td><td valign="top">WGS</td><td valign="top">WES</td><td valign="top">Amplicon (e.g. TCR, BCR, specific loci)</td><td valign="top">RNA-seq</td><td valign="top">Microarray</td></tr><tr><td valign="top">Strengths</td><td valign="top">• Captures coding and non-coding regions <break/>• may be more accurate in some exons as well <break/>• better coverage in low-complexity regions <break/>• no PCR step required</td><td valign="top">• Reduced cost of sequencing since restricted to 2% of genome</td><td valign="top">• Lower cost <break/>• greater sequencing depth</td><td valign="top">• Not limited to known genes with probes <break/>• can identify splice variants <break/>• can include ncRNA <break/>• can identify sequence variations (e.g. mutations)</td><td valign="top">• Can theoretically detect very low abundance transcripts at no additional cost</td></tr><tr><td valign="top">Weaknesses</td><td valign="top">• High cost</td><td valign="top">• Does not capture non-coding regions <break/>• may fail to capture some coding regions depending on probe hybridization <break/>• GC bias can be introduced due to PCR <break/>• hybridization bias can occur in regions with heterozygous SNVs</td><td valign="top">• Limited to specific regions (not genome-wide)</td><td valign="top">• Sequencing depth can limit the ability to detect low-abundance transcripts</td><td valign="top">• Probe bias <break/>• inability to compare relative abundance across genes <break/>• limited to known transcripts (for which there are probes)</td></tr><tr><td valign="top">Single-cell Version?</td><td valign="top">Y</td><td valign="top">Y</td><td valign="top">Y</td><td valign="top">Y (see <xref ref-type="table" rid="table3">Table 3</xref>)</td><td valign="top">Y* (very uncommon, <xref ref-type="bibr" rid="bib169">Esumi et al., 2008</xref>)</td></tr></tbody></table></table-wrap><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Epigenetic profiling technologies.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Measurement</th><th valign="top">Technology</th><th valign="top">Strengths</th><th valign="top">Weaknesses</th><th valign="top">Single-cell version?</th></tr></thead><tbody><tr><td valign="top">Methylation</td><td valign="top">WGBS</td><td valign="top">• No a priori sequence selection</td><td valign="top">• High cost and may require higher coverage <break/>• cannot distinguish type of modification at cytosines</td><td valign="top">Y</td></tr><tr><td valign="top">Methylation</td><td valign="top">RRBS</td><td valign="top">• Lower cost</td><td valign="top">• Limited mainly to CpG islands <break/>• cannot distinguish type of modification at cytosines</td><td valign="top">Y</td></tr><tr><td valign="top">Protein Localization</td><td valign="top">ChIP-seq</td><td valign="top">• Genome-wide profiling of histone modifications and DNA-protein interactions (Histone H3 acetylation/methylation, TF binding site identification, SE identification)</td><td valign="top">• Survey only one type of interaction (protein) at once <break/>• lots of sources of noise/bias <break/>• requires good antibodies <break/>• requires input DNA and isotype controls <break/>• requires large input of cells</td><td valign="top">Y</td></tr><tr><td valign="top">Protein Localization</td><td valign="top">CUT&amp;RUN</td><td valign="top">• Fewer input cells required than ChIP <break/>• less noise <break/>• fewer sequencing reads required <break/>• no cross-linking required</td><td valign="top">• Requires good antibody <break/>• potential for overdigesting DNA</td><td valign="top">Y (CUT&amp;Tag, uliCUT&amp;RUN)</td></tr><tr><td valign="top">Chromatin Accessibility</td><td valign="top">DNAse-seq</td><td valign="top">• Identify a range of <italic>cis</italic> and <italic>trans</italic> regulatory elements including TF binding sites</td><td valign="top">• High input cells requirement <break/>• more time-consuming that ATAC <break/>• sequence bias</td><td valign="top">Y</td></tr><tr><td valign="top">Chromatin Accessibility</td><td valign="top">ATAC-seq</td><td valign="top">• Identify a range of <italic>cis</italic> and <italic>trans</italic> regulatory elements including TF binding sites <break/>• minimal input cells required <break/>• increased sensitivity over DNAse-seq <break/>• simple protocol</td><td valign="top">• Footprint profiles can be less well-defined than DNAse-seq <break/>• potential mitochondrial DNA contamination</td><td valign="top">Y</td></tr><tr><td valign="top">Chromatin Accessibility</td><td valign="top">MNAse-seq</td><td valign="top">• Nucleosome occupancy and positioning <break/>• can be used to predict higher-order structure (e.g. 3D)</td><td valign="top">• Requires crosslinking <break/>• highly dependent on enzyme concentration <break/>• some sequence bias</td><td valign="top">Y</td></tr><tr><td valign="top">Chromatin Accessibility</td><td valign="top">FAIRE-seq</td><td valign="top">• No sequence bias <break/>• simple protocol <break/>• no enzymes required</td><td valign="top">• Requires crosslinking <break/>• lower resolution (crosslinking binds chromatin but also TFs) <break/>• large input cell requirement</td><td valign="top">N</td></tr><tr><td valign="top">3D Conformation</td><td valign="top">3C (Chromosome Conformation Capture)</td><td valign="top">• Identify single chromosomal interaction (one vs. one)</td><td valign="top">• limited resolution (by 6bp cutters) <break/>• laborious <break/>• PCR biases <break/>• high library complexity <break/>• single viewpoint</td><td valign="top">N</td></tr><tr><td valign="top">3D Conformation</td><td valign="top">4C (Circular 3C)</td><td valign="top">• Improved resolution over 3C <break/>• can identify very long range interactions <break/>• can identify all contacts for a locus (one vs. all)</td><td valign="top">• Biases from circularization <break/>• PCR biases <break/>• high input cell requirements <break/>• single viewpoint</td><td valign="top">N</td></tr><tr><td valign="top">3D Conformation</td><td valign="top">5C (3C Carbon Copy)</td><td valign="top">• Can identify many contacts for multiple loci (many vs. many)</td><td valign="top">• Bias introduced by probe ligation efficiencies <break/>• not all fragments can bind probes <break/>• all vs. all prohibitively expensive</td><td valign="top">N</td></tr><tr><td valign="top">3D Conformation</td><td valign="top">NG Capture-C</td><td valign="top">• Analyze hundreds of viewpoints <break/>• can identify PCR duplicates (low bias) <break/>• highest sensitivity and resolution <break/>• fewer input cells required</td><td valign="top">• Occasional non-specific interactions</td><td valign="top">N</td></tr><tr><td valign="top">3D Conformation</td><td valign="top">Hi-C</td><td valign="top">• Maps contacts across whole genome (all vs. all) <break/>• kilobase resolution</td><td valign="top">• Fewer contacts per fragment than 4C or Capture-C <break/>• higher resolution versions require extremely high sequencing depths</td><td valign="top">Y</td></tr><tr><td valign="top">3D Conformation and Protein Localization</td><td valign="top">ChIA-PET</td><td valign="top">• Combines 3D interactions with protein interactions</td><td valign="top">• Interactions defined by few reads <break/>• high input requirements <break/>• bias toward interactions with targeted protein</td><td valign="top">Y* (ChIA-Drop: single molecule, <xref ref-type="bibr" rid="bib672">Zheng et al., 2019</xref>)</td></tr><tr><td valign="top">3D Conformation and Protein Localization</td><td valign="top">Hi-ChIP (and PLAC-seq)</td><td valign="top">• Lower input required <break/>• higher yield than ChIA-PET <break/>• higher signal to noise over Hi-C</td><td valign="top">• Bias toward interactions with targeted protein</td><td valign="top">N</td></tr></tbody></table></table-wrap><table-wrap id="table3" position="float"><label>Table 3.</label><caption><title>scRNA-seq Technologies.</title></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="4" valign="top">Strengths and weaknesses of the ever-evolving compendium of scRNA-seq technologies and analysis packages have been evaluated reviewed extensively in <xref ref-type="bibr" rid="bib676">Ziegenhain et al., 2017</xref>; <xref ref-type="bibr" rid="bib100">Chen et al., 2019a</xref>; <xref ref-type="bibr" rid="bib241">Haque et al., 2017</xref>. Here, we provide a basic overview of the strengths of the general approaches.</th></tr></thead><tbody><tr><td valign="top">Technology</td><td valign="top">Plate-based (e.g. Smart-seq2, MARS-seq)</td><td valign="top">Microfluidic capture (e.g. C1, Seq-well, CEL-seq2/C1)</td><td valign="top">Droplet (e.g. 10X, Drop-Seq)</td></tr><tr><td valign="top">Strengths</td><td valign="top">• Highest sensitivity (number of genes detected) <break/>• fewer multiplets <break/>• full-length transcripts possible</td><td valign="top">• High sensitivity (number of genes detected) <break/>• fewer multiplets <break/>• no sorting required</td><td valign="top">• Inexpensive (per cell) <break/>• profile high numbers of cells <break/>• can identify less frequent cell types <break/>• no sorting required <break/>• Can use UMIs</td></tr><tr><td valign="top">Weaknesses</td><td valign="top">• Requires sorting <break/>• low throughput <break/>• high cost per cell <break/>• not strand specific</td><td valign="top">• 3' Only <break/>• limited cell numbers <break/>• (typically) not strand-specific</td><td valign="top">• 3' Only <break/>• fewer genes/UMIs <break/>• more dropout</td></tr></tbody></table></table-wrap><sec id="s3-1"><title>Bulk sequencing technologies</title><p>The promise of the Human Genome Project and whole genome sequencing (WGS) has inspired the development of –omics technologies capable of characterizing the entirety of a particular attribute within a sample. Such approaches include, but are not limited to, genomics, transcriptomics, epigenomics, proteomics, metabolomics, lipidomics (<xref ref-type="bibr" rid="bib648">Yang and Han, 2016</xref>), and glycomics (<xref ref-type="bibr" rid="bib50">Bennun et al., 2016</xref>; <xref ref-type="bibr" rid="bib122">Cummings and Pierce, 2014</xref>; <xref ref-type="bibr" rid="bib53">Bertozzi and Sasisekharan, 2009</xref>), and their current manifestations typically utilize variations of next-generation sequencing (NGS) or mass spectrometry (MS). The bulk implementations of these technologies (i.e. those that require multiple cells as inputs – frequently, thousands to millions) were the precursors of many of the single-cell versions that have recently gained popularity. While these technologies on their own do not provide single-cell resolution, they frequently provide a degree of sensitivity that cannot yet be achieved at the single-cell level (e.g. most glycomics). Furthermore, the cost of these approaches is typically considerably lower than their single-cell counterparts. Complex mixtures of cells can be purified by fluorescence activated cell sorting (FACS), magnetic purification, or microfluidic systems prior to subjecting them to these technologies, and recent computational approaches provide the means of deconvolving mixed populations when purification is not feasible or gene expression data from such mixed populations have already been collected (<xref ref-type="bibr" rid="bib478">Racle et al., 2017</xref>; <xref ref-type="bibr" rid="bib416">Newman et al., 2015</xref>; <xref ref-type="bibr" rid="bib417">Newman et al., 2019</xref>; <xref ref-type="bibr" rid="bib4">Ahn et al., 2013</xref>; <xref ref-type="bibr" rid="bib652">Yoshihara et al., 2013</xref>; <xref ref-type="bibr" rid="bib219">Gong and Szustakowski, 2013</xref>; <xref ref-type="bibr" rid="bib338">Li et al., 2016b</xref>; <xref ref-type="bibr" rid="bib41">Becht et al., 2016</xref>; <xref ref-type="bibr" rid="bib545">Shen-Orr et al., 2010</xref>; <xref ref-type="bibr" rid="bib673">Zhong et al., 2013</xref>; <xref ref-type="bibr" rid="bib22">Aran et al., 2017</xref>; <xref ref-type="bibr" rid="bib477">Quon et al., 2013</xref>; <xref ref-type="bibr" rid="bib546">Shen-Orr and Gaujoux, 2013</xref>; <xref ref-type="bibr" rid="bib612">Vallania et al., 2018</xref>; <xref ref-type="bibr" rid="bib154">Du et al., 2019</xref>).</p><p>The cornerstone technologies underlying both cancer systems biology and systems immunology are genomic sequencing (WGS and whole exome sequencing, WES) and transcriptomic sequencing (RNA sequencing (RNA-seq)) (<xref ref-type="table" rid="table1">Table 1</xref>). At its core, cancer is a genetic disease; malignant transformation is the consequence of mutations in tumor suppressor genes and oncogenes (<xref ref-type="bibr" rid="bib574">Stratton et al., 2009</xref>). WGS and WES have shed light on the contributions of multiple mutations or copy number variations in such genes, and RNA-seq has revealed pathways and signaling networks involved in tumor progression (<xref ref-type="bibr" rid="bib121">Creixell et al., 2015</xref>; <xref ref-type="bibr" rid="bib328">Lawrence et al., 2014</xref>; <xref ref-type="bibr" rid="bib191">Garraway and Lander, 2013</xref>). While the genomes of leukocytes exhibit considerably less variance than those of malignant populations, there are notable exceptions such as the B cell receptor (BCR) and T cell receptor (TCR) present on B and T lymphocytes, respectively. The genomic loci for these receptors undergo rearrangement in order to generate diversity of the antigen-recognition domains in a manner that confers specific immunity against an enormous range of pathogens (<xref ref-type="bibr" rid="bib260">Hozumi and Tonegawa, 1976</xref>). Elevated expression of a variety of normal proteins, expression of embryonic proteins and antigens, and expression of mutated proteins (neoantigens) all represent targets on tumor cells that can be recognized by BCRs and TCRs to elicit antitumor responses by the immune system. Consequently, cancer systems immunologists have employed targeted amplicon sequencing (typically, of cDNA derived from amplified TCR or BCR mRNA) to evaluate the BCR and TCR repertoires, providing insight into how lymphocytes respond to tumors (<xref ref-type="bibr" rid="bib240">Han et al., 2016</xref>; <xref ref-type="bibr" rid="bib442">Page et al., 2016</xref>; <xref ref-type="bibr" rid="bib640">Woodsworth et al., 2013</xref>; <xref ref-type="bibr" rid="bib552">Sims et al., 2016</xref>; <xref ref-type="bibr" rid="bib347">Linnemann et al., 2013</xref>; <xref ref-type="bibr" rid="bib283">Jiang et al., 2019</xref>; <xref ref-type="bibr" rid="bib351">Liu et al., 2018</xref>; <xref ref-type="bibr" rid="bib96">Chaudhary and Wesemann, 2018</xref>; <xref ref-type="bibr" rid="bib666">Zhang et al., 2017b</xref>). Furthermore, researchers have used WES, frequently in combination with RNA-seq, to identify the range of potential neoantigens expressed by tumor cells as a consequence of their high mutation rates (<xref ref-type="bibr" rid="bib190">Garcia-Garijo et al., 2019</xref>). Finally, RNA-seq has enabled researchers to identify gene networks and transcriptional programs exploited by tumors to evade anti-tumor immunity, as well as changes in the states of immune cells as they interact with tumors.</p><p>While genomic and transcriptomic analyses have been mainstays for Systems Biologists, both cancer biology and immunology have benefitted from epigenetic studies (<xref ref-type="bibr" rid="bib160">Egger et al., 2004</xref>; <xref ref-type="bibr" rid="bib174">Flavahan et al., 2017</xref>; <xref ref-type="bibr" rid="bib168">Esteller, 2008</xref>; <xref ref-type="bibr" rid="bib579">Suvà et al., 2013</xref>; <xref ref-type="bibr" rid="bib336">Li et al., 2013</xref>; <xref ref-type="bibr" rid="bib528">Schmidl et al., 2018</xref>; <xref ref-type="bibr" rid="bib83">Busslinger and Tarakhovsky, 2014</xref>; <xref ref-type="bibr" rid="bib453">Peng et al., 2015</xref>; <xref ref-type="bibr" rid="bib51">Berdasco and Esteller, 2010</xref>; <xref ref-type="bibr" rid="bib173">Feinberg and Vogelstein, 1983</xref>; <xref ref-type="bibr" rid="bib249">Henning et al., 2018</xref>). A number of technologies have enabled investigations into the epigenetic control of gene regulation, and by combining these methods with NGS approaches capable of querying the entire genome, researchers have been able to apply systems-level analyses to epigenetics (<xref ref-type="table" rid="table2">Table 2</xref>). Methylation represents one of the most common epigenetic modifications for silencing transcription (<xref ref-type="bibr" rid="bib288">Jones and Takai, 2001</xref>), and can be surveyed at the genome level through the use of Whole Genome Bisulfite Sequencing (WGBS) or Reduced Representation Bisulfite Sequencing (RRBS), which use sodium bisulfite to convert unmethylated cytosine residues to uracil while leaving their methylated counterparts (5-methylcytosine) intact (<xref ref-type="bibr" rid="bib179">Frommer et al., 1992</xref>; <xref ref-type="bibr" rid="bib348">Lister et al., 2009</xref>; <xref ref-type="bibr" rid="bib384">Meissner et al., 2005</xref>; <xref ref-type="bibr" rid="bib62">Booth et al., 2012</xref>; <xref ref-type="bibr" rid="bib63">Booth et al., 2014</xref>; <xref ref-type="bibr" rid="bib655">Yu et al., 2012</xref>). To interrogate how specific proteins (e.g. transcription factors) interact with DNA, researchers often use Chromatin Immunoprecipitation (ChIP). In this approach, DNA is crosslinked to proteins with which it is interacting, sheared, and precipitated through the use of antibodies against the protein of interest (<xref ref-type="bibr" rid="bib210">Gilmour and Lis, 1985</xref>). Combining ChIP with NGS (ChIP-seq), enables the generation of genome-wide maps of DNA binding to proteins of interest (<xref ref-type="bibr" rid="bib286">Johnson et al., 2007</xref>; <xref ref-type="bibr" rid="bib37">Barski et al., 2007</xref>). An improved version, known as CUT and RUN, also enables a similar approach to be performed in situ with considerably lower background (<xref ref-type="bibr" rid="bib556">Skene and Henikoff, 2017</xref>). In immunology, Bisulfite-Seq and ChIP-seq have proven effective tools for uncovering the underpinning epigenetic modifications driving fate decisions and activation states of leukocytes (<xref ref-type="bibr" rid="bib249">Henning et al., 2018</xref>; <xref ref-type="bibr" rid="bib425">Northrup and Zhao, 2011</xref>; <xref ref-type="bibr" rid="bib663">Zhang et al., 2012</xref>; <xref ref-type="bibr" rid="bib504">Russ et al., 2014</xref>; <xref ref-type="bibr" rid="bib1">Abdelsamed et al., 2017</xref>). Histone modifications represent some of the most important regulators of cell states (<xref ref-type="bibr" rid="bib573">Strahl and Allis, 2000</xref>), and ChIP-seq has proven to be one of the most effective technologies for querying such changes. For example, ChIP-seq has been used to define the super-enhancer (SE) landscape in CD4<sup>+</sup> T cells and identify how polymorphisms in these regions can potentiate risk of autoimmune disease (<xref ref-type="bibr" rid="bib611">Vahedi et al., 2015</xref>). Similarly, using ChIP-seq to profile a variety of methylation and acetylation patterns of Histone H3, researchers have uncovered the regulatory epigenetic signatures that distinguish the naïve, effector, central memory, and effector memory CD8<sup>+</sup> T cell subsets (<xref ref-type="bibr" rid="bib245">He et al., 2016</xref>; <xref ref-type="bibr" rid="bib496">Rodriguez et al., 2017</xref>; <xref ref-type="bibr" rid="bib21">Araki et al., 2009</xref>). In cancer biology, ChIP-seq has proven effective for defining differential enhancer signatures in tumor cells (<xref ref-type="bibr" rid="bib6">Akhtar-Zaidi et al., 2012</xref>). Mutation-independent epigenetic control of tumor suppressors through trimethylation of histone H3 at lysine 4 (H3K4me3) has been uncovered using ChIP-seq approaches (<xref ref-type="bibr" rid="bib98">Chen et al., 2015b</xref>). Similarly, ChIP-seq has revealed patterns of promoter and enhancer invasion by Myc to drive widespread RNA biogenesis in both tumors and immune cells (<xref ref-type="bibr" rid="bib505">Sabò et al., 2014</xref>; <xref ref-type="bibr" rid="bib344">Lin et al., 2012</xref>; <xref ref-type="bibr" rid="bib423">Nie et al., 2012</xref>).</p><p>In addition to approaches that evaluate acetylation, methylation, and protein binding to various loci in the genome, tools to interrogate higher order structure of the genome have recently been developed. Techniques such as DNAse-seq and ATAC-seq (Assay for Transposase Accessible Chromatin) can identify regions of open and closed chromatin (i.e. chromatin accessibility) across the genome (<xref ref-type="bibr" rid="bib78">Buenrostro et al., 2013</xref>; <xref ref-type="bibr" rid="bib65">Boyle et al., 2008</xref>; <xref ref-type="bibr" rid="bib596">Thurman et al., 2012</xref>). These approaches use enzymes to cleave regions of DNA that are not tightly wrapped around nucleosomes, presumably due to active transcription or their occupancy by DNA-binding proteins (e.g. transcription factors). They also enable transcription factor footprinting to identify transcription factor binding sites. Furthermore, by combining these methods with computational approaches, the effects of <italic>cis</italic>- and <italic>trans</italic>-regulatory elements upon gene function can be analyzed. A modified version of these techniques can simultaneously enable Bisulfite-seq on the same sample (methyl-ATAC-seq) (<xref ref-type="bibr" rid="bib561">Spektor et al., 2019</xref>). Chromatin accessibility analyses have enabled genome-wide characterization and determination of functional implications of such changes in a range of cancers (<xref ref-type="bibr" rid="bib115">Corces et al., 2018</xref>; <xref ref-type="bibr" rid="bib140">Denny et al., 2016</xref>), leukocytes (<xref ref-type="bibr" rid="bib80">Buenrostro et al., 2018</xref>; <xref ref-type="bibr" rid="bib548">Shih et al., 2016</xref>; <xref ref-type="bibr" rid="bib522">Scharer et al., 2017</xref>; <xref ref-type="bibr" rid="bib535">Sen et al., 2016</xref>), and tumor immunology studies (<xref ref-type="bibr" rid="bib518">Satpathy et al., 2019</xref>; <xref ref-type="bibr" rid="bib114">Corces et al., 2016</xref>; <xref ref-type="bibr" rid="bib458">Philip et al., 2017</xref>; <xref ref-type="bibr" rid="bib46">Benci et al., 2016</xref>). Such approaches have revealed how widespread increases in chromatin accessibility enable transcriptional programs that drive tumor progression and metastasis (<xref ref-type="bibr" rid="bib140">Denny et al., 2016</xref>). Other studies found that dysfunctional tumor-specific CD8<sup>+</sup> T cells enter one of two distinct chromatin states that determine whether they can be reprogrammed (<xref ref-type="bibr" rid="bib458">Philip et al., 2017</xref>).</p><p>While regions of open chromatin reveal evidence of transcriptional regulation, higher order chromatin structures also play critical roles in controlling gene expression. Long-range distal elements, such as enhancers, affect gene expression even at distances greater than 1 Mb in linear genome space (<xref ref-type="bibr" rid="bib332">Lettice et al., 2003</xref>; <xref ref-type="bibr" rid="bib82">Bulger and Groudine, 2011</xref>; <xref ref-type="bibr" rid="bib137">Dekker, 2008</xref>). To assess how three-dimensional conformations affect regulation, a variety of technologies have been developed that are capable of querying chromosomal interactions at the genome scale (<xref ref-type="bibr" rid="bib132">Davies et al., 2017</xref>). These include derivatives of chromosome conformation capture (3C) (<xref ref-type="bibr" rid="bib136">Dekker et al., 2002</xref>) such as circular chromosome conformation capture (4C) (<xref ref-type="bibr" rid="bib670">Zhao et al., 2006</xref>; <xref ref-type="bibr" rid="bib551">Simonis et al., 2006</xref>), chromosome conformation capture carbon copy (5C) (<xref ref-type="bibr" rid="bib149">Dostie et al., 2006</xref>), NG Capture-C (<xref ref-type="bibr" rid="bib266">Hughes et al., 2014</xref>; <xref ref-type="bibr" rid="bib131">Davies et al., 2016</xref>), Hi-C (<xref ref-type="bibr" rid="bib342">Lieberman-Aiden et al., 2009</xref>), and methods that combine 3C with ChIP such as chromatin interaction analysis by paired-end tag sequencing (ChIA-PET) (<xref ref-type="bibr" rid="bib181">Fullwood et al., 2009</xref>) and HiChIP (<xref ref-type="bibr" rid="bib403">Mumbach et al., 2016</xref>; <xref ref-type="bibr" rid="bib404">Mumbach et al., 2017</xref>). These 3C methodologies are variants of protocols wherein DNA is crosslinked, digested by restriction endonucleases, ligated together, and amplified by PCR to identify regions in close proximity. In particular, Hi-C has enabled mapping of all interactions within the genome at kilobase resolution (<xref ref-type="bibr" rid="bib482">Rao et al., 2014</xref>). These techniques have informed a variety of studies in both tumor biology and immunology. Earlier studies using fluorescence in situ hybridization (FISH) and 3C originally suggested that interchromosomal interactions between promoters and enhancers on distinct chromosomes can drive immune cell development (<xref ref-type="bibr" rid="bib251">Hewitt et al., 2008</xref>; <xref ref-type="bibr" rid="bib346">Ling et al., 2006</xref>), but subsequent high-resolution genome-wide studies using Hi-C failed to confirm the existence of such interactions (<xref ref-type="bibr" rid="bib285">Johanson et al., 2018</xref>). Recently, as part of the Cancer Genome Atlas (TCGA) studies, enhancer activity has been mapped across nearly 9000 cancer patients combining RNA-seq and Hi-C data to characterize enhancer-gene interactions, and this effort identified a key enhancer of the immunomodulatory protein programmed death ligand 1 (PD-L1) (<xref ref-type="bibr" rid="bib99">Chen et al., 2018</xref>). Integrating these multiple types of epigenetic signatures with transcriptional datasets should enable the generation of systems level models for transcriptional regulation in both malignant and immune populations during tumor progression. For example, how do genome-wide changes in chromosomal confirmations within immune or malignant cells alter their states of differentiation, and how do heterotypic cellular interactions drive these changes?</p></sec><sec id="s3-2"><title>Single-cell sequencing technologies</title><p>While light and electron microscopy endowed scientists with the ability to survey biology at the resolution of single cells, perhaps the most influential single-cell technological advance in immunology was the invention of flow cytometry and fluorescence activated cell sorting (FACS) (<xref ref-type="bibr" rid="bib182">Fulwyler, 1965</xref>; <xref ref-type="bibr" rid="bib267">Hulett et al., 1969</xref>). These technologies enable scientists to identify and enumerate phenotypically and functionally distinct immune cells, and query the activation states of individual cells in a suspension based on excitation of fluorescent probes (e.g. fluorescently labeled antibodies, fluorescent protein-based genetic reporters, fluorescent DNA intercalating dyes, etc.). In addition to representing a fundamental tool for investigating and identifying the cellular components of the immune system, flow cytometry has been useful clinically. For example, prior to the discovery of the Human Immunodeficiency Virus, it served as the primary means for identifying individuals at risk for AIDS and monitoring their course and response to therapy, based on the relative frequency of circulating CD4 T cells (<xref ref-type="bibr" rid="bib343">Lifson and Engleman, 1989</xref>). Today, in addition to its use in monitoring the frequencies of various immune cell types in patients with cancers and recipients of organ transplants who are receiving immunosuppressive drugs, flow cytometry is used to characterize malignant cells in blood for clinical diagnosis. By multiplexing these probes, scientists can simultaneously measure tens of markers on individual cells at rates of thousands of cells per second, and recent advances (discussed later) have increased this multiplexing to above 40 markers (<xref ref-type="bibr" rid="bib48">Bendall et al., 2012</xref>). Due to its ability to survey the states of mixed populations at a single-cell resolution, flow cytometry has facilitated the majority of major discoveries in the field of immunology.</p><p>Adaptation of these bulk NGS technologies to single cells has recently led to insights at the single-cell level previously thought to be unattainable. These new technologies were largely enabled by advances in microfluidics and are predicated upon one of three general approaches: (1) single cells are sorted into individual wells of a plate by using conventional FACS, (2) single cells are captured in capture sites of a microfluidic chip, or (3) single cells are captured in emulsion droplets generated in a microfluidic chip. Both microfluidic approaches were derivatives of technologies developed at the turn of the century (<xref ref-type="bibr" rid="bib609">Unger et al., 2000</xref>; <xref ref-type="bibr" rid="bib592">Thorsen et al., 2001</xref>; <xref ref-type="bibr" rid="bib20">Anna et al., 2003</xref>; <xref ref-type="bibr" rid="bib593">Thorsen et al., 2002</xref>; <xref ref-type="bibr" rid="bib597">Tice et al., 2003</xref>), wherein precise control of picoliter volumes, aided by advances in soft lithography, is utilized to isolate individual cells and subject them to chemical and enzymatic reactions. These approaches are particularly amenable to DNA sequencing approaches, as reactions involving endonucleases, transposases, and reverse transcriptases as well as PCR can all be performed with exquisite control in these volumes and formats.</p><p>The vast majority of bulk NGS approaches have been adapted to these single-cell formats (see <xref ref-type="table" rid="table1">Table 1</xref>). The primary tradeoff is that while these approaches provide insights into the distinct profiles of individual cells, far fewer sequencing reads can be gathered for a given cell than bulk approaches due to the low abundance of transcripts or DNA within a cell as well as the high costs of sequencing hundreds to tens of thousands of cells at high read depths. Stochasticity, transcriptional bursting, and dropout also add challenges to interpreting single-cell data. Nonetheless, a variety of computational tools have been developed to help account for some of these effects, and the resultant analyses have been transformative for the field of tumor immunology. Some of the single-cell NGS approaches include RNA-seq (scRNA-seq) (<xref ref-type="bibr" rid="bib244">Hashimshony et al., 2012</xref>; <xref ref-type="bibr" rid="bib275">Islam et al., 2011</xref>; <xref ref-type="bibr" rid="bib540">Shalek et al., 2013</xref>; <xref ref-type="bibr" rid="bib481">Ramsköld et al., 2012</xref>; <xref ref-type="bibr" rid="bib586">Tang et al., 2009</xref>; <xref ref-type="bibr" rid="bib641">Wu et al., 2014</xref>; <xref ref-type="bibr" rid="bib587">Tang et al., 2010</xref>; <xref ref-type="bibr" rid="bib589">Tariq et al., 2011</xref>; <xref ref-type="bibr" rid="bib308">Klein et al., 2015</xref>; <xref ref-type="bibr" rid="bib364">Macosko et al., 2015</xref>; <xref ref-type="bibr" rid="bib208">Gierahn et al., 2017</xref>; <xref ref-type="bibr" rid="bib676">Ziegenhain et al., 2017</xref>; <xref ref-type="bibr" rid="bib144">Ding et al., 2020</xref>; <xref ref-type="table" rid="table3">Table 3</xref>), genome and exome sequencing (<xref ref-type="bibr" rid="bib194">Gawad et al., 2016</xref>; <xref ref-type="bibr" rid="bib626">Wang et al., 2014a</xref>; <xref ref-type="bibr" rid="bib413">Navin et al., 2011</xref>; <xref ref-type="bibr" rid="bib39">Baslan et al., 2012</xref>; <xref ref-type="bibr" rid="bib644">Xu et al., 2012</xref>), nucleus sequencing for RNA or DNA (scNuc-seq) (<xref ref-type="bibr" rid="bib626">Wang et al., 2014a</xref>; <xref ref-type="bibr" rid="bib234">Habib et al., 2016</xref>; <xref ref-type="bibr" rid="bib235">Habib et al., 2017</xref>; <xref ref-type="bibr" rid="bib321">Lacar et al., 2016</xref>; <xref ref-type="bibr" rid="bib262">Hu et al., 2017a</xref>), WGBS or RRBS (scBS-seq) (<xref ref-type="bibr" rid="bib557">Smallwood et al., 2014</xref>; <xref ref-type="bibr" rid="bib107">Clark et al., 2017</xref>; <xref ref-type="bibr" rid="bib231">Guo et al., 2013</xref>; <xref ref-type="bibr" rid="bib172">Farlik et al., 2015</xref>; <xref ref-type="bibr" rid="bib19">Angermueller et al., 2016</xref>), ChIP-seq (scChIP-seq) (<xref ref-type="bibr" rid="bib225">Grosselin et al., 2019</xref>; <xref ref-type="bibr" rid="bib502">Rotem et al., 2015</xref>), ATAC-seq (scATAC-seq) (<xref ref-type="bibr" rid="bib518">Satpathy et al., 2019</xref>; <xref ref-type="bibr" rid="bib86">Cao et al., 2018</xref>; <xref ref-type="bibr" rid="bib125">Cusanovich et al., 2018</xref>; <xref ref-type="bibr" rid="bib124">Cusanovich et al., 2015</xref>; <xref ref-type="bibr" rid="bib79">Buenrostro et al., 2015</xref>; <xref ref-type="bibr" rid="bib517">Satpathy et al., 2018</xref>), and Hi-C (scHi-C) (<xref ref-type="bibr" rid="bib480">Ramani et al., 2017</xref>; <xref ref-type="bibr" rid="bib410">Nagano et al., 2013</xref>; <xref ref-type="bibr" rid="bib570">Stevens et al., 2017</xref>).</p><p>The immune system is comprised of a myriad of cell types with distinct functions working in concert to elicit responses against a pathogenic insult. The multitude and diversity of these cell types render bulk sequencing approaches challenging in that the aggregation of reads from the pool of different cell types often masks differences exhibited by particular subsets. Furthermore, changes in the frequencies of cell types are difficult to distinguish from changes in gene expression within those cells. For example, an increase in <italic>IFNG</italic> within a tumor may reflect increased IFN-γ production by T cells already within tumors or an increase in T cell infiltration into the tumor. Recent computational approaches have helped deconvolve immune subsets from bulk RNA-seq data (discussed below), but single-cell sequencing presents an opportunity to accurately quantitate genome-wide changes at the resolution immunologists have become accustomed to from flow cytometry. Applied to tumor immunology, these studies have revealed heterogeneity in both the malignant and hematopoietic compartments, identified novel subsets, aided in reclassification of existing subsets, revealed activation, exhaustion, and suppression states of multiple immune types within tumors, shed light on responses to immunotherapy, and much more.</p></sec><sec id="s3-3"><title>Single-cell proteomics</title><p>Long before the advent of NGS, immunologists and cancer biologists have been performing low- to moderate-dimensional single cell protein analyses using a variety of platforms such as ELISPOTs, flow cytometry, and various forms of microscopy. More recently, scientists have developed new technologies to achieve higher dimensionality with theoretical ranges reaching the entire proteome. A recent study used confocal immunofluorescence (IF) to image and characterize the subcellular localization of over 12,000 human proteins at the single-cell level and presented the results in an interactive database known as the Cell Atlas (<xref ref-type="bibr" rid="bib595">Thul et al., 2017</xref>). Using an approach based off of Edman Sequencing and total internal refraction microscopy (TIRF), scientists have demonstrated the ability to identify proteins at zeptomolar concentrations in parallel in a manner that should enable single-cell proteomics (<xref ref-type="bibr" rid="bib581">Swaminathan et al., 2018</xref>). As single-cell genomic approaches cannot always replace protein level analyses (<xref ref-type="bibr" rid="bib325">Latonen et al., 2018</xref>), such approaches could greatly enhance our understanding of individual cells.</p><p>To assess heterogeneity in leukocyte populations, bioengineers have developed technologies to quantify secreted cytokines at the single-cell level. Using oligo-barcoded antibodies in microfluidic devices, researchers characterized heterogeneity in the secretome of tumor antigen-specific T cells from melanoma patients (<xref ref-type="bibr" rid="bib361">Ma et al., 2011</xref>). Similarly, a technology based upon single-cell microwells and antibody-coated slides has enabled profiling of the temporal dynamics of T cell cytokine responses at the single-cell level (<xref ref-type="bibr" rid="bib238">Han et al., 2012</xref>). These researchers also adapted their platform to enable low-cost single-cell RNA sequencing (<xref ref-type="bibr" rid="bib208">Gierahn et al., 2017</xref>).</p><p>One of the most widely adopted technologies used by systems immunologists is mass cytometry (CyTOF) (<xref ref-type="bibr" rid="bib48">Bendall et al., 2012</xref>). This approach replaces fluorescent tags on antibodies with transition element metal isotopes, to enable measurement of single cells labeled with such antibodies using time-of-flight mass spectrometry (<xref ref-type="bibr" rid="bib34">Bandura et al., 2009</xref>; <xref ref-type="bibr" rid="bib47">Bendall et al., 2011</xref>). This technology enables researchers to measure the expression of more than 40 proteins simultaneously on single cells, by eliminating limitations derived from spectral overlap of fluorescent probes. This added dimensionality facilitates a more comprehensive characterization of cellular states or population frequencies, particularly among hematopoietic cells, and has been used to evaluate a wide range of complex processes ranging from hematopoiesis and maturation (<xref ref-type="bibr" rid="bib49">Bendall et al., 2014</xref>; <xref ref-type="bibr" rid="bib221">Good et al., 2019</xref>), to antigen-specific responses and vaccine responses (<xref ref-type="bibr" rid="bib414">Newell et al., 2013</xref>; <xref ref-type="bibr" rid="bib415">Newell and Davis, 2014</xref>; <xref ref-type="bibr" rid="bib580">Swadling et al., 2014</xref>), to immune responses to cancer (<xref ref-type="bibr" rid="bib242">Hartmann et al., 2019</xref>; <xref ref-type="bibr" rid="bib220">Good et al., 2018</xref>; <xref ref-type="bibr" rid="bib327">Lavin et al., 2017</xref>; <xref ref-type="bibr" rid="bib274">Irish and Doxie, 2014</xref>; <xref ref-type="bibr" rid="bib102">Chevrier et al., 2017</xref>; <xref ref-type="bibr" rid="bib550">Simoni et al., 2018</xref>; <xref ref-type="bibr" rid="bib396">Mistry et al., 2019</xref>; <xref ref-type="bibr" rid="bib563">Spitzer et al., 2017</xref>). By combining immunolabeling with mass tags, mass cytometry has enabled Systems Immunologists to acquire high-dimensional single-cell data for parameters that cannot be measured by single-cell sequencing approaches.</p></sec><sec id="s3-4"><title>High-dimensional imaging modalities</title><p>With the exception of the peripheral blood, regulation of the immune response relies upon tissue architecture to facilitate homotypic and heterotypic interactions between cells. Secondary lymphoid organs (SLOs, e.g. spleen and lymph nodes) are notable examples wherein local chemokine gradients and tissue architecture enable lymphocytes and APCs to efficiently interact in a manner that orchestrates adaptive immunity (<xref ref-type="bibr" rid="bib126">Cyster, 1999</xref>; <xref ref-type="bibr" rid="bib152">Drayton et al., 2006</xref>). Similarly, immune cell locations and interactions within and surrounding tumors are typically not random, and many tumors contain organized lymphoid structures known as tertiary lymphoid structures that are believed to impact clinical outcome (<xref ref-type="bibr" rid="bib287">Jones et al., 2016</xref>; <xref ref-type="bibr" rid="bib289">Joshi et al., 2015</xref>; <xref ref-type="bibr" rid="bib216">Goc et al., 2013</xref>). While the aforementioned single-cell technologies provide the requisite resolution for evaluating cell-cell interactions, they rely upon tissue dissociation and the generation of cell suspensions, which prohibit the evaluation of interactions within the native tissue architecture. Furthermore, the tissue dissociation process itself may affect the states of the cells results of the analyses (<xref ref-type="bibr" rid="bib613">van den Brink et al., 2017</xref>). Microscopy approaches including light microscopy, fluorescence microscopy, scanning electron microscopy (SEM), transmission electron microscopy (TEM), and variations on these technologies have all enabled clinicians and researchers to investigate tumor-immune interactions in their natural environments, but have been limited in the number of simultaneous parameters that can be measured. As with conventional flow cytometry, spectral overlap limits the number of probes that can be used with fluorescence microscopy. Nonetheless, researchers have used deconvolution approaches with fluorescence confocal imaging to increase the degree multiplexing (<xref ref-type="bibr" rid="bib202">Gerner et al., 2012</xref>).</p><p>Recently, new imaging approaches have been developed that enable increased multiplexing capacity. Following a similar approach as employed with mass cytometry, researchers have combined heavy metal isotope-labeled antibodies to image over 40 parameters simultaneously on histology slides (<xref ref-type="bibr" rid="bib17">Angelo et al., 2014</xref>; <xref ref-type="bibr" rid="bib209">Giesen et al., 2014</xref>). In one approach, histology slides are labeled with metal-conjugated antibodies and a layer of tissue is subsequently removed by laser ablation allowing for evaluation using a mass cytometer (<xref ref-type="bibr" rid="bib209">Giesen et al., 2014</xref>). Another technology, termed multiplexed ion beam imaging (MIBI), uses a focused ion beam to release secondary ions from the antibody-labeled tissue, which are subsequently detected using a magnetic sector mass spectrometer (<xref ref-type="bibr" rid="bib17">Angelo et al., 2014</xref>). The group that developed MIBI has used it to interrogate tumor-immune interactions in triple-negative breast cancer (<xref ref-type="bibr" rid="bib298">Keren et al., 2018</xref>).</p><p>While mass spectrometry-based approaches enable multiplexing and simultaneous quantitation of all of the parameters at subcellular resolution, they require conjugation of heavy metal isotopes to antibodies as well as access to large and expensive instrumentation. One alternative is to use cycles of conventional immunohistochemistry (IHC) by inactivating dyes or stripping antibodies after imaging and restaining with additional antibodies in a cyclical process. A number of variations of this strategy exist (<xref ref-type="bibr" rid="bib197">Gerdes et al., 2013</xref>; <xref ref-type="bibr" rid="bib530">Schubert et al., 2006</xref>; <xref ref-type="bibr" rid="bib345">Lin et al., 2015</xref>; <xref ref-type="bibr" rid="bib605">Tsujikawa et al., 2017</xref>; <xref ref-type="bibr" rid="bib215">Glass et al., 2009</xref>; <xref ref-type="bibr" rid="bib625">Wählby et al., 2002</xref>), but approaches aimed at minimizing target degradation typically either photobleach the samples or exploit alkaline oxidation to bleach the fluorescence of cyanine dyes after each round of imaging. One drawback to these approaches is that they require repeated rounds of staining. A modified version of this approach, termed CODEX, has been developed wherein oligo-conjugated antibodies are used to stain all antigens at once. Subsequently, fluorophore-labeled complementary oligos to two or three of the antigens are hybridized to the probes, imaged, and removed. Additional cycles are performed enabling highly multiplexed imaging without requiring antibody staining between each cycle (<xref ref-type="bibr" rid="bib217">Goltsev et al., 2018</xref>).</p><p>In addition to immunohistochemistry (IHC) approaches, single molecule RNA fluorescence in situ hybridization (FISH) approaches have been adapted to enable multiplexed imaging of tens to thousands of RNA probes in cells and tissues (<xref ref-type="bibr" rid="bib97">Chen et al., 2015a</xref>; <xref ref-type="bibr" rid="bib356">Lubeck and Cai, 2012</xref>; <xref ref-type="bibr" rid="bib355">Lubeck et al., 2014</xref>; <xref ref-type="bibr" rid="bib116">Coskun and Cai, 2016</xref>; <xref ref-type="bibr" rid="bib333">Levesque and Raj, 2013</xref>). In particular, multiplexed error-robust FISH (MERFISH) uses combinatorial barcodes spaced with a Hamming distance of four to enable a high degree of multiplexing while maintaining minimal chances of calling errors (<xref ref-type="bibr" rid="bib97">Chen et al., 2015a</xref>). Using rolling circle amplification, other groups have developed in situ sequencing approaches capable of evaluating spatial transcript patterns in tissues (<xref ref-type="bibr" rid="bib296">Ke et al., 2013</xref>; <xref ref-type="bibr" rid="bib330">Lee et al., 2014</xref>). All these highly multiplexed imaging modalities are designed to enable cancer systems immunologists to investigate how tissue architecture and cell interactions shape immune responses to tumors, and these methods will likely facilitate the development of novel imaging biomarkers for clinical applications in oncology.</p></sec><sec id="s3-5"><title>Additional systems-level technologies</title><p>While sequencing, cytometry, and imaging technologies are currently the predominant tools employed by systems biologists, a number of other highly multiplexed tools have enhanced systems-level studies of tumor-immune interactions. Alterations in metabolic pathways is a key feature of many cancers (<xref ref-type="bibr" rid="bib630">Ward and Thompson, 2012</xref>; <xref ref-type="bibr" rid="bib629">Warburg et al., 1927</xref>). Similarly, immune function is highly impacted by the local metabolic state, and many studies have uncovered important metabolism-mediated tumor-immune interactions that affect tumor progression (<xref ref-type="bibr" rid="bib484">Renner et al., 2017</xref>). The Human Metabolome Database provides a comprehensive collection of human metabolism data enabling systems-level analyses (<xref ref-type="bibr" rid="bib636">Wishart et al., 2007</xref>). While most metabolic profiling is performed by conventional forms of MS or nuclear magnetic resonance (NMR) (<xref ref-type="bibr" rid="bib256">Holmes et al., 2008</xref>; <xref ref-type="bibr" rid="bib421">Nicholson et al., 2002</xref>), recent advances in imaging mass spectrometry have enabled researchers to profile these pathways directly in tissues (<xref ref-type="bibr" rid="bib87">Caprioli, 2016</xref>; <xref ref-type="bibr" rid="bib310">Kompauer et al., 2017</xref>; <xref ref-type="bibr" rid="bib578">Sun et al., 2019</xref>). Metabolomics has been adopted by systems biologists, who have coined the term ‘Metabonomics’ to refer to the combined outputs of the various metabolomic influences in a multicellular system (<xref ref-type="bibr" rid="bib421">Nicholson et al., 2002</xref>; <xref ref-type="bibr" rid="bib422">Nicholson et al., 2008</xref>). Similarly, the field of Glycomics has been transformed by advances in MS and NMR as well as technologies such as glycan microarrays (<xref ref-type="bibr" rid="bib560">Song et al., 2011</xref>). These technologies have enabled systems-level studies into tumor-immune interactions, and in particular the ability of the immune system to recognize tumor-specific carbohydrate antigens (<xref ref-type="bibr" rid="bib515">Satomaa et al., 2009</xref>; <xref ref-type="bibr" rid="bib341">Liau et al., 2017</xref>).</p><p>Both tumor cells and immune cells rely heavily upon a variety of soluble proteins for their growth, development, and migration. These collections of secreted proteins, sometimes referred to as the ‘Secretome’ (<xref ref-type="bibr" rid="bib599">Tjalsma et al., 2000</xref>), have been profiled using a variety of MS-based techniques (<xref ref-type="bibr" rid="bib367">Makridakis and Vlahou, 2010</xref>; <xref ref-type="bibr" rid="bib409">Naba et al., 2012</xref>; <xref ref-type="bibr" rid="bib385">Meissner et al., 2013</xref>). Approaches using antibody arrays and microfluidics have also enabled secretome profiling (<xref ref-type="bibr" rid="bib408">Mustafa et al., 2011</xref>; <xref ref-type="bibr" rid="bib318">Kshitiz et al., 2019</xref>). Cytokines and chemokines, in particular, mediate crosstalk between tumors and immune cells and orchestrate immune responses to tumors. To profile these molecules, a number of companies now offer bead-based platforms wherein antibody-labeled beads are incubated with samples and analytes are detected with a secondary antibody, akin to a sandwich ELISA, and quantified on a flow cytometer or dedicated instrument. By performing these assays in solution, multiple analytes can be assayed simultaneously in the same sample, enabling high degrees of multiplexing.</p><p>Finally, it is worth noting that while the majority of the technologies discussed above enable characterization of endogenous states, the implementation of genetic screens, particularly those employing the CRISPR/Cas9 system, have made it possible to determine the genetic underpinnings of pathways and phenotypes in a variety of settings (<xref ref-type="bibr" rid="bib627">Wang et al., 2014b</xref>; <xref ref-type="bibr" rid="bib542">Shalem et al., 2014</xref>; <xref ref-type="bibr" rid="bib146">Doench et al., 2016</xref>). These screens have been pioneered in both cancer and immune cells and have revealed previously unappreciated underlying regulatory networks beneath common signaling molecules (<xref ref-type="bibr" rid="bib52">Berger et al., 2016</xref>; <xref ref-type="bibr" rid="bib448">Parnas et al., 2015</xref>; <xref ref-type="bibr" rid="bib547">Shifrut et al., 2018</xref>). In particular, these approaches have been used to interrogate lymphocyte responses to tumors, including in the context of immunotherapy (<xref ref-type="bibr" rid="bib547">Shifrut et al., 2018</xref>; <xref ref-type="bibr" rid="bib147">Dong et al., 2019</xref>; <xref ref-type="bibr" rid="bib674">Zhou et al., 2014</xref>; <xref ref-type="bibr" rid="bib452">Pech et al., 2019</xref>). A recent study used CRISPR activation (CRISPRa) (<xref ref-type="bibr" rid="bib311">Konermann et al., 2015</xref>) to activate endogenous genes within tumors as potential neoantigens in a multiplexed fashion that renders the tumors susceptible to immunotherapy (<xref ref-type="bibr" rid="bib628">Wang et al., 2019</xref>). A number of approaches enable these screens to be applied to single cells (<xref ref-type="bibr" rid="bib145">Dixit et al., 2016</xref>; <xref ref-type="bibr" rid="bib130">Datlinger et al., 2017</xref>; <xref ref-type="bibr" rid="bib280">Jaitin et al., 2016</xref>). Among these approaches is Perturb-seq, which combines multi-locus CRISPR screens with scRNA-seq (<xref ref-type="bibr" rid="bib145">Dixit et al., 2016</xref>), making it possible to interrogate the effects of higher order interactions that cannot be predicted by the responses to single-gene knockouts. In addition to simply identifying new gene targets, these genome-wide screens should enable systems biologists to discover emergent behaviors of tumor-immune interactions by combining multiple genetic perturbations, cell types, or by performing these screens in vivo.</p></sec></sec><sec id="s4"><title>Modeling approaches for cancer systems immunology</title><p>While often disparate fields, mathematical modeling, computational modeling, informatics tools, and statistical analyses are often inextricably linked, as mathematical modeling (e.g. differential equations) can be aided by computational approaches and bioinformatics tools often rely upon novel or existing mathematical analyses for their implementation. The breadth of modeling approaches and informatics tools in the field of Systems Biology (applied to cancer, the immune system, or both) is too large to review here and has been discussed elsewhere (<xref ref-type="bibr" rid="bib199">Germain et al., 2011</xref>; <xref ref-type="bibr" rid="bib11">Altrock et al., 2015</xref>; <xref ref-type="bibr" rid="bib391">Meyer and Heiser, 2019</xref>; <xref ref-type="bibr" rid="bib363">Machado et al., 2011</xref>; <xref ref-type="bibr" rid="bib426">Norton et al., 2019</xref>; <xref ref-type="bibr" rid="bib638">Woelke et al., 2010</xref>; <xref ref-type="bibr" rid="bib576">Stuart and Satija, 2019</xref>; <xref ref-type="bibr" rid="bib376">Materi and Wishart, 2007</xref>). Many modeling approaches, such as Petri Nets (<xref ref-type="bibr" rid="bib457">Petri, 1962</xref>; <xref ref-type="bibr" rid="bib506">Sackmann et al., 2006</xref>; <xref ref-type="bibr" rid="bib309">Koch, 2015</xref>) and Boolean Networks (<xref ref-type="bibr" rid="bib591">Thomas, 1973</xref>; <xref ref-type="bibr" rid="bib509">Saez-Rodriguez et al., 2007</xref>; <xref ref-type="bibr" rid="bib365">Mai and Liu, 2009</xref>; <xref ref-type="bibr" rid="bib572">Stoll et al., 2012</xref>), have been used extensively to model regulatory and signaling networks within cells (<xref ref-type="bibr" rid="bib621">Vieira and Vera-Licona, 2019</xref>). While such networks play important roles in governing tumor-immune interactions, the multiscale nature and complexity of immune responses to tumors often renders these approaches challenging to scale up for many applications in cancer systems immunology. Here, we focus on some general principles and tools that are particularly germane to the field of tumor immunology.</p><p>Both malignant and immune cells respond to their microenvironments. Factors such as the mechanics of the extracellular matrix (ECM), gradients in cytokines and chemokines, availability of nutrients, and much more drive cells to alter their behavior. Frequently, tumor cells and immune cells influence their own behavior and that of each other by inducing changes in these factors (e.g. immune cells secreting cytokines to recruit and activate more immune cells or cancer cells invading along stiff ECM). To model these elements, mathematicians have frequently turned to systems of ordinary differential equations (ODEs, e.g. for mechanics or chemical reactions) (<xref ref-type="bibr" rid="bib270">Ideker, 2001</xref>; <xref ref-type="bibr" rid="bib35">Bangasser and Odde, 2013</xref>) and partial differential equations (PDEs, e.g. for reaction-diffusion analyses) (<xref ref-type="bibr" rid="bib607">Turing, 1952</xref>; <xref ref-type="bibr" rid="bib379">Matzavinos et al., 2004</xref>; <xref ref-type="bibr" rid="bib300">Khain and Sander, 2006</xref>). These models are both intuitive and adaptable and can be solved under many conditions with the assistance of computational approaches. Indeed, such deterministic models have been employed to evaluate tumor-immune interactions (<xref ref-type="bibr" rid="bib44">Bellomo et al., 1999</xref>; <xref ref-type="bibr" rid="bib379">Matzavinos et al., 2004</xref>; <xref ref-type="bibr" rid="bib439">Owen and Sherratt, 1998</xref>). With increasing complexity (e.g. inclusion of many cell types, all producing gradients of multiple soluble factors and responding to them outside the assumptions of steady state conditions), however, analysis of ODEs and PDEs can become cumbersome and computationally impractical, and in such instances, alternate approaches can be more computationally feasible.</p><p>A variety of approaches have been used to model competition between immune cells and different clones within tumors. Probabilistic models that utilize evolutionary game theory (EGT) can be amenable to such modeling (<xref ref-type="bibr" rid="bib38">Basanta et al., 2012</xref>; <xref ref-type="bibr" rid="bib441">Pacheco et al., 2014</xref>; <xref ref-type="bibr" rid="bib565">Stanková et al., 2019</xref>; <xref ref-type="bibr" rid="bib428">Nowak and Sigmund, 2004</xref>; <xref ref-type="bibr" rid="bib24">Archetti, 2013</xref>; <xref ref-type="bibr" rid="bib45">Bellomo and Delitala, 2008</xref>). Rule-based approaches have gained popularity for modeling complex systems. Cellular automaton (CA) models can be used to study effects of the microenvironment on tumor growth (<xref ref-type="bibr" rid="bib284">Jiao and Torquato, 2011</xref>; <xref ref-type="bibr" rid="bib198">Gerlee and Anderson, 2007</xref>) and immune system homeostasis (<xref ref-type="bibr" rid="bib534">Seiden and Celada, 1992</xref>; <xref ref-type="bibr" rid="bib295">Kaufman et al., 1985</xref>). These models place cells within lattices and rely on defined rules to simulate their interactions. Stochasticity (e.g. Brownian motion) can be incorporated into such models as well as the ability to evaluate temporal responses. Perhaps, one of the most powerful modeling approaches in systems biology is agent-based modeling (ABM) (<xref ref-type="bibr" rid="bib559">Soheilypour and Mofrad, 2018</xref>; <xref ref-type="bibr" rid="bib254">Holcombe et al., 2012</xref>; <xref ref-type="bibr" rid="bib463">Pogson et al., 2008</xref>; <xref ref-type="bibr" rid="bib433">Odell and Foe, 2008</xref>; <xref ref-type="bibr" rid="bib151">Drasdo and Höhme, 2005</xref>; <xref ref-type="bibr" rid="bib205">Ghaffarizadeh et al., 2018</xref>; <xref ref-type="bibr" rid="bib464">Poleszczuk et al., 2016</xref>; <xref ref-type="bibr" rid="bib14">An, 2008</xref>; <xref ref-type="bibr" rid="bib103">Chiacchio et al., 2014</xref>). ABM is based upon the interactions of agents, which can be anything from molecules, to cells, to organisms. Their interactions and behaviors are governed by a set of rules, but unlike CA, they are not restricted to a lattice. The agents are autonomous; they can evolve, and their interactions can reveal collective emergent behavior. The ability to simulate interactions between thousands of agents, which could represent a myriad of cell types or molecules, renders this approach particularly amenable to the study of tumor immune interactions (<xref ref-type="bibr" rid="bib426">Norton et al., 2019</xref>). A number of studies have used ABM to model these interactions during tumor progression (<xref ref-type="bibr" rid="bib163">Enderling et al., 2012</xref>; <xref ref-type="bibr" rid="bib9">Alfonso et al., 2016</xref>; <xref ref-type="bibr" rid="bib466">Pourhasanzade et al., 2017</xref>; <xref ref-type="bibr" rid="bib153">Dréau, 2009</xref>) or response to immunotherapy (<xref ref-type="bibr" rid="bib444">Pappalardo et al., 2011</xref>; <xref ref-type="bibr" rid="bib218">Gong et al., 2017</xref>). PhysiCell is an ABM tool that has been used to interrogate adaptive immune responses to tumors (<xref ref-type="bibr" rid="bib205">Ghaffarizadeh et al., 2018</xref>; <xref ref-type="bibr" rid="bib440">Ozik et al., 2018</xref>). In this model, oxygen consumption by cells can result in necrosis and is determined by a normally-distributed parameter representing ‘oncoprotein’ expression. This parameter also affects immunogenicity of a given cell (as an approximation for neoantigen burden) and affects the degree to which immune cells attack the tumor. PhysiCell analyses have revealed how gradients of immunogenicity can ‘trap’ immune cells at the tumor center and allow tumor cells at the outside to escape immune attack and reestablish a tumor (<xref ref-type="bibr" rid="bib440">Ozik et al., 2018</xref>). Another recent study combined EGT with ABM to model tumor invasion and show how subpopulations within tumors can co-opt distinct macrophage populations to both degrade stroma and suppress immune responses (<xref ref-type="bibr" rid="bib193">Gatenbee, 2019</xref>).</p><p>One of the most promising aspects of systems biology analyses is their potential to integrate observations across multiple physical and temporal scales to discover emergent behavior that is not discernable from analysis of the individual components. This potential is especially attractive in the tumor setting where orchestration of immune responses occurs across all these levels (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). To address these types of problems, systems biologists often use multi-level or hybrid analyses (<xref ref-type="bibr" rid="bib426">Norton et al., 2019</xref>; <xref ref-type="bibr" rid="bib198">Gerlee and Anderson, 2007</xref>; <xref ref-type="bibr" rid="bib331">Letort et al., 2019</xref>; <xref ref-type="bibr" rid="bib282">Jeon et al., 2010</xref>; <xref ref-type="bibr" rid="bib135">Deisboeck et al., 2011</xref>; <xref ref-type="bibr" rid="bib95">Chamseddine and Rejniak, 2019</xref>). Such modeling approaches combine continuous or deterministic models (e.g. ODEs and PDEs) with discrete models such as agent-based models (ABMs). By combining discrete and continuum models, researchers can bridge scales and combine bottom-up approaches that efficiently model cell-cell interactions with rules governed by differential equations spanning larger physical scales to achieve a systems-level understanding of the biology (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). For example, combining CA models with PDEs has facilitated investigation of tumor-immune interactions during tumor growth (<xref ref-type="bibr" rid="bib368">Mallet and De Pillis, 2006</xref>). One hybrid model revealed how spatial and phenotypic heterogeneity can lead to immunosuppression (<xref ref-type="bibr" rid="bib632">Wells et al., 2015</xref>). These hybrid approaches will enable researchers to bridge existing multivariate datasets and observations to generate more holistic models of tumor immune interactions capable of predicting emergent phenomena that may be difficult to discern with existing experimental approaches.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Modeling approaches for cancer systems immunology.</title><p>(<bold>A</bold>) Modeling approaches used in cancer systems immunology operate within or across multiple scales in order to describe how tumors interact with the immune system. (<bold>B</bold>) Hybrid models, in particular, combine continuous models (e.g. differential equations) with discrete models (e.g. CA or ABM).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-53839-fig2-v1.tif"/></fig></sec><sec id="s5"><title>Bioinformatics tools for analyzing systems-level data</title><p>In addition to the use of computational approaches to develop models of tumor-immune interactions, bioinformaticians have developed a large array of tools for analyzing the data that are produced by the technologies described earlier. While the full extent of these tools is beyond the scope of this review, we highlight a few topics that are particularly relevant to cancer systems immunology.</p><p>The reduced cost and increased accessibility of DNA microarrays and NGS have resulted in vast amounts of publicly available human datasets. The Immunological Genome Project (ImmGen) provides transcriptional profiles from all the major immune subsets in mouse and human (<xref ref-type="bibr" rid="bib248">Heng et al., 2008</xref>; <xref ref-type="bibr" rid="bib544">Shay and Kang, 2013</xref>). Resources such as InnateDB, ImmuneXpresso, and the Human Immunology Project Consortium also provide large databases of immune expression profiles and interaction networks (<xref ref-type="bibr" rid="bib69">Breuer et al., 2013</xref>; <xref ref-type="bibr" rid="bib319">Kveler et al., 2018</xref>; <xref ref-type="bibr" rid="bib77">Brusic et al., 2014</xref>). Projects such as the Cancer Genome Atlas (TCGA) have collected –omics data from tens of thousands of patients (<xref ref-type="bibr" rid="bib590">The Cancer Genome Atlas, 2006</xref>). A recent herculean effort by multiple investigators used TCGA data across 33 cancer types and 10,000 tumors to identify six immune subtypes conserved across cancers that can inform outcome predictions and identify regulatory networks independent of tumor type (<xref ref-type="bibr" rid="bib594">Thorsson et al., 2018</xref>). By performing a pan-cancer meta-analysis of transcriptional profiles in 18,000 patients using a tool called PRECOG, researchers identified specific signatures of distinct leukocyte infiltration that correlates with outcome (<xref ref-type="bibr" rid="bib196">Gentles et al., 2015</xref>), while another study correlated the antigenicity of tumors with immune responses to characterize the ‘antigenome’ of tumors (<xref ref-type="bibr" rid="bib18">Angelova et al., 2015</xref>). One of the challenges that arises when analyzing these data is the heterogeneous nature of the tissue collected for these bulk analyses. The sequenced tumors typically contain not only malignant cells but also a variety of stromal and immune populations making it difficult to determine whether observed differences in for example, gene expression or allele frequency, reflect changes within a tumor, changes in other cells, or simply differences in cellular makeup. To address this challenge, bioinformaticians have developed deconvolution algorithms that can approximate cellular content from bulk transcriptomic data (<xref ref-type="bibr" rid="bib478">Racle et al., 2017</xref>; <xref ref-type="bibr" rid="bib416">Newman et al., 2015</xref>; <xref ref-type="bibr" rid="bib417">Newman et al., 2019</xref>; <xref ref-type="bibr" rid="bib4">Ahn et al., 2013</xref>; <xref ref-type="bibr" rid="bib652">Yoshihara et al., 2013</xref>; <xref ref-type="bibr" rid="bib219">Gong and Szustakowski, 2013</xref>; <xref ref-type="bibr" rid="bib338">Li et al., 2016b</xref>; <xref ref-type="bibr" rid="bib41">Becht et al., 2016</xref>; <xref ref-type="bibr" rid="bib545">Shen-Orr et al., 2010</xref>; <xref ref-type="bibr" rid="bib673">Zhong et al., 2013</xref>; <xref ref-type="bibr" rid="bib22">Aran et al., 2017</xref>; <xref ref-type="bibr" rid="bib477">Quon et al., 2013</xref>; <xref ref-type="bibr" rid="bib546">Shen-Orr and Gaujoux, 2013</xref>; <xref ref-type="bibr" rid="bib612">Vallania et al., 2018</xref>; <xref ref-type="bibr" rid="bib154">Du et al., 2019</xref>). CIBERSORTx is capable of not only deconvolving cellular mixtures, but also quantifying cell-type-specific gene expression profiles (<xref ref-type="bibr" rid="bib417">Newman et al., 2019</xref>). It performs this analysis by developing signature matrices derived from scRNA-seq and FACS sorted bulk RNA-seq datasets. These types of approaches will allow systems biologists to leverage the prodigious amounts of publicly available bulk RNA-seq data to discover how specific immune subsets interact with tumors and influence clinical outcome.</p><p>Even with advances in deconvolution, however, scRNA-seq remains one of the most effective methods for evaluating immune profiles within tumors (<xref ref-type="bibr" rid="bib540">Shalek et al., 2013</xref>; <xref ref-type="bibr" rid="bib677">Zilionis et al., 2019</xref>; <xref ref-type="bibr" rid="bib471">Puram et al., 2017</xref>; <xref ref-type="bibr" rid="bib30">Azizi et al., 2018</xref>; <xref ref-type="bibr" rid="bib598">Tirosh et al., 2016</xref>; <xref ref-type="bibr" rid="bib523">Schelker et al., 2017</xref>; <xref ref-type="bibr" rid="bib476">Qiu et al., 2019</xref>; <xref ref-type="bibr" rid="bib671">Zheng et al., 2017</xref>). This approach enables interrogation of the immune composition of tumors in an unbiased fashion. The amount of data and diversity of cell types can render interpretation of the datasets challenging, however. Computational biologists have developed a number of tools to analyze these datasets and present the findings in an interpretable fashion (<xref ref-type="bibr" rid="bib567">Stegle et al., 2015</xref>; <xref ref-type="bibr" rid="bib100">Chen et al., 2019a</xref>). Typically, expression profiles are clustered in an unsupervised manner and visualized using dimensional reduction techniques (<xref ref-type="bibr" rid="bib364">Macosko et al., 2015</xref>; <xref ref-type="bibr" rid="bib279">Jaitin et al., 2014</xref>; <xref ref-type="bibr" rid="bib362">Maaten and Hinton, 2008</xref>; <xref ref-type="bibr" rid="bib678">Žurauskienė and Yau, 2016</xref>; <xref ref-type="bibr" rid="bib645">Xu and Su, 2015</xref>; <xref ref-type="bibr" rid="bib232">Guo et al., 2015</xref>; <xref ref-type="bibr" rid="bib226">Grün et al., 2015</xref>; <xref ref-type="bibr" rid="bib305">Kiselev et al., 2017</xref>; <xref ref-type="bibr" rid="bib42">Becht et al., 2019</xref>; <xref ref-type="bibr" rid="bib334">Levine et al., 2015</xref>). Dimensional reduction and visualization approaches such as principal component analysis (PCA) (<xref ref-type="bibr" rid="bib451">Pearson, 1901</xref>), diffusion maps (<xref ref-type="bibr" rid="bib111">Coifman et al., 2005</xref>), t-distributed stochastic neighbor embedding (t-SNE) (<xref ref-type="bibr" rid="bib362">Maaten and Hinton, 2008</xref>), and uniform approximation and projection (UMAP) (<xref ref-type="bibr" rid="bib382">McInnes et al., 2018</xref>) enable researchers to quickly visualize changes in cell populations. Many ‘all-in-one’ pipelines, such as Seurat, incorporate the normalization, clustering, and visualization algorithms in a single R package to assist in efficient interpretation (<xref ref-type="bibr" rid="bib85">Butler et al., 2018</xref>; <xref ref-type="bibr" rid="bib575">Stuart et al., 2019</xref>). A major challenge in scRNA-seq analysis is the occurrence of batch effects. For example, the effects may result in the T cells of one patient clustering more closely with macrophages from the same patient than with T cells from another patient. Such effects are especially prominent when attempting to compare data acquired on different platforms (e.g. 10X Chromium vs. inDrop vs. Fluidigm C1). Furthermore, scRNA-seq captures only a small percentage of the transcripts in any given cell due to undersampling and technical limitationss, resulting in dropout. A variety of techniques have been developed to deal with batch effects and dropout by imputing expression of zero-read genes and defining anchors onto which clusters can be mapped (<xref ref-type="bibr" rid="bib575">Stuart et al., 2019</xref>; <xref ref-type="bibr" rid="bib614">van Dijk et al., 2018</xref>). Using a method termed ‘Biscuit’, one approach normalizes and clusters cells simultaneously using co-expression of genes to identify cell types, which are then normalized independently and dropout gene expression is imputed (<xref ref-type="bibr" rid="bib30">Azizi et al., 2018</xref>; <xref ref-type="bibr" rid="bib468">Prabhakaran, 2016</xref>). This approach enabled robust comparisons of scRNA-seq datasets across platforms, and was used to demonstrate the diversity of T cell states in human breast tumors.</p><p>Single-cell cytometry and imaging technologies also produce large high-parameter datasets whose interpretation has been aided by the development of computational tools. For example, spanning-tree progression analysis of density-normalized events (SPADE) overcomes the limitations of biaxial plots frequently employed in the analysis of conventional flow cytometry to facilitate analysis of mass cytometry data (<xref ref-type="bibr" rid="bib47">Bendall et al., 2011</xref>; <xref ref-type="bibr" rid="bib475">Qiu et al., 2011</xref>). This approach uses agglomerative clustering on down-sampled data along with a minimum spanning tree approach to generate a visual representation upon which the original data is displayed. Like many of the mass cytometry analysis tools, SPADE does not rely upon preexisting knowledge and enables an agnostic interpretation of the data. Other methods include viSNE (an adapted version of t-SNE) (<xref ref-type="bibr" rid="bib12">Amir et al., 2013</xref>), FlowSOM (<xref ref-type="bibr" rid="bib615">Van Gassen, 2015</xref>), Citrus (<xref ref-type="bibr" rid="bib76">Bruggner et al., 2014</xref>), PhenoGraph (<xref ref-type="bibr" rid="bib334">Levine et al., 2015</xref>), X-shift (<xref ref-type="bibr" rid="bib512">Samusik et al., 2016</xref>). Another tool, Wanderlust, is capable of inferring a trajectory continuum of cell states from mass cytometry data and has been applied to understanding the transitions during B cell development (<xref ref-type="bibr" rid="bib49">Bendall et al., 2014</xref>). In collaboration with the lab of Garry Nolan, our group developed a tool known as Scaffold Maps that uses manual gating of mass cytometry data to define landmark nodes in combination with force-directed layouts to generate a graphical reference map of the immune system that can be used to compare tissues, species, or other parameters (<xref ref-type="bibr" rid="bib562">Spitzer et al., 2015</xref>). By augmenting this approach with statistical inference adopted from the significance analysis of microarrays (SAM) (<xref ref-type="bibr" rid="bib32">Bair and Tibshirani, 2004</xref>), we applied this approach to interrogating cancer immunotherapy in genetically-engineered mouse models of breast cancer and melanoma (<xref ref-type="bibr" rid="bib563">Spitzer et al., 2017</xref>). These analyses revealed the importance of secondary lymphoid tissues in orchestrating anti-tumor immune responses as well as identified an emergent CD4<sup>+</sup> T cell population that is a key element of effective immunotherapy. As with mass cytometry, high-parameter imaging modalities require the advent of new analysis tools. A recent study exploring immune infiltration in triple-negative breast cancer patients by MIBI used a deep-learning approach to aid in image segmentation and revealed populational co-occurrence patterns that correlate with prognosis (<xref ref-type="bibr" rid="bib298">Keren et al., 2018</xref>). Deconvolution approaches have also been applied in combination with multiplexed fluorescence confocal imaging to interrogate immune interactions in entire organs, such as lymph nodes (<xref ref-type="bibr" rid="bib202">Gerner et al., 2012</xref>). This approach was recently used to demonstrate how autoreactive T cells are regulated by clustering with Tregs and migratory dendritic cells in lymph nodes (<xref ref-type="bibr" rid="bib350">Liu et al., 2015</xref>). To visualize interactions between immune cells such as T cell interactions with antigen-presenting DCs, researchers have traditionally used two-photon excitation microscopy (<xref ref-type="bibr" rid="bib571">Stoll et al., 2002</xref>; <xref ref-type="bibr" rid="bib386">Mempel et al., 2004</xref>; <xref ref-type="bibr" rid="bib394">Miller et al., 2002</xref>). In a recent study, researchers developed a deep convolution neural network to identify and characterize DC-T cell interactions in fixed tissue samples, thus enabling quantification of these interactions tissues from mice and humans without requiring the use of transgenic animals expressing fluorescent reporters (<xref ref-type="bibr" rid="bib340">Liarski et al., 2019</xref>). These analyses could have important implications for understanding how tumors interact with the immune system during malignant progression.</p></sec><sec id="s6"><title>Systems approaches to understanding the roles of specific immune subsets in the tumor immune microenvironment</title><p>Studies investigating the immune status of tumors have revealed that the prognosis of patients often strongly correlates with the degree of T cell infiltration into the local tumor microenvironment (TME) (<xref ref-type="bibr" rid="bib188">Galon et al., 2006</xref>; <xref ref-type="bibr" rid="bib54">Binnewies et al., 2018</xref>; <xref ref-type="bibr" rid="bib186">Gajewski et al., 2013</xref>). Immune infiltrates have also served as effective prognostic biomarkers of response to immune checkpoint blockade (ICB) (<xref ref-type="bibr" rid="bib250">Herbst et al., 2014</xref>; <xref ref-type="bibr" rid="bib606">Tumeh et al., 2014</xref>). Tumor immunologists frequently refer to tumors as ‘hot’ or ‘cold’ (or ‘deserts’, in extreme cases) to describe the degree of infiltration of immune cells beyond the tumor margin, but these crude epithets fail to capture the breadth of nuance, and presumably prognostic value, that can be extracted using systems biology approaches to interrogate the TME. Furthermore, the TME does not exist in isolation, but rather is the product of constant communication with the entire organism (<xref ref-type="bibr" rid="bib159">Egeblad et al., 2010</xref>) rendering its analysis particularly amenable to systems approaches. While most systems analyses have focused on immune responses within the primary tumor or peripheral blood, some recent studies have extended their analyses to the TME of metastatic sites such as LNs (<xref ref-type="bibr" rid="bib471">Puram et al., 2017</xref>; <xref ref-type="bibr" rid="bib598">Tirosh et al., 2016</xref>; <xref ref-type="bibr" rid="bib304">Kim et al., 2020</xref>). Further studies are needed to comprehensively interrogate systemic immune responses to metastases, as lymph node metastases can render the systemic immune response permissive to tumor progression (<xref ref-type="bibr" rid="bib486">Reticker-Flynn et al., 2020</xref>), and the invocation of systemic immunity is required for the efficacy of immunotherapy (<xref ref-type="bibr" rid="bib563">Spitzer et al., 2017</xref>).</p><sec id="s6-1"><title>Macrophages</title><p>In the mid-nineteenth century, Rudolf Virchow first recognized that tumors frequently contain leukocytes. He posited that chronic inflammation lies at the origins of tumors (<xref ref-type="bibr" rid="bib624">Virchow, 1863</xref>; <xref ref-type="bibr" rid="bib623">Virchow, 1858</xref>), leading <xref ref-type="bibr" rid="bib158">Dvorak, 1986</xref>, to describe tumors as ‘wounds that do not heal’, a century later. Many of the initial investigations into the TME focused on the role of myeloid cells in promoting tumorigenesis and metastasis (<xref ref-type="bibr" rid="bib290">Joyce and Pollard, 2009</xref>; <xref ref-type="bibr" rid="bib473">Qian and Pollard, 2010</xref>; <xref ref-type="bibr" rid="bib118">Coussens and Werb, 2002</xref>; <xref ref-type="bibr" rid="bib164">Engblom et al., 2016</xref>). In particular, researchers have focused on macrophages as key instigators of both tumor-promoting inflammation as well as immunosuppression. While macrophages represent essential components of innate immunity due to their capacity to scavenge for microbial pathogens, drive new blood vessel formation, and process and present antigens to lymphocytes, they have long been associated with a range of pathologies including atherosclerosis, cirrhosis, neurodegeneration, and malignancy (<xref ref-type="bibr" rid="bib407">Murray and Wynn, 2011</xref>). Nearly all solid tumors exhibit evidence of macrophage involvement regardless of the presence of other infiltrating immune types. While tumor-associated macrophages (TAMs) have been reviewed extensively elsewhere (<xref ref-type="bibr" rid="bib335">Lewis and Pollard, 2006</xref>), we focus here on recent systems biology approaches employed to elucidate their roles in the TME.</p><p>Macrophages within tissues are derived from one of two sources: either, they differentiate from circulating bone-marrow-derived monocytes that have extravasated from blood vessels or, in the case of some specialized tissues, they were seeded during development by macrophages derived from the yolk sac or monocytes from the fetal liver (<xref ref-type="bibr" rid="bib213">Ginhoux and Guilliams, 2016</xref>; <xref ref-type="bibr" rid="bib166">Epelman et al., 2014</xref>). Langerhans cells of the epidermis (<xref ref-type="bibr" rid="bib387">Merad et al., 2002</xref>), microglia of the brain (<xref ref-type="bibr" rid="bib211">Ginhoux et al., 2010</xref>; <xref ref-type="bibr" rid="bib5">Ajami et al., 2007</xref>; <xref ref-type="bibr" rid="bib651">Yona et al., 2013</xref>), Kupffer cells of the liver (<xref ref-type="bibr" rid="bib651">Yona et al., 2013</xref>), and alveolar macrophages of the lungs (<xref ref-type="bibr" rid="bib651">Yona et al., 2013</xref>; <xref ref-type="bibr" rid="bib243">Hashimoto et al., 2013</xref>; <xref ref-type="bibr" rid="bib229">Guilliams et al., 2013</xref>) are all examples of the latter ontogeny and are known as tissue-resident macrophages. Circulating bone-marrow-derived monocytes serve as the other major macrophage source and the primary source after birth. The majority of these monocytes are known as inflammatory or classical monocytes. They express high levels of Ly6C (in mice) and are recruited to sites of inflammation, often through CCR2, where they differentiate into macrophages (although such differentiation typically does not occur during steady state conditions) (<xref ref-type="bibr" rid="bib281">Jakubzick et al., 2013</xref>; <xref ref-type="bibr" rid="bib604">Tsou et al., 2007</xref>; <xref ref-type="bibr" rid="bib537">Serbina and Pamer, 2006</xref>). Ly6C<sup>lo</sup> nonclassical or patrolling monocytes typically remain within vessels and crawl along the endothelial walls to clean up debris from dying endothelium (<xref ref-type="bibr" rid="bib29">Auffray et al., 2007</xref>; <xref ref-type="bibr" rid="bib89">Carlin et al., 2013</xref>).</p><p>The majority of TAM research has focused on macrophages derived from inflammatory monocytes and recruited to the TME (<xref ref-type="bibr" rid="bib306">Kitamura et al., 2015</xref>; <xref ref-type="bibr" rid="bib490">Richards et al., 2013</xref>). Classically, macrophages have been divided into M1 and M2 macrophages in an attempt to mimic the nomenclature of T helper (Th) cells (<xref ref-type="bibr" rid="bib395">Mills et al., 2000</xref>). M1 macrophages (or classically activated macrophages) were thought to represent a state of polarization induced by Th1-derived cytokines such as IFN-γ or microbial stimuli (e.g. LPS). They exhibit elevated MHC-II expression and produce nitrous oxide (NO), reactive oxygen species (ROS), TNF-α, and a milieu of inflammatory cytokines (e.g. IL-12, IL-23, IL-6, IL-1, etc.) (<xref ref-type="bibr" rid="bib128">Dalton et al., 1993</xref>; <xref ref-type="bibr" rid="bib373">Mantovani et al., 2004</xref>; <xref ref-type="bibr" rid="bib28">Atri et al., 1801</xref>). In contrast, M2 macrophages (alternatively-activated macrophages) were initially reported to be polarized by Th2 cytokines such as IL-4 and IL-13 that drive alternative macrophage activation (<xref ref-type="bibr" rid="bib568">Stein et al., 1992</xref>; <xref ref-type="bibr" rid="bib150">Doyle et al., 1994</xref>; <xref ref-type="bibr" rid="bib223">Gordon, 2003</xref>). These macrophages express arginase 1, IL-10, CCL17, CCL22, and CCL24 and are generally considered anti-inflammatory and immunosuppressive (<xref ref-type="bibr" rid="bib57">Biswas and Mantovani, 2010</xref>). Consequently, M1 macrophages have traditionally been associated with anti-tumor effects while M2 macrophages were considered pro-tumor (though M1 ROS production has been suggested to play a role in tumorigenesis) (<xref ref-type="bibr" rid="bib315">Kratochvill et al., 2015</xref>; <xref ref-type="bibr" rid="bib664">Zhang et al., 2013</xref>). Over time, it became apparent that the initial nomenclature, derived primarily from in vitro activation experiments, was likely not sufficient to classify the M2 macrophage states, in particular. Distinctions between Th2 cytokine production, IL-10-mediated immunosuppression, and immune complex and TLR stimulation have led to an effort to subset M2 macrophages into three groups (<xref ref-type="bibr" rid="bib373">Mantovani et al., 2004</xref>).</p><p>Recently, a number of studies that have employed systems approaches have revealed that this binary interpretation of macrophage polarization is vastly oversimplified and fails to capture the diversity of phenotypes exhibited by macrophages (<xref ref-type="bibr" rid="bib401">Mosser and Edwards, 2008</xref>; <xref ref-type="bibr" rid="bib646">Xue et al., 2014</xref>; <xref ref-type="bibr" rid="bib406">Murray et al., 2014</xref>; <xref ref-type="bibr" rid="bib375">Martinez and Gordon, 2014</xref>; <xref ref-type="bibr" rid="bib326">Lavin et al., 2014</xref>; <xref ref-type="bibr" rid="bib212">Ginhoux et al., 2016</xref>; <xref ref-type="bibr" rid="bib483">Reinartz et al., 2014</xref>; <xref ref-type="bibr" rid="bib669">Zhang et al., 2019</xref>). One group of investigators interrogated the regulatory landscape of tissue-resident macrophages across a variety of organs by combining RNA-seq, ChIP-seq, and ATAC-seq (<xref ref-type="bibr" rid="bib326">Lavin et al., 2014</xref>). In this study, the corresponding tissue-resident macrophages from the brain, lungs, liver, spleen, peritoneum, ileum, and colon were purified by FACS, and subjected to these analyses to reveal distinct gene expression, enhancer methylation, and chromatin states depending on their tissue of residence. In accordance with reports describing the considerable plasticity of macrophages, this study also showed that transplanted macrophages could be reprogrammed by their new tissue of residence in a manner that mimics the regulatory landscape of macrophages in those tissues. Seeking to characterize the diversity of macrophage activation states, other investigators performed transcriptional profiling of human macrophages following in vitro activation with a variety of stimuli and found that the cells exhibit a range of distinct states that extend well beyond the conventional M1/M2 polarization axis (<xref ref-type="bibr" rid="bib646">Xue et al., 2014</xref>). Similarly, TAMs frequently fail to conform to the traditional M1/M2 polarization model (<xref ref-type="bibr" rid="bib23">Aras and Zaidi, 2017</xref>). In one study that used mass cytometry to profile macrophages and T cells within the tumors of 73 clear cell renal cell carcinoma patients, the authors characterized 17 distinct TAM phenotypes (<xref ref-type="bibr" rid="bib102">Chevrier et al., 2017</xref>). In lung adenocarcinoma, researchers used both MARS-seq and mass cytometry to reveal that tumor-specific macrophages exhibit distinct profiles from other mononuclear phagocytes, including lung-specific macrophages, conventional macrophages, DCs, and monocytes (<xref ref-type="bibr" rid="bib327">Lavin et al., 2017</xref>). Characterization of myeloid cell diversity in lung adenocarcinoma using scRNA-seq identified multiple populations of neutrophils, DCs, monocytes, and macrophages that were conserved across patients and species (<xref ref-type="bibr" rid="bib677">Zilionis et al., 2019</xref>). Of note, while some of the macrophage populations exhibited enrichment for M2 gene signatures, they did not cluster to a singular state and the myeloid cells, in general, exhibit a spectrum of states within tumors. Similarly, another study performed scRNA-seq on 45,000 leukocytes from human breast tumors along with corresponding blood, lymph nodes, and normal breast tissue (<xref ref-type="bibr" rid="bib30">Azizi et al., 2018</xref>). Using diffusion maps (<xref ref-type="bibr" rid="bib111">Coifman et al., 2005</xref>), they characterized the heterogeneity in both the T cell and myeloid compartments. In particular, they noted considerable diversity in the myeloid compartments, and surprisingly, found a strong positive correlation between M1 and M2 gene signatures (<xref ref-type="fig" rid="fig3">Figure 3</xref>). The three TAM populations that they identified often expressed both gene signatures in the same cells, again suggesting that the original M1/M2 polarization concept does not recapitulate what occurs in vivo, particularly in human tumors. Taken together, these studies suggest that macrophages within tumors do not comport to the theorized discrete M1/M2 polarization states, but rather exist within a spectrum of activation states that even permits concomitant expression of the two profiles. While mixtures of the transcriptional and epigenetic repression by the opposing cytokines IL-4 and IFN-γ may be partially responsible for the mixed phenotypes exhibited in vivo where complex mixtures of cytokines are present (<xref ref-type="bibr" rid="bib461">Piccolo et al., 2017</xref>), it still remains unclear how such inhibitory programs could result in coexpression of both gene sets within the same cells. Adding to the complexity of TAM characterization, a number of recent studies investigating macrophage ontogeny in the context of tumors have revealed that TAMs are not only derived from bone marrow-derived monocyte precursors, but also tissue-resident macrophages seeded during embryogenesis. A recent study that used parabiosis and congenic mice revealed that TAMs in pancreatic ductal adenocarcinoma are derived from both blood monocytes and tissue-resident macrophages and that these populations serve distinct functions during tumor progression (<xref ref-type="bibr" rid="bib675">Zhu et al., 2017</xref>). Similarly, lineage-tracing approaches, scRNA-seq, and ATAC-seq have all been used to reveal that both microglia and bone marrow-derived macrophages are involved in gliomas and exhibit distinct profiles and contributions to tumor progression (<xref ref-type="bibr" rid="bib64">Bowman et al., 2016</xref>; <xref ref-type="bibr" rid="bib402">Müller et al., 2017</xref>). Through an appreciation of the diversity, ontogeny, and complexity of TAM phenotypes cancer systems biologists are beginning to reveal how the interplay of these populations can facilitate tumor progression.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Systems approaches to the TME.</title><p>Many systems approaches have been applied to analyzing the TME to reveal the cellular makeup and relationships between immune cells at the single-cell level. Studies have revealed heterogeneity among myeloid and lymphocyte populations, trafficking of cDC subsets to the draining LNs, and epigenetic exhaustion profiles of T cells infiltrating tumors following ICB.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-53839-fig3-v1.tif"/></fig></sec><sec id="s6-2"><title>Dendritic Cells</title><p>Compared to macrophages, dendritic cells (DCs) represent a relative minority of the myeloid cells present within most tumors. Nonetheless, DCs are critical orchestrators of immune responses due to their exquisite capacity to present antigens and license, stimulate, or suppress T cells (<xref ref-type="bibr" rid="bib33">Banchereau and Steinman, 1998</xref>). They can present antigens in the TME to T cells in situ or in lymph nodes (LNs) by accruing tumor debris that has drained there through the lymphatics or by themselves trafficking from the TME into LNs. Their essential role in choreographing the adaptive immune response across an organism makes them an ideal subject for integrated multi-level systems biology investigations.</p><p>Many cells of the DC lineage, including classical DCs (cDCs) and plasmacytoid DCs (pDCs), are derived from a common bone-marrow progenitor, the common DC precursor (CDP), which gives rise to a lineage distinct from other leukocytes (<xref ref-type="bibr" rid="bib437">Onai et al., 2007</xref>; <xref ref-type="bibr" rid="bib411">Naik et al., 2007</xref>; <xref ref-type="bibr" rid="bib349">Liu et al., 2009</xref>; <xref ref-type="bibr" rid="bib388">Merad et al., 2013</xref>). Traditionally, DCs have been described as belonging to four subsets: cDCs, pDCs, monocyte-derived DCs (MoDCs), and Langerhan cells (LCs), which closely resemble other tissue-resident macrophages in gene expression and phenotype (<xref ref-type="bibr" rid="bib516">Satpathy et al., 2012</xref>; <xref ref-type="bibr" rid="bib161">Eisenbarth, 2019</xref>). cDCs, so called as they were the first DCs described (<xref ref-type="bibr" rid="bib569">Steinman and Cohn, 1973</xref>), are potent antigen presenting cells that efficiently phagocytose antigens and license T cells. Consequently, they play a critical role in facilitating anti- or pro-tumor T cell responses both in the local TME and LNs. cDCs can be further divided into two subsets: cDC1 and cDC2. cDC1 express the chemokine receptor XCR1 (<xref ref-type="bibr" rid="bib31">Bachem et al., 2012</xref>; <xref ref-type="bibr" rid="bib148">Dorner et al., 2009</xref>), require the AP-1 transcription factor BATF3 for development (<xref ref-type="bibr" rid="bib252">Hildner et al., 2008</xref>; <xref ref-type="bibr" rid="bib405">Murphy et al., 2013</xref>), and are characterized by their ability to cross-present antigens to CD8<sup>+</sup> T cells. In lymphoid tissues, cDC1s typically express CD8α, while peripheral cDC1s express integrin αE (CD103) in mice (both express BDCA3 in humans) and exhibit the ability to efficiently migrate to LNs to present antigen. Both typically lack CD11b. cDC2 have been primarily associated with activation of CD4<sup>+</sup> T cells, though both cDC subsets can activate both T cell subsets (<xref ref-type="bibr" rid="bib161">Eisenbarth, 2019</xref>; <xref ref-type="bibr" rid="bib43">Bedoui et al., 2009</xref>). While a number of markers have proven useful in delineating DCs subsets, recent unbiased mass cytometry and scRNA-seq studies have added clarity and revealed correlations between DC subsets across anatomical locations and species (<xref ref-type="bibr" rid="bib230">Guilliams et al., 2016</xref>; <xref ref-type="bibr" rid="bib622">Villani et al., 2017</xref>; <xref ref-type="bibr" rid="bib533">See et al., 2017</xref>; <xref ref-type="bibr" rid="bib7">Alcántara-Hernández et al., 2017</xref>).</p><p>It is likely that all of the DC subsets play important roles in tumor progression. pDCs, in particular, have been suggested to play an immunosuppressive role (<xref ref-type="bibr" rid="bib138">Demoulin et al., 2013</xref>; <xref ref-type="bibr" rid="bib554">Sisirak et al., 2012</xref>; <xref ref-type="bibr" rid="bib397">Mitchell et al., 2018</xref>; <xref ref-type="bibr" rid="bib667">Zhang et al., 2017c</xref>; <xref ref-type="bibr" rid="bib320">Labidi-Galy et al., 2011</xref>), yet the cDC1 subset is perhaps the best-studied due to its relevance in priming antitumor CD8<sup>+</sup> T cells, while MoDCs are frequently the most numerous in the TME. cDCs are critical for antitumor T-cell-mediated immunity (<xref ref-type="bibr" rid="bib252">Hildner et al., 2008</xref>; <xref ref-type="bibr" rid="bib180">Fuertes et al., 2011</xref>). They exist at the borders of tumors and exhibit prolonged interactions with tumor-specific CD8<sup>+</sup> T cells, yet they frequently fail to stimulate the T cells to mediate an antitumor effect (<xref ref-type="bibr" rid="bib165">Engelhardt et al., 2012</xref>; <xref ref-type="bibr" rid="bib61">Boissonnas et al., 2013</xref>; <xref ref-type="bibr" rid="bib72">Broz et al., 2014</xref>). Furthermore, migratory CD103<sup>+</sup> peripheral cDC1s traffic to tumor-draining LNs in a CCR7-dependent fashion, where they interact with tumor-specific T cells and transfer tumor antigens to other LN resident DC subsets, at much higher levels than migratory CD11b<sup>+</sup> DCs (<xref ref-type="bibr" rid="bib495">Roberts et al., 2016</xref>; <xref ref-type="bibr" rid="bib511">Salmon et al., 2016</xref>). FcγR engagement of immune complexes (ICs) by DCs induces their CCR-7 dependent migration to LNs (<xref ref-type="bibr" rid="bib108">Clatworthy et al., 2014</xref>), and we have shown that the combination of DC adjuvants with tumor-bound allogeneic antibody ICs induce robust anti-tumor T cell responses (<xref ref-type="bibr" rid="bib90">Carmi et al., 2015</xref>). Vaccines expressing Flt3 ligand (Flt3L), which induces CDP lineage commitment, have been shown to improve ICB efficacy (<xref ref-type="bibr" rid="bib123">Curran and Allison, 2009</xref>).</p><p>Systems-level analyses have helped extend our understanding of cDC functions in tumors. One study, in which mass cytometry was used to evaluate the TME during early- and late-stage tumor development, showed that Flt3L injections vastly increases the numbers of CD103<sup>+</sup> DCs in the TME (<xref ref-type="bibr" rid="bib511">Salmon et al., 2016</xref>). Furthermore, these DCs transport antigen to the draining LNs where they augment PD-L1 ICB to elicit anti-tumor T cell responses. Using mass cytometry to profile the evolution of the immune repertoire at an organism-wide level in response to immunotherapy, we found that in the initiation of anti-tumor immune responses, CD103<sup>+</sup> DCs in the tumor microenvironment exhibit a strong increase in proliferation (<xref ref-type="bibr" rid="bib563">Spitzer et al., 2017</xref>). Furthermore, the cDC frequencies decrease in the local TME during the therapy initiation phase while increasing in the draining LNs during the rejection phase, suggesting that they may become activated at the tumors and subsequently traffic to LNs to facilitate the generation of anti-tumor T cell responses. Using scRNA-seq, one study found that migration of cDC2s from tumors to the draining LNs is required for priming of CD4<sup>+</sup> T<sub>conv</sub> and eliciting a potent antitumor response, but Tregs inhibit their efficacy likely by preventing their migration to the LNs (<xref ref-type="fig" rid="fig3">Figure 3</xref>; <xref ref-type="bibr" rid="bib55">Binnewies et al., 2019</xref>). A recent study combined 10X Chromium with SMART-seq scRNA-seq platforms to investigate the cellular diversity of hepatocellular carcinoma (HCC) and found that the droplet and plate-based approaches identify distinct populations (<xref ref-type="bibr" rid="bib669">Zhang et al., 2019</xref>). Additionally, they identified a LAMP3<sup>+</sup> subset of DCs that appeared to migrate from the tumor to draining LNs from their RNA velocity analysis, but these DCs share transcriptional features with both cDC subsets as well as pDCs. This population appears to be inducible from multiple lineages upon stimulation with various DC adjuvants, although it remains unclear whether this subset represents an activation state or a different state of differentiation. These agnostic systems approaches have been particularly useful in understanding these types of complex interactions where DCs are interacting with many different cell types in multiple organs in manners that change considerably over the timecourse of the immune response.</p></sec><sec id="s6-3"><title>T cells</title><p>While investigations into adaptive immune responses to tumors have long been a major focus of tumor immunologists, the recent successes of immune checkpoint blockade (ICB) and engineered chimeric antigen receptor T cells (CAR-T cells) have stimulated a renewed interest in understanding T cell interactions with tumors. Consequently, many novel systems approaches have been applied to T cells. Due to their ability to recognize tumor-specific antigens and kill tumor cells in an antigen-specific manner, T cells represent one of the most critical components of anti-tumor immune responses. Nonetheless, T cells frequently fail to eliminate tumors likely due to immune evasion (<xref ref-type="bibr" rid="bib157">DuPage et al., 2012</xref>; <xref ref-type="bibr" rid="bib378">Matsushita et al., 2012</xref>; <xref ref-type="bibr" rid="bib454">Pereira et al., 2017</xref>; <xref ref-type="bibr" rid="bib507">Sade-Feldman et al., 2017</xref>) or suppression (<xref ref-type="bibr" rid="bib289">Joshi et al., 2015</xref>; <xref ref-type="bibr" rid="bib635">Willimsky and Blankenstein, 2005</xref>; <xref ref-type="bibr" rid="bib450">Pauken and Wherry, 2015</xref>) mechanisms of the tumors. Furthermore, while a variety of cells and conditions can promote broad immunosuppression of a host, T cells can become subject to tolerance or exhaustion in a manner that impairs tumor-specific immunity without affecting the ability of the immune system to defend against unrelated pathogens (<xref ref-type="bibr" rid="bib526">Schietinger and Greenberg, 2014</xref>). It is this latter feature that renders tumors such pernicious adversaries in efforts at both detecting and combatting malignancies.</p><p>Systems approaches have aided our understanding of T cell responses to tumors in a variety of contexts. One of the mechanisms by which tumor-specific T cells are thought to become dysfunctional is through processes related to exhaustion. T cell exhaustion, first identified in chronic viral infections (<xref ref-type="bibr" rid="bib658">Zajac et al., 1998</xref>; <xref ref-type="bibr" rid="bib187">Gallimore et al., 1998</xref>), is induced by persistent exposure to antigen accompanied by failure to eliminate it (<xref ref-type="bibr" rid="bib634">Wherry, 2011</xref>). It can take multiple forms and likely evolved as a mechanism to avoid inflammation-induced pathologies in which pathogens cannot be resolved (<xref ref-type="bibr" rid="bib60">Blank et al., 2019</xref>). It is worth noting that T<sub>Ex</sub> are not entirely ineffective and exhibit some anti-pathogen efficacy even if unable to eliminate the pathogen. Features of exhaustion include elevated expression of inhibitory receptors (e.g. PD1, Lag3, Tim-3, etc.), reduced cytokine expression, reduced proliferation, altered metabolism, and reduced effector function (<xref ref-type="bibr" rid="bib383">McLane et al., 2019</xref>). In tumors, T cells often acquire a phenotype that is analogous to exhaustion, although it is unclear whether this dysfunctional state exhibits a similar capacity to be reprogrammed, as is often evidenced in the context of viral infections (<xref ref-type="bibr" rid="bib459">Philip and Schietinger, 2019</xref>).</p><p>Through the use of systems approaches to evaluate the regulatory landscape of tumor-specific T cells, what has become abundantly clear is that, like most T cell states (<xref ref-type="bibr" rid="bib663">Zhang et al., 2012</xref>; <xref ref-type="bibr" rid="bib548">Shih et al., 2016</xref>; <xref ref-type="bibr" rid="bib656">Yu et al., 2017</xref>), the exhausted phenotype of these cells is regulated at an epigenetic level, suggesting that T<sub>Ex</sub> represent a distinct cell type (<xref ref-type="fig" rid="fig3">Figure 3</xref>; <xref ref-type="bibr" rid="bib535">Sen et al., 2016</xref>). Evaluation of chromatin accessibility landscapes by ATAC-seq has revealed that naïve, effector, memory, and exhausted T cells exhibit profound differences in open chromatin regions (OCR) (<xref ref-type="bibr" rid="bib535">Sen et al., 2016</xref>). While PD-1 signaling blockade can reinvigorate exhausted T cells, it induces only moderate changes in the OCRs that do not revert the cells to a T<sub>mem</sub> epigenetic profile, perhaps explaining why the reinvigoration is transient (<xref ref-type="bibr" rid="bib449">Pauken et al., 2016</xref>). Yet while these epigenetic states persist during PD-1 blockade, as also evidenced through bisulfite sequencing, combining DNA demethylating agents with PD-1 blockade has shown the potential to reverse the exhaustion state and improve antitumor response (<xref ref-type="bibr" rid="bib207">Ghoneim et al., 2017</xref>). Recent studies combining differential gene expression and OCR analyses between T<sub>mem</sub> and T<sub>Ex</sub>. suggest that epigenetic control of the exhaustion state is mediated by the transcription factor TOX, which is induced by chronic TCR stimulation, and in particular, calcineurin and NFAT signaling and is responsible for upregulation of inhibitory receptors such as PD1 (<xref ref-type="bibr" rid="bib302">Khan et al., 2019</xref>; <xref ref-type="bibr" rid="bib8">Alfei et al., 2019</xref>; <xref ref-type="bibr" rid="bib532">Scott et al., 2019</xref>). Notably, inhibition of calcineurin signaling following TOX induction by treatment with FK506 or cyclosporin A did not ablate TOX expression or the T<sub>Ex</sub> phenotype, suggesting that once induced, TOX expression remains stable (<xref ref-type="bibr" rid="bib302">Khan et al., 2019</xref>). Augmenting these studies, scRNAs-eq has revealed similar TOX-driven phenotypes in the context of chronic viral infection (<xref ref-type="bibr" rid="bib649">Yao et al., 2019</xref>). Similarly, by combining transcriptional analysis with genome-wide H3K4me3 and H3K27me3 analyses, researchers identified a critical role for the NR4A1 transcription factor in instilling the T<sub>Ex</sub> state by inhibiting binding of the AP-1 transcription factor to binding sites of effector-related genes (<xref ref-type="bibr" rid="bib352">Liu et al., 2019</xref>). These effects extend to cell therapies, where genetic ablation of NR4A genes can prevent exhaustion in CAR-T cells and improve tumor clearance (<xref ref-type="bibr" rid="bib101">Chen et al., 2019b</xref>). Another CAR-T study found similar effects with ablation of <italic>TOX</italic> and <italic>TOX2</italic> and suggested that TOX and NR4A positively regulate each other (<xref ref-type="bibr" rid="bib536">Seo et al., 2019</xref>).</p><p>Studies interrogating the stability of T cell dysfunction and exhaustion in the context of viral infection, autoimmunity, and malignancy have identified a number of states, some of which are defined by their inherent reversibility and others by their proliferative or progenitor capacity, although they are frequently referred to as reprogrammable-non-reprogrammable, partial-complete, or progenitor-terminal exhaustion (<xref ref-type="bibr" rid="bib458">Philip et al., 2017</xref>; <xref ref-type="bibr" rid="bib383">McLane et al., 2019</xref>; <xref ref-type="bibr" rid="bib525">Schietinger et al., 2016</xref>; <xref ref-type="bibr" rid="bib354">Long et al., 2016</xref>; <xref ref-type="bibr" rid="bib59">Blackburn et al., 2008</xref>; <xref ref-type="bibr" rid="bib443">Paley et al., 2012</xref>; <xref ref-type="bibr" rid="bib272">Im et al., 2016</xref>). Progenitor T<sub>Ex</sub>, or less-differentiated T<sub>Ex</sub>, express high levels of TCF-1 or T-bet and exhibit the capacity to replenish the terminally differentiated T<sub>Ex</sub> (<xref ref-type="bibr" rid="bib443">Paley et al., 2012</xref>; <xref ref-type="bibr" rid="bib272">Im et al., 2016</xref>; <xref ref-type="bibr" rid="bib642">Wu et al., 2016</xref>; <xref ref-type="bibr" rid="bib610">Utzschneider et al., 2016</xref>). Of note, these subsets typically respond quite differently upon treatment with PD-1 blockade with the progenitors expanding during therapy. As these states appear to be largely regulated at an epigenetic level, ATAC-seq has been used to reveal distinct chromatin states that distinguish dysfunctional tumor-specific CD8<sup>+</sup> T cells that can be recovered from those that are resistant to reprogramming (<xref ref-type="bibr" rid="bib458">Philip et al., 2017</xref>). Additional technologies have facilitated systems analyses of T cell exhaustion. A recent droplet-based ATAC-seq protocol that enables massively parallel scATAC-seq profiling was used to interrogate T cell exhaustion in tumors in the context of ICB (<xref ref-type="bibr" rid="bib518">Satpathy et al., 2019</xref>). The results revealed a massive expansion of T<sub>Ex</sub> in patients post treatment with PD1 blockade. The results further revealed differences in OCRs corresponding to intermediate and terminally-exhausted T<sub>Ex</sub> as well as a shared regulatory program between T<sub>Ex</sub> and T<sub>fh</sub>. A recent study that combined MARS-seq with single-cell TCR sequencing in melanoma patients to evaluate clonality of dysfunctional T cells revealed that the transcriptional profile of T cells forms a gradient of states exhibiting a range of profiles from highly cytotoxic to highly dysfunctional with shared clones occupying multiple transitional states of dysfunction (<xref ref-type="bibr" rid="bib339">Li et al., 2019</xref>) Surprisingly, although T<sub>Ex</sub> are thought to have a reduced proliferative capacity, the most proliferative T cells (by Ki67 and clonal expansion) were the dysfunctional T cells.</p><p>In addition to exhaustion, systems analyses of the TME have revealed a variety of other T cell features. By combining scRNA-seq with TCR sequencing, one group of investigators identified specific subsets of CD8<sup>+</sup> T cells and Tregs that are enriched in hepatocellular carcinoma compared to other tissues and identified a gene, LAYN, that inhibits IFN-γ production (<xref ref-type="bibr" rid="bib671">Zheng et al., 2017</xref>). The same investigators used this approach to characterize fate decisions in tumors, revealing a variety of relationships between various T cell subsets in the TME (<xref ref-type="bibr" rid="bib668">Zhang et al., 2018</xref>; <xref ref-type="bibr" rid="bib233">Guo et al., 2018</xref>). Studies interrogating the tumor specificity of tumor-infiltrating T cells by TCR sequencing (<xref ref-type="bibr" rid="bib524">Scheper et al., 2019</xref>) and mass cytometry (<xref ref-type="bibr" rid="bib550">Simoni et al., 2018</xref>) have revealed that many T cells within the TME do not actually recognize tumor antigens. In breast cancer, researchers used scRNA-seq to reveal that T cells with transcriptional profiles analogous to resident memory T cells (T<sub>RM</sub>) can be found within tumors and correlate with improved prognosis (<xref ref-type="bibr" rid="bib521">Savas et al., 2018</xref>). Using scRNA-seq, ATAC-seq, and TCR-seq to query ICB responsiveness in melanoma patients revealed a variety of T cell-related factors that correspond to ICB efficacy including TCF7 expression on tumors and CD39 blockade (<xref ref-type="bibr" rid="bib508">Sade-Feldman et al., 2018</xref>). An additional study also suggests that T cells exist along a continuum of differentiation states evidenced by scRNA-seq analyses and that tumor-involved Tregs may exhibit more heterogeneity than previously appreciated (<xref ref-type="bibr" rid="bib30">Azizi et al., 2018</xref>). In agreement with scRNA-seq reports, a mass cytometry approach found that the lung cancer TME is enriched for T cells that are dysfunctional or regulatory (<xref ref-type="bibr" rid="bib327">Lavin et al., 2017</xref>).</p></sec><sec id="s6-4"><title>B cells</title><p>While far fewer studies have interrogated the roles of B cells in tumor progression and antitumor immunity than T cells, tumor-infiltrating B cells can be found in most solid malignancies and are readily amenable to the same types of systems analyses. The primary function of B cells is to orchestrate the humoral immune response through the production of antibodies, but there exist a number of different subsets of B cells that have additional functions (<xref ref-type="bibr" rid="bib10">Allman and Pillai, 2008</xref>). Some B cells can elicit immunosuppressive activity, including in the context of malignancy, through a variety of mechanisms including expression of PD-L1 and production of IL-10, IL-35, and TGF-β leading some to refer to this subset as regulatory B cells (Bregs) in analogy to Tregs (<xref ref-type="bibr" rid="bib527">Schioppa et al., 2011</xref>; <xref ref-type="bibr" rid="bib647">Yanaba et al., 2008</xref>; <xref ref-type="bibr" rid="bib501">Rosser and Mauri, 2015</xref>; <xref ref-type="bibr" rid="bib143">DiLillo et al., 2010</xref>; <xref ref-type="bibr" rid="bib301">Khan et al., 2015</xref>; <xref ref-type="bibr" rid="bib435">Olkhanud et al., 2011</xref>; <xref ref-type="bibr" rid="bib265">Huang et al., 2017</xref>). Production of cytokines from B cell subsets such as Bregs, B10 cells, or B1 cells can induce a myriad of effects, including repolarization of macrophage populations, induction of Tregs, or activation of survival signals within tumor cells themselves (<xref ref-type="bibr" rid="bib639">Wong et al., 2010</xref>; <xref ref-type="bibr" rid="bib393">Mielle et al., 2018</xref>; <xref ref-type="bibr" rid="bib13">Ammirante et al., 2010</xref>). Furthermore, B cells can promote lymphangiogenesis (<xref ref-type="bibr" rid="bib16">Angeli et al., 2006</xref>), which, in turn, can enable trafficking of DCs or tumor cells themselves from primary tumors to draining LNs (<xref ref-type="bibr" rid="bib495">Roberts et al., 2016</xref>; <xref ref-type="bibr" rid="bib55">Binnewies et al., 2019</xref>; <xref ref-type="bibr" rid="bib564">Stacker et al., 2014</xref>; <xref ref-type="bibr" rid="bib584">Tammela and Alitalo, 2010</xref>). Consequently, B cells have frequently been associated with promoting tumorigenesis and metastasis (<xref ref-type="bibr" rid="bib134">de Visser et al., 2005</xref>; <xref ref-type="bibr" rid="bib539">Shah et al., 2005</xref>; <xref ref-type="bibr" rid="bib474">Qin et al., 1998</xref>; <xref ref-type="bibr" rid="bib3">Affara et al., 2014</xref>; <xref ref-type="bibr" rid="bib70">Brodt and Gordon, 1982</xref>). These immunosuppressive mechanisms typically occur in a manner that does not require antigen recognition by the BCR (<xref ref-type="bibr" rid="bib539">Shah et al., 2005</xref>). Yet other studies have suggested that the production of antibodies themselves may promote tumor progression and metastasis by activation of Fc Receptors (FcRs) on myeloid cells, induction of tumor-intrinsic signaling through activation of surface receptors, promotion of pro-inflammatory granulocyte responses, promotion of angiogenesis, and suppression of cellular immunity (<xref ref-type="bibr" rid="bib474">Qin et al., 1998</xref>; <xref ref-type="bibr" rid="bib470">Pucci et al., 2016</xref>; <xref ref-type="bibr" rid="bib228">Gu et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Andreu et al., 2010</xref>; <xref ref-type="bibr" rid="bib36">Barbera-Guillem et al., 1999</xref>; <xref ref-type="bibr" rid="bib432">Nyhus et al., 2001</xref>; <xref ref-type="bibr" rid="bib585">Tan and Coussens, 2007</xref>).</p><p>Although B cells have the potential to elicit these tumor-promoting effects, they have also been implicated as key regulators of antitumor immunity in the context of immunotherapy. Tumors often acquire tertiary lymphoid structures (TLSs), which closely resemble lymphoid follicles, containing T cells, B cells, FDCs, T<sub>fh</sub>-like cells, fibroblast reticular cells (FRCs), and even high endothial venules (HEVs) (<xref ref-type="bibr" rid="bib287">Jones et al., 2016</xref>; <xref ref-type="bibr" rid="bib216">Goc et al., 2013</xref>; <xref ref-type="bibr" rid="bib142">Dieu-Nosjean et al., 2014</xref>; <xref ref-type="bibr" rid="bib112">Colbeck et al., 2017</xref>). Although TLSs can serve as a source of protumoral Tregs (<xref ref-type="bibr" rid="bib289">Joshi et al., 2015</xref>), their presence in tumors has classically correlated with improved survival in a variety of cancers (<xref ref-type="bibr" rid="bib112">Colbeck et al., 2017</xref>; <xref ref-type="bibr" rid="bib322">Ladányi et al., 2007</xref>; <xref ref-type="bibr" rid="bib141">Dieu-Nosjean et al., 2008</xref>; <xref ref-type="bibr" rid="bib462">Pitzalis et al., 2014</xref>). Like SLOs, these TLSs contain germinal centers (GCs) where B cells can proliferate and undergo class switching and somatic hypermutation (<xref ref-type="bibr" rid="bib204">GeurtsvanKessel et al., 2009</xref>; <xref ref-type="bibr" rid="bib455">Perros et al., 2012</xref>; <xref ref-type="bibr" rid="bib418">Neyt et al., 2012</xref>), and the presence and differentiation of B cells, in particular, within GCs correlates with improved prognosis (<xref ref-type="bibr" rid="bib200">Germain et al., 2014</xref>). Thus, activation of humoral responses within TLS can improve responses, particularly in the context of immunotherapy (<xref ref-type="bibr" rid="bib200">Germain et al., 2014</xref>; <xref ref-type="bibr" rid="bib247">Helmink et al., 2020</xref>; <xref ref-type="bibr" rid="bib398">Montfort et al., 2017</xref>; <xref ref-type="bibr" rid="bib519">Sautès-Fridman et al., 2016</xref>; <xref ref-type="bibr" rid="bib117">Cottrell et al., 2018</xref>; <xref ref-type="bibr" rid="bib520">Sautès-Fridman et al., 2019</xref>). Furthermore, while FcR binding of tumor-immune complexes has been suggested to promote tumor progression (<xref ref-type="bibr" rid="bib15">Andreu et al., 2010</xref>), we have found that combining tumor-binding antibodies with DC adjuvants and CD40 agonists results in extremely potent anti-tumor responses in a manner that is FcR-dependent (<xref ref-type="bibr" rid="bib563">Spitzer et al., 2017</xref>; <xref ref-type="bibr" rid="bib90">Carmi et al., 2015</xref>; <xref ref-type="bibr" rid="bib91">Carmi et al., 2016</xref>).</p><p>Given the importance of B cells in both tumor progression and antitumor responses, researchers have begun to apply a variety of systems-level approaches to elucidate their roles in malignancy. While the use of TCR repertoire profiling is discussed in detail in the following section, analogous approaches have been developed for BCRs and employed in the context of malignancy to identify the sequences of tumor-reactive antibodies and identify their cognate antigens (<xref ref-type="bibr" rid="bib294">Katoh et al., 2017</xref>). Building upon their TRUST algorithm developed to identify TCR CDR3 sequences from bulk RNA-seq data (<xref ref-type="bibr" rid="bib337">Li et al., 2016a</xref>), researchers adapted their approach to BCRs to evaluate humoral responses in TCGA data across 32 cancer types (<xref ref-type="bibr" rid="bib264">Hu et al., 2019</xref>). They characterized broad clonal expansion across malignancies and suggested roles for subclass switching in conjunction with defective ADCC. The roles that these alterations play in tumor progression or anti-tumor immune responses, however, remain to be clarified. Similarly, as part of their characterization of six distinct conserved immune subtypes using TCGA data, researchers employed immunoglobulin heavy chain repertoire profiling using V’DJer (<xref ref-type="bibr" rid="bib400">Mose et al., 2016</xref>) on bulk RNA-seq data. This analysis revealed high variance of IgH diversity depending on immune subtype with the IFN-γ and TGFβ dominated subtypes exhibiting high variance and the ‘lymphocyte depleted’ and ‘immunologically quiet’ subtypes exhibiting considerably lower diversity.</p><p>To understand the role of TLS B cells during immunotherapy, one group combined bulk RNA-seq of melanoma and renal cell carcinoma (RCC) responders and non-responders with deconvolution algorithms to identify a strong enrichment in B cell signatures in responders. They further analyzed the BCRs of these patients from the bulk RNA-seq and found increases in both clonal diversity and expansion of individual clones in responders, suggesting antigen-specific humoral responses. Finally, using mass cytometry, they demonstrated an enrichment for memory B cells, plasma cells, and GC B cells specifically within the tumors of responders, suggesting a role for B cell activation and humoral responses in patients benefiting from ICB (<xref ref-type="bibr" rid="bib247">Helmink et al., 2020</xref>). Other researchers combined novel GEMMs with BCR sequencing and scRNA-seq to identify a role for T<sub>fh</sub>-induced B cells in promoting ICB responses (<xref ref-type="bibr" rid="bib255">Hollern et al., 2019</xref>). While not as common as existing T cell analyses, these types of multimodal systems approaches to understanding the involvement of B cells in malignancy and associated therapeutic responses will be critical for uncovering the role that these lymphocytes play in tumor progression and treatment.</p></sec><sec id="s6-5"><title>NK cells, non-canonical APCs, and other myeloid cells</title><p>Although T cells, B cells, TAMS, and DCs have been the subject of the majority of systems analyses of the TME, other lymphocytes, myeloid cells, and non-hematopoietic APCs play important roles in tumor progression. Similarly, the importance of NK cells and other innate lymphoid cells (ILCs) (<xref ref-type="bibr" rid="bib94">Cerwenka and Lanier, 2001</xref>; <xref ref-type="bibr" rid="bib643">Wu and Lanier, 2003</xref>; <xref ref-type="bibr" rid="bib374">Marcus et al., 2014</xref>; <xref ref-type="bibr" rid="bib369">Malmberg et al., 2017</xref>; <xref ref-type="bibr" rid="bib261">Hsu et al., 2018</xref>; <xref ref-type="bibr" rid="bib75">Bruchard and Ghiringhelli, 2019</xref>) and PMNs (<xref ref-type="bibr" rid="bib583">Szczerba et al., 2019</xref>; <xref ref-type="bibr" rid="bib178">Fridlender et al., 2009</xref>; <xref ref-type="bibr" rid="bib431">Nozawa et al., 2006</xref>; <xref ref-type="bibr" rid="bib460">Piccard et al., 2012</xref>; <xref ref-type="bibr" rid="bib167">Eruslanov et al., 2014</xref>; <xref ref-type="bibr" rid="bib553">Singhal et al., 2016</xref>) in tumor progression have been well documented but are only beginning to be explored at a systems level (<xref ref-type="bibr" rid="bib677">Zilionis et al., 2019</xref>; <xref ref-type="bibr" rid="bib259">Horowitz et al., 2013</xref>). In addition to DCs, macrophages, and B cells, there exist a number of non-professional APCs capable of inducing tolerance (<xref ref-type="bibr" rid="bib608">Turley et al., 2010</xref>). Many of these cells, such as lymphatic endothelial cells and fibroblastic reticular cells, exist in or near SLOs and can induce tolerance or immunosuppression, including in the context of tumors (<xref ref-type="bibr" rid="bib110">Cohen et al., 2010</xref>; <xref ref-type="bibr" rid="bib420">Nichols et al., 2007</xref>; <xref ref-type="bibr" rid="bib358">Lund et al., 2012</xref>; <xref ref-type="bibr" rid="bib359">Lund et al., 2016</xref>; <xref ref-type="bibr" rid="bib582">Swartz, 2014</xref>; <xref ref-type="bibr" rid="bib175">Fletcher et al., 2010</xref>; <xref ref-type="bibr" rid="bib176">Fletcher et al., 2015</xref>; <xref ref-type="bibr" rid="bib329">Lee et al., 2007</xref>). The functional relevance of these cells in the induction of tumor-specific immune tolerance is in its nascent days of exploration, and systems approaches will certainly aid in advancing our understanding of their role in tumor progression.</p><p>For over a decade there has been interest in a group of cells frequently associated with tumors referred to as ‘myeloid derived suppressor cells’ (MDSCs). This nomenclature was based upon expression of the integrin subunit αM (CD11b) and staining (in mice) for a marker known as ‘Gr-1’ with an antibody that exhibits a high affinity for Ly-6G and weak affinity for Ly-6C (<xref ref-type="bibr" rid="bib184">Gabrilovich et al., 2007</xref>). It should be noted that CD11b, Ly-6G, and Ly-6C are expressed on a wide range of immune cells at various levels including monocytes, neutrophils (PMNs), macrophages, DCs, NK cells, and even T cells. Numerous studies, including our own, have revealed that cells bearing these markers can promote tumor progression, metastasis, or suppression of T cell immunity (<xref ref-type="bibr" rid="bib487">Reticker-Flynn and Bhatia, 2015</xref>; <xref ref-type="bibr" rid="bib185">Gabrilovich, 2017</xref>). Nonetheless, expression of these markers, on their own, does not confer immune suppressive function. Indeed, anti-Gr-1 antibodies are frequently used to deplete neutrophils, although such antibodies also deplete some monocytes and T cells due to their Ly-6C expression (<xref ref-type="bibr" rid="bib127">Daley et al., 2008</xref>; <xref ref-type="bibr" rid="bib170">Faget et al., 2018</xref>). Furthermore, many studies have demonstrated the immune-suppressive and tumor-promoting capacities of PMNs (<xref ref-type="bibr" rid="bib178">Fridlender et al., 2009</xref>; <xref ref-type="bibr" rid="bib460">Piccard et al., 2012</xref>), monocytes (<xref ref-type="bibr" rid="bib472">Qian et al., 2011</xref>; <xref ref-type="bibr" rid="bib292">Jung et al., 2017</xref>), macrophages (<xref ref-type="bibr" rid="bib430">Noy and Pollard, 2014</xref>), and DCs (<xref ref-type="bibr" rid="bib297">Kenkel et al., 2017</xref>; <xref ref-type="bibr" rid="bib549">Shurin et al., 2013</xref>) in tumors, making it unclear whether MDSCs represent a distinct activation state or lineage from those cell types. In an attempt to clarify the nature of this population, researchers have further divided MDSCs into granulocytic and monocytic lineages, but acknowledge that the differentiating markers have no impact on the suppressive function of these cells (<xref ref-type="bibr" rid="bib654">Youn et al., 2008</xref>). Analogous subsets have been described in humans and their identification also relies upon markers shared by many known hematopoietic subsets (<xref ref-type="bibr" rid="bib71">Bronte et al., 2016</xref>; <xref ref-type="bibr" rid="bib372">Mandruzzato et al., 2016</xref>). Reliance upon these nonspecific markers has resulted in a concerning number of publications claiming MDSC classification without functionally validating the suppressive capacity of the cells. Functional analysis of sorted populations does not prove that the cells of interest are distinct from other myeloid populations (e.g. monocytes, macrophages, DCs, or neutrophils), but is capable of determining whether some cells in the sorted population have suppressive capacity (<xref ref-type="bibr" rid="bib71">Bronte et al., 2016</xref>).</p><p>Systems biology approaches provide a more comprehensive agnostic approach toward evaluating the myeloid repertoire, as has been discussed above. One study purports to identify a specific marker, LOX-1, of PMN-MDSCs by bulk RNA-seq, though this marker is only upregulated in human PMN-MDSCs (<xref ref-type="bibr" rid="bib113">Condamine et al., 2016</xref>). Separation of the PMN-MDSC population from PMNs, however, was performed by density centrifugation, which results in mixed populations, highlighting the inadequacy of bulk analysis approaches for populations without unique markers. While LOX-1<sup>+</sup> cells exhibit an increased capacity to suppress T cell responses, it is unclear whether this is a feature of all LOX-1<sup>+</sup> cells or a subset and whether the marker represents a distinct lineage rather than an activation or maturation state of PMNs. Furthermore, genetic ablation of the gene (<italic>Olr1</italic>) in mice had no impact on the suppressive function of the cells in vitro nor growth of tumors in wild-type mice reconstituted with <italic>Olr1<sup>-/-</sup></italic> bone marrow following lethal irradiation. In contrast to bulk approaches, single-cell analyses such as scRNA-seq are particularly useful for identifying distinguishing features of individual cells, evaluating heterogeneity of populations, and reconstructing lineage relationships between populations. Indeed, when unbiased clustering of systems level single-cell data has been performed under a myriad of conditions, none of the studies report the existence of distinct MDSC clusters (<xref ref-type="bibr" rid="bib563">Spitzer et al., 2017</xref>; <xref ref-type="bibr" rid="bib471">Puram et al., 2017</xref>; <xref ref-type="bibr" rid="bib30">Azizi et al., 2018</xref>; <xref ref-type="bibr" rid="bib598">Tirosh et al., 2016</xref>; <xref ref-type="bibr" rid="bib55">Binnewies et al., 2019</xref>; <xref ref-type="bibr" rid="bib508">Sade-Feldman et al., 2018</xref>). In one recent exception, researchers labeled a myeloid cluster ‘MDSC-like macrophages’ due to their expression of S100A family genes, but the suppressive capacity of these cells was not evaluated. Furthermore, these cells fell along a continuum with other macrophages on diffusion maps and did not distinctly segregate from other myeloid populations in the UMAP projections. Current transcriptional, epigenetic, and proteomic analyses do not support the notion that MDSCs represent a singular or dual lineage(s) or distinct differentiation states. Most likely, they represent a heterogeneous plastic phenotypic state of neutrophils, monocytes, macrophages, and their precursors, some of which exhibit immune suppressive capacity. Thus, it is best to use caution when employing a nomenclature that ascribes function based solely upon unrelated marker expression.</p></sec><sec id="s6-6"><title>T cell receptor repertoires and neoantigens: understanding and harnessing tumor-immune specificity</title><p>While the generation of effective naturally occurring or therapeutically induced immune responses typically requires the involvement of many immune cell types, T cells are frequently the most critical element of these responses. Patient prognosis often correlates with the degree of T cell infiltration into tumors (<xref ref-type="bibr" rid="bib188">Galon et al., 2006</xref>; <xref ref-type="bibr" rid="bib662">Zhang et al., 2003</xref>), and adoptive transfer of ex vivo stimulated autologous tumor infiltrating lymphocytes remains one of the most effective tumor immunotherapies (<xref ref-type="bibr" rid="bib499">Rosenberg et al., 2008</xref>; <xref ref-type="bibr" rid="bib498">Rosenberg et al., 1988</xref>). Similarly, CAR-T therapy involves engineering T cells to directly recognize tumors, and ICB works by stimulating or reinvigorating tumor-reactive T cells. A critical factor explaining the efficacy of T cell responses to tumors is the ability of the TCR to distinguish malignant from healthy tissue by its overexpression of normal antigens, re-expression of embryonic antigens, or expression of neoantigens (mutated proteins expressed only by the malignant cells). Neoantigens are frequently genomic in origin, resulting from point mutations, indels, or translocations, but can also arise from post-translational modifications such as phosphorylation or glycosylation (<xref ref-type="bibr" rid="bib67">Bräunlein and Krackhardt, 1702</xref>; <xref ref-type="bibr" rid="bib109">Cobbold et al., 2013</xref>; <xref ref-type="bibr" rid="bib661">Zarling et al., 2006</xref>). Some cancers may escape T cell surveillance by reducing or eliminating expression of these neoantigens in a process known as ‘immunoediting’ (<xref ref-type="bibr" rid="bib157">DuPage et al., 2012</xref>; <xref ref-type="bibr" rid="bib378">Matsushita et al., 2012</xref>; <xref ref-type="bibr" rid="bib529">Schreiber et al., 2011</xref>), while others escape by downregulating MHC-I presentation (<xref ref-type="bibr" rid="bib454">Pereira et al., 2017</xref>; <xref ref-type="bibr" rid="bib507">Sade-Feldman et al., 2017</xref>; <xref ref-type="bibr" rid="bib203">Gettinger et al., 2017</xref>; <xref ref-type="bibr" rid="bib660">Zaretsky et al., 2016</xref>; <xref ref-type="bibr" rid="bib510">Sahin et al., 2017</xref>). Furthermore, efficacy of ICB is correlated with neoantigen burden for a variety of cancers (<xref ref-type="bibr" rid="bib650">Yarchoan et al., 2017</xref>; <xref ref-type="bibr" rid="bib558">Snyder et al., 2014</xref>; <xref ref-type="bibr" rid="bib88">Carbone et al., 2017</xref>; <xref ref-type="bibr" rid="bib492">Rizvi et al., 2015a</xref>; <xref ref-type="bibr" rid="bib189">Galsky et al., 2017</xref>; <xref ref-type="bibr" rid="bib381">McGranahan et al., 2016</xref>), and tumor mutational burden (TMB) may be a better predictor of ICB response than PD-L1-positive staining in some instances (<xref ref-type="bibr" rid="bib246">Hellmann et al., 2018</xref>). Furthermore, the degree to which neoantigens are shared across tumor clones also correlates with ICB efficacy (<xref ref-type="bibr" rid="bib381">McGranahan et al., 2016</xref>). Consequently, bioinformaticians and systems biologists have developed an array of tools and approaches for predicting and quantifying neoantigens as well as mapping T cell clonality and neoantigen recognition (<xref ref-type="bibr" rid="bib353">Liu and Mardis, 2017</xref>).</p><p>As effective anti-tumor immune responses typically involve T cell recognition of neoantigens, approaches have been developed to vaccinate patients against the neoantigens of their tumors. Early attempts at cancer vaccines and cell therapies did not rely upon a priori knowledge of the specific neoantigens of the tumors (<xref ref-type="bibr" rid="bib177">Fong and Engleman, 2000</xref>; <xref ref-type="bibr" rid="bib500">Rosenberg and Restifo, 2015</xref>). Building off initial proof-of-principal studies in mice (<xref ref-type="bibr" rid="bib370">Mandelboim et al., 1994</xref>; <xref ref-type="bibr" rid="bib371">Mandelboim et al., 1995</xref>; <xref ref-type="bibr" rid="bib93">Castle et al., 2012</xref>), a variety of strategies have recently been designed to specifically target the neoantigens of patient tumors (<xref ref-type="bibr" rid="bib531">Schumacher and Schreiber, 2015</xref>; <xref ref-type="bibr" rid="bib236">Hacohen et al., 2013</xref>). The existence of mutations within tumors does not mean that those mutations will serve as neoantigens. In order for a given mutation to result in T cell recognition, it must be in a protein coding region, be non-synonymous, be in a gene that is expressed by the tumor cells, be maintained following proteasomal degradation, result in a peptide that can be loaded onto the specific MHC-I molecules of that patient, and, of course, be recognized by the TCR of a T cell that can enter the tumor. A variety of tools have been developed to use WES data (often combined with RNA-seq data) to predict potential neoantigens in a tumor (<xref ref-type="bibr" rid="bib58">Bjerregaard et al., 2017</xref>; <xref ref-type="bibr" rid="bib360">Lundegaard et al., 2008</xref>; <xref ref-type="bibr" rid="bib224">Gowthaman et al., 2010</xref>; <xref ref-type="bibr" rid="bib479">Rajasagi et al., 2014</xref>; <xref ref-type="bibr" rid="bib155">Duan et al., 2014</xref>; <xref ref-type="bibr" rid="bib268">Hundal et al., 2016</xref>; <xref ref-type="bibr" rid="bib357">Łuksza et al., 2017</xref>). Additionally, MS has been used to characterize the peptidome of tumors to identify neoantigens directly, frequently by affinity purification of HLA molecules and MS analysis of eluted HLA-bound peptides (<xref ref-type="bibr" rid="bib120">Creech, 2018</xref>; <xref ref-type="bibr" rid="bib119">Cox et al., 1994</xref>; <xref ref-type="bibr" rid="bib469">Pritchard et al., 2015</xref>; <xref ref-type="bibr" rid="bib40">Bassani-Sternberg et al., 2010</xref>). Using these types of tools, researchers have begun testing pipelines for developing personalized neoantigen vaccines in humans (<xref ref-type="bibr" rid="bib510">Sahin et al., 2017</xref>; <xref ref-type="bibr" rid="bib438">Ott et al., 2017</xref>; <xref ref-type="bibr" rid="bib92">Carreno et al., 2015</xref>; <xref ref-type="bibr" rid="bib263">Hu et al., 2017b</xref>). These approaches typically begin with excision of tumors and WES to identify candidate neoantigen peptides. In one case, long peptides (15 to 30 amino acids) were synthesized containing the top candidate peptides and administered to patients in conjunction with immune adjuvants in multiple priming and boosting injections. Use of the long peptides was chosen to enable elicitation of both CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses. To improve HLA-binding prediction, the same researchers used an LC-MS/MS approach wherein peptides were eluted from single HLA allele-expressing cell lines and subjected to MS resulting in the identification of 24,000 peptides and their cognate HLA class I molecules (<xref ref-type="bibr" rid="bib2">Abelin et al., 2017</xref>). Furthermore, using this database of peptide-MHC interactions, they trained a neural network algorithm to predict peptide loading with a higher degree of accuracy than preexisting binding affinity-based approaches. The initial neoantigen vaccine trials have now been extended to glioblastoma, a notoriously immune cold tumor, and appear to generate antigen-specific T cells and increases in tumor infiltration by the T cells (<xref ref-type="bibr" rid="bib299">Keskin et al., 2019</xref>).</p><p>In addition to vaccine design, systems approaches to neoantigen identification have been employed for TIL therapy. Following analogous approaches as used for vaccines, researchers identified candidate peptides based on WES of 75 patients with GI cancers. They then screened TIL cultures by ELISPOT for reactivity in response to autologous DCs pulsed with the peptides or transfected with minigenes harboring the mutations. By subsequently sequencing TCRs of T cells responding to particular neoantigens they were then able to transduce new T cells with these TCRs to enable greater T cell expansion and the ability to generate personalized T cell therapies (<xref ref-type="bibr" rid="bib447">Parkhurst et al., 2019</xref>). These types of approaches highlight the potential benefits that systems biology can bring to patient care and personalized medicine. Only by taking advantage of the synergies of high-throughput technologies, novel bioinformatics approaches, mathematical models, and the ability to monitor and predict immune responses across an entire patient can such an approach be rendered feasible and uncover new avenues for patient care and tumor immunotherapy.</p><p>While antitumor T cell-mediated immunity is typically predicated upon recognition of tumor-specific antigens, it also requires a TCR repertoire capable of recognizing those epitopes. The profound diversity of the TCR is not germline encoded but rather is the consequence of V(D)J rearrangement that results in the generation of more possible sequences than there are T cells within an individual (<xref ref-type="bibr" rid="bib25">Arstila et al., 1999</xref>). While conventional T cells recognize only specific antigens, the TCR is relatively cross-reactive compared to antibodies. One elegant systems-level study used yeast display of peptide-MHC constructs to reveal that a given TCR is capable of recognizing hundreds of distinct peptides provided that they contain specific ‘hot spots’ where the TCR contacts the complex (<xref ref-type="bibr" rid="bib56">Birnbaum et al., 2014</xref>). The peptides shared among a cross-reactive TCR bear many similarities, permitting researchers to predict potential naturally-occurring ligands given a TCR sequence. The group that developed this approach subsequently applied it to CRC by sequencing patient tumors and TCRs to determine peptide-MHC ligands for expanded TILs (<xref ref-type="bibr" rid="bib195">Gee et al., 2018</xref>). Epitope prediction revealed TCR-specificity including multiple TCRs that recognized non-mutated self-antigens. Nonetheless, prediction of TCR ligands from their sequences remains one of the holy grails of immunology. To address this need, researchers developed GLIPH, an algorithm capable of grouping TCRs based on predicted shared epitopes using similarity of the CDR3 regions and demonstrated that they could predict shared binding partners across individuals (<xref ref-type="bibr" rid="bib214">Glanville et al., 2017</xref>). Another study combined MHC tetramer selection with single-cell TCR sequencing to develop an algorithm, TCRdist, that also groups TCRs of related specificities (<xref ref-type="bibr" rid="bib129">Dash et al., 2017</xref>). Such approaches might help researchers understand whether distinct clones in a patient recognize similar antigens, perhaps present at different tumor sites or even across different patients with similar malignancies. Cancer systems immunologists could exploit existing TCR sequencing data to determine the antigens most frequently recognized by T cells in patients responding to ICB, for example.</p><p>In addition to identifying epitopes, understanding the clonal evolution of the T cell response as well as the phenotypes of T cells bearing TCRs of a particular specificity can be highly informative when considering the immune responses to tumors. To investigate the relationships between functions of T cells and their TCR specificity, researchers developed a single-cell sequencing approach for T cells that combines targeted RNA-seq with TCRα and TCRβ gene sequencing (<xref ref-type="bibr" rid="bib239">Han et al., 2014</xref>). Applying their approach to CRC, they found expanded clones within the tumors that shared specificity and were absent from adjacent normal tissue. Similarly, other researchers combined scATAC-seq with TCR-seq to evaluate clonal relationships with epigenetic profiles and applied it to patients with cutaneous T cell lymphoma to identify differences in the regulatory pathways between normal and leukemic T cells (<xref ref-type="bibr" rid="bib517">Satpathy et al., 2018</xref>). In a recent study, this same group combined single-cell TCR and RNA sequencing on nearly 80,000 cells from patients with basal and squamous cell carcinomas before and after ICB treatment with anti-PD1 (<xref ref-type="bibr" rid="bib653">Yost et al., 2019</xref>). By comparing clonotypes with phenotypes, they showed that exhausted and effector CD8<sup>+</sup> T cells in tumors shared clonotypes with memory T cells but not with each other, suggesting that these distinct states are not shared between the same T cell clones. Even more notably, they found considerable expansion of T<sub>Ex</sub> post-treatment that did not exist before therapy, with only minor contributions from pre-existing <italic>TCF7</italic><sup>+</sup> clones. These clones can be found within the blood at much lower percentages. In contrast with conventional wisdom suggesting that ICB works by reinvigorating existing T cells within the TME, these results suggest that anti-PD1 stimulates recruitment of new tumor-specific T cells to the TME and are in agreement with our own findings that trafficking of lymphocytes from SLOs is required for effective immunotherapy (<xref ref-type="bibr" rid="bib563">Spitzer et al., 2017</xref>). While this approach cannot rule out the existence of rare T cell clones in the TME prior to treatment that exist below the sequencing depth and expand following treatment, the data suggest this is unlikely and future complementary systems-level studies interrogating clonal trafficking could help shed light on this question.</p><p>Nonetheless, while these T<sub>Ex</sub> clones that are tumor-specific can be found within blood of treated patients and recruitment of T cells from SLOs is important for treatment efficacy, some of these effects may be transient, and it remains unclear which T cell populations are the most critical for effective immunotherapy. It is possible that T<sub>mem</sub> and cells from both T<sub>Ex</sub> states within the TME and extratumoral tissues play important roles during immunotherapy. It is important to note that autologous transplant of ex vivo expanded tumor-infiltrating lymphocytes (TIL therapy) has proven effective, and even curative, in a number of malignancies including melanoma, breast cancer, and multiple GI cancers (<xref ref-type="bibr" rid="bib498">Rosenberg et al., 1988</xref>; <xref ref-type="bibr" rid="bib500">Rosenberg and Restifo, 2015</xref>; <xref ref-type="bibr" rid="bib156">Dudley et al., 2002</xref>; <xref ref-type="bibr" rid="bib485">Restifo et al., 2012</xref>; <xref ref-type="bibr" rid="bib602">Tran et al., 2014</xref>; <xref ref-type="bibr" rid="bib603">Tran et al., 2016</xref>; <xref ref-type="bibr" rid="bib657">Zacharakis et al., 2018</xref>). Moreover, in the case of melanoma, some patients who have failed ICB still benefit from TIL therapy (<xref ref-type="bibr" rid="bib514">Sarnaik et al., 2020</xref>; <xref ref-type="bibr" rid="bib497">Rohaan et al., 2018</xref>). These successes highlight the fact that there exist tumor-specific T cells within tumors that can be expanded and used to eliminate tumors. Thus, it is unclear whether these T cells reflect exhausted or dysfunctional T cells whose state is reversible in the context of ex vivo expansion with or without engineering or whether there exist a minority subset of tumor-specific T cells that are not in any state of exhaustion and can be expanded and act as T<sub>Eff</sub> and T<sub>mem</sub> once reinfused. In either case, it is quite reasonable to expect that ICB and TIL therapy have highly distinct effects on the nature of the T cells eliciting the anti-tumor immunity. A systems-level characterization of TIL approaches might help shed light on the states of the expanded T cells, whether they were derived from progenitor T<sub>Ex</sub> or other T cell subsets, and to what extent the ex vivo processing is capable of reprogramming them.</p></sec><sec id="s6-7"><title>The microbiome and its effects on tumor immunity</title><p>Microbiota consist of the microorganisms that inhabit a host and include bacteria, fungi, viruses, and archaea. Sites such as the skin, respiratory tract, gastrointestinal tract, and vagina are colonized by these organisms, which play critical roles in health and disease. Systems approaches and –omics, in particular, have been utilized extensively to analyze the microbiota, resulting in the adoption of the term ‘microbiome’ to represent the collection of these organisms in a host. The microbiome affects everything from obesity, to resistance to colonization by pathogenic bacteria, to cancer (<xref ref-type="bibr" rid="bib491">Ridaura et al., 2013</xref>; <xref ref-type="bibr" rid="bib456">Petersen et al., 2019</xref>; <xref ref-type="bibr" rid="bib277">Jacobson et al., 2018</xref>; <xref ref-type="bibr" rid="bib271">Iida et al., 2013</xref>; <xref ref-type="bibr" rid="bib81">Buffie et al., 2015</xref>; <xref ref-type="bibr" rid="bib616">van Nood et al., 2013</xref>; <xref ref-type="bibr" rid="bib620">Viaud et al., 2013</xref>; <xref ref-type="bibr" rid="bib555">Sivan et al., 2015</xref>; <xref ref-type="bibr" rid="bib619">Vetizou et al., 2015</xref>; <xref ref-type="bibr" rid="bib222">Gopalakrishnan et al., 2018</xref>; <xref ref-type="bibr" rid="bib503">Routy et al., 2018</xref>; <xref ref-type="bibr" rid="bib588">Tanoue et al., 2019</xref>; <xref ref-type="bibr" rid="bib377">Matson et al., 2018</xref>; <xref ref-type="bibr" rid="bib192">Garrett, 2015</xref>; <xref ref-type="bibr" rid="bib488">Reticker-Flynn and Engleman, 2019</xref>). While the microbiome mediates some of these effects directly (e.g. production of short-chain fatty acids), many are the indirect result of effects upon the immune system (<xref ref-type="bibr" rid="bib588">Tanoue et al., 2019</xref>; <xref ref-type="bibr" rid="bib257">Honda and Littman, 2016</xref>; <xref ref-type="bibr" rid="bib380">Mazmanian et al., 2005</xref>; <xref ref-type="bibr" rid="bib27">Atarashi et al., 2017</xref>; <xref ref-type="bibr" rid="bib26">Atarashi et al., 2013</xref>; <xref ref-type="bibr" rid="bib276">Ivanov et al., 2009</xref>; <xref ref-type="bibr" rid="bib183">Gaboriau-Routhiau et al., 2009</xref>). In an effort to identify specific microbial components that are capable of influencing the adaptive immune response, researchers have colonized germ-free mice with feces from healthy human donors. Through 16S rRNA sequencing of the caecal contents of mice exhibiting enrichment of particular T cell subsets in their colons following fecal transplant or in comparison to mice under different housing conditions, they were able to define commensal consortia capable of inducing expansion of Tregs (<xref ref-type="bibr" rid="bib26">Atarashi et al., 2013</xref>), T<sub>H</sub>1 (<xref ref-type="bibr" rid="bib27">Atarashi et al., 2017</xref>), T<sub>H</sub>17 (<xref ref-type="bibr" rid="bib276">Ivanov et al., 2009</xref>; <xref ref-type="bibr" rid="bib183">Gaboriau-Routhiau et al., 2009</xref>), or IFN-γ<sup>+</sup> CD8<sup>+</sup> T cells (<xref ref-type="bibr" rid="bib588">Tanoue et al., 2019</xref>). The last of these resulted in expansion of the T cells not only within the intestines, but also throughout the host in a manner that was protective against <italic>Listeria monocytogenes</italic> and augmented the efficacy of ICB. Similarly, among tumor-bearing mice, a comparison of germ-free to specific pathogen-free mice or mice from different vendors demonstrated differences in tumor growth depending on the microbiota. Moreover, specific commensals affected responses to ICB, with <italic>Bifidobacterium</italic> aiding anti-PD-1 (<xref ref-type="bibr" rid="bib555">Sivan et al., 2015</xref>) and <italic>Bacteroidales fragilis</italic> aiding anti-CTLA-4 (<xref ref-type="bibr" rid="bib619">Vetizou et al., 2015</xref>). To investigate whether the microbiome influences responses to ICB in humans, researchers characterized the diversity and composition of the microbiomes of patients receiving these therapies. These results showed that increased diversity and enrichment for Ruminococcaceae family bacteria correlate with improved response to anti-PD-1 and increases in CD8<sup>+</sup> T cell activity (<xref ref-type="bibr" rid="bib222">Gopalakrishnan et al., 2018</xref>) and that <italic>Bifidobacterium longum</italic>, <italic>Collinsella aerofaciens</italic>, and <italic>Enterococcus faecium</italic> may also augment responses by expanding tumor-specific CD8<sup>+</sup> T cells without affecting Treg numbers (<xref ref-type="bibr" rid="bib377">Matson et al., 2018</xref>). Similarly, fecal transplant into mice from human ICB responders resulted in increased efficacy of PD-1 blockade compared to that from non-responders, possibly due to the effects on recruitment of a CD4<sup>+</sup> T cell subset (<xref ref-type="bibr" rid="bib503">Routy et al., 2018</xref>). The ability to identify defined microbiota capable of improving responses to tumor immunotherapy is extremely exciting and would have been highly challenging without the –omics-level profiling technologies. It remains unclear, however, precisely how changes in the intestinal microbiota elicit systemic changes in adaptive immunity that extend beyond the gastrointestinal tract and against antigens that are not being presented there. Systems approaches will be critical to reveal the mechanisms by which this antigen-specific systemic immunity is established in response to alterations in the microbiota. Ultimately, these investigations are likely to lead to new ways of improving patient responses to ICB and possibly to altogether novel immunotherapies.</p></sec><sec id="s6-8"><title>Systems approaches to designing, monitoring, and evaluating clinical responses to tumor immunotherapy</title><p>Cancer immunotherapy, and ICB in particular, represents one of the most significant advances in oncology in decades and has the ability to elicit durable responses and cures in some patients with advanced stage malignancies (<xref ref-type="bibr" rid="bib500">Rosenberg and Restifo, 2015</xref>; <xref ref-type="bibr" rid="bib66">Brahmer et al., 2012</xref>; <xref ref-type="bibr" rid="bib237">Hamid et al., 2013</xref>; <xref ref-type="bibr" rid="bib253">Hodi et al., 2010</xref>; <xref ref-type="bibr" rid="bib419">Nghiem et al., 2016</xref>; <xref ref-type="bibr" rid="bib445">Pardoll, 2012</xref>; <xref ref-type="bibr" rid="bib494">Robert et al., 2015</xref>; <xref ref-type="bibr" rid="bib543">Sharma and Allison, 2015</xref>; <xref ref-type="bibr" rid="bib493">Rizvi et al., 2015b</xref>; <xref ref-type="bibr" rid="bib227">Grupp et al., 2013</xref>; <xref ref-type="bibr" rid="bib68">Brentjens et al., 2013</xref>; <xref ref-type="bibr" rid="bib465">Porter et al., 2011</xref>; <xref ref-type="bibr" rid="bib291">June et al., 2018</xref>). Nonetheless, while subsets of patients with melanoma, RCC, Hodgkin’s lymphoma, NSCLC, urothelial cancer, and MSI high GI cancers have experienced durable responses and even complete tumor regression (<xref ref-type="bibr" rid="bib659">Zappasodi et al., 2018</xref>), the majority of patients who receive the therapy do not exhibit such responses. Thus, there is an urgent need to distinguish in advance of treatment which patients will respond to which therapies as well as learn why certain patients exhibit durable responses while others either fail to respond at all or relapse after varying periods of response. The tools and approaches used by systems biologists to investigate tumor immune biology have enabled a variety of new approaches for designing and evaluating clinical responses. In many ways, most clinical practice could be construed as systems biology. Clinicians integrate cellular and molecular blood biomarkers (e.g. blood chemistry, complete blood counts, hematocrit, serum immunoglobulin levels, etc.), imaging, and biophysical measurements (e.g. temperature, blood pressure, etc.) in a longitudinal manner to gain an understanding of disease progression. Thus, the practice of medicine epitomizes the multiscale integrated analyses that lie at the core of systems biology. Indeed, pharmaceutical companies have used systems biology approaches in drug discovery and clinical trial design (<xref ref-type="bibr" rid="bib84">Butcher et al., 2004</xref>). This holistic integration of multi-level datasets and the quantitation tools that accompany them render medicine amenable to the recent advances in cancer systems immunology and their application to evaluating tumor immunotherapy (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Clinical applications of cancer systems immunology.</title><p>Tumor and peripheral blood samples are frequently harvested from patients in a longitudinal fashion. Model organisms such as mice enable researchers to query as many tissues as desired. These samples can be subjected to high-dimensional analysis platforms such as various NGS modalities or mass cytometry. Results from these analyses have been used to monitor responses to ICB (including immune repertoire analysis), mapping changes in the immune system across an organism, and for the design of personalized neoantigen vaccines.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-53839-fig4-v1.tif"/></fig><p>Many of the systems approaches discussed in this review are now being applied to advancing our understanding of the effects of existing immunotherapies and designing new approaches. As discussed in the previous section, researchers and clinicians have combined WES of patient tumors with HLA-binding and TCR prediction algorithms to design personalized neoantigen peptide vaccines (<xref ref-type="fig" rid="fig4">Figure 4</xref>; <xref ref-type="bibr" rid="bib438">Ott et al., 2017</xref>; <xref ref-type="bibr" rid="bib263">Hu et al., 2017b</xref>; <xref ref-type="bibr" rid="bib299">Keskin et al., 2019</xref>). Staining for targeted costimulatory molecules (e.g. PD-L1) on tumors has exhibited variable predictive power in ICB, showing positive correlations in many studies but failing to predict responders whose tumors appear negative for the markers (<xref ref-type="bibr" rid="bib600">Topalian et al., 2012</xref>; <xref ref-type="bibr" rid="bib424">Nishino et al., 2017</xref>). In addition to the utility of WES in vaccine design, evaluation of neoantigen burden by WES has revealed that the response to anti-CTLA-4 (<xref ref-type="bibr" rid="bib558">Snyder et al., 2014</xref>) and anti-PD1 (<xref ref-type="bibr" rid="bib492">Rizvi et al., 2015a</xref>) therapies correlates with mutational burden. Recent studies have sought to exploit mass cytometry to develop high-dimensional cellular biomarkers of treatment response to ICB (<xref ref-type="bibr" rid="bib317">Krieg et al., 2018</xref>; <xref ref-type="bibr" rid="bib637">Wistuba-Hamprecht et al., 2017</xref>). One study identified not only differences in lymphocyte populations but also evidence of classical monocyte activation in PBMCs of patients who responded to anti-PD1 (<xref ref-type="bibr" rid="bib317">Krieg et al., 2018</xref>). Additionally, standardized mass cytometry-based immunophenotyping approaches have been developed for monitoring clinical responses to immunotherapies (<xref ref-type="bibr" rid="bib242">Hartmann et al., 2019</xref>), and this approach is currently being applied to monitoring responses to DC vaccination trials (<xref ref-type="bibr" rid="bib429">Nowicki et al., 2019</xref>). Similarly, scRNA-seq approaches are being considered for monitoring immune responses to therapies and evaluating tumor heterogeneity, and will become increasingly feasible with the continual reduction in cost of these technologies (<xref ref-type="bibr" rid="bib541">Shalek and Benson, 2017</xref>; <xref ref-type="bibr" rid="bib303">Kim et al., 2016</xref>).</p><p>In addition to monitoring therapy in patients, systems approaches can reveal underlying biology about responses to treatment. A recent study revealing the clonal replacement of exhausted T cells following ICB is one such example demonstrating the power of integrative systems analyses to improve our understanding of the mechanisms of ICB (<xref ref-type="fig" rid="fig4">Figure 4</xref>; <xref ref-type="bibr" rid="bib653">Yost et al., 2019</xref>). We believe that it is important to gain a holistic understanding of how immunity is orchestrated across an organism in order to understand the basis of immune responses in cancer. By combining our visualization method known as Statistical Scaffold with mass cytometry, we were able to generate an organism-wide map of differences in immune responses that distinguish effective from ineffective immunotherapy (<xref ref-type="bibr" rid="bib563">Spitzer et al., 2017</xref>). This approach allowed us to compare immune repertoires in distinct tissues to each other and across treatment conditions, facilitating a systems-level understanding of immune responses across an organism. In addition to identifying differences in key immune populations such as a subset activated memory CD4<sup>+</sup> T cells, we found that the key differentiator of effective immune responses is its orchestration from extratumoral sites such as LNs rather than a simple reinvigoration of existing TILs. Information gleaned from these types of systems-level analyses should facilitate the design of approaches that augment our current arsenal of immunotherapies (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p></sec><sec id="s6-9"><title>Expanding the future potential of cancer systems immunology</title><p>Technological and computational advances in the life sciences and the profound clinical successes of tumor immunotherapy have ushered the fields of systems biology and tumor immunology to the forefront of biomedical research. Understandably, the application of systems biology to tumor immunology is intuitive and has generated considerable excitement. Once lauded as representing the future of optimal cancer treatment and potential cures, personalized medicine fell out of fashion with the failure of targeted therapies to realize their promise (<xref ref-type="bibr" rid="bib412">Nature Biotechnology, 2012</xref>). While –omics technologies bolstered the original enthusiasm for the field, they were ultimately applied in a reductionist fashion. Personalized medicine in cancer used to be construed as identifying oncogenic mutations and designing and treating with targeted small molecule or biological inhibitors of these mutations. These approaches demonstrated the innate shortcoming of reductionist analyses; that is, they fail to account for the inherent complexity of the tumor and its context within the patient. Escape mechanisms can involve a myriad of molecules and cell types requiring systems-level analyses to understand the emergent behavior of the tumor and its interactions with other cell types. In contrast to targeted therapies, immunotherapy exhibits the capacity, in many instances, to evolve with the tumor. Furthermore, it is capable of addressing the multifaceted components of the tumor that confer its malignant potential. The inherent systems-level nature of antitumor immunity thus requires a complementary set of approaches to interrogate the responsible immune cells and molecules, and to inform the design and implementation of new and existing therapies. Indeed, personalized medicine is experiencing a resurgence due to the potential of immunotherapies such as CAR-T cells and neoantigen vaccines to enable tumor targeting with a greater precision than previously possible. With an increased understanding of the dynamics underlying the coevolution of tumors and their immune responses during additional immunotherapies, such as ICB, systems biology will enhance our capacity to design and deliver personalized care to patients with advanced malignancies.</p><p>Cancer systems immunology is at an important transition point in its maturation. To date, preclinical and clinical studies exploiting systems approaches have generated profound amounts of data enabling characterization of immune responses and the generation of data rich atlases and accompanying tools for analysis. These important advances have laid the groundwork for discovery in the field of tumor immunology. The challenge moving forward will be to expand these approaches to uncover new biology that can be functionally validated. Many of the studies in the field have been largely descriptive and devoid of functional validation. In order to ensure that the field does not fall short of its promise, cancer systems immunologists will need to meet the higher bar of not only characterizing differences in immune responses to tumors but also performing the requisite experiments to determine the significance of the findings. Compared to other fields in cancer, this task is considerably more challenging. By definition, systems immunology typically uncovers interactions that involve many cellular components operating across multiple organ systems and timescales making perturbation of the components in a physiologically relevant manner difficult. Investigations in immunocompetent animal models, despite their challenges, represent some of the best approaches for testing the hypotheses generated from systems analyses. These models have served as the backbone for many discoveries in the field of immunology and will be necessary for advancing our understanding of tumor immunology. Future studies in the field should utilize advances in modeling approaches, such as ABM, to inform preclinical studies and focus the parameter space to one that is experimentally feasible. In some instances, where animal models are incapable of predicting patient responses, the use of systems approaches to integrate data sets and model human biology can inform the design of new therapies. Despite the challenges that confront the field, cancer systems immunology will continue to provide discoveries that lead to the next generation of life-saving immunotherapies.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>The authors thank members of the Engleman Lab for insightful discussions. This work was supported by NIH grant U54 CA209971 (Engleman).</p></ack><sec id="s7" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdelsamed</surname> <given-names>HA</given-names></name><name><surname>Moustaki</surname> <given-names>A</given-names></name><name><surname>Fan</surname> <given-names>Y</given-names></name><name><surname>Dogra</surname> <given-names>P</given-names></name><name><surname>Ghoneim</surname> <given-names>HE</given-names></name><name><surname>Zebley</surname> <given-names>CC</given-names></name><name><surname>Triplett</surname> <given-names>BM</given-names></name><name><surname>Sekaly</surname> <given-names>RP</given-names></name><name><surname>Youngblood</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Human memory CD8 T cell effector potential is epigenetically preserved during in vivo homeostasis</article-title><source>Journal of Experimental Medicine</source><volume>214</volume><fpage>1593</fpage><lpage>1606</lpage><pub-id pub-id-type="doi">10.1084/jem.20161760</pub-id><pub-id pub-id-type="pmid">28490440</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abelin</surname> <given-names>JG</given-names></name><name><surname>Keskin</surname> <given-names>DB</given-names></name><name><surname>Sarkizova</surname> <given-names>S</given-names></name><name><surname>Hartigan</surname> <given-names>CR</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Sidney</surname> <given-names>J</given-names></name><name><surname>Stevens</surname> <given-names>J</given-names></name><name><surname>Lane</surname> <given-names>W</given-names></name><name><surname>Zhang</surname> <given-names>GL</given-names></name><name><surname>Eisenhaure</surname> <given-names>TM</given-names></name><name><surname>Clauser</surname> <given-names>KR</given-names></name><name><surname>Hacohen</surname> <given-names>N</given-names></name><name><surname>Rooney</surname> <given-names>MS</given-names></name><name><surname>Carr</surname> <given-names>SA</given-names></name><name><surname>Wu</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mass spectrometry profiling of HLA-Associated peptidomes in Mono-allelic cells enables more accurate epitope prediction</article-title><source>Immunity</source><volume>46</volume><fpage>315</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2017.02.007</pub-id><pub-id pub-id-type="pmid">28228285</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Affara</surname> <given-names>NI</given-names></name><name><surname>Ruffell</surname> <given-names>B</given-names></name><name><surname>Medler</surname> <given-names>TR</given-names></name><name><surname>Gunderson</surname> <given-names>AJ</given-names></name><name><surname>Johansson</surname> <given-names>M</given-names></name><name><surname>Bornstein</surname> <given-names>S</given-names></name><name><surname>Bergsland</surname> <given-names>E</given-names></name><name><surname>Steinhoff</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Gong</surname> <given-names>Q</given-names></name><name><surname>Ma</surname> <given-names>Y</given-names></name><name><surname>Wiesen</surname> <given-names>JF</given-names></name><name><surname>Wong</surname> <given-names>MH</given-names></name><name><surname>Kulesz-Martin</surname> <given-names>M</given-names></name><name><surname>Irving</surname> <given-names>B</given-names></name><name><surname>Coussens</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas</article-title><source>Cancer Cell</source><volume>25</volume><fpage>809</fpage><lpage>821</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2014.04.026</pub-id><pub-id pub-id-type="pmid">24909985</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname> <given-names>J</given-names></name><name><surname>Yuan</surname> <given-names>Y</given-names></name><name><surname>Parmigiani</surname> <given-names>G</given-names></name><name><surname>Suraokar</surname> <given-names>MB</given-names></name><name><surname>Diao</surname> <given-names>L</given-names></name><name><surname>Wistuba</surname> <given-names>II</given-names></name><name><surname>Wang</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>DeMix: deconvolution for mixed Cancer transcriptomes using raw measured data</article-title><source>Bioinformatics</source><volume>29</volume><fpage>1865</fpage><lpage>1871</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt301</pub-id><pub-id pub-id-type="pmid">23712657</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ajami</surname> <given-names>B</given-names></name><name><surname>Bennett</surname> <given-names>JL</given-names></name><name><surname>Krieger</surname> <given-names>C</given-names></name><name><surname>Tetzlaff</surname> <given-names>W</given-names></name><name><surname>Rossi</surname> <given-names>FM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Local self-renewal can sustain CNS microglia maintenance and function throughout adult life</article-title><source>Nature Neuroscience</source><volume>10</volume><fpage>1538</fpage><lpage>1543</lpage><pub-id pub-id-type="doi">10.1038/nn2014</pub-id><pub-id pub-id-type="pmid">18026097</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akhtar-Zaidi</surname> <given-names>B</given-names></name><name><surname>Cowper-Sal-lari</surname> <given-names>R</given-names></name><name><surname>Corradin</surname> <given-names>O</given-names></name><name><surname>Saiakhova</surname> <given-names>A</given-names></name><name><surname>Bartels</surname> <given-names>CF</given-names></name><name><surname>Balasubramanian</surname> <given-names>D</given-names></name><name><surname>Myeroff</surname> <given-names>L</given-names></name><name><surname>Lutterbaugh</surname> <given-names>J</given-names></name><name><surname>Jarrar</surname> <given-names>A</given-names></name><name><surname>Kalady</surname> <given-names>MF</given-names></name><name><surname>Willis</surname> <given-names>J</given-names></name><name><surname>Moore</surname> <given-names>JH</given-names></name><name><surname>Tesar</surname> <given-names>PJ</given-names></name><name><surname>Laframboise</surname> <given-names>T</given-names></name><name><surname>Markowitz</surname> <given-names>S</given-names></name><name><surname>Lupien</surname> <given-names>M</given-names></name><name><surname>Scacheri</surname> <given-names>PC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Epigenomic enhancer profiling defines a signature of Colon cancer</article-title><source>Science</source><volume>336</volume><fpage>736</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1126/science.1217277</pub-id><pub-id pub-id-type="pmid">22499810</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alcántara-Hernández</surname> <given-names>M</given-names></name><name><surname>Leylek</surname> <given-names>R</given-names></name><name><surname>Wagar</surname> <given-names>LE</given-names></name><name><surname>Engleman</surname> <given-names>EG</given-names></name><name><surname>Keler</surname> <given-names>T</given-names></name><name><surname>Marinkovich</surname> <given-names>MP</given-names></name><name><surname>Davis</surname> <given-names>MM</given-names></name><name><surname>Nolan</surname> <given-names>GP</given-names></name><name><surname>Idoyaga</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>High-Dimensional phenotypic mapping of human dendritic cells reveals interindividual variation and tissue specialization</article-title><source>Immunity</source><volume>47</volume><fpage>1037</fpage><lpage>1050</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2017.11.001</pub-id><pub-id pub-id-type="pmid">29221729</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfei</surname> <given-names>F</given-names></name><name><surname>Kanev</surname> <given-names>K</given-names></name><name><surname>Hofmann</surname> <given-names>M</given-names></name><name><surname>Wu</surname> <given-names>M</given-names></name><name><surname>Ghoneim</surname> <given-names>HE</given-names></name><name><surname>Roelli</surname> <given-names>P</given-names></name><name><surname>Utzschneider</surname> <given-names>DT</given-names></name><name><surname>von Hoesslin</surname> <given-names>M</given-names></name><name><surname>Cullen</surname> <given-names>JG</given-names></name><name><surname>Fan</surname> <given-names>Y</given-names></name><name><surname>Eisenberg</surname> <given-names>V</given-names></name><name><surname>Wohlleber</surname> <given-names>D</given-names></name><name><surname>Steiger</surname> <given-names>K</given-names></name><name><surname>Merkler</surname> <given-names>D</given-names></name><name><surname>Delorenzi</surname> <given-names>M</given-names></name><name><surname>Knolle</surname> <given-names>PA</given-names></name><name><surname>Cohen</surname> <given-names>CJ</given-names></name><name><surname>Thimme</surname> <given-names>R</given-names></name><name><surname>Youngblood</surname> <given-names>B</given-names></name><name><surname>Zehn</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection</article-title><source>Nature</source><volume>571</volume><fpage>265</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1326-9</pub-id><pub-id pub-id-type="pmid">31207605</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfonso</surname> <given-names>JC</given-names></name><name><surname>Schaadt</surname> <given-names>NS</given-names></name><name><surname>Schönmeyer</surname> <given-names>R</given-names></name><name><surname>Brieu</surname> <given-names>N</given-names></name><name><surname>Forestier</surname> <given-names>G</given-names></name><name><surname>Wemmert</surname> <given-names>C</given-names></name><name><surname>Feuerhake</surname> <given-names>F</given-names></name><name><surname>Hatzikirou</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>In-silico insights on the prognostic potential of immune cell infiltration patterns in the breast lobular epithelium</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>33322</elocation-id><pub-id pub-id-type="doi">10.1038/srep33322</pub-id><pub-id pub-id-type="pmid">27659691</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allman</surname> <given-names>D</given-names></name><name><surname>Pillai</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Peripheral B cell subsets</article-title><source>Current Opinion in Immunology</source><volume>20</volume><fpage>149</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2008.03.014</pub-id><pub-id pub-id-type="pmid">18434123</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altrock</surname> <given-names>PM</given-names></name><name><surname>Liu</surname> <given-names>LL</given-names></name><name><surname>Michor</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The mathematics of Cancer: integrating quantitative models</article-title><source>Nature Reviews Cancer</source><volume>15</volume><fpage>730</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1038/nrc4029</pub-id><pub-id pub-id-type="pmid">26597528</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amir</surname> <given-names>AD</given-names></name><name><surname>Davis</surname> <given-names>KL</given-names></name><name><surname>Tadmor</surname> <given-names>MD</given-names></name><name><surname>Simonds</surname> <given-names>EF</given-names></name><name><surname>Levine</surname> <given-names>JH</given-names></name><name><surname>Bendall</surname> <given-names>SC</given-names></name><name><surname>Shenfeld</surname> <given-names>DK</given-names></name><name><surname>Krishnaswamy</surname> <given-names>S</given-names></name><name><surname>Nolan</surname> <given-names>GP</given-names></name><name><surname>Pe'er</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia</article-title><source>Nature Biotechnology</source><volume>31</volume><fpage>545</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1038/nbt.2594</pub-id><pub-id pub-id-type="pmid">23685480</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ammirante</surname> <given-names>M</given-names></name><name><surname>Luo</surname> <given-names>JL</given-names></name><name><surname>Grivennikov</surname> <given-names>S</given-names></name><name><surname>Nedospasov</surname> <given-names>S</given-names></name><name><surname>Karin</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>B-cell-derived lymphotoxin promotes castration-resistant prostate Cancer</article-title><source>Nature</source><volume>464</volume><fpage>302</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1038/nature08782</pub-id><pub-id pub-id-type="pmid">20220849</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Introduction of an agent-based multi-scale modular architecture for dynamic knowledge representation of acute inflammation</article-title><source>Theoretical Biology and Medical Modelling</source><volume>5</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.1186/1742-4682-5-11</pub-id><pub-id pub-id-type="pmid">18505587</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreu</surname> <given-names>P</given-names></name><name><surname>Johansson</surname> <given-names>M</given-names></name><name><surname>Affara</surname> <given-names>NI</given-names></name><name><surname>Pucci</surname> <given-names>F</given-names></name><name><surname>Tan</surname> <given-names>T</given-names></name><name><surname>Junankar</surname> <given-names>S</given-names></name><name><surname>Korets</surname> <given-names>L</given-names></name><name><surname>Lam</surname> <given-names>J</given-names></name><name><surname>Tawfik</surname> <given-names>D</given-names></name><name><surname>DeNardo</surname> <given-names>DG</given-names></name><name><surname>Naldini</surname> <given-names>L</given-names></name><name><surname>de Visser</surname> <given-names>KE</given-names></name><name><surname>De Palma</surname> <given-names>M</given-names></name><name><surname>Coussens</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>FcRgamma activation regulates inflammation-associated squamous carcinogenesis</article-title><source>Cancer Cell</source><volume>17</volume><fpage>121</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2009.12.019</pub-id><pub-id pub-id-type="pmid">20138013</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angeli</surname> <given-names>V</given-names></name><name><surname>Ginhoux</surname> <given-names>F</given-names></name><name><surname>Llodrà</surname> <given-names>J</given-names></name><name><surname>Quemeneur</surname> <given-names>L</given-names></name><name><surname>Frenette</surname> <given-names>PS</given-names></name><name><surname>Skobe</surname> <given-names>M</given-names></name><name><surname>Jessberger</surname> <given-names>R</given-names></name><name><surname>Merad</surname> <given-names>M</given-names></name><name><surname>Randolph</surname> <given-names>GJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization</article-title><source>Immunity</source><volume>24</volume><fpage>203</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2006.01.003</pub-id><pub-id pub-id-type="pmid">16473832</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angelo</surname> <given-names>M</given-names></name><name><surname>Bendall</surname> <given-names>SC</given-names></name><name><surname>Finck</surname> <given-names>R</given-names></name><name><surname>Hale</surname> <given-names>MB</given-names></name><name><surname>Hitzman</surname> <given-names>C</given-names></name><name><surname>Borowsky</surname> <given-names>AD</given-names></name><name><surname>Levenson</surname> <given-names>RM</given-names></name><name><surname>Lowe</surname> <given-names>JB</given-names></name><name><surname>Liu</surname> <given-names>SD</given-names></name><name><surname>Zhao</surname> <given-names>S</given-names></name><name><surname>Natkunam</surname> <given-names>Y</given-names></name><name><surname>Nolan</surname> <given-names>GP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Multiplexed ion beam imaging of human breast tumors</article-title><source>Nature Medicine</source><volume>20</volume><fpage>436</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1038/nm.3488</pub-id><pub-id pub-id-type="pmid">24584119</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angelova</surname> <given-names>M</given-names></name><name><surname>Charoentong</surname> <given-names>P</given-names></name><name><surname>Hackl</surname> <given-names>H</given-names></name><name><surname>Fischer</surname> <given-names>ML</given-names></name><name><surname>Snajder</surname> <given-names>R</given-names></name><name><surname>Krogsdam</surname> <given-names>AM</given-names></name><name><surname>Waldner</surname> <given-names>MJ</given-names></name><name><surname>Bindea</surname> <given-names>G</given-names></name><name><surname>Mlecnik</surname> <given-names>B</given-names></name><name><surname>Galon</surname> <given-names>J</given-names></name><name><surname>Trajanoski</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy</article-title><source>Genome Biology</source><volume>16</volume><elocation-id>64</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-015-0620-6</pub-id><pub-id pub-id-type="pmid">25853550</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angermueller</surname> <given-names>C</given-names></name><name><surname>Clark</surname> <given-names>SJ</given-names></name><name><surname>Lee</surname> <given-names>HJ</given-names></name><name><surname>Macaulay</surname> <given-names>IC</given-names></name><name><surname>Teng</surname> <given-names>MJ</given-names></name><name><surname>Hu</surname> <given-names>TX</given-names></name><name><surname>Krueger</surname> <given-names>F</given-names></name><name><surname>Smallwood</surname> <given-names>S</given-names></name><name><surname>Ponting</surname> <given-names>CP</given-names></name><name><surname>Voet</surname> <given-names>T</given-names></name><name><surname>Kelsey</surname> <given-names>G</given-names></name><name><surname>Stegle</surname> <given-names>O</given-names></name><name><surname>Reik</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Parallel single-cell sequencing links transcriptional and epigenetic heterogeneity</article-title><source>Nature Methods</source><volume>13</volume><fpage>229</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3728</pub-id><pub-id pub-id-type="pmid">26752769</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anna</surname> <given-names>SL</given-names></name><name><surname>Bontoux</surname> <given-names>N</given-names></name><name><surname>Stone</surname> <given-names>HA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Formation of dispersions using “flow focusing” in microchannels</article-title><source>Applied Physics Letters</source><volume>82</volume><fpage>364</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1063/1.1537519</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araki</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Zang</surname> <given-names>C</given-names></name><name><surname>Wood</surname> <given-names>WH</given-names></name><name><surname>Schones</surname> <given-names>D</given-names></name><name><surname>Cui</surname> <given-names>K</given-names></name><name><surname>Roh</surname> <given-names>TY</given-names></name><name><surname>Lhotsky</surname> <given-names>B</given-names></name><name><surname>Wersto</surname> <given-names>RP</given-names></name><name><surname>Peng</surname> <given-names>W</given-names></name><name><surname>Becker</surname> <given-names>KG</given-names></name><name><surname>Zhao</surname> <given-names>K</given-names></name><name><surname>Weng</surname> <given-names>NP</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8+ T cells</article-title><source>Immunity</source><volume>30</volume><fpage>912</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2009.05.006</pub-id><pub-id pub-id-type="pmid">19523850</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aran</surname> <given-names>D</given-names></name><name><surname>Hu</surname> <given-names>Z</given-names></name><name><surname>Butte</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>xCell: digitally portraying the tissue cellular heterogeneity landscape</article-title><source>Genome Biology</source><volume>18</volume><elocation-id>220</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-017-1349-1</pub-id><pub-id pub-id-type="pmid">29141660</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aras</surname> <given-names>S</given-names></name><name><surname>Zaidi</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>TAMeless traitors: macrophages in Cancer progression and metastasis</article-title><source>British Journal of Cancer</source><volume>117</volume><fpage>1583</fpage><lpage>1591</lpage><pub-id pub-id-type="doi">10.1038/bjc.2017.356</pub-id><pub-id pub-id-type="pmid">29065107</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Archetti</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Evolutionary game theory of growth factor production: implications for tumour heterogeneity and resistance to therapies</article-title><source>British Journal of Cancer</source><volume>109</volume><fpage>1056</fpage><lpage>1062</lpage><pub-id pub-id-type="doi">10.1038/bjc.2013.336</pub-id><pub-id pub-id-type="pmid">23922110</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arstila</surname> <given-names>TP</given-names></name><name><surname>Casrouge</surname> <given-names>A</given-names></name><name><surname>Baron</surname> <given-names>V</given-names></name><name><surname>Even</surname> <given-names>J</given-names></name><name><surname>Kanellopoulos</surname> <given-names>J</given-names></name><name><surname>Kourilsky</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>A direct estimate of the human alphabeta T cell receptor diversity</article-title><source>Science</source><volume>286</volume><fpage>958</fpage><lpage>961</lpage><pub-id pub-id-type="doi">10.1126/science.286.5441.958</pub-id><pub-id pub-id-type="pmid">10542151</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atarashi</surname> <given-names>K</given-names></name><name><surname>Tanoue</surname> <given-names>T</given-names></name><name><surname>Oshima</surname> <given-names>K</given-names></name><name><surname>Suda</surname> <given-names>W</given-names></name><name><surname>Nagano</surname> <given-names>Y</given-names></name><name><surname>Nishikawa</surname> <given-names>H</given-names></name><name><surname>Fukuda</surname> <given-names>S</given-names></name><name><surname>Saito</surname> <given-names>T</given-names></name><name><surname>Narushima</surname> <given-names>S</given-names></name><name><surname>Hase</surname> <given-names>K</given-names></name><name><surname>Kim</surname> <given-names>S</given-names></name><name><surname>Fritz</surname> <given-names>JV</given-names></name><name><surname>Wilmes</surname> <given-names>P</given-names></name><name><surname>Ueha</surname> <given-names>S</given-names></name><name><surname>Matsushima</surname> <given-names>K</given-names></name><name><surname>Ohno</surname> <given-names>H</given-names></name><name><surname>Olle</surname> <given-names>B</given-names></name><name><surname>Sakaguchi</surname> <given-names>S</given-names></name><name><surname>Taniguchi</surname> <given-names>T</given-names></name><name><surname>Morita</surname> <given-names>H</given-names></name><name><surname>Hattori</surname> <given-names>M</given-names></name><name><surname>Honda</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Treg induction by a rationally selected mixture of clostridia strains from the human Microbiota</article-title><source>Nature</source><volume>500</volume><fpage>232</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1038/nature12331</pub-id><pub-id pub-id-type="pmid">23842501</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atarashi</surname> <given-names>K</given-names></name><name><surname>Suda</surname> <given-names>W</given-names></name><name><surname>Luo</surname> <given-names>C</given-names></name><name><surname>Kawaguchi</surname> <given-names>T</given-names></name><name><surname>Motoo</surname> <given-names>I</given-names></name><name><surname>Narushima</surname> <given-names>S</given-names></name><name><surname>Kiguchi</surname> <given-names>Y</given-names></name><name><surname>Yasuma</surname> <given-names>K</given-names></name><name><surname>Watanabe</surname> <given-names>E</given-names></name><name><surname>Tanoue</surname> <given-names>T</given-names></name><name><surname>Thaiss</surname> <given-names>CA</given-names></name><name><surname>Sato</surname> <given-names>M</given-names></name><name><surname>Toyooka</surname> <given-names>K</given-names></name><name><surname>Said</surname> <given-names>HS</given-names></name><name><surname>Yamagami</surname> <given-names>H</given-names></name><name><surname>Rice</surname> <given-names>SA</given-names></name><name><surname>Gevers</surname> <given-names>D</given-names></name><name><surname>Johnson</surname> <given-names>RC</given-names></name><name><surname>Segre</surname> <given-names>JA</given-names></name><name><surname>Chen</surname> <given-names>K</given-names></name><name><surname>Kolls</surname> <given-names>JK</given-names></name><name><surname>Elinav</surname> <given-names>E</given-names></name><name><surname>Morita</surname> <given-names>H</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name><name><surname>Hattori</surname> <given-names>M</given-names></name><name><surname>Honda</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Ectopic colonization of oral Bacteria in the intestine drives T<sub>H</sub>1 cell induction and inflammation</article-title><source>Science</source><volume>358</volume><fpage>359</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1126/science.aan4526</pub-id><pub-id pub-id-type="pmid">29051379</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atri</surname> <given-names>C</given-names></name><name><surname>Guerfali</surname> <given-names>F</given-names></name><name><surname>Laouini</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="1801">1801</year><article-title>Role of human macrophage polarization in inflammation during infectious diseases</article-title><source>International Journal of Molecular Sciences</source><volume>19</volume><elocation-id>1801</elocation-id><pub-id pub-id-type="doi">10.3390/ijms19061801</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auffray</surname> <given-names>C</given-names></name><name><surname>Fogg</surname> <given-names>D</given-names></name><name><surname>Garfa</surname> <given-names>M</given-names></name><name><surname>Elain</surname> <given-names>G</given-names></name><name><surname>Join-Lambert</surname> <given-names>O</given-names></name><name><surname>Kayal</surname> <given-names>S</given-names></name><name><surname>Sarnacki</surname> <given-names>S</given-names></name><name><surname>Cumano</surname> <given-names>A</given-names></name><name><surname>Lauvau</surname> <given-names>G</given-names></name><name><surname>Geissmann</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior</article-title><source>Science</source><volume>317</volume><fpage>666</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.1126/science.1142883</pub-id><pub-id pub-id-type="pmid">17673663</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azizi</surname> <given-names>E</given-names></name><name><surname>Carr</surname> <given-names>AJ</given-names></name><name><surname>Plitas</surname> <given-names>G</given-names></name><name><surname>Cornish</surname> <given-names>AE</given-names></name><name><surname>Konopacki</surname> <given-names>C</given-names></name><name><surname>Prabhakaran</surname> <given-names>S</given-names></name><name><surname>Nainys</surname> <given-names>J</given-names></name><name><surname>Wu</surname> <given-names>K</given-names></name><name><surname>Kiseliovas</surname> <given-names>V</given-names></name><name><surname>Setty</surname> <given-names>M</given-names></name><name><surname>Choi</surname> <given-names>K</given-names></name><name><surname>Fromme</surname> <given-names>RM</given-names></name><name><surname>Dao</surname> <given-names>P</given-names></name><name><surname>McKenney</surname> <given-names>PT</given-names></name><name><surname>Wasti</surname> <given-names>RC</given-names></name><name><surname>Kadaveru</surname> <given-names>K</given-names></name><name><surname>Mazutis</surname> <given-names>L</given-names></name><name><surname>Rudensky</surname> <given-names>AY</given-names></name><name><surname>Pe'er</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Single-Cell map of diverse immune phenotypes in the breast tumor microenvironment</article-title><source>Cell</source><volume>174</volume><fpage>1293</fpage><lpage>1308</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.05.060</pub-id><pub-id pub-id-type="pmid">29961579</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachem</surname> <given-names>A</given-names></name><name><surname>Hartung</surname> <given-names>E</given-names></name><name><surname>Güttler</surname> <given-names>S</given-names></name><name><surname>Mora</surname> <given-names>A</given-names></name><name><surname>Zhou</surname> <given-names>X</given-names></name><name><surname>Hegemann</surname> <given-names>A</given-names></name><name><surname>Plantinga</surname> <given-names>M</given-names></name><name><surname>Mazzini</surname> <given-names>E</given-names></name><name><surname>Stoitzner</surname> <given-names>P</given-names></name><name><surname>Gurka</surname> <given-names>S</given-names></name><name><surname>Henn</surname> <given-names>V</given-names></name><name><surname>Mages</surname> <given-names>HW</given-names></name><name><surname>Kroczek</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Expression of XCR1 characterizes the Batf3-Dependent lineage of dendritic cells capable of antigen Cross-Presentation</article-title><source>Frontiers in Immunology</source><volume>3</volume><elocation-id>214</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2012.00214</pub-id><pub-id pub-id-type="pmid">22826713</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bair</surname> <given-names>E</given-names></name><name><surname>Tibshirani</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Semi-Supervised methods to predict patient survival from gene expression data</article-title><source>PLOS Biology</source><volume>2</volume><elocation-id>e108</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.0020108</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banchereau</surname> <given-names>J</given-names></name><name><surname>Steinman</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Dendritic cells and the control of immunity</article-title><source>Nature</source><volume>392</volume><fpage>245</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1038/32588</pub-id><pub-id pub-id-type="pmid">9521319</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bandura</surname> <given-names>DR</given-names></name><name><surname>Baranov</surname> <given-names>VI</given-names></name><name><surname>Ornatsky</surname> <given-names>OI</given-names></name><name><surname>Antonov</surname> <given-names>A</given-names></name><name><surname>Kinach</surname> <given-names>R</given-names></name><name><surname>Lou</surname> <given-names>X</given-names></name><name><surname>Pavlov</surname> <given-names>S</given-names></name><name><surname>Vorobiev</surname> <given-names>S</given-names></name><name><surname>Dick</surname> <given-names>JE</given-names></name><name><surname>Tanner</surname> <given-names>SD</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma Time-of-Flight mass spectrometry</article-title><source>Analytical Chemistry</source><volume>81</volume><fpage>6813</fpage><lpage>6822</lpage><pub-id pub-id-type="doi">10.1021/ac901049w</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bangasser</surname> <given-names>BL</given-names></name><name><surname>Odde</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Master equation-based analysis of a motor-clutch model for cell traction force</article-title><source>Cellular and Molecular Bioengineering</source><volume>6</volume><fpage>449</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1007/s12195-013-0296-5</pub-id><pub-id pub-id-type="pmid">24465279</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbera-Guillem</surname> <given-names>E</given-names></name><name><surname>May</surname> <given-names>KF</given-names></name><name><surname>Nyhus</surname> <given-names>JK</given-names></name><name><surname>Nelson</surname> <given-names>MB</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Promotion of tumor invasion by cooperation of granulocytes and macrophages activated by anti-tumor antibodies</article-title><source>Neoplasia</source><volume>1</volume><fpage>453</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1038/sj.neo.7900054</pub-id><pub-id pub-id-type="pmid">10933061</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barski</surname> <given-names>A</given-names></name><name><surname>Cuddapah</surname> <given-names>S</given-names></name><name><surname>Cui</surname> <given-names>K</given-names></name><name><surname>Roh</surname> <given-names>TY</given-names></name><name><surname>Schones</surname> <given-names>DE</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Wei</surname> <given-names>G</given-names></name><name><surname>Chepelev</surname> <given-names>I</given-names></name><name><surname>Zhao</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>High-resolution profiling of histone methylations in the human genome</article-title><source>Cell</source><volume>129</volume><fpage>823</fpage><lpage>837</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.05.009</pub-id><pub-id pub-id-type="pmid">17512414</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basanta</surname> <given-names>D</given-names></name><name><surname>Scott</surname> <given-names>JG</given-names></name><name><surname>Fishman</surname> <given-names>MN</given-names></name><name><surname>Ayala</surname> <given-names>G</given-names></name><name><surname>Hayward</surname> <given-names>SW</given-names></name><name><surname>Anderson</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Investigating prostate cancer tumour-stroma interactions: clinical and biological insights from an evolutionary game</article-title><source>British Journal of Cancer</source><volume>106</volume><fpage>174</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1038/bjc.2011.517</pub-id><pub-id pub-id-type="pmid">22134510</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baslan</surname> <given-names>T</given-names></name><name><surname>Kendall</surname> <given-names>J</given-names></name><name><surname>Rodgers</surname> <given-names>L</given-names></name><name><surname>Cox</surname> <given-names>H</given-names></name><name><surname>Riggs</surname> <given-names>M</given-names></name><name><surname>Stepansky</surname> <given-names>A</given-names></name><name><surname>Troge</surname> <given-names>J</given-names></name><name><surname>Ravi</surname> <given-names>K</given-names></name><name><surname>Esposito</surname> <given-names>D</given-names></name><name><surname>Lakshmi</surname> <given-names>B</given-names></name><name><surname>Wigler</surname> <given-names>M</given-names></name><name><surname>Navin</surname> <given-names>N</given-names></name><name><surname>Hicks</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Genome-wide copy number analysis of single cells</article-title><source>Nature Protocols</source><volume>7</volume><fpage>1024</fpage><lpage>1041</lpage><pub-id pub-id-type="doi">10.1038/nprot.2012.039</pub-id><pub-id pub-id-type="pmid">22555242</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassani-Sternberg</surname> <given-names>M</given-names></name><name><surname>Barnea</surname> <given-names>E</given-names></name><name><surname>Beer</surname> <given-names>I</given-names></name><name><surname>Avivi</surname> <given-names>I</given-names></name><name><surname>Katz</surname> <given-names>T</given-names></name><name><surname>Admon</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Soluble plasma HLA peptidome as a potential source for Cancer biomarkers</article-title><source>PNAS</source><volume>107</volume><fpage>18769</fpage><lpage>18776</lpage><pub-id pub-id-type="doi">10.1073/pnas.1008501107</pub-id><pub-id pub-id-type="pmid">20974924</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becht</surname> <given-names>E</given-names></name><name><surname>Giraldo</surname> <given-names>NA</given-names></name><name><surname>Lacroix</surname> <given-names>L</given-names></name><name><surname>Buttard</surname> <given-names>B</given-names></name><name><surname>Elarouci</surname> <given-names>N</given-names></name><name><surname>Petitprez</surname> <given-names>F</given-names></name><name><surname>Selves</surname> <given-names>J</given-names></name><name><surname>Laurent-Puig</surname> <given-names>P</given-names></name><name><surname>Sautès-Fridman</surname> <given-names>C</given-names></name><name><surname>Fridman</surname> <given-names>WH</given-names></name><name><surname>de Reyniès</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression</article-title><source>Genome Biology</source><volume>17</volume><elocation-id>218</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-016-1070-5</pub-id><pub-id pub-id-type="pmid">27765066</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becht</surname> <given-names>E</given-names></name><name><surname>McInnes</surname> <given-names>L</given-names></name><name><surname>Healy</surname> <given-names>J</given-names></name><name><surname>Dutertre</surname> <given-names>C-A</given-names></name><name><surname>Kwok</surname> <given-names>IWH</given-names></name><name><surname>Ng</surname> <given-names>LG</given-names></name><name><surname>Ginhoux</surname> <given-names>F</given-names></name><name><surname>Newell</surname> <given-names>EW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dimensionality reduction for visualizing single-cell data using UMAP</article-title><source>Nature Biotechnology</source><volume>37</volume><fpage>38</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1038/nbt.4314</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bedoui</surname> <given-names>S</given-names></name><name><surname>Whitney</surname> <given-names>PG</given-names></name><name><surname>Waithman</surname> <given-names>J</given-names></name><name><surname>Eidsmo</surname> <given-names>L</given-names></name><name><surname>Wakim</surname> <given-names>L</given-names></name><name><surname>Caminschi</surname> <given-names>I</given-names></name><name><surname>Allan</surname> <given-names>RS</given-names></name><name><surname>Wojtasiak</surname> <given-names>M</given-names></name><name><surname>Shortman</surname> <given-names>K</given-names></name><name><surname>Carbone</surname> <given-names>FR</given-names></name><name><surname>Brooks</surname> <given-names>AG</given-names></name><name><surname>Heath</surname> <given-names>WR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells</article-title><source>Nature Immunology</source><volume>10</volume><fpage>488</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1038/ni.1724</pub-id><pub-id pub-id-type="pmid">19349986</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellomo</surname> <given-names>N</given-names></name><name><surname>Firmani</surname> <given-names>B</given-names></name><name><surname>Guerri</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Bifurcation analysis for a nonlinear system of integro-differential equations modelling tumor-immune cells competition</article-title><source>Applied Mathematics Letters</source><volume>12</volume><fpage>39</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/S0893-9659(98)00146-3</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellomo</surname> <given-names>N</given-names></name><name><surname>Delitala</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>From the mathematical kinetic, and stochastic game theory to modelling mutations, onset, progression and immune competition of cancer cells</article-title><source>Physics of Life Reviews</source><volume>5</volume><fpage>183</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1016/j.plrev.2008.07.001</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benci</surname> <given-names>JL</given-names></name><name><surname>Xu</surname> <given-names>B</given-names></name><name><surname>Qiu</surname> <given-names>Y</given-names></name><name><surname>Wu</surname> <given-names>TJ</given-names></name><name><surname>Dada</surname> <given-names>H</given-names></name><name><surname>Twyman-Saint Victor</surname> <given-names>C</given-names></name><name><surname>Cucolo</surname> <given-names>L</given-names></name><name><surname>Lee</surname> <given-names>DSM</given-names></name><name><surname>Pauken</surname> <given-names>KE</given-names></name><name><surname>Huang</surname> <given-names>AC</given-names></name><name><surname>Gangadhar</surname> <given-names>TC</given-names></name><name><surname>Amaravadi</surname> <given-names>RK</given-names></name><name><surname>Schuchter</surname> <given-names>LM</given-names></name><name><surname>Feldman</surname> <given-names>MD</given-names></name><name><surname>Ishwaran</surname> <given-names>H</given-names></name><name><surname>Vonderheide</surname> <given-names>RH</given-names></name><name><surname>Maity</surname> <given-names>A</given-names></name><name><surname>Wherry</surname> <given-names>EJ</given-names></name><name><surname>Minn</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade</article-title><source>Cell</source><volume>167</volume><fpage>1540</fpage><lpage>1554</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.11.022</pub-id><pub-id pub-id-type="pmid">27912061</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bendall</surname> <given-names>SC</given-names></name><name><surname>Simonds</surname> <given-names>EF</given-names></name><name><surname>Qiu</surname> <given-names>P</given-names></name><name><surname>Amir</surname> <given-names>AD</given-names></name><name><surname>Krutzik</surname> <given-names>PO</given-names></name><name><surname>Finck</surname> <given-names>R</given-names></name><name><surname>Bruggner</surname> <given-names>RV</given-names></name><name><surname>Melamed</surname> <given-names>R</given-names></name><name><surname>Trejo</surname> <given-names>A</given-names></name><name><surname>Ornatsky</surname> <given-names>OI</given-names></name><name><surname>Balderas</surname> <given-names>RS</given-names></name><name><surname>Plevritis</surname> <given-names>SK</given-names></name><name><surname>Sachs</surname> <given-names>K</given-names></name><name><surname>Pe'er</surname> <given-names>D</given-names></name><name><surname>Tanner</surname> <given-names>SD</given-names></name><name><surname>Nolan</surname> <given-names>GP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum</article-title><source>Science</source><volume>332</volume><fpage>687</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1126/science.1198704</pub-id><pub-id pub-id-type="pmid">21551058</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bendall</surname> <given-names>SC</given-names></name><name><surname>Nolan</surname> <given-names>GP</given-names></name><name><surname>Roederer</surname> <given-names>M</given-names></name><name><surname>Chattopadhyay</surname> <given-names>PK</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A deep profiler's guide to cytometry</article-title><source>Trends in Immunology</source><volume>33</volume><fpage>323</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1016/j.it.2012.02.010</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bendall</surname> <given-names>SC</given-names></name><name><surname>Davis</surname> <given-names>KL</given-names></name><name><surname>Amir</surname> <given-names>AD</given-names></name><name><surname>Tadmor</surname> <given-names>MD</given-names></name><name><surname>Simonds</surname> <given-names>EF</given-names></name><name><surname>Chen</surname> <given-names>TJ</given-names></name><name><surname>Shenfeld</surname> <given-names>DK</given-names></name><name><surname>Nolan</surname> <given-names>GP</given-names></name><name><surname>Pe'er</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Single-cell trajectory detection uncovers progression and regulatory coordination in human B cell development</article-title><source>Cell</source><volume>157</volume><fpage>714</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.04.005</pub-id><pub-id pub-id-type="pmid">24766814</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennun</surname> <given-names>SV</given-names></name><name><surname>Hizal</surname> <given-names>DB</given-names></name><name><surname>Heffner</surname> <given-names>K</given-names></name><name><surname>Can</surname> <given-names>O</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Betenbaugh</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Systems glycobiology: integrating glycogenomics, glycoproteomics, glycomics, and other 'Omics Data Sets to Characterize Cellular Glycosylation Processes</article-title><source>Journal of Molecular Biology</source><volume>428</volume><fpage>3337</fpage><lpage>3352</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2016.07.005</pub-id><pub-id pub-id-type="pmid">27423401</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berdasco</surname> <given-names>M</given-names></name><name><surname>Esteller</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Aberrant epigenetic landscape in Cancer: how cellular identity Goes awry</article-title><source>Developmental Cell</source><volume>19</volume><fpage>698</fpage><lpage>711</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2010.10.005</pub-id><pub-id pub-id-type="pmid">21074720</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname> <given-names>AH</given-names></name><name><surname>Brooks</surname> <given-names>AN</given-names></name><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Shrestha</surname> <given-names>Y</given-names></name><name><surname>Chouinard</surname> <given-names>C</given-names></name><name><surname>Piccioni</surname> <given-names>F</given-names></name><name><surname>Bagul</surname> <given-names>M</given-names></name><name><surname>Kamburov</surname> <given-names>A</given-names></name><name><surname>Imielinski</surname> <given-names>M</given-names></name><name><surname>Hogstrom</surname> <given-names>L</given-names></name><name><surname>Zhu</surname> <given-names>C</given-names></name><name><surname>Yang</surname> <given-names>X</given-names></name><name><surname>Pantel</surname> <given-names>S</given-names></name><name><surname>Sakai</surname> <given-names>R</given-names></name><name><surname>Watson</surname> <given-names>J</given-names></name><name><surname>Kaplan</surname> <given-names>N</given-names></name><name><surname>Campbell</surname> <given-names>JD</given-names></name><name><surname>Singh</surname> <given-names>S</given-names></name><name><surname>Root</surname> <given-names>DE</given-names></name><name><surname>Narayan</surname> <given-names>R</given-names></name><name><surname>Natoli</surname> <given-names>T</given-names></name><name><surname>Lahr</surname> <given-names>DL</given-names></name><name><surname>Tirosh</surname> <given-names>I</given-names></name><name><surname>Tamayo</surname> <given-names>P</given-names></name><name><surname>Getz</surname> <given-names>G</given-names></name><name><surname>Wong</surname> <given-names>B</given-names></name><name><surname>Doench</surname> <given-names>J</given-names></name><name><surname>Subramanian</surname> <given-names>A</given-names></name><name><surname>Golub</surname> <given-names>TR</given-names></name><name><surname>Meyerson</surname> <given-names>M</given-names></name><name><surname>Boehm</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>High-throughput Phenotyping of Lung Cancer Somatic Mutations</article-title><source>Cancer Cell</source><volume>30</volume><fpage>214</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2016.06.022</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bertozzi</surname> <given-names>CR</given-names></name><name><surname>Sasisekharan</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><chapter-title>Glycomics</chapter-title><person-group person-group-type="editor"><name><surname>Varki</surname> <given-names>A</given-names></name><name><surname>Cummings</surname> <given-names>RD</given-names></name><name><surname>Esko</surname> <given-names>JD</given-names></name></person-group><source>Essentials of Glycobiology</source><edition>2nd edition</edition><publisher-name>Cold Spring Harbor Laboratory Press</publisher-name><fpage>2015</fpage><lpage>2017</lpage></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binnewies</surname> <given-names>M</given-names></name><name><surname>Roberts</surname> <given-names>EW</given-names></name><name><surname>Kersten</surname> <given-names>K</given-names></name><name><surname>Chan</surname> <given-names>V</given-names></name><name><surname>Fearon</surname> <given-names>DF</given-names></name><name><surname>Merad</surname> <given-names>M</given-names></name><name><surname>Coussens</surname> <given-names>LM</given-names></name><name><surname>Gabrilovich</surname> <given-names>DI</given-names></name><name><surname>Ostrand-Rosenberg</surname> <given-names>S</given-names></name><name><surname>Hedrick</surname> <given-names>CC</given-names></name><name><surname>Vonderheide</surname> <given-names>RH</given-names></name><name><surname>Pittet</surname> <given-names>MJ</given-names></name><name><surname>Jain</surname> <given-names>RK</given-names></name><name><surname>Zou</surname> <given-names>W</given-names></name><name><surname>Howcroft</surname> <given-names>TK</given-names></name><name><surname>Woodhouse</surname> <given-names>EC</given-names></name><name><surname>Weinberg</surname> <given-names>RA</given-names></name><name><surname>Krummel</surname> <given-names>MF</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Understanding the tumor immune microenvironment (TIME) for effective therapy</article-title><source>Nature Medicine</source><volume>24</volume><fpage>541</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1038/s41591-018-0014-x</pub-id><pub-id pub-id-type="pmid">29686425</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binnewies</surname> <given-names>M</given-names></name><name><surname>Mujal</surname> <given-names>AM</given-names></name><name><surname>Pollack</surname> <given-names>JL</given-names></name><name><surname>Combes</surname> <given-names>AJ</given-names></name><name><surname>Hardison</surname> <given-names>EA</given-names></name><name><surname>Barry</surname> <given-names>KC</given-names></name><name><surname>Tsui</surname> <given-names>J</given-names></name><name><surname>Ruhland</surname> <given-names>MK</given-names></name><name><surname>Kersten</surname> <given-names>K</given-names></name><name><surname>Abushawish</surname> <given-names>MA</given-names></name><name><surname>Spasic</surname> <given-names>M</given-names></name><name><surname>Giurintano</surname> <given-names>JP</given-names></name><name><surname>Chan</surname> <given-names>V</given-names></name><name><surname>Daud</surname> <given-names>AI</given-names></name><name><surname>Ha</surname> <given-names>P</given-names></name><name><surname>Ye</surname> <given-names>CJ</given-names></name><name><surname>Roberts</surname> <given-names>EW</given-names></name><name><surname>Krummel</surname> <given-names>MF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Unleashing Type-2 dendritic cells to drive protective antitumor CD4<sup>+</sup> T Cell Immunity</article-title><source>Cell</source><volume>177</volume><fpage>556</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.02.005</pub-id><pub-id pub-id-type="pmid">30955881</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birnbaum</surname> <given-names>ME</given-names></name><name><surname>Mendoza</surname> <given-names>JL</given-names></name><name><surname>Sethi</surname> <given-names>DK</given-names></name><name><surname>Dong</surname> <given-names>S</given-names></name><name><surname>Glanville</surname> <given-names>J</given-names></name><name><surname>Dobbins</surname> <given-names>J</given-names></name><name><surname>Ozkan</surname> <given-names>E</given-names></name><name><surname>Davis</surname> <given-names>MM</given-names></name><name><surname>Wucherpfennig</surname> <given-names>KW</given-names></name><name><surname>Garcia</surname> <given-names>KC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Deconstructing the peptide-MHC specificity of T cell recognition</article-title><source>Cell</source><volume>157</volume><fpage>1073</fpage><lpage>1087</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.03.047</pub-id><pub-id pub-id-type="pmid">24855945</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname> <given-names>SK</given-names></name><name><surname>Mantovani</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm</article-title><source>Nature Immunology</source><volume>11</volume><fpage>889</fpage><lpage>896</lpage><pub-id pub-id-type="doi">10.1038/ni.1937</pub-id><pub-id pub-id-type="pmid">20856220</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjerregaard</surname> <given-names>A-M</given-names></name><name><surname>Nielsen</surname> <given-names>M</given-names></name><name><surname>Hadrup</surname> <given-names>SR</given-names></name><name><surname>Szallasi</surname> <given-names>Z</given-names></name><name><surname>Eklund</surname> <given-names>AC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>MuPeXI: prediction of neo-epitopes from tumor sequencing data</article-title><source>Cancer Immunology, Immunotherapy</source><volume>66</volume><fpage>1123</fpage><lpage>1130</lpage><pub-id pub-id-type="doi">10.1007/s00262-017-2001-3</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blackburn</surname> <given-names>SD</given-names></name><name><surname>Shin</surname> <given-names>H</given-names></name><name><surname>Freeman</surname> <given-names>GJ</given-names></name><name><surname>Wherry</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade</article-title><source>PNAS</source><volume>105</volume><fpage>15016</fpage><lpage>15021</lpage><pub-id pub-id-type="doi">10.1073/pnas.0801497105</pub-id><pub-id pub-id-type="pmid">18809920</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blank</surname> <given-names>CU</given-names></name><name><surname>Haining</surname> <given-names>WN</given-names></name><name><surname>Held</surname> <given-names>W</given-names></name><name><surname>Hogan</surname> <given-names>PG</given-names></name><name><surname>Kallies</surname> <given-names>A</given-names></name><name><surname>Lugli</surname> <given-names>E</given-names></name><name><surname>Lynn</surname> <given-names>RC</given-names></name><name><surname>Philip</surname> <given-names>M</given-names></name><name><surname>Rao</surname> <given-names>A</given-names></name><name><surname>Restifo</surname> <given-names>NP</given-names></name><name><surname>Schietinger</surname> <given-names>A</given-names></name><name><surname>Schumacher</surname> <given-names>TN</given-names></name><name><surname>Schwartzberg</surname> <given-names>PL</given-names></name><name><surname>Sharpe</surname> <given-names>AH</given-names></name><name><surname>Speiser</surname> <given-names>DE</given-names></name><name><surname>Wherry</surname> <given-names>EJ</given-names></name><name><surname>Youngblood</surname> <given-names>BA</given-names></name><name><surname>Zehn</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Defining 'T cell exhaustion'</article-title><source>Nature Reviews Immunology</source><volume>19</volume><fpage>665</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1038/s41577-019-0221-9</pub-id><pub-id pub-id-type="pmid">31570879</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boissonnas</surname> <given-names>A</given-names></name><name><surname>Licata</surname> <given-names>F</given-names></name><name><surname>Poupel</surname> <given-names>L</given-names></name><name><surname>Jacquelin</surname> <given-names>S</given-names></name><name><surname>Fetler</surname> <given-names>L</given-names></name><name><surname>Krumeich</surname> <given-names>S</given-names></name><name><surname>Théry</surname> <given-names>C</given-names></name><name><surname>Amigorena</surname> <given-names>S</given-names></name><name><surname>Combadière</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>CD8+ tumor-infiltrating T cells are trapped in the tumor-dendritic cell network</article-title><source>Neoplasia</source><volume>15</volume><fpage>85</fpage><lpage>IN26</lpage><pub-id pub-id-type="doi">10.1593/neo.121572</pub-id><pub-id pub-id-type="pmid">23359264</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Booth</surname> <given-names>MJ</given-names></name><name><surname>Branco</surname> <given-names>MR</given-names></name><name><surname>Ficz</surname> <given-names>G</given-names></name><name><surname>Oxley</surname> <given-names>D</given-names></name><name><surname>Krueger</surname> <given-names>F</given-names></name><name><surname>Reik</surname> <given-names>W</given-names></name><name><surname>Balasubramanian</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution</article-title><source>Science</source><volume>336</volume><fpage>934</fpage><lpage>937</lpage><pub-id pub-id-type="doi">10.1126/science.1220671</pub-id><pub-id pub-id-type="pmid">22539555</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Booth</surname> <given-names>MJ</given-names></name><name><surname>Marsico</surname> <given-names>G</given-names></name><name><surname>Bachman</surname> <given-names>M</given-names></name><name><surname>Beraldi</surname> <given-names>D</given-names></name><name><surname>Balasubramanian</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Quantitative sequencing of 5-formylcytosine in DNA at single-base resolution</article-title><source>Nature Chemistry</source><volume>6</volume><fpage>435</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1038/nchem.1893</pub-id><pub-id pub-id-type="pmid">24755596</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowman</surname> <given-names>RL</given-names></name><name><surname>Klemm</surname> <given-names>F</given-names></name><name><surname>Akkari</surname> <given-names>L</given-names></name><name><surname>Pyonteck</surname> <given-names>SM</given-names></name><name><surname>Sevenich</surname> <given-names>L</given-names></name><name><surname>Quail</surname> <given-names>DF</given-names></name><name><surname>Dhara</surname> <given-names>S</given-names></name><name><surname>Simpson</surname> <given-names>K</given-names></name><name><surname>Gardner</surname> <given-names>EE</given-names></name><name><surname>Iacobuzio-Donahue</surname> <given-names>CA</given-names></name><name><surname>Brennan</surname> <given-names>CW</given-names></name><name><surname>Tabar</surname> <given-names>V</given-names></name><name><surname>Gutin</surname> <given-names>PH</given-names></name><name><surname>Joyce</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Macrophage ontogeny underlies differences in Tumor-Specific education in brain malignancies</article-title><source>Cell Reports</source><volume>17</volume><fpage>2445</fpage><lpage>2459</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.10.052</pub-id><pub-id pub-id-type="pmid">27840052</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname> <given-names>AP</given-names></name><name><surname>Davis</surname> <given-names>S</given-names></name><name><surname>Shulha</surname> <given-names>HP</given-names></name><name><surname>Meltzer</surname> <given-names>P</given-names></name><name><surname>Margulies</surname> <given-names>EH</given-names></name><name><surname>Weng</surname> <given-names>Z</given-names></name><name><surname>Furey</surname> <given-names>TS</given-names></name><name><surname>Crawford</surname> <given-names>GE</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>High-resolution mapping and characterization of open chromatin across the genome</article-title><source>Cell</source><volume>132</volume><fpage>311</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.12.014</pub-id><pub-id pub-id-type="pmid">18243105</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brahmer</surname> <given-names>JR</given-names></name><name><surname>Tykodi</surname> <given-names>SS</given-names></name><name><surname>Chow</surname> <given-names>LQ</given-names></name><name><surname>Hwu</surname> <given-names>WJ</given-names></name><name><surname>Topalian</surname> <given-names>SL</given-names></name><name><surname>Hwu</surname> <given-names>P</given-names></name><name><surname>Drake</surname> <given-names>CG</given-names></name><name><surname>Camacho</surname> <given-names>LH</given-names></name><name><surname>Kauh</surname> <given-names>J</given-names></name><name><surname>Odunsi</surname> <given-names>K</given-names></name><name><surname>Pitot</surname> <given-names>HC</given-names></name><name><surname>Hamid</surname> <given-names>O</given-names></name><name><surname>Bhatia</surname> <given-names>S</given-names></name><name><surname>Martins</surname> <given-names>R</given-names></name><name><surname>Eaton</surname> <given-names>K</given-names></name><name><surname>Chen</surname> <given-names>S</given-names></name><name><surname>Salay</surname> <given-names>TM</given-names></name><name><surname>Alaparthy</surname> <given-names>S</given-names></name><name><surname>Grosso</surname> <given-names>JF</given-names></name><name><surname>Korman</surname> <given-names>AJ</given-names></name><name><surname>Parker</surname> <given-names>SM</given-names></name><name><surname>Agrawal</surname> <given-names>S</given-names></name><name><surname>Goldberg</surname> <given-names>SM</given-names></name><name><surname>Pardoll</surname> <given-names>DM</given-names></name><name><surname>Gupta</surname> <given-names>A</given-names></name><name><surname>Wigginton</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Safety and activity of anti-PD-L1 antibody in patients with advanced Cancer</article-title><source>New England Journal of Medicine</source><volume>366</volume><fpage>2455</fpage><lpage>2465</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1200694</pub-id><pub-id pub-id-type="pmid">22658128</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bräunlein</surname> <given-names>E</given-names></name><name><surname>Krackhardt</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="1702">1702</year><article-title>Identification and characterization of neoantigens as well as respective immune responses in Cancer patients</article-title><source>Frontiers in Immunology</source><volume>8</volume><elocation-id>1702</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2017.01702</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brentjens</surname> <given-names>RJ</given-names></name><name><surname>Davila</surname> <given-names>ML</given-names></name><name><surname>Riviere</surname> <given-names>I</given-names></name><name><surname>Park</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Cowell</surname> <given-names>LG</given-names></name><name><surname>Bartido</surname> <given-names>S</given-names></name><name><surname>Stefanski</surname> <given-names>J</given-names></name><name><surname>Taylor</surname> <given-names>C</given-names></name><name><surname>Olszewska</surname> <given-names>M</given-names></name><name><surname>Borquez-Ojeda</surname> <given-names>O</given-names></name><name><surname>Qu</surname> <given-names>J</given-names></name><name><surname>Wasielewska</surname> <given-names>T</given-names></name><name><surname>He</surname> <given-names>Q</given-names></name><name><surname>Bernal</surname> <given-names>Y</given-names></name><name><surname>Rijo</surname> <given-names>IV</given-names></name><name><surname>Hedvat</surname> <given-names>C</given-names></name><name><surname>Kobos</surname> <given-names>R</given-names></name><name><surname>Curran</surname> <given-names>K</given-names></name><name><surname>Steinherz</surname> <given-names>P</given-names></name><name><surname>Jurcic</surname> <given-names>J</given-names></name><name><surname>Rosenblat</surname> <given-names>T</given-names></name><name><surname>Maslak</surname> <given-names>P</given-names></name><name><surname>Frattini</surname> <given-names>M</given-names></name><name><surname>Sadelain</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia</article-title><source>Science Translational Medicine</source><volume>5</volume><elocation-id>177ra38</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3005930</pub-id><pub-id pub-id-type="pmid">23515080</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breuer</surname> <given-names>K</given-names></name><name><surname>Foroushani</surname> <given-names>AK</given-names></name><name><surname>Laird</surname> <given-names>MR</given-names></name><name><surname>Chen</surname> <given-names>C</given-names></name><name><surname>Sribnaia</surname> <given-names>A</given-names></name><name><surname>Lo</surname> <given-names>R</given-names></name><name><surname>Winsor</surname> <given-names>GL</given-names></name><name><surname>Hancock</surname> <given-names>RE</given-names></name><name><surname>Brinkman</surname> <given-names>FS</given-names></name><name><surname>Lynn</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>InnateDB: systems biology of innate immunity and beyond--recent updates and continuing curation</article-title><source>Nucleic Acids Research</source><volume>41</volume><fpage>D1228</fpage><lpage>D1233</lpage><pub-id pub-id-type="doi">10.1093/nar/gks1147</pub-id><pub-id pub-id-type="pmid">23180781</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brodt</surname> <given-names>P</given-names></name><name><surname>Gordon</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Natural resistance mechanisms may play a role in protection against chemical carcinogenesis</article-title><source>Cancer Immunology Immunotherapy</source><volume>13</volume><fpage>125</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1007/BF00205312</pub-id><pub-id pub-id-type="pmid">6984356</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bronte</surname> <given-names>V</given-names></name><name><surname>Brandau</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>SH</given-names></name><name><surname>Colombo</surname> <given-names>MP</given-names></name><name><surname>Frey</surname> <given-names>AB</given-names></name><name><surname>Greten</surname> <given-names>TF</given-names></name><name><surname>Mandruzzato</surname> <given-names>S</given-names></name><name><surname>Murray</surname> <given-names>PJ</given-names></name><name><surname>Ochoa</surname> <given-names>A</given-names></name><name><surname>Ostrand-Rosenberg</surname> <given-names>S</given-names></name><name><surname>Rodriguez</surname> <given-names>PC</given-names></name><name><surname>Sica</surname> <given-names>A</given-names></name><name><surname>Umansky</surname> <given-names>V</given-names></name><name><surname>Vonderheide</surname> <given-names>RH</given-names></name><name><surname>Gabrilovich</surname> <given-names>DI</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>12150</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms12150</pub-id><pub-id pub-id-type="pmid">27381735</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broz</surname> <given-names>ML</given-names></name><name><surname>Binnewies</surname> <given-names>M</given-names></name><name><surname>Boldajipour</surname> <given-names>B</given-names></name><name><surname>Nelson</surname> <given-names>AE</given-names></name><name><surname>Pollack</surname> <given-names>JL</given-names></name><name><surname>Erle</surname> <given-names>DJ</given-names></name><name><surname>Barczak</surname> <given-names>A</given-names></name><name><surname>Rosenblum</surname> <given-names>MD</given-names></name><name><surname>Daud</surname> <given-names>A</given-names></name><name><surname>Barber</surname> <given-names>DL</given-names></name><name><surname>Amigorena</surname> <given-names>S</given-names></name><name><surname>Van't Veer</surname> <given-names>LJ</given-names></name><name><surname>Sperling</surname> <given-names>AI</given-names></name><name><surname>Wolf</surname> <given-names>DM</given-names></name><name><surname>Krummel</surname> <given-names>MF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity</article-title><source>Cancer Cell</source><volume>26</volume><fpage>638</fpage><lpage>652</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2014.09.007</pub-id><pub-id pub-id-type="pmid">25446897</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brubaker</surname> <given-names>DK</given-names></name><name><surname>Proctor</surname> <given-names>EA</given-names></name><name><surname>Haigis</surname> <given-names>KM</given-names></name><name><surname>Lauffenburger</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Computational translation of genomic responses from experimental model systems to humans</article-title><source>PLOS Computational Biology</source><volume>15</volume><elocation-id>e1006286</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1006286</pub-id><pub-id pub-id-type="pmid">30629591</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brubaker</surname> <given-names>DK</given-names></name><name><surname>Lauffenburger</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Translating preclinical models to humans</article-title><source>Science</source><volume>367</volume><fpage>742</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1126/science.aay8086</pub-id><pub-id pub-id-type="pmid">32054749</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruchard</surname> <given-names>M</given-names></name><name><surname>Ghiringhelli</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Deciphering the roles of innate lymphoid cells in Cancer</article-title><source>Frontiers in Immunology</source><volume>10</volume><elocation-id>656</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.00656</pub-id><pub-id pub-id-type="pmid">31024531</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruggner</surname> <given-names>RV</given-names></name><name><surname>Bodenmiller</surname> <given-names>B</given-names></name><name><surname>Dill</surname> <given-names>DL</given-names></name><name><surname>Tibshirani</surname> <given-names>RJ</given-names></name><name><surname>Nolan</surname> <given-names>GP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Automated identification of stratifying signatures in cellular subpopulations</article-title><source>PNAS</source><volume>111</volume><fpage>E2770</fpage><lpage>E2777</lpage><pub-id pub-id-type="doi">10.1073/pnas.1408792111</pub-id><pub-id pub-id-type="pmid">24979804</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brusic</surname> <given-names>V</given-names></name><name><surname>Gottardo</surname> <given-names>R</given-names></name><name><surname>Kleinstein</surname> <given-names>SH</given-names></name><name><surname>Davis</surname> <given-names>MM</given-names></name><collab>HIPC steering committee</collab></person-group><year iso-8601-date="2014">2014</year><article-title>Computational resources for high-dimensional immune analysis from the human immunology project consortium</article-title><source>Nature Biotechnology</source><volume>32</volume><fpage>146</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1038/nbt.2777</pub-id><pub-id pub-id-type="pmid">24441472</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buenrostro</surname> <given-names>JD</given-names></name><name><surname>Giresi</surname> <given-names>PG</given-names></name><name><surname>Zaba</surname> <given-names>LC</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name><name><surname>Greenleaf</surname> <given-names>WJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position</article-title><source>Nature Methods</source><volume>10</volume><fpage>1213</fpage><lpage>1218</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2688</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buenrostro</surname> <given-names>JD</given-names></name><name><surname>Wu</surname> <given-names>B</given-names></name><name><surname>Litzenburger</surname> <given-names>UM</given-names></name><name><surname>Ruff</surname> <given-names>D</given-names></name><name><surname>Gonzales</surname> <given-names>ML</given-names></name><name><surname>Snyder</surname> <given-names>MP</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name><name><surname>Greenleaf</surname> <given-names>WJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Single-cell chromatin accessibility reveals principles of regulatory variation</article-title><source>Nature</source><volume>523</volume><fpage>486</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.1038/nature14590</pub-id><pub-id pub-id-type="pmid">26083756</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buenrostro</surname> <given-names>JD</given-names></name><name><surname>Corces</surname> <given-names>MR</given-names></name><name><surname>Lareau</surname> <given-names>CA</given-names></name><name><surname>Wu</surname> <given-names>B</given-names></name><name><surname>Schep</surname> <given-names>AN</given-names></name><name><surname>Aryee</surname> <given-names>MJ</given-names></name><name><surname>Majeti</surname> <given-names>R</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name><name><surname>Greenleaf</surname> <given-names>WJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Integrated Single-Cell analysis maps the continuous regulatory landscape of human hematopoietic differentiation</article-title><source>Cell</source><volume>173</volume><fpage>1535</fpage><lpage>1548</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.03.074</pub-id><pub-id pub-id-type="pmid">29706549</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buffie</surname> <given-names>CG</given-names></name><name><surname>Bucci</surname> <given-names>V</given-names></name><name><surname>Stein</surname> <given-names>RR</given-names></name><name><surname>McKenney</surname> <given-names>PT</given-names></name><name><surname>Ling</surname> <given-names>L</given-names></name><name><surname>Gobourne</surname> <given-names>A</given-names></name><name><surname>No</surname> <given-names>D</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>Kinnebrew</surname> <given-names>M</given-names></name><name><surname>Viale</surname> <given-names>A</given-names></name><name><surname>Littmann</surname> <given-names>E</given-names></name><name><surname>van den Brink</surname> <given-names>MR</given-names></name><name><surname>Jenq</surname> <given-names>RR</given-names></name><name><surname>Taur</surname> <given-names>Y</given-names></name><name><surname>Sander</surname> <given-names>C</given-names></name><name><surname>Cross</surname> <given-names>JR</given-names></name><name><surname>Toussaint</surname> <given-names>NC</given-names></name><name><surname>Xavier</surname> <given-names>JB</given-names></name><name><surname>Pamer</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile</article-title><source>Nature</source><volume>517</volume><fpage>205</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1038/nature13828</pub-id><pub-id pub-id-type="pmid">25337874</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulger</surname> <given-names>M</given-names></name><name><surname>Groudine</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Functional and mechanistic diversity of distal transcription enhancers</article-title><source>Cell</source><volume>144</volume><fpage>327</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.01.024</pub-id><pub-id pub-id-type="pmid">21295696</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busslinger</surname> <given-names>M</given-names></name><name><surname>Tarakhovsky</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Epigenetic control of immunity</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>6</volume><elocation-id>a024174</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a024174</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butcher</surname> <given-names>EC</given-names></name><name><surname>Berg</surname> <given-names>EL</given-names></name><name><surname>Kunkel</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Systems biology in drug discovery</article-title><source>Nature Biotechnology</source><volume>22</volume><fpage>1253</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.1038/nbt1017</pub-id><pub-id pub-id-type="pmid">15470465</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname> <given-names>A</given-names></name><name><surname>Hoffman</surname> <given-names>P</given-names></name><name><surname>Smibert</surname> <given-names>P</given-names></name><name><surname>Papalexi</surname> <given-names>E</given-names></name><name><surname>Satija</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title><source>Nature Biotechnology</source><volume>36</volume><fpage>411</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id><pub-id pub-id-type="pmid">29608179</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname> <given-names>J</given-names></name><name><surname>Cusanovich</surname> <given-names>DA</given-names></name><name><surname>Ramani</surname> <given-names>V</given-names></name><name><surname>Aghamirzaie</surname> <given-names>D</given-names></name><name><surname>Pliner</surname> <given-names>HA</given-names></name><name><surname>Hill</surname> <given-names>AJ</given-names></name><name><surname>Daza</surname> <given-names>RM</given-names></name><name><surname>McFaline-Figueroa</surname> <given-names>JL</given-names></name><name><surname>Packer</surname> <given-names>JS</given-names></name><name><surname>Christiansen</surname> <given-names>L</given-names></name><name><surname>Steemers</surname> <given-names>FJ</given-names></name><name><surname>Adey</surname> <given-names>AC</given-names></name><name><surname>Trapnell</surname> <given-names>C</given-names></name><name><surname>Shendure</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Joint profiling of chromatin accessibility and gene expression in thousands of single cells</article-title><source>Science</source><volume>361</volume><fpage>1380</fpage><lpage>1385</lpage><pub-id pub-id-type="doi">10.1126/science.aau0730</pub-id><pub-id pub-id-type="pmid">30166440</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caprioli</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Imaging mass spectrometry: molecular microscopy for the new age of biology and medicine</article-title><source>Proteomics</source><volume>16</volume><fpage>1607</fpage><lpage>1612</lpage><pub-id pub-id-type="doi">10.1002/pmic.201600133</pub-id><pub-id pub-id-type="pmid">27159897</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carbone</surname> <given-names>DP</given-names></name><name><surname>Reck</surname> <given-names>M</given-names></name><name><surname>Paz-Ares</surname> <given-names>L</given-names></name><name><surname>Creelan</surname> <given-names>B</given-names></name><name><surname>Horn</surname> <given-names>L</given-names></name><name><surname>Steins</surname> <given-names>M</given-names></name><name><surname>Felip</surname> <given-names>E</given-names></name><name><surname>van den Heuvel</surname> <given-names>MM</given-names></name><name><surname>Ciuleanu</surname> <given-names>TE</given-names></name><name><surname>Badin</surname> <given-names>F</given-names></name><name><surname>Ready</surname> <given-names>N</given-names></name><name><surname>Hiltermann</surname> <given-names>TJN</given-names></name><name><surname>Nair</surname> <given-names>S</given-names></name><name><surname>Juergens</surname> <given-names>R</given-names></name><name><surname>Peters</surname> <given-names>S</given-names></name><name><surname>Minenza</surname> <given-names>E</given-names></name><name><surname>Wrangle</surname> <given-names>JM</given-names></name><name><surname>Rodriguez-Abreu</surname> <given-names>D</given-names></name><name><surname>Borghaei</surname> <given-names>H</given-names></name><name><surname>Blumenschein</surname> <given-names>GR</given-names></name><name><surname>Villaruz</surname> <given-names>LC</given-names></name><name><surname>Havel</surname> <given-names>L</given-names></name><name><surname>Krejci</surname> <given-names>J</given-names></name><name><surname>Corral Jaime</surname> <given-names>J</given-names></name><name><surname>Chang</surname> <given-names>H</given-names></name><name><surname>Geese</surname> <given-names>WJ</given-names></name><name><surname>Bhagavatheeswaran</surname> <given-names>P</given-names></name><name><surname>Chen</surname> <given-names>AC</given-names></name><name><surname>Socinski</surname> <given-names>MA</given-names></name><collab>CheckMate 026 Investigators</collab></person-group><year iso-8601-date="2017">2017</year><article-title>First-Line nivolumab in stage IV or recurrent Non-Small-Cell lung Cancer</article-title><source>New England Journal of Medicine</source><volume>376</volume><fpage>2415</fpage><lpage>2426</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1613493</pub-id><pub-id pub-id-type="pmid">28636851</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlin</surname> <given-names>LM</given-names></name><name><surname>Stamatiades</surname> <given-names>EG</given-names></name><name><surname>Auffray</surname> <given-names>C</given-names></name><name><surname>Hanna</surname> <given-names>RN</given-names></name><name><surname>Glover</surname> <given-names>L</given-names></name><name><surname>Vizcay-Barrena</surname> <given-names>G</given-names></name><name><surname>Hedrick</surname> <given-names>CC</given-names></name><name><surname>Cook</surname> <given-names>HT</given-names></name><name><surname>Diebold</surname> <given-names>S</given-names></name><name><surname>Geissmann</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal</article-title><source>Cell</source><volume>153</volume><fpage>362</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.03.010</pub-id><pub-id pub-id-type="pmid">23582326</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmi</surname> <given-names>Y</given-names></name><name><surname>Spitzer</surname> <given-names>MH</given-names></name><name><surname>Linde</surname> <given-names>IL</given-names></name><name><surname>Burt</surname> <given-names>BM</given-names></name><name><surname>Prestwood</surname> <given-names>TR</given-names></name><name><surname>Perlman</surname> <given-names>N</given-names></name><name><surname>Davidson</surname> <given-names>MG</given-names></name><name><surname>Kenkel</surname> <given-names>JA</given-names></name><name><surname>Segal</surname> <given-names>E</given-names></name><name><surname>Pusapati</surname> <given-names>GV</given-names></name><name><surname>Bhattacharya</surname> <given-names>N</given-names></name><name><surname>Engleman</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity</article-title><source>Nature</source><volume>521</volume><fpage>99</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1038/nature14424</pub-id><pub-id pub-id-type="pmid">25924063</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmi</surname> <given-names>Y</given-names></name><name><surname>Prestwood</surname> <given-names>TR</given-names></name><name><surname>Spitzer</surname> <given-names>MH</given-names></name><name><surname>Linde</surname> <given-names>IL</given-names></name><name><surname>Chabon</surname> <given-names>J</given-names></name><name><surname>Reticker-Flynn</surname> <given-names>NE</given-names></name><name><surname>Bhattacharya</surname> <given-names>N</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Basto</surname> <given-names>PA</given-names></name><name><surname>Burt</surname> <given-names>BM</given-names></name><name><surname>Alonso</surname> <given-names>MN</given-names></name><name><surname>Engleman</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Akt and SHP-1 are DC-intrinsic checkpoints for tumor immunity</article-title><source>JCI Insight</source><volume>1</volume><elocation-id>89020</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.89020</pub-id><pub-id pub-id-type="pmid">27812544</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carreno</surname> <given-names>BM</given-names></name><name><surname>Magrini</surname> <given-names>V</given-names></name><name><surname>Becker-Hapak</surname> <given-names>M</given-names></name><name><surname>Kaabinejadian</surname> <given-names>S</given-names></name><name><surname>Hundal</surname> <given-names>J</given-names></name><name><surname>Petti</surname> <given-names>AA</given-names></name><name><surname>Ly</surname> <given-names>A</given-names></name><name><surname>Lie</surname> <given-names>WR</given-names></name><name><surname>Hildebrand</surname> <given-names>WH</given-names></name><name><surname>Mardis</surname> <given-names>ER</given-names></name><name><surname>Linette</surname> <given-names>GP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells</article-title><source>Science</source><volume>348</volume><fpage>803</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1126/science.aaa3828</pub-id><pub-id pub-id-type="pmid">25837513</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castle</surname> <given-names>JC</given-names></name><name><surname>Kreiter</surname> <given-names>S</given-names></name><name><surname>Diekmann</surname> <given-names>J</given-names></name><name><surname>Löwer</surname> <given-names>M</given-names></name><name><surname>van de Roemer</surname> <given-names>N</given-names></name><name><surname>de Graaf</surname> <given-names>J</given-names></name><name><surname>Selmi</surname> <given-names>A</given-names></name><name><surname>Diken</surname> <given-names>M</given-names></name><name><surname>Boegel</surname> <given-names>S</given-names></name><name><surname>Paret</surname> <given-names>C</given-names></name><name><surname>Koslowski</surname> <given-names>M</given-names></name><name><surname>Kuhn</surname> <given-names>AN</given-names></name><name><surname>Britten</surname> <given-names>CM</given-names></name><name><surname>Huber</surname> <given-names>C</given-names></name><name><surname>Türeci</surname> <given-names>O</given-names></name><name><surname>Sahin</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Exploiting the mutanome for tumor Vaccination</article-title><source>Cancer Research</source><volume>72</volume><fpage>1081</fpage><lpage>1091</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-11-3722</pub-id><pub-id pub-id-type="pmid">22237626</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerwenka</surname> <given-names>A</given-names></name><name><surname>Lanier</surname> <given-names>LL</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Natural killer cells, viruses and Cancer</article-title><source>Nature Reviews Immunology</source><volume>1</volume><fpage>41</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1038/35095564</pub-id><pub-id pub-id-type="pmid">11905813</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamseddine</surname> <given-names>IM</given-names></name><name><surname>Rejniak</surname> <given-names>KA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Hybrid modeling frameworks of tumor development and treatment</article-title><source>Wiley Interdisciplinary Reviews: Systems Biology and Medicine</source><volume>14</volume><elocation-id>1461</elocation-id><pub-id pub-id-type="doi">10.1002/wsbm.1461</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaudhary</surname> <given-names>N</given-names></name><name><surname>Wesemann</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Analyzing immunoglobulin repertoires</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>462</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.00462</pub-id><pub-id pub-id-type="pmid">29593723</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>KH</given-names></name><name><surname>Boettiger</surname> <given-names>AN</given-names></name><name><surname>Moffitt</surname> <given-names>JR</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Zhuang</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2015">2015a</year><article-title>RNA imaging. Spatially resolved, highly multiplexed RNA profiling in single cells</article-title><source>Science</source><volume>348</volume><elocation-id>aaa6090</elocation-id><pub-id pub-id-type="doi">10.1126/science.aaa6090</pub-id><pub-id pub-id-type="pmid">25858977</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>K</given-names></name><name><surname>Chen</surname> <given-names>Z</given-names></name><name><surname>Wu</surname> <given-names>D</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Lin</surname> <given-names>X</given-names></name><name><surname>Su</surname> <given-names>J</given-names></name><name><surname>Rodriguez</surname> <given-names>B</given-names></name><name><surname>Xi</surname> <given-names>Y</given-names></name><name><surname>Xia</surname> <given-names>Z</given-names></name><name><surname>Chen</surname> <given-names>X</given-names></name><name><surname>Shi</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>Q</given-names></name><name><surname>Li</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015b</year><article-title>Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes</article-title><source>Nature Genetics</source><volume>47</volume><fpage>1149</fpage><lpage>1157</lpage><pub-id pub-id-type="doi">10.1038/ng.3385</pub-id><pub-id pub-id-type="pmid">26301496</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Li</surname> <given-names>C</given-names></name><name><surname>Peng</surname> <given-names>X</given-names></name><name><surname>Zhou</surname> <given-names>Z</given-names></name><name><surname>Weinstein</surname> <given-names>JN</given-names></name><name><surname>Liang</surname> <given-names>H</given-names></name><collab>Cancer Genome Atlas Research Network</collab></person-group><year iso-8601-date="2018">2018</year><article-title>A Pan-Cancer analysis of enhancer expression in nearly 9000 patient samples</article-title><source>Cell</source><volume>173</volume><fpage>386</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.03.027</pub-id><pub-id pub-id-type="pmid">29625054</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>G</given-names></name><name><surname>Ning</surname> <given-names>B</given-names></name><name><surname>Shi</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019a</year><article-title>Single-Cell RNA-Seq technologies and related computational data analysis</article-title><source>Frontiers in Genetics</source><volume>10</volume><elocation-id>317</elocation-id><pub-id pub-id-type="doi">10.3389/fgene.2019.00317</pub-id><pub-id pub-id-type="pmid">31024627</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>López-Moyado</surname> <given-names>IF</given-names></name><name><surname>Seo</surname> <given-names>H</given-names></name><name><surname>Lio</surname> <given-names>CJ</given-names></name><name><surname>Hempleman</surname> <given-names>LJ</given-names></name><name><surname>Sekiya</surname> <given-names>T</given-names></name><name><surname>Yoshimura</surname> <given-names>A</given-names></name><name><surname>Scott-Browne</surname> <given-names>JP</given-names></name><name><surname>Rao</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019b</year><article-title>NR4A transcription factors limit CAR T cell function in solid tumours</article-title><source>Nature</source><volume>567</volume><fpage>530</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-0985-x</pub-id><pub-id pub-id-type="pmid">30814732</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chevrier</surname> <given-names>S</given-names></name><name><surname>Levine</surname> <given-names>JH</given-names></name><name><surname>Zanotelli</surname> <given-names>VRT</given-names></name><name><surname>Silina</surname> <given-names>K</given-names></name><name><surname>Schulz</surname> <given-names>D</given-names></name><name><surname>Bacac</surname> <given-names>M</given-names></name><name><surname>Ries</surname> <given-names>CH</given-names></name><name><surname>Ailles</surname> <given-names>L</given-names></name><name><surname>Jewett</surname> <given-names>MAS</given-names></name><name><surname>Moch</surname> <given-names>H</given-names></name><name><surname>van den Broek</surname> <given-names>M</given-names></name><name><surname>Beisel</surname> <given-names>C</given-names></name><name><surname>Stadler</surname> <given-names>MB</given-names></name><name><surname>Gedye</surname> <given-names>C</given-names></name><name><surname>Reis</surname> <given-names>B</given-names></name><name><surname>Pe'er</surname> <given-names>D</given-names></name><name><surname>Bodenmiller</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>An immune atlas of clear cell renal cell carcinoma</article-title><source>Cell</source><volume>169</volume><fpage>736</fpage><lpage>749</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.04.016</pub-id><pub-id pub-id-type="pmid">28475899</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiacchio</surname> <given-names>F</given-names></name><name><surname>Pennisi</surname> <given-names>M</given-names></name><name><surname>Russo</surname> <given-names>G</given-names></name><name><surname>Motta</surname> <given-names>S</given-names></name><name><surname>Pappalardo</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Agent-Based modeling of the immune system: netlogo, a promising framework</article-title><source>BioMed Research International</source><volume>2014</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1155/2014/907171</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chikina</surname> <given-names>MD</given-names></name><name><surname>Troyanskaya</surname> <given-names>OG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Accurate quantification of functional analogy among close homologs</article-title><source>PLOS Computational Biology</source><volume>7</volume><elocation-id>e1001074</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1001074</pub-id><pub-id pub-id-type="pmid">21304936</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuang</surname> <given-names>HY</given-names></name><name><surname>Hofree</surname> <given-names>M</given-names></name><name><surname>Ideker</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A decade of systems biology</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>26</volume><fpage>721</fpage><lpage>744</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-100109-104122</pub-id><pub-id pub-id-type="pmid">20604711</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Citron</surname> <given-names>ML</given-names></name><name><surname>Berry</surname> <given-names>DA</given-names></name><name><surname>Cirrincione</surname> <given-names>C</given-names></name><name><surname>Hudis</surname> <given-names>C</given-names></name><name><surname>Winer</surname> <given-names>EP</given-names></name><name><surname>Gradishar</surname> <given-names>WJ</given-names></name><name><surname>Davidson</surname> <given-names>NE</given-names></name><name><surname>Martino</surname> <given-names>S</given-names></name><name><surname>Livingston</surname> <given-names>R</given-names></name><name><surname>Ingle</surname> <given-names>JN</given-names></name><name><surname>Perez</surname> <given-names>EA</given-names></name><name><surname>Carpenter</surname> <given-names>J</given-names></name><name><surname>Hurd</surname> <given-names>D</given-names></name><name><surname>Holland</surname> <given-names>JF</given-names></name><name><surname>Smith</surname> <given-names>BL</given-names></name><name><surname>Sartor</surname> <given-names>CI</given-names></name><name><surname>Leung</surname> <given-names>EH</given-names></name><name><surname>Abrams</surname> <given-names>J</given-names></name><name><surname>Schilsky</surname> <given-names>RL</given-names></name><name><surname>Muss</surname> <given-names>HB</given-names></name><name><surname>Norton</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast Cancer: first report of intergroup trial C9741/Cancer and leukemia group B trial 9741</article-title><source>Journal of Clinical Oncology</source><volume>21</volume><fpage>1431</fpage><lpage>1439</lpage><pub-id pub-id-type="doi">10.1200/JCO.2003.09.081</pub-id><pub-id pub-id-type="pmid">12668651</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname> <given-names>SJ</given-names></name><name><surname>Smallwood</surname> <given-names>SA</given-names></name><name><surname>Lee</surname> <given-names>HJ</given-names></name><name><surname>Krueger</surname> <given-names>F</given-names></name><name><surname>Reik</surname> <given-names>W</given-names></name><name><surname>Kelsey</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genome-wide base-resolution mapping of DNA methylation in single cells using single-cell bisulfite sequencing (scBS-seq)</article-title><source>Nature Protocols</source><volume>12</volume><fpage>534</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1038/nprot.2016.187</pub-id><pub-id pub-id-type="pmid">28182018</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clatworthy</surname> <given-names>MR</given-names></name><name><surname>Aronin</surname> <given-names>CE</given-names></name><name><surname>Mathews</surname> <given-names>RJ</given-names></name><name><surname>Morgan</surname> <given-names>NY</given-names></name><name><surname>Smith</surname> <given-names>KG</given-names></name><name><surname>Germain</surname> <given-names>RN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Immune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodes</article-title><source>Nature Medicine</source><volume>20</volume><fpage>1458</fpage><lpage>1463</lpage><pub-id pub-id-type="doi">10.1038/nm.3709</pub-id><pub-id pub-id-type="pmid">25384086</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cobbold</surname> <given-names>M</given-names></name><name><surname>De La Peña</surname> <given-names>H</given-names></name><name><surname>Norris</surname> <given-names>A</given-names></name><name><surname>Polefrone</surname> <given-names>JM</given-names></name><name><surname>Qian</surname> <given-names>J</given-names></name><name><surname>English</surname> <given-names>AM</given-names></name><name><surname>Cummings</surname> <given-names>KL</given-names></name><name><surname>Penny</surname> <given-names>S</given-names></name><name><surname>Turner</surname> <given-names>JE</given-names></name><name><surname>Cottine</surname> <given-names>J</given-names></name><name><surname>Abelin</surname> <given-names>JG</given-names></name><name><surname>Malaker</surname> <given-names>SA</given-names></name><name><surname>Zarling</surname> <given-names>AL</given-names></name><name><surname>Huang</surname> <given-names>HW</given-names></name><name><surname>Goodyear</surname> <given-names>O</given-names></name><name><surname>Freeman</surname> <given-names>SD</given-names></name><name><surname>Shabanowitz</surname> <given-names>J</given-names></name><name><surname>Pratt</surname> <given-names>G</given-names></name><name><surname>Craddock</surname> <given-names>C</given-names></name><name><surname>Williams</surname> <given-names>ME</given-names></name><name><surname>Hunt</surname> <given-names>DF</given-names></name><name><surname>Engelhard</surname> <given-names>VH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia</article-title><source>Science Translational Medicine</source><volume>5</volume><elocation-id>203ra125</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3006061</pub-id><pub-id pub-id-type="pmid">24048523</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname> <given-names>JN</given-names></name><name><surname>Guidi</surname> <given-names>CJ</given-names></name><name><surname>Tewalt</surname> <given-names>EF</given-names></name><name><surname>Qiao</surname> <given-names>H</given-names></name><name><surname>Rouhani</surname> <given-names>SJ</given-names></name><name><surname>Ruddell</surname> <given-names>A</given-names></name><name><surname>Farr</surname> <given-names>AG</given-names></name><name><surname>Tung</surname> <given-names>KS</given-names></name><name><surname>Engelhard</surname> <given-names>VH</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation</article-title><source>The Journal of Experimental Medicine</source><volume>207</volume><fpage>681</fpage><lpage>688</lpage><pub-id pub-id-type="doi">10.1084/jem.20092465</pub-id><pub-id pub-id-type="pmid">20308365</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coifman</surname> <given-names>RR</given-names></name><name><surname>Lafon</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>AB</given-names></name><name><surname>Maggioni</surname> <given-names>M</given-names></name><name><surname>Nadler</surname> <given-names>B</given-names></name><name><surname>Warner</surname> <given-names>F</given-names></name><name><surname>Zucker</surname> <given-names>SW</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Geometric diffusions as a tool for harmonic analysis and structure definition of data: diffusion maps</article-title><source>PNAS</source><volume>102</volume><fpage>7426</fpage><lpage>7431</lpage><pub-id pub-id-type="doi">10.1073/pnas.0500334102</pub-id><pub-id pub-id-type="pmid">15899970</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colbeck</surname> <given-names>EJ</given-names></name><name><surname>Ager</surname> <given-names>A</given-names></name><name><surname>Gallimore</surname> <given-names>A</given-names></name><name><surname>Jones</surname> <given-names>GW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Tertiary lymphoid structures in Cancer: drivers of antitumor immunity, immunosuppression, or bystander sentinels in disease?</article-title><source>Frontiers in Immunology</source><volume>8</volume><elocation-id>1830</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2017.01830</pub-id><pub-id pub-id-type="pmid">29312327</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Condamine</surname> <given-names>T</given-names></name><name><surname>Dominguez</surname> <given-names>GA</given-names></name><name><surname>Youn</surname> <given-names>JI</given-names></name><name><surname>Kossenkov</surname> <given-names>AV</given-names></name><name><surname>Mony</surname> <given-names>S</given-names></name><name><surname>Alicea-Torres</surname> <given-names>K</given-names></name><name><surname>Tcyganov</surname> <given-names>E</given-names></name><name><surname>Hashimoto</surname> <given-names>A</given-names></name><name><surname>Nefedova</surname> <given-names>Y</given-names></name><name><surname>Lin</surname> <given-names>C</given-names></name><name><surname>Partlova</surname> <given-names>S</given-names></name><name><surname>Garfall</surname> <given-names>A</given-names></name><name><surname>Vogl</surname> <given-names>DT</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Knight</surname> <given-names>SC</given-names></name><name><surname>Malietzis</surname> <given-names>G</given-names></name><name><surname>Lee</surname> <given-names>GH</given-names></name><name><surname>Eruslanov</surname> <given-names>E</given-names></name><name><surname>Albelda</surname> <given-names>SM</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Mehta</surname> <given-names>JL</given-names></name><name><surname>Bewtra</surname> <given-names>M</given-names></name><name><surname>Rustgi</surname> <given-names>A</given-names></name><name><surname>Hockstein</surname> <given-names>N</given-names></name><name><surname>Witt</surname> <given-names>R</given-names></name><name><surname>Masters</surname> <given-names>G</given-names></name><name><surname>Nam</surname> <given-names>B</given-names></name><name><surname>Smirnov</surname> <given-names>D</given-names></name><name><surname>Sepulveda</surname> <given-names>MA</given-names></name><name><surname>Gabrilovich</surname> <given-names>DI</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in Cancer patients</article-title><source>Science Immunology</source><volume>1</volume><elocation-id>aaf8943</elocation-id><pub-id pub-id-type="doi">10.1126/sciimmunol.aaf8943</pub-id><pub-id pub-id-type="pmid">28417112</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corces</surname> <given-names>MR</given-names></name><name><surname>Buenrostro</surname> <given-names>JD</given-names></name><name><surname>Wu</surname> <given-names>B</given-names></name><name><surname>Greenside</surname> <given-names>PG</given-names></name><name><surname>Chan</surname> <given-names>SM</given-names></name><name><surname>Koenig</surname> <given-names>JL</given-names></name><name><surname>Snyder</surname> <given-names>MP</given-names></name><name><surname>Pritchard</surname> <given-names>JK</given-names></name><name><surname>Kundaje</surname> <given-names>A</given-names></name><name><surname>Greenleaf</surname> <given-names>WJ</given-names></name><name><surname>Majeti</surname> <given-names>R</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution</article-title><source>Nature Genetics</source><volume>48</volume><fpage>1193</fpage><lpage>1203</lpage><pub-id pub-id-type="doi">10.1038/ng.3646</pub-id><pub-id pub-id-type="pmid">27526324</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corces</surname> <given-names>MR</given-names></name><name><surname>Granja</surname> <given-names>JM</given-names></name><name><surname>Shams</surname> <given-names>S</given-names></name><name><surname>Louie</surname> <given-names>BH</given-names></name><name><surname>Seoane</surname> <given-names>JA</given-names></name><name><surname>Zhou</surname> <given-names>W</given-names></name><name><surname>Silva</surname> <given-names>TC</given-names></name><name><surname>Groeneveld</surname> <given-names>C</given-names></name><name><surname>Wong</surname> <given-names>CK</given-names></name><name><surname>Cho</surname> <given-names>SW</given-names></name><name><surname>Satpathy</surname> <given-names>AT</given-names></name><name><surname>Mumbach</surname> <given-names>MR</given-names></name><name><surname>Hoadley</surname> <given-names>KA</given-names></name><name><surname>Robertson</surname> <given-names>AG</given-names></name><name><surname>Sheffield</surname> <given-names>NC</given-names></name><name><surname>Felau</surname> <given-names>I</given-names></name><name><surname>Castro</surname> <given-names>MAA</given-names></name><name><surname>Berman</surname> <given-names>BP</given-names></name><name><surname>Staudt</surname> <given-names>LM</given-names></name><name><surname>Zenklusen</surname> <given-names>JC</given-names></name><name><surname>Laird</surname> <given-names>PW</given-names></name><name><surname>Curtis</surname> <given-names>C</given-names></name><name><surname>Greenleaf</surname> <given-names>WJ</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The chromatin accessibility landscape of primary human cancers</article-title><source>Science</source><volume>362</volume><elocation-id>eaav1898</elocation-id><pub-id pub-id-type="doi">10.1126/science.aav1898</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coskun</surname> <given-names>AF</given-names></name><name><surname>Cai</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dense transcript profiling in single cells by image correlation decoding</article-title><source>Nature Methods</source><volume>13</volume><fpage>657</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3895</pub-id><pub-id pub-id-type="pmid">27271198</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cottrell</surname> <given-names>TR</given-names></name><name><surname>Thompson</surname> <given-names>ED</given-names></name><name><surname>Forde</surname> <given-names>PM</given-names></name><name><surname>Stein</surname> <given-names>JE</given-names></name><name><surname>Duffield</surname> <given-names>AS</given-names></name><name><surname>Anagnostou</surname> <given-names>V</given-names></name><name><surname>Rekhtman</surname> <given-names>N</given-names></name><name><surname>Anders</surname> <given-names>RA</given-names></name><name><surname>Cuda</surname> <given-names>JD</given-names></name><name><surname>Illei</surname> <given-names>PB</given-names></name><name><surname>Gabrielson</surname> <given-names>E</given-names></name><name><surname>Askin</surname> <given-names>FB</given-names></name><name><surname>Niknafs</surname> <given-names>N</given-names></name><name><surname>Smith</surname> <given-names>KN</given-names></name><name><surname>Velez</surname> <given-names>MJ</given-names></name><name><surname>Sauter</surname> <given-names>JL</given-names></name><name><surname>Isbell</surname> <given-names>JM</given-names></name><name><surname>Jones</surname> <given-names>DR</given-names></name><name><surname>Battafarano</surname> <given-names>RJ</given-names></name><name><surname>Yang</surname> <given-names>SC</given-names></name><name><surname>Danilova</surname> <given-names>L</given-names></name><name><surname>Wolchok</surname> <given-names>JD</given-names></name><name><surname>Topalian</surname> <given-names>SL</given-names></name><name><surname>Velculescu</surname> <given-names>VE</given-names></name><name><surname>Pardoll</surname> <given-names>DM</given-names></name><name><surname>Brahmer</surname> <given-names>JR</given-names></name><name><surname>Hellmann</surname> <given-names>MD</given-names></name><name><surname>Chaft</surname> <given-names>JE</given-names></name><name><surname>Cimino-Mathews</surname> <given-names>A</given-names></name><name><surname>Taube</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)</article-title><source>Annals of Oncology</source><volume>29</volume><fpage>1853</fpage><lpage>1860</lpage><pub-id pub-id-type="doi">10.1093/annonc/mdy218</pub-id><pub-id pub-id-type="pmid">29982279</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coussens</surname> <given-names>LM</given-names></name><name><surname>Werb</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Inflammation and cancer</article-title><source>Nature</source><volume>420</volume><fpage>860</fpage><lpage>867</lpage><pub-id pub-id-type="doi">10.1038/nature01322</pub-id><pub-id pub-id-type="pmid">12490959</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname> <given-names>AL</given-names></name><name><surname>Skipper</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Henderson</surname> <given-names>RA</given-names></name><name><surname>Darrow</surname> <given-names>TL</given-names></name><name><surname>Shabanowitz</surname> <given-names>J</given-names></name><name><surname>Engelhard</surname> <given-names>VH</given-names></name><name><surname>Hunt</surname> <given-names>DF</given-names></name><name><surname>Slingluff</surname> <given-names>CL</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines</article-title><source>Science</source><volume>264</volume><fpage>716</fpage><lpage>719</lpage><pub-id pub-id-type="doi">10.1126/science.7513441</pub-id><pub-id pub-id-type="pmid">7513441</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Creech</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The role of mass spectrometry and proteogenomics in the advancement of HLA epitope prediction</article-title><source>Proteomics</source><volume>18</volume><elocation-id>1700259</elocation-id><pub-id pub-id-type="doi">10.1002/pmic.201700259</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Creixell</surname> <given-names>P</given-names></name><name><surname>Reimand</surname> <given-names>J</given-names></name><name><surname>Haider</surname> <given-names>S</given-names></name><name><surname>Wu</surname> <given-names>G</given-names></name><name><surname>Shibata</surname> <given-names>T</given-names></name><name><surname>Vazquez</surname> <given-names>M</given-names></name><name><surname>Mustonen</surname> <given-names>V</given-names></name><name><surname>Gonzalez-Perez</surname> <given-names>A</given-names></name><name><surname>Pearson</surname> <given-names>J</given-names></name><name><surname>Sander</surname> <given-names>C</given-names></name><name><surname>Raphael</surname> <given-names>BJ</given-names></name><name><surname>Marks</surname> <given-names>DS</given-names></name><name><surname>Ouellette</surname> <given-names>BFF</given-names></name><name><surname>Valencia</surname> <given-names>A</given-names></name><name><surname>Bader</surname> <given-names>GD</given-names></name><name><surname>Boutros</surname> <given-names>PC</given-names></name><name><surname>Stuart</surname> <given-names>JM</given-names></name><name><surname>Linding</surname> <given-names>R</given-names></name><name><surname>Lopez-Bigas</surname> <given-names>N</given-names></name><name><surname>Stein</surname> <given-names>LD</given-names></name><collab>Mutation Consequences and Pathway Analysis Working Group of the International Cancer Genome Consortium</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Pathway and network analysis of Cancer genomes</article-title><source>Nature Methods</source><volume>12</volume><fpage>615</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3440</pub-id><pub-id pub-id-type="pmid">26125594</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cummings</surname> <given-names>RD</given-names></name><name><surname>Pierce</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The challenge and promise of glycomics</article-title><source>Chemistry &amp; Biology</source><volume>21</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2013.12.010</pub-id><pub-id pub-id-type="pmid">24439204</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curran</surname> <given-names>MA</given-names></name><name><surname>Allison</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors</article-title><source>Cancer Research</source><volume>69</volume><fpage>7747</fpage><lpage>7755</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-3289</pub-id><pub-id pub-id-type="pmid">19738077</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cusanovich</surname> <given-names>DA</given-names></name><name><surname>Daza</surname> <given-names>R</given-names></name><name><surname>Adey</surname> <given-names>A</given-names></name><name><surname>Pliner</surname> <given-names>HA</given-names></name><name><surname>Christiansen</surname> <given-names>L</given-names></name><name><surname>Gunderson</surname> <given-names>KL</given-names></name><name><surname>Steemers</surname> <given-names>FJ</given-names></name><name><surname>Trapnell</surname> <given-names>C</given-names></name><name><surname>Shendure</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Multiplex single cell profiling of chromatin accessibility by combinatorial cellular indexing</article-title><source>Science</source><volume>348</volume><fpage>910</fpage><lpage>914</lpage><pub-id pub-id-type="doi">10.1126/science.aab1601</pub-id><pub-id pub-id-type="pmid">25953818</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cusanovich</surname> <given-names>DA</given-names></name><name><surname>Hill</surname> <given-names>AJ</given-names></name><name><surname>Aghamirzaie</surname> <given-names>D</given-names></name><name><surname>Daza</surname> <given-names>RM</given-names></name><name><surname>Pliner</surname> <given-names>HA</given-names></name><name><surname>Berletch</surname> <given-names>JB</given-names></name><name><surname>Filippova</surname> <given-names>GN</given-names></name><name><surname>Huang</surname> <given-names>X</given-names></name><name><surname>Christiansen</surname> <given-names>L</given-names></name><name><surname>DeWitt</surname> <given-names>WS</given-names></name><name><surname>Lee</surname> <given-names>C</given-names></name><name><surname>Regalado</surname> <given-names>SG</given-names></name><name><surname>Read</surname> <given-names>DF</given-names></name><name><surname>Steemers</surname> <given-names>FJ</given-names></name><name><surname>Disteche</surname> <given-names>CM</given-names></name><name><surname>Trapnell</surname> <given-names>C</given-names></name><name><surname>Shendure</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A Single-Cell atlas of in Vivo Mammalian Chromatin Accessibility</article-title><source>Cell</source><volume>174</volume><fpage>1309</fpage><lpage>1324</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.06.052</pub-id><pub-id pub-id-type="pmid">30078704</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cyster</surname> <given-names>JG</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Chemokines and cell migration in secondary lymphoid organs</article-title><source>Science</source><volume>286</volume><fpage>2098</fpage><lpage>2102</lpage><pub-id pub-id-type="doi">10.1126/science.286.5447.2098</pub-id><pub-id pub-id-type="pmid">10617422</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daley</surname> <given-names>JM</given-names></name><name><surname>Thomay</surname> <given-names>AA</given-names></name><name><surname>Connolly</surname> <given-names>MD</given-names></name><name><surname>Reichner</surname> <given-names>JS</given-names></name><name><surname>Albina</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice</article-title><source>Journal of Leukocyte Biology</source><volume>83</volume><fpage>64</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1189/jlb.0407247</pub-id><pub-id pub-id-type="pmid">17884993</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalton</surname> <given-names>DK</given-names></name><name><surname>Pitts-Meek</surname> <given-names>S</given-names></name><name><surname>Keshav</surname> <given-names>S</given-names></name><name><surname>Figari</surname> <given-names>IS</given-names></name><name><surname>Bradley</surname> <given-names>A</given-names></name><name><surname>Stewart</surname> <given-names>TA</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Multiple defects of immune cell function in mice with disrupted interferon-gamma genes</article-title><source>Science</source><volume>259</volume><fpage>1739</fpage><lpage>1742</lpage><pub-id pub-id-type="doi">10.1126/science.8456300</pub-id><pub-id pub-id-type="pmid">8456300</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dash</surname> <given-names>P</given-names></name><name><surname>Fiore-Gartland</surname> <given-names>AJ</given-names></name><name><surname>Hertz</surname> <given-names>T</given-names></name><name><surname>Wang</surname> <given-names>GC</given-names></name><name><surname>Sharma</surname> <given-names>S</given-names></name><name><surname>Souquette</surname> <given-names>A</given-names></name><name><surname>Crawford</surname> <given-names>JC</given-names></name><name><surname>Clemens</surname> <given-names>EB</given-names></name><name><surname>Nguyen</surname> <given-names>THO</given-names></name><name><surname>Kedzierska</surname> <given-names>K</given-names></name><name><surname>La Gruta</surname> <given-names>NL</given-names></name><name><surname>Bradley</surname> <given-names>P</given-names></name><name><surname>Thomas</surname> <given-names>PG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Quantifiable predictive features define epitope-specific T cell receptor repertoires</article-title><source>Nature</source><volume>547</volume><fpage>89</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1038/nature22383</pub-id><pub-id pub-id-type="pmid">28636592</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Datlinger</surname> <given-names>P</given-names></name><name><surname>Rendeiro</surname> <given-names>AF</given-names></name><name><surname>Schmidl</surname> <given-names>C</given-names></name><name><surname>Krausgruber</surname> <given-names>T</given-names></name><name><surname>Traxler</surname> <given-names>P</given-names></name><name><surname>Klughammer</surname> <given-names>J</given-names></name><name><surname>Schuster</surname> <given-names>LC</given-names></name><name><surname>Kuchler</surname> <given-names>A</given-names></name><name><surname>Alpar</surname> <given-names>D</given-names></name><name><surname>Bock</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Pooled CRISPR screening with single-cell transcriptome readout</article-title><source>Nature Methods</source><volume>14</volume><fpage>297</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4177</pub-id><pub-id pub-id-type="pmid">28099430</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname> <given-names>JO</given-names></name><name><surname>Telenius</surname> <given-names>JM</given-names></name><name><surname>McGowan</surname> <given-names>SJ</given-names></name><name><surname>Roberts</surname> <given-names>NA</given-names></name><name><surname>Taylor</surname> <given-names>S</given-names></name><name><surname>Higgs</surname> <given-names>DR</given-names></name><name><surname>Hughes</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Multiplexed analysis of chromosome conformation at vastly improved sensitivity</article-title><source>Nature Methods</source><volume>13</volume><fpage>74</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3664</pub-id><pub-id pub-id-type="pmid">26595209</pub-id></element-citation></ref><ref id="bib132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname> <given-names>JO</given-names></name><name><surname>Oudelaar</surname> <given-names>AM</given-names></name><name><surname>Higgs</surname> <given-names>DR</given-names></name><name><surname>Hughes</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>How best to identify chromosomal interactions: a comparison of approaches</article-title><source>Nature Methods</source><volume>14</volume><fpage>125</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4146</pub-id><pub-id pub-id-type="pmid">28139673</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname> <given-names>MM</given-names></name><name><surname>Tato</surname> <given-names>CM</given-names></name><name><surname>Furman</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Systems immunology: just getting started</article-title><source>Nature Immunology</source><volume>18</volume><fpage>725</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1038/ni.3768</pub-id><pub-id pub-id-type="pmid">28632713</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Visser</surname> <given-names>KE</given-names></name><name><surname>Korets</surname> <given-names>LV</given-names></name><name><surname>Coussens</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent</article-title><source>Cancer Cell</source><volume>7</volume><fpage>411</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2005.04.014</pub-id><pub-id pub-id-type="pmid">15894262</pub-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deisboeck</surname> <given-names>TS</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Macklin</surname> <given-names>P</given-names></name><name><surname>Cristini</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Multiscale cancer modeling</article-title><source>Annual Review of Biomedical Engineering</source><volume>13</volume><fpage>127</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1146/annurev-bioeng-071910-124729</pub-id><pub-id pub-id-type="pmid">21529163</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dekker</surname> <given-names>J</given-names></name><name><surname>Rippe</surname> <given-names>K</given-names></name><name><surname>Dekker</surname> <given-names>M</given-names></name><name><surname>Kleckner</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Capturing chromosome conformation</article-title><source>Science</source><volume>295</volume><fpage>1306</fpage><lpage>1311</lpage><pub-id pub-id-type="doi">10.1126/science.1067799</pub-id><pub-id pub-id-type="pmid">11847345</pub-id></element-citation></ref><ref id="bib137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dekker</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Gene regulation in the third dimension</article-title><source>Science</source><volume>319</volume><fpage>1793</fpage><lpage>1794</lpage><pub-id pub-id-type="doi">10.1126/science.1152850</pub-id><pub-id pub-id-type="pmid">18369139</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demoulin</surname> <given-names>S</given-names></name><name><surname>Herfs</surname> <given-names>M</given-names></name><name><surname>Delvenne</surname> <given-names>P</given-names></name><name><surname>Hubert</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms</article-title><source>Journal of Leukocyte Biology</source><volume>93</volume><fpage>343</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1189/jlb.0812397</pub-id><pub-id pub-id-type="pmid">23136258</pub-id></element-citation></ref><ref id="bib139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denayer</surname> <given-names>T</given-names></name><name><surname>Stöhr</surname> <given-names>T</given-names></name><name><surname>Van Roy</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Animal models in translational medicine: validation and prediction</article-title><source>New Horizons in Translational Medicine</source><volume>2</volume><fpage>5</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.nhtm.2014.08.001</pub-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denny</surname> <given-names>SK</given-names></name><name><surname>Yang</surname> <given-names>D</given-names></name><name><surname>Chuang</surname> <given-names>CH</given-names></name><name><surname>Brady</surname> <given-names>JJ</given-names></name><name><surname>Lim</surname> <given-names>JS</given-names></name><name><surname>Grüner</surname> <given-names>BM</given-names></name><name><surname>Chiou</surname> <given-names>SH</given-names></name><name><surname>Schep</surname> <given-names>AN</given-names></name><name><surname>Baral</surname> <given-names>J</given-names></name><name><surname>Hamard</surname> <given-names>C</given-names></name><name><surname>Antoine</surname> <given-names>M</given-names></name><name><surname>Wislez</surname> <given-names>M</given-names></name><name><surname>Kong</surname> <given-names>CS</given-names></name><name><surname>Connolly</surname> <given-names>AJ</given-names></name><name><surname>Park</surname> <given-names>KS</given-names></name><name><surname>Sage</surname> <given-names>J</given-names></name><name><surname>Greenleaf</surname> <given-names>WJ</given-names></name><name><surname>Winslow</surname> <given-names>MM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Nfib promotes metastasis through a widespread increase in chromatin accessibility</article-title><source>Cell</source><volume>166</volume><fpage>328</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.05.052</pub-id><pub-id pub-id-type="pmid">27374332</pub-id></element-citation></ref><ref id="bib141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dieu-Nosjean</surname> <given-names>MC</given-names></name><name><surname>Antoine</surname> <given-names>M</given-names></name><name><surname>Danel</surname> <given-names>C</given-names></name><name><surname>Heudes</surname> <given-names>D</given-names></name><name><surname>Wislez</surname> <given-names>M</given-names></name><name><surname>Poulot</surname> <given-names>V</given-names></name><name><surname>Rabbe</surname> <given-names>N</given-names></name><name><surname>Laurans</surname> <given-names>L</given-names></name><name><surname>Tartour</surname> <given-names>E</given-names></name><name><surname>de Chaisemartin</surname> <given-names>L</given-names></name><name><surname>Lebecque</surname> <given-names>S</given-names></name><name><surname>Fridman</surname> <given-names>WH</given-names></name><name><surname>Cadranel</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Long-term survival for patients with non-small-cell lung Cancer with intratumoral lymphoid structures</article-title><source>Journal of Clinical Oncology</source><volume>26</volume><fpage>4410</fpage><lpage>4417</lpage><pub-id pub-id-type="doi">10.1200/JCO.2007.15.0284</pub-id><pub-id pub-id-type="pmid">18802153</pub-id></element-citation></ref><ref id="bib142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dieu-Nosjean</surname> <given-names>MC</given-names></name><name><surname>Goc</surname> <given-names>J</given-names></name><name><surname>Giraldo</surname> <given-names>NA</given-names></name><name><surname>Sautès-Fridman</surname> <given-names>C</given-names></name><name><surname>Fridman</surname> <given-names>WH</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Tertiary lymphoid structures in cancer and beyond</article-title><source>Trends in Immunology</source><volume>35</volume><fpage>571</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1016/j.it.2014.09.006</pub-id><pub-id pub-id-type="pmid">25443495</pub-id></element-citation></ref><ref id="bib143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiLillo</surname> <given-names>DJ</given-names></name><name><surname>Matsushita</surname> <given-names>T</given-names></name><name><surname>Tedder</surname> <given-names>TF</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer</article-title><source>Annals of the New York Academy of Sciences</source><volume>1183</volume><fpage>38</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.2009.05137.x</pub-id><pub-id pub-id-type="pmid">20146707</pub-id></element-citation></ref><ref id="bib144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname> <given-names>J</given-names></name><name><surname>Adiconis</surname> <given-names>X</given-names></name><name><surname>Simmons</surname> <given-names>SK</given-names></name><name><surname>Kowalczyk</surname> <given-names>MS</given-names></name><name><surname>Hession</surname> <given-names>CC</given-names></name><name><surname>Marjanovic</surname> <given-names>ND</given-names></name><name><surname>Hughes</surname> <given-names>TK</given-names></name><name><surname>Wadsworth</surname> <given-names>MH</given-names></name><name><surname>Burks</surname> <given-names>T</given-names></name><name><surname>Nguyen</surname> <given-names>LT</given-names></name><name><surname>Kwon</surname> <given-names>JYH</given-names></name><name><surname>Barak</surname> <given-names>B</given-names></name><name><surname>Ge</surname> <given-names>W</given-names></name><name><surname>Kedaigle</surname> <given-names>AJ</given-names></name><name><surname>Carroll</surname> <given-names>S</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>Hacohen</surname> <given-names>N</given-names></name><name><surname>Rozenblatt-Rosen</surname> <given-names>O</given-names></name><name><surname>Shalek</surname> <given-names>AK</given-names></name><name><surname>Villani</surname> <given-names>AC</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name><name><surname>Levin</surname> <given-names>JZ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Systematic comparison of single-cell and single-nucleus RNA-sequencing methods</article-title><source>Nature Biotechnology</source><volume>38</volume><fpage>737</fpage><lpage>746</lpage><pub-id pub-id-type="doi">10.1038/s41587-020-0465-8</pub-id><pub-id pub-id-type="pmid">32341560</pub-id></element-citation></ref><ref id="bib145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixit</surname> <given-names>A</given-names></name><name><surname>Parnas</surname> <given-names>O</given-names></name><name><surname>Li</surname> <given-names>B</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Fulco</surname> <given-names>CP</given-names></name><name><surname>Jerby-Arnon</surname> <given-names>L</given-names></name><name><surname>Marjanovic</surname> <given-names>ND</given-names></name><name><surname>Dionne</surname> <given-names>D</given-names></name><name><surname>Burks</surname> <given-names>T</given-names></name><name><surname>Raychowdhury</surname> <given-names>R</given-names></name><name><surname>Adamson</surname> <given-names>B</given-names></name><name><surname>Norman</surname> <given-names>TM</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Weissman</surname> <given-names>JS</given-names></name><name><surname>Friedman</surname> <given-names>N</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Perturb-Seq: dissecting molecular circuits with scalable Single-Cell RNA profiling of pooled genetic screens</article-title><source>Cell</source><volume>167</volume><fpage>1853</fpage><lpage>1866</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.11.038</pub-id><pub-id pub-id-type="pmid">27984732</pub-id></element-citation></ref><ref id="bib146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doench</surname> <given-names>JG</given-names></name><name><surname>Fusi</surname> <given-names>N</given-names></name><name><surname>Sullender</surname> <given-names>M</given-names></name><name><surname>Hegde</surname> <given-names>M</given-names></name><name><surname>Vaimberg</surname> <given-names>EW</given-names></name><name><surname>Donovan</surname> <given-names>KF</given-names></name><name><surname>Smith</surname> <given-names>I</given-names></name><name><surname>Tothova</surname> <given-names>Z</given-names></name><name><surname>Wilen</surname> <given-names>C</given-names></name><name><surname>Orchard</surname> <given-names>R</given-names></name><name><surname>Virgin</surname> <given-names>HW</given-names></name><name><surname>Listgarten</surname> <given-names>J</given-names></name><name><surname>Root</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9</article-title><source>Nature Biotechnology</source><volume>34</volume><fpage>184</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1038/nbt.3437</pub-id><pub-id pub-id-type="pmid">26780180</pub-id></element-citation></ref><ref id="bib147"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname> <given-names>MB</given-names></name><name><surname>Wang</surname> <given-names>G</given-names></name><name><surname>Chow</surname> <given-names>RD</given-names></name><name><surname>Ye</surname> <given-names>L</given-names></name><name><surname>Zhu</surname> <given-names>L</given-names></name><name><surname>Dai</surname> <given-names>X</given-names></name><name><surname>Park</surname> <given-names>JJ</given-names></name><name><surname>Kim</surname> <given-names>HR</given-names></name><name><surname>Errami</surname> <given-names>Y</given-names></name><name><surname>Guzman</surname> <given-names>CD</given-names></name><name><surname>Zhou</surname> <given-names>X</given-names></name><name><surname>Chen</surname> <given-names>KY</given-names></name><name><surname>Renauer</surname> <given-names>PA</given-names></name><name><surname>Du</surname> <given-names>Y</given-names></name><name><surname>Shen</surname> <given-names>J</given-names></name><name><surname>Lam</surname> <given-names>SZ</given-names></name><name><surname>Zhou</surname> <given-names>JJ</given-names></name><name><surname>Lannin</surname> <given-names>DR</given-names></name><name><surname>Herbst</surname> <given-names>RS</given-names></name><name><surname>Chen</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title><italic>Systematic immunotherapy target discovery using Genome-Scale</italic> In<italic> Vivo CRISPR Screens in CD8 T Cells</italic></article-title><source>Cell</source><volume>178</volume><fpage>1189</fpage><lpage>1204</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.07.044</pub-id><pub-id pub-id-type="pmid">31442407</pub-id></element-citation></ref><ref id="bib148"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorner</surname> <given-names>BG</given-names></name><name><surname>Dorner</surname> <given-names>MB</given-names></name><name><surname>Zhou</surname> <given-names>X</given-names></name><name><surname>Opitz</surname> <given-names>C</given-names></name><name><surname>Mora</surname> <given-names>A</given-names></name><name><surname>Güttler</surname> <given-names>S</given-names></name><name><surname>Hutloff</surname> <given-names>A</given-names></name><name><surname>Mages</surname> <given-names>HW</given-names></name><name><surname>Ranke</surname> <given-names>K</given-names></name><name><surname>Schaefer</surname> <given-names>M</given-names></name><name><surname>Jack</surname> <given-names>RS</given-names></name><name><surname>Henn</surname> <given-names>V</given-names></name><name><surname>Kroczek</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells</article-title><source>Immunity</source><volume>31</volume><fpage>823</fpage><lpage>833</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2009.08.027</pub-id><pub-id pub-id-type="pmid">19913446</pub-id></element-citation></ref><ref id="bib149"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dostie</surname> <given-names>J</given-names></name><name><surname>Richmond</surname> <given-names>TA</given-names></name><name><surname>Arnaout</surname> <given-names>RA</given-names></name><name><surname>Selzer</surname> <given-names>RR</given-names></name><name><surname>Lee</surname> <given-names>WL</given-names></name><name><surname>Honan</surname> <given-names>TA</given-names></name><name><surname>Rubio</surname> <given-names>ED</given-names></name><name><surname>Krumm</surname> <given-names>A</given-names></name><name><surname>Lamb</surname> <given-names>J</given-names></name><name><surname>Nusbaum</surname> <given-names>C</given-names></name><name><surname>Green</surname> <given-names>RD</given-names></name><name><surname>Dekker</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Chromosome conformation capture carbon copy (5C): a massively parallel solution for mapping interactions between genomic elements</article-title><source>Genome Research</source><volume>16</volume><fpage>1299</fpage><lpage>1309</lpage><pub-id pub-id-type="doi">10.1101/gr.5571506</pub-id><pub-id pub-id-type="pmid">16954542</pub-id></element-citation></ref><ref id="bib150"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doyle</surname> <given-names>AG</given-names></name><name><surname>Herbein</surname> <given-names>G</given-names></name><name><surname>Montaner</surname> <given-names>LJ</given-names></name><name><surname>Minty</surname> <given-names>AJ</given-names></name><name><surname>Caput</surname> <given-names>D</given-names></name><name><surname>Ferrara</surname> <given-names>P</given-names></name><name><surname>Gordon</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-γ</article-title><source>European Journal of Immunology</source><volume>24</volume><fpage>1441</fpage><lpage>1445</lpage><pub-id pub-id-type="doi">10.1002/eji.1830240630</pub-id><pub-id pub-id-type="pmid">7911424</pub-id></element-citation></ref><ref id="bib151"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drasdo</surname> <given-names>D</given-names></name><name><surname>Höhme</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A single-cell-based model of tumor growth <italic>in vitro</italic>: monolayers and spheroids</article-title><source>Physical Biology</source><volume>2</volume><fpage>133</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1088/1478-3975/2/3/001</pub-id><pub-id pub-id-type="pmid">16224119</pub-id></element-citation></ref><ref id="bib152"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drayton</surname> <given-names>DL</given-names></name><name><surname>Liao</surname> <given-names>S</given-names></name><name><surname>Mounzer</surname> <given-names>RH</given-names></name><name><surname>Ruddle</surname> <given-names>NH</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Lymphoid organ development: from ontogeny to neogenesis</article-title><source>Nature Immunology</source><volume>7</volume><fpage>344</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1038/ni1330</pub-id><pub-id pub-id-type="pmid">16550197</pub-id></element-citation></ref><ref id="bib153"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dréau</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2009">2009</year><source>An Agent-Based Model of Solid Tumor Progression</source><publisher-loc>Berlin, Heidelberg</publisher-loc><publisher-name>Springer Berlin Heidelberg</publisher-name></element-citation></ref><ref id="bib154"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname> <given-names>R</given-names></name><name><surname>Carey</surname> <given-names>V</given-names></name><name><surname>Weiss</surname> <given-names>ST</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>deconvSeq: deconvolution of cell mixture distribution in sequencing data</article-title><source>Bioinformatics</source><volume>35</volume><fpage>5095</fpage><lpage>5102</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btz444</pub-id><pub-id pub-id-type="pmid">31147676</pub-id></element-citation></ref><ref id="bib155"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname> <given-names>F</given-names></name><name><surname>Duitama</surname> <given-names>J</given-names></name><name><surname>Al Seesi</surname> <given-names>S</given-names></name><name><surname>Ayres</surname> <given-names>CM</given-names></name><name><surname>Corcelli</surname> <given-names>SA</given-names></name><name><surname>Pawashe</surname> <given-names>AP</given-names></name><name><surname>Blanchard</surname> <given-names>T</given-names></name><name><surname>McMahon</surname> <given-names>D</given-names></name><name><surname>Sidney</surname> <given-names>J</given-names></name><name><surname>Sette</surname> <given-names>A</given-names></name><name><surname>Baker</surname> <given-names>BM</given-names></name><name><surname>Mandoiu</surname> <given-names>II</given-names></name><name><surname>Srivastava</surname> <given-names>PK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity</article-title><source>Journal of Experimental Medicine</source><volume>211</volume><fpage>2231</fpage><lpage>2248</lpage><pub-id pub-id-type="doi">10.1084/jem.20141308</pub-id><pub-id pub-id-type="pmid">25245761</pub-id></element-citation></ref><ref id="bib156"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudley</surname> <given-names>ME</given-names></name><name><surname>Wunderlich</surname> <given-names>JR</given-names></name><name><surname>Robbins</surname> <given-names>PF</given-names></name><name><surname>Yang</surname> <given-names>JC</given-names></name><name><surname>Hwu</surname> <given-names>P</given-names></name><name><surname>Schwartzentruber</surname> <given-names>DJ</given-names></name><name><surname>Topalian</surname> <given-names>SL</given-names></name><name><surname>Sherry</surname> <given-names>R</given-names></name><name><surname>Restifo</surname> <given-names>NP</given-names></name><name><surname>Hubicki</surname> <given-names>AM</given-names></name><name><surname>Robinson</surname> <given-names>MR</given-names></name><name><surname>Raffeld</surname> <given-names>M</given-names></name><name><surname>Duray</surname> <given-names>P</given-names></name><name><surname>Seipp</surname> <given-names>CA</given-names></name><name><surname>Rogers-Freezer</surname> <given-names>L</given-names></name><name><surname>Morton</surname> <given-names>KE</given-names></name><name><surname>Mavroukakis</surname> <given-names>SA</given-names></name><name><surname>White</surname> <given-names>DE</given-names></name><name><surname>Rosenberg</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes</article-title><source>Science</source><volume>298</volume><fpage>850</fpage><lpage>854</lpage><pub-id pub-id-type="doi">10.1126/science.1076514</pub-id><pub-id pub-id-type="pmid">12242449</pub-id></element-citation></ref><ref id="bib157"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DuPage</surname> <given-names>M</given-names></name><name><surname>Mazumdar</surname> <given-names>C</given-names></name><name><surname>Schmidt</surname> <given-names>LM</given-names></name><name><surname>Cheung</surname> <given-names>AF</given-names></name><name><surname>Jacks</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Expression of tumour-specific antigens underlies Cancer immunoediting</article-title><source>Nature</source><volume>482</volume><fpage>405</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1038/nature10803</pub-id><pub-id pub-id-type="pmid">22318517</pub-id></element-citation></ref><ref id="bib158"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dvorak</surname> <given-names>HF</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Tumors: wounds that do not heal</article-title><source>New England Journal of Medicine</source><volume>315</volume><fpage>1650</fpage><lpage>1659</lpage><pub-id pub-id-type="doi">10.1158/2326-6066.CIR-14-0209</pub-id></element-citation></ref><ref id="bib159"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egeblad</surname> <given-names>M</given-names></name><name><surname>Nakasone</surname> <given-names>ES</given-names></name><name><surname>Werb</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Tumors as organs: complex tissues that interface with the entire organism</article-title><source>Developmental Cell</source><volume>18</volume><fpage>884</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2010.05.012</pub-id><pub-id pub-id-type="pmid">20627072</pub-id></element-citation></ref><ref id="bib160"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egger</surname> <given-names>G</given-names></name><name><surname>Liang</surname> <given-names>G</given-names></name><name><surname>Aparicio</surname> <given-names>A</given-names></name><name><surname>Jones</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Epigenetics in human disease and prospects for epigenetic therapy</article-title><source>Nature</source><volume>429</volume><fpage>457</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1038/nature02625</pub-id><pub-id pub-id-type="pmid">15164071</pub-id></element-citation></ref><ref id="bib161"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisenbarth</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dendritic cell subsets in T cell programming: location dictates function</article-title><source>Nature Reviews Immunology</source><volume>19</volume><fpage>89</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1038/s41577-018-0088-1</pub-id><pub-id pub-id-type="pmid">30464294</pub-id></element-citation></ref><ref id="bib162"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elyada</surname> <given-names>E</given-names></name><name><surname>Bolisetty</surname> <given-names>M</given-names></name><name><surname>Laise</surname> <given-names>P</given-names></name><name><surname>Flynn</surname> <given-names>WF</given-names></name><name><surname>Courtois</surname> <given-names>ET</given-names></name><name><surname>Burkhart</surname> <given-names>RA</given-names></name><name><surname>Teinor</surname> <given-names>JA</given-names></name><name><surname>Belleau</surname> <given-names>P</given-names></name><name><surname>Biffi</surname> <given-names>G</given-names></name><name><surname>Lucito</surname> <given-names>MS</given-names></name><name><surname>Sivajothi</surname> <given-names>S</given-names></name><name><surname>Armstrong</surname> <given-names>TD</given-names></name><name><surname>Engle</surname> <given-names>DD</given-names></name><name><surname>Yu</surname> <given-names>KH</given-names></name><name><surname>Hao</surname> <given-names>Y</given-names></name><name><surname>Wolfgang</surname> <given-names>CL</given-names></name><name><surname>Park</surname> <given-names>Y</given-names></name><name><surname>Preall</surname> <given-names>J</given-names></name><name><surname>Jaffee</surname> <given-names>EM</given-names></name><name><surname>Califano</surname> <given-names>A</given-names></name><name><surname>Robson</surname> <given-names>P</given-names></name><name><surname>Tuveson</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cross-Species Single-Cell analysis of pancreatic ductal adenocarcinoma reveals Antigen-Presenting Cancer-Associated fibroblasts</article-title><source>Cancer Discovery</source><volume>9</volume><fpage>1102</fpage><lpage>1123</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-19-0094</pub-id><pub-id pub-id-type="pmid">31197017</pub-id></element-citation></ref><ref id="bib163"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enderling</surname> <given-names>H</given-names></name><name><surname>Hlatky</surname> <given-names>L</given-names></name><name><surname>Hahnfeldt</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Immunoediting: evidence of the multifaceted role of the immune system in self-metastatic tumor growth</article-title><source>Theoretical Biology and Medical Modelling</source><volume>9</volume><elocation-id>31</elocation-id><pub-id pub-id-type="doi">10.1186/1742-4682-9-31</pub-id><pub-id pub-id-type="pmid">22838395</pub-id></element-citation></ref><ref id="bib164"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engblom</surname> <given-names>C</given-names></name><name><surname>Pfirschke</surname> <given-names>C</given-names></name><name><surname>Pittet</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The role of myeloid cells in Cancer therapies</article-title><source>Nature Reviews Cancer</source><volume>16</volume><fpage>447</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1038/nrc.2016.54</pub-id><pub-id pub-id-type="pmid">27339708</pub-id></element-citation></ref><ref id="bib165"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engelhardt</surname> <given-names>JJ</given-names></name><name><surname>Boldajipour</surname> <given-names>B</given-names></name><name><surname>Beemiller</surname> <given-names>P</given-names></name><name><surname>Pandurangi</surname> <given-names>P</given-names></name><name><surname>Sorensen</surname> <given-names>C</given-names></name><name><surname>Werb</surname> <given-names>Z</given-names></name><name><surname>Egeblad</surname> <given-names>M</given-names></name><name><surname>Krummel</surname> <given-names>MF</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells</article-title><source>Cancer Cell</source><volume>21</volume><fpage>402</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2012.01.008</pub-id><pub-id pub-id-type="pmid">22439936</pub-id></element-citation></ref><ref id="bib166"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epelman</surname> <given-names>S</given-names></name><name><surname>Lavine</surname> <given-names>KJ</given-names></name><name><surname>Randolph</surname> <given-names>GJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Origin and functions of tissue macrophages</article-title><source>Immunity</source><volume>41</volume><fpage>21</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.06.013</pub-id><pub-id pub-id-type="pmid">25035951</pub-id></element-citation></ref><ref id="bib167"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eruslanov</surname> <given-names>EB</given-names></name><name><surname>Bhojnagarwala</surname> <given-names>PS</given-names></name><name><surname>Quatromoni</surname> <given-names>JG</given-names></name><name><surname>Stephen</surname> <given-names>TL</given-names></name><name><surname>Ranganathan</surname> <given-names>A</given-names></name><name><surname>Deshpande</surname> <given-names>C</given-names></name><name><surname>Akimova</surname> <given-names>T</given-names></name><name><surname>Vachani</surname> <given-names>A</given-names></name><name><surname>Litzky</surname> <given-names>L</given-names></name><name><surname>Hancock</surname> <given-names>WW</given-names></name><name><surname>Conejo-Garcia</surname> <given-names>JR</given-names></name><name><surname>Feldman</surname> <given-names>M</given-names></name><name><surname>Albelda</surname> <given-names>SM</given-names></name><name><surname>Singhal</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer</article-title><source>Journal of Clinical Investigation</source><volume>124</volume><fpage>5466</fpage><lpage>5480</lpage><pub-id pub-id-type="doi">10.1172/JCI77053</pub-id><pub-id pub-id-type="pmid">25384214</pub-id></element-citation></ref><ref id="bib168"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esteller</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Epigenetics in Cancer</article-title><source>New England Journal of Medicine</source><volume>358</volume><fpage>1148</fpage><lpage>1159</lpage><pub-id pub-id-type="doi">10.1056/NEJMra072067</pub-id><pub-id pub-id-type="pmid">18337604</pub-id></element-citation></ref><ref id="bib169"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esumi</surname> <given-names>S</given-names></name><name><surname>Wu</surname> <given-names>SX</given-names></name><name><surname>Yanagawa</surname> <given-names>Y</given-names></name><name><surname>Obata</surname> <given-names>K</given-names></name><name><surname>Sugimoto</surname> <given-names>Y</given-names></name><name><surname>Tamamaki</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Method for single-cell microarray analysis and application to gene-expression profiling of GABAergic neuron progenitors</article-title><source>Neuroscience Research</source><volume>60</volume><fpage>439</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1016/j.neures.2007.12.011</pub-id><pub-id pub-id-type="pmid">18280602</pub-id></element-citation></ref><ref id="bib170"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Faget</surname> <given-names>J</given-names></name><name><surname>Boivin</surname> <given-names>G</given-names></name><name><surname>Ancey</surname> <given-names>P-B</given-names></name><name><surname>Gkasti</surname> <given-names>A</given-names></name><name><surname>Mussard</surname> <given-names>J</given-names></name><name><surname>Engblom</surname> <given-names>C</given-names></name><name><surname>Pfirschke</surname> <given-names>C</given-names></name><name><surname>Vazquez</surname> <given-names>J</given-names></name><name><surname>Bendriss-Vermare</surname> <given-names>N</given-names></name><name><surname>Caux</surname> <given-names>C</given-names></name><name><surname>Vozenin</surname> <given-names>M-C</given-names></name><name><surname>Pittet</surname> <given-names>MJ</given-names></name><name><surname>Gunzer</surname> <given-names>M</given-names></name><name><surname>Meylan</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Efficient and specific Ly6G+ cell depletion: A change in the current practices toward more relevant functional analyses of neutrophils</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/498881</pub-id></element-citation></ref><ref id="bib171"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Faratian</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2010">2010</year><chapter-title>Cancer Systems Biology Systems Biology in Drug Discovery and Development</chapter-title><person-group person-group-type="editor"><name><surname>Yan</surname> <given-names>Q</given-names></name></person-group><source>Methods and Protocols</source><publisher-loc>Totowa, NJ</publisher-loc><publisher-name>Humana Press</publisher-name><fpage>245</fpage><lpage>263</lpage></element-citation></ref><ref id="bib172"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farlik</surname> <given-names>M</given-names></name><name><surname>Sheffield</surname> <given-names>NC</given-names></name><name><surname>Nuzzo</surname> <given-names>A</given-names></name><name><surname>Datlinger</surname> <given-names>P</given-names></name><name><surname>Schönegger</surname> <given-names>A</given-names></name><name><surname>Klughammer</surname> <given-names>J</given-names></name><name><surname>Bock</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Single-cell DNA methylome sequencing and bioinformatic inference of epigenomic cell-state dynamics</article-title><source>Cell Reports</source><volume>10</volume><fpage>1386</fpage><lpage>1397</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.02.001</pub-id><pub-id pub-id-type="pmid">25732828</pub-id></element-citation></ref><ref id="bib173"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feinberg</surname> <given-names>AP</given-names></name><name><surname>Vogelstein</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>Hypomethylation distinguishes genes of some human cancers from their normal counterparts</article-title><source>Nature</source><volume>301</volume><fpage>89</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1038/301089a0</pub-id><pub-id pub-id-type="pmid">6185846</pub-id></element-citation></ref><ref id="bib174"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flavahan</surname> <given-names>WA</given-names></name><name><surname>Gaskell</surname> <given-names>E</given-names></name><name><surname>Bernstein</surname> <given-names>BE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Epigenetic plasticity and the hallmarks of Cancer</article-title><source>Science</source><volume>357</volume><elocation-id>eaal2380</elocation-id><pub-id pub-id-type="doi">10.1126/science.aal2380</pub-id><pub-id pub-id-type="pmid">28729483</pub-id></element-citation></ref><ref id="bib175"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname> <given-names>AL</given-names></name><name><surname>Lukacs-Kornek</surname> <given-names>V</given-names></name><name><surname>Reynoso</surname> <given-names>ED</given-names></name><name><surname>Pinner</surname> <given-names>SE</given-names></name><name><surname>Bellemare-Pelletier</surname> <given-names>A</given-names></name><name><surname>Curry</surname> <given-names>MS</given-names></name><name><surname>Collier</surname> <given-names>AR</given-names></name><name><surname>Boyd</surname> <given-names>RL</given-names></name><name><surname>Turley</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions</article-title><source>The Journal of Experimental Medicine</source><volume>207</volume><fpage>689</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1084/jem.20092642</pub-id><pub-id pub-id-type="pmid">20308362</pub-id></element-citation></ref><ref id="bib176"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname> <given-names>AL</given-names></name><name><surname>Acton</surname> <given-names>SE</given-names></name><name><surname>Knoblich</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Lymph node fibroblastic reticular cells in health and disease</article-title><source>Nature Reviews Immunology</source><volume>15</volume><fpage>350</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1038/nri3846</pub-id><pub-id pub-id-type="pmid">25998961</pub-id></element-citation></ref><ref id="bib177"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fong</surname> <given-names>L</given-names></name><name><surname>Engleman</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Dendritic cells in Cancer immunotherapy</article-title><source>Annual Review of Immunology</source><volume>18</volume><fpage>245</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.18.1.245</pub-id><pub-id pub-id-type="pmid">10837059</pub-id></element-citation></ref><ref id="bib178"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fridlender</surname> <given-names>ZG</given-names></name><name><surname>Sun</surname> <given-names>J</given-names></name><name><surname>Kim</surname> <given-names>S</given-names></name><name><surname>Kapoor</surname> <given-names>V</given-names></name><name><surname>Cheng</surname> <given-names>G</given-names></name><name><surname>Ling</surname> <given-names>L</given-names></name><name><surname>Worthen</surname> <given-names>GS</given-names></name><name><surname>Albelda</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Polarization of tumor-associated neutrophil phenotype by TGF-beta: &quot;N1&quot; versus &quot;N2&quot; TAN</article-title><source>Cancer Cell</source><volume>16</volume><fpage>183</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2009.06.017</pub-id><pub-id pub-id-type="pmid">19732719</pub-id></element-citation></ref><ref id="bib179"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frommer</surname> <given-names>M</given-names></name><name><surname>McDonald</surname> <given-names>LE</given-names></name><name><surname>Millar</surname> <given-names>DS</given-names></name><name><surname>Collis</surname> <given-names>CM</given-names></name><name><surname>Watt</surname> <given-names>F</given-names></name><name><surname>Grigg</surname> <given-names>GW</given-names></name><name><surname>Molloy</surname> <given-names>PL</given-names></name><name><surname>Paul</surname> <given-names>CL</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands</article-title><source>PNAS</source><volume>89</volume><fpage>1827</fpage><lpage>1831</lpage><pub-id pub-id-type="doi">10.1073/pnas.89.5.1827</pub-id><pub-id pub-id-type="pmid">1542678</pub-id></element-citation></ref><ref id="bib180"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuertes</surname> <given-names>MB</given-names></name><name><surname>Kacha</surname> <given-names>AK</given-names></name><name><surname>Kline</surname> <given-names>J</given-names></name><name><surname>Woo</surname> <given-names>SR</given-names></name><name><surname>Kranz</surname> <given-names>DM</given-names></name><name><surname>Murphy</surname> <given-names>KM</given-names></name><name><surname>Gajewski</surname> <given-names>TF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells</article-title><source>The Journal of Experimental Medicine</source><volume>208</volume><fpage>2005</fpage><lpage>2016</lpage><pub-id pub-id-type="doi">10.1084/jem.20101159</pub-id><pub-id pub-id-type="pmid">21930765</pub-id></element-citation></ref><ref id="bib181"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fullwood</surname> <given-names>MJ</given-names></name><name><surname>Liu</surname> <given-names>MH</given-names></name><name><surname>Pan</surname> <given-names>YF</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Xu</surname> <given-names>H</given-names></name><name><surname>Mohamed</surname> <given-names>YB</given-names></name><name><surname>Orlov</surname> <given-names>YL</given-names></name><name><surname>Velkov</surname> <given-names>S</given-names></name><name><surname>Ho</surname> <given-names>A</given-names></name><name><surname>Mei</surname> <given-names>PH</given-names></name><name><surname>Chew</surname> <given-names>EG</given-names></name><name><surname>Huang</surname> <given-names>PY</given-names></name><name><surname>Welboren</surname> <given-names>WJ</given-names></name><name><surname>Han</surname> <given-names>Y</given-names></name><name><surname>Ooi</surname> <given-names>HS</given-names></name><name><surname>Ariyaratne</surname> <given-names>PN</given-names></name><name><surname>Vega</surname> <given-names>VB</given-names></name><name><surname>Luo</surname> <given-names>Y</given-names></name><name><surname>Tan</surname> <given-names>PY</given-names></name><name><surname>Choy</surname> <given-names>PY</given-names></name><name><surname>Wansa</surname> <given-names>KD</given-names></name><name><surname>Zhao</surname> <given-names>B</given-names></name><name><surname>Lim</surname> <given-names>KS</given-names></name><name><surname>Leow</surname> <given-names>SC</given-names></name><name><surname>Yow</surname> <given-names>JS</given-names></name><name><surname>Joseph</surname> <given-names>R</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Desai</surname> <given-names>KV</given-names></name><name><surname>Thomsen</surname> <given-names>JS</given-names></name><name><surname>Lee</surname> <given-names>YK</given-names></name><name><surname>Karuturi</surname> <given-names>RK</given-names></name><name><surname>Herve</surname> <given-names>T</given-names></name><name><surname>Bourque</surname> <given-names>G</given-names></name><name><surname>Stunnenberg</surname> <given-names>HG</given-names></name><name><surname>Ruan</surname> <given-names>X</given-names></name><name><surname>Cacheux-Rataboul</surname> <given-names>V</given-names></name><name><surname>Sung</surname> <given-names>WK</given-names></name><name><surname>Liu</surname> <given-names>ET</given-names></name><name><surname>Wei</surname> <given-names>CL</given-names></name><name><surname>Cheung</surname> <given-names>E</given-names></name><name><surname>Ruan</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>An oestrogen-receptor-alpha-bound human chromatin interactome</article-title><source>Nature</source><volume>462</volume><fpage>58</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1038/nature08497</pub-id><pub-id pub-id-type="pmid">19890323</pub-id></element-citation></ref><ref id="bib182"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fulwyler</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="1965">1965</year><article-title>Electronic separation of biological cells by volume</article-title><source>Science</source><volume>150</volume><fpage>910</fpage><lpage>911</lpage><pub-id pub-id-type="doi">10.1126/science.150.3698.910</pub-id><pub-id pub-id-type="pmid">5891056</pub-id></element-citation></ref><ref id="bib183"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaboriau-Routhiau</surname> <given-names>V</given-names></name><name><surname>Rakotobe</surname> <given-names>S</given-names></name><name><surname>Lécuyer</surname> <given-names>E</given-names></name><name><surname>Mulder</surname> <given-names>I</given-names></name><name><surname>Lan</surname> <given-names>A</given-names></name><name><surname>Bridonneau</surname> <given-names>C</given-names></name><name><surname>Rochet</surname> <given-names>V</given-names></name><name><surname>Pisi</surname> <given-names>A</given-names></name><name><surname>De Paepe</surname> <given-names>M</given-names></name><name><surname>Brandi</surname> <given-names>G</given-names></name><name><surname>Eberl</surname> <given-names>G</given-names></name><name><surname>Snel</surname> <given-names>J</given-names></name><name><surname>Kelly</surname> <given-names>D</given-names></name><name><surname>Cerf-Bensussan</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The key role of segmented filamentous Bacteria in the coordinated maturation of gut helper T cell responses</article-title><source>Immunity</source><volume>31</volume><fpage>677</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2009.08.020</pub-id><pub-id pub-id-type="pmid">19833089</pub-id></element-citation></ref><ref id="bib184"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabrilovich</surname> <given-names>DI</given-names></name><name><surname>Bronte</surname> <given-names>V</given-names></name><name><surname>Chen</surname> <given-names>SH</given-names></name><name><surname>Colombo</surname> <given-names>MP</given-names></name><name><surname>Ochoa</surname> <given-names>A</given-names></name><name><surname>Ostrand-Rosenberg</surname> <given-names>S</given-names></name><name><surname>Schreiber</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The terminology issue for myeloid-derived suppressor cells</article-title><source>Cancer Research</source><volume>67</volume><fpage>425</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-3037</pub-id><pub-id pub-id-type="pmid">17210725</pub-id></element-citation></ref><ref id="bib185"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabrilovich</surname> <given-names>DI</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Myeloid-Derived suppressor cells</article-title><source>Cancer Immunology Research</source><volume>5</volume><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1158/2326-6066.CIR-16-0297</pub-id><pub-id pub-id-type="pmid">28052991</pub-id></element-citation></ref><ref id="bib186"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gajewski</surname> <given-names>TF</given-names></name><name><surname>Schreiber</surname> <given-names>H</given-names></name><name><surname>Fu</surname> <given-names>YX</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Innate and adaptive immune cells in the tumor microenvironment</article-title><source>Nature Immunology</source><volume>14</volume><fpage>1014</fpage><lpage>1022</lpage><pub-id pub-id-type="doi">10.1038/ni.2703</pub-id><pub-id pub-id-type="pmid">24048123</pub-id></element-citation></ref><ref id="bib187"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallimore</surname> <given-names>A</given-names></name><name><surname>Glithero</surname> <given-names>A</given-names></name><name><surname>Godkin</surname> <given-names>A</given-names></name><name><surname>Tissot</surname> <given-names>AC</given-names></name><name><surname>Plückthun</surname> <given-names>A</given-names></name><name><surname>Elliott</surname> <given-names>T</given-names></name><name><surname>Hengartner</surname> <given-names>H</given-names></name><name><surname>Zinkernagel</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes</article-title><source>Journal of Experimental Medicine</source><volume>187</volume><fpage>1383</fpage><lpage>1393</lpage><pub-id pub-id-type="doi">10.1084/jem.187.9.1383</pub-id><pub-id pub-id-type="pmid">9565631</pub-id></element-citation></ref><ref id="bib188"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galon</surname> <given-names>J</given-names></name><name><surname>Costes</surname> <given-names>A</given-names></name><name><surname>Sanchez-Cabo</surname> <given-names>F</given-names></name><name><surname>Kirilovsky</surname> <given-names>A</given-names></name><name><surname>Mlecnik</surname> <given-names>B</given-names></name><name><surname>Lagorce-Pagès</surname> <given-names>C</given-names></name><name><surname>Tosolini</surname> <given-names>M</given-names></name><name><surname>Camus</surname> <given-names>M</given-names></name><name><surname>Berger</surname> <given-names>A</given-names></name><name><surname>Wind</surname> <given-names>P</given-names></name><name><surname>Zinzindohoué</surname> <given-names>F</given-names></name><name><surname>Bruneval</surname> <given-names>P</given-names></name><name><surname>Cugnenc</surname> <given-names>PH</given-names></name><name><surname>Trajanoski</surname> <given-names>Z</given-names></name><name><surname>Fridman</surname> <given-names>WH</given-names></name><name><surname>Pagès</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Type, density, and location of immune cells within human colorectal tumors predict clinical outcome</article-title><source>Science</source><volume>313</volume><fpage>1960</fpage><lpage>1964</lpage><pub-id pub-id-type="doi">10.1126/science.1129139</pub-id><pub-id pub-id-type="pmid">17008531</pub-id></element-citation></ref><ref id="bib189"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galsky</surname> <given-names>MD</given-names></name><name><surname>Saci</surname> <given-names>A</given-names></name><name><surname>Szabo</surname> <given-names>PM</given-names></name><name><surname>Azrilevich</surname> <given-names>A</given-names></name><name><surname>Horak</surname> <given-names>C</given-names></name><name><surname>Lambert</surname> <given-names>A</given-names></name><name><surname>Siefker-Radtke</surname> <given-names>A</given-names></name><name><surname>Necchi</surname> <given-names>A</given-names></name><name><surname>Sharma</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Impact of zumor mutation burden on nivolumab efficacy in second-line urothelial carcinoma patients: exploratory analysis of the phase ii checkmate 275 study</article-title><source>Annals of Oncology</source><volume>28</volume><fpage>v296</fpage><lpage>v297</lpage><pub-id pub-id-type="doi">10.1093/annonc/mdx371.003</pub-id></element-citation></ref><ref id="bib190"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Garijo</surname> <given-names>A</given-names></name><name><surname>Fajardo</surname> <given-names>CA</given-names></name><name><surname>Gros</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Determinants for neoantigen identification</article-title><source>Frontiers in Immunology</source><volume>10</volume><elocation-id>1392</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.01392</pub-id><pub-id pub-id-type="pmid">31293573</pub-id></element-citation></ref><ref id="bib191"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garraway</surname> <given-names>LA</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Lessons from the Cancer genome</article-title><source>Cell</source><volume>153</volume><fpage>17</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.03.002</pub-id><pub-id pub-id-type="pmid">23540688</pub-id></element-citation></ref><ref id="bib192"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrett</surname> <given-names>WS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cancer and the microbiota</article-title><source>Science</source><volume>348</volume><fpage>80</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1126/science.aaa4972</pub-id><pub-id pub-id-type="pmid">25838377</pub-id></element-citation></ref><ref id="bib193"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Gatenbee</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Macrophage-mediated immunoediting drives ductal carcinoma evolution: space is the game changer</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/594598</pub-id></element-citation></ref><ref id="bib194"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gawad</surname> <given-names>C</given-names></name><name><surname>Koh</surname> <given-names>W</given-names></name><name><surname>Quake</surname> <given-names>SR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Single-cell genome sequencing: current state of the science</article-title><source>Nature Reviews Genetics</source><volume>17</volume><fpage>175</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1038/nrg.2015.16</pub-id><pub-id pub-id-type="pmid">26806412</pub-id></element-citation></ref><ref id="bib195"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gee</surname> <given-names>MH</given-names></name><name><surname>Han</surname> <given-names>A</given-names></name><name><surname>Lofgren</surname> <given-names>SM</given-names></name><name><surname>Beausang</surname> <given-names>JF</given-names></name><name><surname>Mendoza</surname> <given-names>JL</given-names></name><name><surname>Birnbaum</surname> <given-names>ME</given-names></name><name><surname>Bethune</surname> <given-names>MT</given-names></name><name><surname>Fischer</surname> <given-names>S</given-names></name><name><surname>Yang</surname> <given-names>X</given-names></name><name><surname>Gomez-Eerland</surname> <given-names>R</given-names></name><name><surname>Bingham</surname> <given-names>DB</given-names></name><name><surname>Sibener</surname> <given-names>LV</given-names></name><name><surname>Fernandes</surname> <given-names>RA</given-names></name><name><surname>Velasco</surname> <given-names>A</given-names></name><name><surname>Baltimore</surname> <given-names>D</given-names></name><name><surname>Schumacher</surname> <given-names>TN</given-names></name><name><surname>Khatri</surname> <given-names>P</given-names></name><name><surname>Quake</surname> <given-names>SR</given-names></name><name><surname>Davis</surname> <given-names>MM</given-names></name><name><surname>Garcia</surname> <given-names>KC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Antigen identification for orphan T cell receptors expressed on Tumor-Infiltrating lymphocytes</article-title><source>Cell</source><volume>172</volume><fpage>549</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.11.043</pub-id><pub-id pub-id-type="pmid">29275860</pub-id></element-citation></ref><ref id="bib196"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gentles</surname> <given-names>AJ</given-names></name><name><surname>Newman</surname> <given-names>AM</given-names></name><name><surname>Liu</surname> <given-names>CL</given-names></name><name><surname>Bratman</surname> <given-names>SV</given-names></name><name><surname>Feng</surname> <given-names>W</given-names></name><name><surname>Kim</surname> <given-names>D</given-names></name><name><surname>Nair</surname> <given-names>VS</given-names></name><name><surname>Xu</surname> <given-names>Y</given-names></name><name><surname>Khuong</surname> <given-names>A</given-names></name><name><surname>Hoang</surname> <given-names>CD</given-names></name><name><surname>Diehn</surname> <given-names>M</given-names></name><name><surname>West</surname> <given-names>RB</given-names></name><name><surname>Plevritis</surname> <given-names>SK</given-names></name><name><surname>Alizadeh</surname> <given-names>AA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The prognostic landscape of genes and infiltrating immune cells across human cancers</article-title><source>Nature Medicine</source><volume>21</volume><fpage>938</fpage><lpage>945</lpage><pub-id pub-id-type="doi">10.1038/nm.3909</pub-id><pub-id pub-id-type="pmid">26193342</pub-id></element-citation></ref><ref id="bib197"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerdes</surname> <given-names>MJ</given-names></name><name><surname>Sevinsky</surname> <given-names>CJ</given-names></name><name><surname>Sood</surname> <given-names>A</given-names></name><name><surname>Adak</surname> <given-names>S</given-names></name><name><surname>Bello</surname> <given-names>MO</given-names></name><name><surname>Bordwell</surname> <given-names>A</given-names></name><name><surname>Can</surname> <given-names>A</given-names></name><name><surname>Corwin</surname> <given-names>A</given-names></name><name><surname>Dinn</surname> <given-names>S</given-names></name><name><surname>Filkins</surname> <given-names>RJ</given-names></name><name><surname>Hollman</surname> <given-names>D</given-names></name><name><surname>Kamath</surname> <given-names>V</given-names></name><name><surname>Kaanumalle</surname> <given-names>S</given-names></name><name><surname>Kenny</surname> <given-names>K</given-names></name><name><surname>Larsen</surname> <given-names>M</given-names></name><name><surname>Lazare</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>Q</given-names></name><name><surname>Lowes</surname> <given-names>C</given-names></name><name><surname>McCulloch</surname> <given-names>CC</given-names></name><name><surname>McDonough</surname> <given-names>E</given-names></name><name><surname>Montalto</surname> <given-names>MC</given-names></name><name><surname>Pang</surname> <given-names>Z</given-names></name><name><surname>Rittscher</surname> <given-names>J</given-names></name><name><surname>Santamaria-Pang</surname> <given-names>A</given-names></name><name><surname>Sarachan</surname> <given-names>BD</given-names></name><name><surname>Seel</surname> <given-names>ML</given-names></name><name><surname>Seppo</surname> <given-names>A</given-names></name><name><surname>Shaikh</surname> <given-names>K</given-names></name><name><surname>Sui</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Ginty</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue</article-title><source>PNAS</source><volume>110</volume><fpage>11982</fpage><lpage>11987</lpage><pub-id pub-id-type="doi">10.1073/pnas.1300136110</pub-id><pub-id pub-id-type="pmid">23818604</pub-id></element-citation></ref><ref id="bib198"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerlee</surname> <given-names>P</given-names></name><name><surname>Anderson</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>An evolutionary hybrid cellular automaton model of solid tumour growth</article-title><source>Journal of Theoretical Biology</source><volume>246</volume><fpage>583</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.1016/j.jtbi.2007.01.027</pub-id><pub-id pub-id-type="pmid">17374383</pub-id></element-citation></ref><ref id="bib199"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Germain</surname> <given-names>RN</given-names></name><name><surname>Meier-Schellersheim</surname> <given-names>M</given-names></name><name><surname>Nita-Lazar</surname> <given-names>A</given-names></name><name><surname>Fraser</surname> <given-names>ID</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Systems biology in immunology: a computational modeling perspective</article-title><source>Annual Review of Immunology</source><volume>29</volume><fpage>527</fpage><lpage>585</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-030409-101317</pub-id><pub-id pub-id-type="pmid">21219182</pub-id></element-citation></ref><ref id="bib200"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Germain</surname> <given-names>C</given-names></name><name><surname>Gnjatic</surname> <given-names>S</given-names></name><name><surname>Tamzalit</surname> <given-names>F</given-names></name><name><surname>Knockaert</surname> <given-names>S</given-names></name><name><surname>Remark</surname> <given-names>R</given-names></name><name><surname>Goc</surname> <given-names>J</given-names></name><name><surname>Lepelley</surname> <given-names>A</given-names></name><name><surname>Becht</surname> <given-names>E</given-names></name><name><surname>Katsahian</surname> <given-names>S</given-names></name><name><surname>Bizouard</surname> <given-names>G</given-names></name><name><surname>Validire</surname> <given-names>P</given-names></name><name><surname>Damotte</surname> <given-names>D</given-names></name><name><surname>Alifano</surname> <given-names>M</given-names></name><name><surname>Magdeleinat</surname> <given-names>P</given-names></name><name><surname>Cremer</surname> <given-names>I</given-names></name><name><surname>Teillaud</surname> <given-names>JL</given-names></name><name><surname>Fridman</surname> <given-names>WH</given-names></name><name><surname>Sautès-Fridman</surname> <given-names>C</given-names></name><name><surname>Dieu-Nosjean</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung Cancer</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>189</volume><fpage>832</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1164/rccm.201309-1611OC</pub-id><pub-id pub-id-type="pmid">24484236</pub-id></element-citation></ref><ref id="bib201"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Germain</surname> <given-names>RN</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Will systems biology deliver its promise and contribute to the development of new or improved vaccines? what really constitutes the study of &quot;Systems Biology&quot; and How Might Such an Approach Facilitate Vaccine Design</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>10</volume><elocation-id>a033308</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a033308</pub-id><pub-id pub-id-type="pmid">29038120</pub-id></element-citation></ref><ref id="bib202"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerner</surname> <given-names>MY</given-names></name><name><surname>Kastenmuller</surname> <given-names>W</given-names></name><name><surname>Ifrim</surname> <given-names>I</given-names></name><name><surname>Kabat</surname> <given-names>J</given-names></name><name><surname>Germain</surname> <given-names>RN</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Histo-cytometry: a method for highly multiplex quantitative tissue imaging analysis applied to dendritic cell subset microanatomy in lymph nodes</article-title><source>Immunity</source><volume>37</volume><fpage>364</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2012.07.011</pub-id><pub-id pub-id-type="pmid">22863836</pub-id></element-citation></ref><ref id="bib203"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gettinger</surname> <given-names>S</given-names></name><name><surname>Choi</surname> <given-names>J</given-names></name><name><surname>Hastings</surname> <given-names>K</given-names></name><name><surname>Truini</surname> <given-names>A</given-names></name><name><surname>Datar</surname> <given-names>I</given-names></name><name><surname>Sowell</surname> <given-names>R</given-names></name><name><surname>Wurtz</surname> <given-names>A</given-names></name><name><surname>Dong</surname> <given-names>W</given-names></name><name><surname>Cai</surname> <given-names>G</given-names></name><name><surname>Melnick</surname> <given-names>MA</given-names></name><name><surname>Du</surname> <given-names>VY</given-names></name><name><surname>Schlessinger</surname> <given-names>J</given-names></name><name><surname>Goldberg</surname> <given-names>SB</given-names></name><name><surname>Chiang</surname> <given-names>A</given-names></name><name><surname>Sanmamed</surname> <given-names>MF</given-names></name><name><surname>Melero</surname> <given-names>I</given-names></name><name><surname>Agorreta</surname> <given-names>J</given-names></name><name><surname>Montuenga</surname> <given-names>LM</given-names></name><name><surname>Lifton</surname> <given-names>R</given-names></name><name><surname>Ferrone</surname> <given-names>S</given-names></name><name><surname>Kavathas</surname> <given-names>P</given-names></name><name><surname>Rimm</surname> <given-names>DL</given-names></name><name><surname>Kaech</surname> <given-names>SM</given-names></name><name><surname>Schalper</surname> <given-names>K</given-names></name><name><surname>Herbst</surname> <given-names>RS</given-names></name><name><surname>Politi</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Impaired HLA class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung Cancer</article-title><source>Cancer Discovery</source><volume>7</volume><fpage>1420</fpage><lpage>1435</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-17-0593</pub-id><pub-id pub-id-type="pmid">29025772</pub-id></element-citation></ref><ref id="bib204"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>GeurtsvanKessel</surname> <given-names>CH</given-names></name><name><surname>Willart</surname> <given-names>MA</given-names></name><name><surname>Bergen</surname> <given-names>IM</given-names></name><name><surname>van Rijt</surname> <given-names>LS</given-names></name><name><surname>Muskens</surname> <given-names>F</given-names></name><name><surname>Elewaut</surname> <given-names>D</given-names></name><name><surname>Osterhaus</surname> <given-names>AD</given-names></name><name><surname>Hendriks</surname> <given-names>R</given-names></name><name><surname>Rimmelzwaan</surname> <given-names>GF</given-names></name><name><surname>Lambrecht</surname> <given-names>BN</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice</article-title><source>The Journal of Experimental Medicine</source><volume>206</volume><fpage>2339</fpage><lpage>2349</lpage><pub-id pub-id-type="doi">10.1084/jem.20090410</pub-id><pub-id pub-id-type="pmid">19808255</pub-id></element-citation></ref><ref id="bib205"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghaffarizadeh</surname> <given-names>A</given-names></name><name><surname>Heiland</surname> <given-names>R</given-names></name><name><surname>Friedman</surname> <given-names>SH</given-names></name><name><surname>Mumenthaler</surname> <given-names>SM</given-names></name><name><surname>Macklin</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>PhysiCell: an open source physics-based cell simulator for 3-D multicellular systems</article-title><source>PLOS Computational Biology</source><volume>14</volume><elocation-id>e1005991</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1005991</pub-id><pub-id pub-id-type="pmid">29474446</pub-id></element-citation></ref><ref id="bib206"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gharib</surname> <given-names>WH</given-names></name><name><surname>Robinson-Rechavi</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>When orthologs diverge between human and mouse</article-title><source>Briefings in Bioinformatics</source><volume>12</volume><fpage>436</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1093/bib/bbr031</pub-id><pub-id pub-id-type="pmid">21677033</pub-id></element-citation></ref><ref id="bib207"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghoneim</surname> <given-names>HE</given-names></name><name><surname>Fan</surname> <given-names>Y</given-names></name><name><surname>Moustaki</surname> <given-names>A</given-names></name><name><surname>Abdelsamed</surname> <given-names>HA</given-names></name><name><surname>Dash</surname> <given-names>P</given-names></name><name><surname>Dogra</surname> <given-names>P</given-names></name><name><surname>Carter</surname> <given-names>R</given-names></name><name><surname>Awad</surname> <given-names>W</given-names></name><name><surname>Neale</surname> <given-names>G</given-names></name><name><surname>Thomas</surname> <given-names>PG</given-names></name><name><surname>Youngblood</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>De novo epigenetic programs inhibit PD-1 Blockade-Mediated T cell rejuvenation</article-title><source>Cell</source><volume>170</volume><fpage>142</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.06.007</pub-id><pub-id pub-id-type="pmid">28648661</pub-id></element-citation></ref><ref id="bib208"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gierahn</surname> <given-names>TM</given-names></name><name><surname>Wadsworth</surname> <given-names>MH</given-names></name><name><surname>Hughes</surname> <given-names>TK</given-names></name><name><surname>Bryson</surname> <given-names>BD</given-names></name><name><surname>Butler</surname> <given-names>A</given-names></name><name><surname>Satija</surname> <given-names>R</given-names></name><name><surname>Fortune</surname> <given-names>S</given-names></name><name><surname>Love</surname> <given-names>JC</given-names></name><name><surname>Shalek</surname> <given-names>AK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Seq-Well: portable, low-cost RNA sequencing of single cells at high throughput</article-title><source>Nature Methods</source><volume>14</volume><fpage>395</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4179</pub-id><pub-id pub-id-type="pmid">28192419</pub-id></element-citation></ref><ref id="bib209"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giesen</surname> <given-names>C</given-names></name><name><surname>Wang</surname> <given-names>HA</given-names></name><name><surname>Schapiro</surname> <given-names>D</given-names></name><name><surname>Zivanovic</surname> <given-names>N</given-names></name><name><surname>Jacobs</surname> <given-names>A</given-names></name><name><surname>Hattendorf</surname> <given-names>B</given-names></name><name><surname>Schüffler</surname> <given-names>PJ</given-names></name><name><surname>Grolimund</surname> <given-names>D</given-names></name><name><surname>Buhmann</surname> <given-names>JM</given-names></name><name><surname>Brandt</surname> <given-names>S</given-names></name><name><surname>Varga</surname> <given-names>Z</given-names></name><name><surname>Wild</surname> <given-names>PJ</given-names></name><name><surname>Günther</surname> <given-names>D</given-names></name><name><surname>Bodenmiller</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry</article-title><source>Nature Methods</source><volume>11</volume><fpage>417</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2869</pub-id><pub-id pub-id-type="pmid">24584193</pub-id></element-citation></ref><ref id="bib210"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilmour</surname> <given-names>DS</given-names></name><name><surname>Lis</surname> <given-names>JT</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>In vivo interactions of RNA polymerase II with genes of <italic>Drosophila melanogaster</italic></article-title><source>Molecular and Cellular Biology</source><volume>5</volume><fpage>2009</fpage><lpage>2018</lpage><pub-id pub-id-type="doi">10.1128/MCB.5.8.2009</pub-id><pub-id pub-id-type="pmid">3018544</pub-id></element-citation></ref><ref id="bib211"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginhoux</surname> <given-names>F</given-names></name><name><surname>Greter</surname> <given-names>M</given-names></name><name><surname>Leboeuf</surname> <given-names>M</given-names></name><name><surname>Nandi</surname> <given-names>S</given-names></name><name><surname>See</surname> <given-names>P</given-names></name><name><surname>Gokhan</surname> <given-names>S</given-names></name><name><surname>Mehler</surname> <given-names>MF</given-names></name><name><surname>Conway</surname> <given-names>SJ</given-names></name><name><surname>Ng</surname> <given-names>LG</given-names></name><name><surname>Stanley</surname> <given-names>ER</given-names></name><name><surname>Samokhvalov</surname> <given-names>IM</given-names></name><name><surname>Merad</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Fate mapping analysis reveals that adult microglia derive from primitive macrophages</article-title><source>Science</source><volume>330</volume><fpage>841</fpage><lpage>845</lpage><pub-id pub-id-type="doi">10.1126/science.1194637</pub-id></element-citation></ref><ref id="bib212"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginhoux</surname> <given-names>F</given-names></name><name><surname>Schultze</surname> <given-names>JL</given-names></name><name><surname>Murray</surname> <given-names>PJ</given-names></name><name><surname>Ochando</surname> <given-names>J</given-names></name><name><surname>Biswas</surname> <given-names>SK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>New insights into the multidimensional concept of macrophage ontogeny, activation and function</article-title><source>Nature Immunology</source><volume>17</volume><fpage>34</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1038/ni.3324</pub-id><pub-id pub-id-type="pmid">26681460</pub-id></element-citation></ref><ref id="bib213"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginhoux</surname> <given-names>F</given-names></name><name><surname>Guilliams</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Tissue-Resident macrophage ontogeny and homeostasis</article-title><source>Immunity</source><volume>44</volume><fpage>439</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.02.024</pub-id><pub-id pub-id-type="pmid">26982352</pub-id></element-citation></ref><ref id="bib214"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glanville</surname> <given-names>J</given-names></name><name><surname>Huang</surname> <given-names>H</given-names></name><name><surname>Nau</surname> <given-names>A</given-names></name><name><surname>Hatton</surname> <given-names>O</given-names></name><name><surname>Wagar</surname> <given-names>LE</given-names></name><name><surname>Rubelt</surname> <given-names>F</given-names></name><name><surname>Ji</surname> <given-names>X</given-names></name><name><surname>Han</surname> <given-names>A</given-names></name><name><surname>Krams</surname> <given-names>SM</given-names></name><name><surname>Pettus</surname> <given-names>C</given-names></name><name><surname>Haas</surname> <given-names>N</given-names></name><name><surname>Arlehamn</surname> <given-names>CSL</given-names></name><name><surname>Sette</surname> <given-names>A</given-names></name><name><surname>Boyd</surname> <given-names>SD</given-names></name><name><surname>Scriba</surname> <given-names>TJ</given-names></name><name><surname>Martinez</surname> <given-names>OM</given-names></name><name><surname>Davis</surname> <given-names>MM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Identifying specificity groups in the T cell receptor repertoire</article-title><source>Nature</source><volume>547</volume><fpage>94</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1038/nature22976</pub-id><pub-id pub-id-type="pmid">28636589</pub-id></element-citation></ref><ref id="bib215"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glass</surname> <given-names>G</given-names></name><name><surname>Papin</surname> <given-names>JA</given-names></name><name><surname>Mandell</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>SIMPLE: a sequential immunoperoxidase labeling and erasing method</article-title><source>Journal of Histochemistry &amp; Cytochemistry</source><volume>57</volume><fpage>899</fpage><lpage>905</lpage><pub-id pub-id-type="doi">10.1369/jhc.2009.953612</pub-id><pub-id pub-id-type="pmid">19365090</pub-id></element-citation></ref><ref id="bib216"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goc</surname> <given-names>J</given-names></name><name><surname>Fridman</surname> <given-names>WH</given-names></name><name><surname>Sautès-Fridman</surname> <given-names>C</given-names></name><name><surname>Dieu-Nosjean</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Characteristics of tertiary lymphoid structures in primary cancers</article-title><source>OncoImmunology</source><volume>2</volume><elocation-id>e26836</elocation-id><pub-id pub-id-type="doi">10.4161/onci.26836</pub-id><pub-id pub-id-type="pmid">24498556</pub-id></element-citation></ref><ref id="bib217"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goltsev</surname> <given-names>Y</given-names></name><name><surname>Samusik</surname> <given-names>N</given-names></name><name><surname>Kennedy-Darling</surname> <given-names>J</given-names></name><name><surname>Bhate</surname> <given-names>S</given-names></name><name><surname>Hale</surname> <given-names>M</given-names></name><name><surname>Vazquez</surname> <given-names>G</given-names></name><name><surname>Black</surname> <given-names>S</given-names></name><name><surname>Nolan</surname> <given-names>GP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Deep profiling of mouse splenic architecture with CODEX multiplexed imaging</article-title><source>Cell</source><volume>174</volume><fpage>968</fpage><lpage>981</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.07.010</pub-id><pub-id pub-id-type="pmid">30078711</pub-id></element-citation></ref><ref id="bib218"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname> <given-names>C</given-names></name><name><surname>Milberg</surname> <given-names>O</given-names></name><name><surname>Wang</surname> <given-names>B</given-names></name><name><surname>Vicini</surname> <given-names>P</given-names></name><name><surname>Narwal</surname> <given-names>R</given-names></name><name><surname>Roskos</surname> <given-names>L</given-names></name><name><surname>Popel</surname> <given-names>AS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A computational multiscale agent-based model for simulating spatio-temporal tumour immune response to PD1 and PDL1 inhibition</article-title><source>Journal of the Royal Society Interface</source><volume>14</volume><elocation-id>20170320</elocation-id><pub-id pub-id-type="doi">10.1098/rsif.2017.0320</pub-id></element-citation></ref><ref id="bib219"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname> <given-names>T</given-names></name><name><surname>Szustakowski</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>DeconRNASeq: a statistical framework for deconvolution of heterogeneous tissue samples based on mRNA-Seq data</article-title><source>Bioinformatics</source><volume>29</volume><fpage>1083</fpage><lpage>1085</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt090</pub-id><pub-id pub-id-type="pmid">23428642</pub-id></element-citation></ref><ref id="bib220"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Good</surname> <given-names>Z</given-names></name><name><surname>Sarno</surname> <given-names>J</given-names></name><name><surname>Jager</surname> <given-names>A</given-names></name><name><surname>Samusik</surname> <given-names>N</given-names></name><name><surname>Aghaeepour</surname> <given-names>N</given-names></name><name><surname>Simonds</surname> <given-names>EF</given-names></name><name><surname>White</surname> <given-names>L</given-names></name><name><surname>Lacayo</surname> <given-names>NJ</given-names></name><name><surname>Fantl</surname> <given-names>WJ</given-names></name><name><surname>Fazio</surname> <given-names>G</given-names></name><name><surname>Gaipa</surname> <given-names>G</given-names></name><name><surname>Biondi</surname> <given-names>A</given-names></name><name><surname>Tibshirani</surname> <given-names>R</given-names></name><name><surname>Bendall</surname> <given-names>SC</given-names></name><name><surname>Nolan</surname> <given-names>GP</given-names></name><name><surname>Davis</surname> <given-names>KL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse</article-title><source>Nature Medicine</source><volume>24</volume><fpage>474</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1038/nm.4505</pub-id><pub-id pub-id-type="pmid">29505032</pub-id></element-citation></ref><ref id="bib221"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Good</surname> <given-names>Z</given-names></name><name><surname>Borges</surname> <given-names>L</given-names></name><name><surname>Vivanco Gonzalez</surname> <given-names>N</given-names></name><name><surname>Sahaf</surname> <given-names>B</given-names></name><name><surname>Samusik</surname> <given-names>N</given-names></name><name><surname>Tibshirani</surname> <given-names>R</given-names></name><name><surname>Nolan</surname> <given-names>GP</given-names></name><name><surname>Bendall</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Proliferation tracing with single-cell mass cytometry optimizes generation of stem cell memory-like T cells</article-title><source>Nature Biotechnology</source><volume>37</volume><fpage>259</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1038/s41587-019-0033-2</pub-id><pub-id pub-id-type="pmid">30742126</pub-id></element-citation></ref><ref id="bib222"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gopalakrishnan</surname> <given-names>V</given-names></name><name><surname>Spencer</surname> <given-names>CN</given-names></name><name><surname>Nezi</surname> <given-names>L</given-names></name><name><surname>Reuben</surname> <given-names>A</given-names></name><name><surname>Andrews</surname> <given-names>MC</given-names></name><name><surname>Karpinets</surname> <given-names>TV</given-names></name><name><surname>Prieto</surname> <given-names>PA</given-names></name><name><surname>Vicente</surname> <given-names>D</given-names></name><name><surname>Hoffman</surname> <given-names>K</given-names></name><name><surname>Wei</surname> <given-names>SC</given-names></name><name><surname>Cogdill</surname> <given-names>AP</given-names></name><name><surname>Zhao</surname> <given-names>L</given-names></name><name><surname>Hudgens</surname> <given-names>CW</given-names></name><name><surname>Hutchinson</surname> <given-names>DS</given-names></name><name><surname>Manzo</surname> <given-names>T</given-names></name><name><surname>Petaccia de Macedo</surname> <given-names>M</given-names></name><name><surname>Cotechini</surname> <given-names>T</given-names></name><name><surname>Kumar</surname> <given-names>T</given-names></name><name><surname>Chen</surname> <given-names>WS</given-names></name><name><surname>Reddy</surname> <given-names>SM</given-names></name><name><surname>Szczepaniak Sloane</surname> <given-names>R</given-names></name><name><surname>Galloway-Pena</surname> <given-names>J</given-names></name><name><surname>Jiang</surname> <given-names>H</given-names></name><name><surname>Chen</surname> <given-names>PL</given-names></name><name><surname>Shpall</surname> <given-names>EJ</given-names></name><name><surname>Rezvani</surname> <given-names>K</given-names></name><name><surname>Alousi</surname> <given-names>AM</given-names></name><name><surname>Chemaly</surname> <given-names>RF</given-names></name><name><surname>Shelburne</surname> <given-names>S</given-names></name><name><surname>Vence</surname> <given-names>LM</given-names></name><name><surname>Okhuysen</surname> <given-names>PC</given-names></name><name><surname>Jensen</surname> <given-names>VB</given-names></name><name><surname>Swennes</surname> <given-names>AG</given-names></name><name><surname>McAllister</surname> <given-names>F</given-names></name><name><surname>Marcelo Riquelme Sanchez</surname> <given-names>E</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Le Chatelier</surname> <given-names>E</given-names></name><name><surname>Zitvogel</surname> <given-names>L</given-names></name><name><surname>Pons</surname> <given-names>N</given-names></name><name><surname>Austin-Breneman</surname> <given-names>JL</given-names></name><name><surname>Haydu</surname> <given-names>LE</given-names></name><name><surname>Burton</surname> <given-names>EM</given-names></name><name><surname>Gardner</surname> <given-names>JM</given-names></name><name><surname>Sirmans</surname> <given-names>E</given-names></name><name><surname>Hu</surname> <given-names>J</given-names></name><name><surname>Lazar</surname> <given-names>AJ</given-names></name><name><surname>Tsujikawa</surname> <given-names>T</given-names></name><name><surname>Diab</surname> <given-names>A</given-names></name><name><surname>Tawbi</surname> <given-names>H</given-names></name><name><surname>Glitza</surname> <given-names>IC</given-names></name><name><surname>Hwu</surname> <given-names>WJ</given-names></name><name><surname>Patel</surname> <given-names>SP</given-names></name><name><surname>Woodman</surname> <given-names>SE</given-names></name><name><surname>Amaria</surname> <given-names>RN</given-names></name><name><surname>Davies</surname> <given-names>MA</given-names></name><name><surname>Gershenwald</surname> <given-names>JE</given-names></name><name><surname>Hwu</surname> <given-names>P</given-names></name><name><surname>Lee</surname> <given-names>JE</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Coussens</surname> <given-names>LM</given-names></name><name><surname>Cooper</surname> <given-names>ZA</given-names></name><name><surname>Futreal</surname> <given-names>PA</given-names></name><name><surname>Daniel</surname> <given-names>CR</given-names></name><name><surname>Ajami</surname> <given-names>NJ</given-names></name><name><surname>Petrosino</surname> <given-names>JF</given-names></name><name><surname>Tetzlaff</surname> <given-names>MT</given-names></name><name><surname>Sharma</surname> <given-names>P</given-names></name><name><surname>Allison</surname> <given-names>JP</given-names></name><name><surname>Jenq</surname> <given-names>RR</given-names></name><name><surname>Wargo</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients</article-title><source>Science</source><volume>359</volume><fpage>97</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1126/science.aan4236</pub-id><pub-id pub-id-type="pmid">29097493</pub-id></element-citation></ref><ref id="bib223"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Alternative activation of macrophages</article-title><source>Nature Reviews Immunology</source><volume>3</volume><fpage>23</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1038/nri978</pub-id><pub-id pub-id-type="pmid">12511873</pub-id></element-citation></ref><ref id="bib224"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gowthaman</surname> <given-names>U</given-names></name><name><surname>Chodisetti</surname> <given-names>SB</given-names></name><name><surname>Parihar</surname> <given-names>P</given-names></name><name><surname>Agrewala</surname> <given-names>JN</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Evaluation of different generic in silico methods for predicting HLA class I binding peptide vaccine candidates using a reverse approach</article-title><source>Amino Acids</source><volume>39</volume><fpage>1333</fpage><lpage>1342</lpage><pub-id pub-id-type="doi">10.1007/s00726-010-0579-2</pub-id><pub-id pub-id-type="pmid">20379752</pub-id></element-citation></ref><ref id="bib225"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grosselin</surname> <given-names>K</given-names></name><name><surname>Durand</surname> <given-names>A</given-names></name><name><surname>Marsolier</surname> <given-names>J</given-names></name><name><surname>Poitou</surname> <given-names>A</given-names></name><name><surname>Marangoni</surname> <given-names>E</given-names></name><name><surname>Nemati</surname> <given-names>F</given-names></name><name><surname>Dahmani</surname> <given-names>A</given-names></name><name><surname>Lameiras</surname> <given-names>S</given-names></name><name><surname>Reyal</surname> <given-names>F</given-names></name><name><surname>Frenoy</surname> <given-names>O</given-names></name><name><surname>Pousse</surname> <given-names>Y</given-names></name><name><surname>Reichen</surname> <given-names>M</given-names></name><name><surname>Woolfe</surname> <given-names>A</given-names></name><name><surname>Brenan</surname> <given-names>C</given-names></name><name><surname>Griffiths</surname> <given-names>AD</given-names></name><name><surname>Vallot</surname> <given-names>C</given-names></name><name><surname>Gérard</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>High-throughput single-cell ChIP-seq identifies heterogeneity of chromatin states in breast Cancer</article-title><source>Nature Genetics</source><volume>51</volume><fpage>1060</fpage><lpage>1066</lpage><pub-id pub-id-type="doi">10.1038/s41588-019-0424-9</pub-id><pub-id pub-id-type="pmid">31152164</pub-id></element-citation></ref><ref id="bib226"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grün</surname> <given-names>D</given-names></name><name><surname>Lyubimova</surname> <given-names>A</given-names></name><name><surname>Kester</surname> <given-names>L</given-names></name><name><surname>Wiebrands</surname> <given-names>K</given-names></name><name><surname>Basak</surname> <given-names>O</given-names></name><name><surname>Sasaki</surname> <given-names>N</given-names></name><name><surname>Clevers</surname> <given-names>H</given-names></name><name><surname>van Oudenaarden</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Single-cell messenger RNA sequencing reveals rare intestinal cell types</article-title><source>Nature</source><volume>525</volume><fpage>251</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1038/nature14966</pub-id><pub-id pub-id-type="pmid">26287467</pub-id></element-citation></ref><ref id="bib227"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grupp</surname> <given-names>SA</given-names></name><name><surname>Kalos</surname> <given-names>M</given-names></name><name><surname>Barrett</surname> <given-names>D</given-names></name><name><surname>Aplenc</surname> <given-names>R</given-names></name><name><surname>Porter</surname> <given-names>DL</given-names></name><name><surname>Rheingold</surname> <given-names>SR</given-names></name><name><surname>Teachey</surname> <given-names>DT</given-names></name><name><surname>Chew</surname> <given-names>A</given-names></name><name><surname>Hauck</surname> <given-names>B</given-names></name><name><surname>Wright</surname> <given-names>JF</given-names></name><name><surname>Milone</surname> <given-names>MC</given-names></name><name><surname>Levine</surname> <given-names>BL</given-names></name><name><surname>June</surname> <given-names>CH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Chimeric antigen receptor-modified T cells for acute lymphoid leukemia</article-title><source>New England Journal of Medicine</source><volume>368</volume><fpage>1509</fpage><lpage>1518</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1215134</pub-id><pub-id pub-id-type="pmid">23527958</pub-id></element-citation></ref><ref id="bib228"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Fu</surname> <given-names>L</given-names></name><name><surname>Zhai</surname> <given-names>L</given-names></name><name><surname>Zhu</surname> <given-names>J</given-names></name><name><surname>Han</surname> <given-names>Y</given-names></name><name><surname>Jiang</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>P</given-names></name><name><surname>Jiang</surname> <given-names>Z</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Cao</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG</article-title><source>Nature Medicine</source><volume>25</volume><fpage>312</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1038/s41591-018-0309-y</pub-id><pub-id pub-id-type="pmid">30643287</pub-id></element-citation></ref><ref id="bib229"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilliams</surname> <given-names>M</given-names></name><name><surname>De Kleer</surname> <given-names>I</given-names></name><name><surname>Henri</surname> <given-names>S</given-names></name><name><surname>Post</surname> <given-names>S</given-names></name><name><surname>Vanhoutte</surname> <given-names>L</given-names></name><name><surname>De Prijck</surname> <given-names>S</given-names></name><name><surname>Deswarte</surname> <given-names>K</given-names></name><name><surname>Malissen</surname> <given-names>B</given-names></name><name><surname>Hammad</surname> <given-names>H</given-names></name><name><surname>Lambrecht</surname> <given-names>BN</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF</article-title><source>The Journal of Experimental Medicine</source><volume>210</volume><fpage>1977</fpage><lpage>1992</lpage><pub-id pub-id-type="doi">10.1084/jem.20131199</pub-id><pub-id pub-id-type="pmid">24043763</pub-id></element-citation></ref><ref id="bib230"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilliams</surname> <given-names>M</given-names></name><name><surname>Dutertre</surname> <given-names>CA</given-names></name><name><surname>Scott</surname> <given-names>CL</given-names></name><name><surname>McGovern</surname> <given-names>N</given-names></name><name><surname>Sichien</surname> <given-names>D</given-names></name><name><surname>Chakarov</surname> <given-names>S</given-names></name><name><surname>Van Gassen</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Poidinger</surname> <given-names>M</given-names></name><name><surname>De Prijck</surname> <given-names>S</given-names></name><name><surname>Tavernier</surname> <given-names>SJ</given-names></name><name><surname>Low</surname> <given-names>I</given-names></name><name><surname>Irac</surname> <given-names>SE</given-names></name><name><surname>Mattar</surname> <given-names>CN</given-names></name><name><surname>Sumatoh</surname> <given-names>HR</given-names></name><name><surname>Low</surname> <given-names>GHL</given-names></name><name><surname>Chung</surname> <given-names>TJK</given-names></name><name><surname>Chan</surname> <given-names>DKH</given-names></name><name><surname>Tan</surname> <given-names>KK</given-names></name><name><surname>Hon</surname> <given-names>TLK</given-names></name><name><surname>Fossum</surname> <given-names>E</given-names></name><name><surname>Bogen</surname> <given-names>B</given-names></name><name><surname>Choolani</surname> <given-names>M</given-names></name><name><surname>Chan</surname> <given-names>JKY</given-names></name><name><surname>Larbi</surname> <given-names>A</given-names></name><name><surname>Luche</surname> <given-names>H</given-names></name><name><surname>Henri</surname> <given-names>S</given-names></name><name><surname>Saeys</surname> <given-names>Y</given-names></name><name><surname>Newell</surname> <given-names>EW</given-names></name><name><surname>Lambrecht</surname> <given-names>BN</given-names></name><name><surname>Malissen</surname> <given-names>B</given-names></name><name><surname>Ginhoux</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Unsupervised High-Dimensional analysis aligns dendritic cells across tissues and species</article-title><source>Immunity</source><volume>45</volume><fpage>669</fpage><lpage>684</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.08.015</pub-id><pub-id pub-id-type="pmid">27637149</pub-id></element-citation></ref><ref id="bib231"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>H</given-names></name><name><surname>Zhu</surname> <given-names>P</given-names></name><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Wen</surname> <given-names>L</given-names></name><name><surname>Tang</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Single-cell methylome landscapes of mouse embryonic stem cells and early embryos analyzed using reduced representation bisulfite sequencing</article-title><source>Genome Research</source><volume>23</volume><fpage>2126</fpage><lpage>2135</lpage><pub-id pub-id-type="doi">10.1101/gr.161679.113</pub-id><pub-id pub-id-type="pmid">24179143</pub-id></element-citation></ref><ref id="bib232"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Potter</surname> <given-names>SS</given-names></name><name><surname>Whitsett</surname> <given-names>JA</given-names></name><name><surname>Xu</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>SINCERA: a pipeline for Single-Cell RNA-Seq profiling analysis</article-title><source>PLOS Computational Biology</source><volume>11</volume><elocation-id>e1004575</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1004575</pub-id><pub-id pub-id-type="pmid">26600239</pub-id></element-citation></ref><ref id="bib233"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Zheng</surname> <given-names>L</given-names></name><name><surname>Zheng</surname> <given-names>C</given-names></name><name><surname>Song</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>Q</given-names></name><name><surname>Kang</surname> <given-names>B</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Jin</surname> <given-names>L</given-names></name><name><surname>Xing</surname> <given-names>R</given-names></name><name><surname>Gao</surname> <given-names>R</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Dong</surname> <given-names>M</given-names></name><name><surname>Hu</surname> <given-names>X</given-names></name><name><surname>Ren</surname> <given-names>X</given-names></name><name><surname>Kirchhoff</surname> <given-names>D</given-names></name><name><surname>Roider</surname> <given-names>HG</given-names></name><name><surname>Yan</surname> <given-names>T</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing</article-title><source>Nature Medicine</source><volume>24</volume><fpage>978</fpage><lpage>985</lpage><pub-id pub-id-type="doi">10.1038/s41591-018-0045-3</pub-id><pub-id pub-id-type="pmid">29942094</pub-id></element-citation></ref><ref id="bib234"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habib</surname> <given-names>N</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Heidenreich</surname> <given-names>M</given-names></name><name><surname>Swiech</surname> <given-names>L</given-names></name><name><surname>Avraham-Davidi</surname> <given-names>I</given-names></name><name><surname>Trombetta</surname> <given-names>JJ</given-names></name><name><surname>Hession</surname> <given-names>C</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Div-Seq: single-nucleus RNA-Seq reveals dynamics of rare adult newborn neurons</article-title><source>Science</source><volume>353</volume><fpage>925</fpage><lpage>928</lpage><pub-id pub-id-type="doi">10.1126/science.aad7038</pub-id><pub-id pub-id-type="pmid">27471252</pub-id></element-citation></ref><ref id="bib235"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habib</surname> <given-names>N</given-names></name><name><surname>Avraham-Davidi</surname> <given-names>I</given-names></name><name><surname>Basu</surname> <given-names>A</given-names></name><name><surname>Burks</surname> <given-names>T</given-names></name><name><surname>Shekhar</surname> <given-names>K</given-names></name><name><surname>Hofree</surname> <given-names>M</given-names></name><name><surname>Choudhury</surname> <given-names>SR</given-names></name><name><surname>Aguet</surname> <given-names>F</given-names></name><name><surname>Gelfand</surname> <given-names>E</given-names></name><name><surname>Ardlie</surname> <given-names>K</given-names></name><name><surname>Weitz</surname> <given-names>DA</given-names></name><name><surname>Rozenblatt-Rosen</surname> <given-names>O</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Massively parallel single-nucleus RNA-seq with DroNc-seq</article-title><source>Nature Methods</source><volume>14</volume><fpage>955</fpage><lpage>958</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4407</pub-id><pub-id pub-id-type="pmid">28846088</pub-id></element-citation></ref><ref id="bib236"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hacohen</surname> <given-names>N</given-names></name><name><surname>Fritsch</surname> <given-names>EF</given-names></name><name><surname>Carter</surname> <given-names>TA</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Wu</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Getting personal with neoantigen-based therapeutic Cancer vaccines</article-title><source>Cancer Immunology Research</source><volume>1</volume><fpage>11</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1158/2326-6066.CIR-13-0022</pub-id><pub-id pub-id-type="pmid">24777245</pub-id></element-citation></ref><ref id="bib237"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamid</surname> <given-names>O</given-names></name><name><surname>Robert</surname> <given-names>C</given-names></name><name><surname>Daud</surname> <given-names>A</given-names></name><name><surname>Hodi</surname> <given-names>FS</given-names></name><name><surname>Hwu</surname> <given-names>WJ</given-names></name><name><surname>Kefford</surname> <given-names>R</given-names></name><name><surname>Wolchok</surname> <given-names>JD</given-names></name><name><surname>Hersey</surname> <given-names>P</given-names></name><name><surname>Joseph</surname> <given-names>RW</given-names></name><name><surname>Weber</surname> <given-names>JS</given-names></name><name><surname>Dronca</surname> <given-names>R</given-names></name><name><surname>Gangadhar</surname> <given-names>TC</given-names></name><name><surname>Patnaik</surname> <given-names>A</given-names></name><name><surname>Zarour</surname> <given-names>H</given-names></name><name><surname>Joshua</surname> <given-names>AM</given-names></name><name><surname>Gergich</surname> <given-names>K</given-names></name><name><surname>Elassaiss-Schaap</surname> <given-names>J</given-names></name><name><surname>Algazi</surname> <given-names>A</given-names></name><name><surname>Mateus</surname> <given-names>C</given-names></name><name><surname>Boasberg</surname> <given-names>P</given-names></name><name><surname>Tumeh</surname> <given-names>PC</given-names></name><name><surname>Chmielowski</surname> <given-names>B</given-names></name><name><surname>Ebbinghaus</surname> <given-names>SW</given-names></name><name><surname>Li</surname> <given-names>XN</given-names></name><name><surname>Kang</surname> <given-names>SP</given-names></name><name><surname>Ribas</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma</article-title><source>New England Journal of Medicine</source><volume>369</volume><fpage>134</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1305133</pub-id><pub-id pub-id-type="pmid">23724846</pub-id></element-citation></ref><ref id="bib238"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>Q</given-names></name><name><surname>Bagheri</surname> <given-names>N</given-names></name><name><surname>Bradshaw</surname> <given-names>EM</given-names></name><name><surname>Hafler</surname> <given-names>DA</given-names></name><name><surname>Lauffenburger</surname> <given-names>DA</given-names></name><name><surname>Love</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Polyfunctional responses by human T cells result from sequential release of cytokines</article-title><source>PNAS</source><volume>109</volume><fpage>1607</fpage><lpage>1612</lpage><pub-id pub-id-type="doi">10.1073/pnas.1117194109</pub-id><pub-id pub-id-type="pmid">22160692</pub-id></element-citation></ref><ref id="bib239"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>A</given-names></name><name><surname>Glanville</surname> <given-names>J</given-names></name><name><surname>Hansmann</surname> <given-names>L</given-names></name><name><surname>Davis</surname> <given-names>MM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Linking T-cell receptor sequence to functional phenotype at the single-cell level</article-title><source>Nature Biotechnology</source><volume>32</volume><fpage>684</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1038/nbt.2938</pub-id><pub-id pub-id-type="pmid">24952902</pub-id></element-citation></ref><ref id="bib240"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Guan</surname> <given-names>Y</given-names></name><name><surname>Huang</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Immune repertoire: a potential biomarker and therapeutic for hepatocellular carcinoma</article-title><source>Cancer Letters</source><volume>379</volume><fpage>206</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2015.06.022</pub-id><pub-id pub-id-type="pmid">26188280</pub-id></element-citation></ref><ref id="bib241"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haque</surname> <given-names>A</given-names></name><name><surname>Engel</surname> <given-names>J</given-names></name><name><surname>Teichmann</surname> <given-names>SA</given-names></name><name><surname>Lönnberg</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications</article-title><source>Genome Medicine</source><volume>9</volume><elocation-id>75</elocation-id><pub-id pub-id-type="doi">10.1186/s13073-017-0467-4</pub-id><pub-id pub-id-type="pmid">28821273</pub-id></element-citation></ref><ref id="bib242"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartmann</surname> <given-names>FJ</given-names></name><name><surname>Babdor</surname> <given-names>J</given-names></name><name><surname>Gherardini</surname> <given-names>PF</given-names></name><name><surname>Amir</surname> <given-names>ED</given-names></name><name><surname>Jones</surname> <given-names>K</given-names></name><name><surname>Sahaf</surname> <given-names>B</given-names></name><name><surname>Marquez</surname> <given-names>DM</given-names></name><name><surname>Krutzik</surname> <given-names>P</given-names></name><name><surname>O'Donnell</surname> <given-names>E</given-names></name><name><surname>Sigal</surname> <given-names>N</given-names></name><name><surname>Maecker</surname> <given-names>HT</given-names></name><name><surname>Meyer</surname> <given-names>E</given-names></name><name><surname>Spitzer</surname> <given-names>MH</given-names></name><name><surname>Bendall</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Comprehensive immune monitoring of clinical trials to advance human immunotherapy</article-title><source>Cell Reports</source><volume>28</volume><fpage>819</fpage><lpage>831</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.06.049</pub-id><pub-id pub-id-type="pmid">31315057</pub-id></element-citation></ref><ref id="bib243"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname> <given-names>D</given-names></name><name><surname>Chow</surname> <given-names>A</given-names></name><name><surname>Noizat</surname> <given-names>C</given-names></name><name><surname>Teo</surname> <given-names>P</given-names></name><name><surname>Beasley</surname> <given-names>MB</given-names></name><name><surname>Leboeuf</surname> <given-names>M</given-names></name><name><surname>Becker</surname> <given-names>CD</given-names></name><name><surname>See</surname> <given-names>P</given-names></name><name><surname>Price</surname> <given-names>J</given-names></name><name><surname>Lucas</surname> <given-names>D</given-names></name><name><surname>Greter</surname> <given-names>M</given-names></name><name><surname>Mortha</surname> <given-names>A</given-names></name><name><surname>Boyer</surname> <given-names>SW</given-names></name><name><surname>Forsberg</surname> <given-names>EC</given-names></name><name><surname>Tanaka</surname> <given-names>M</given-names></name><name><surname>van Rooijen</surname> <given-names>N</given-names></name><name><surname>García-Sastre</surname> <given-names>A</given-names></name><name><surname>Stanley</surname> <given-names>ER</given-names></name><name><surname>Ginhoux</surname> <given-names>F</given-names></name><name><surname>Frenette</surname> <given-names>PS</given-names></name><name><surname>Merad</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes</article-title><source>Immunity</source><volume>38</volume><fpage>792</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2013.04.004</pub-id><pub-id pub-id-type="pmid">23601688</pub-id></element-citation></ref><ref id="bib244"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimshony</surname> <given-names>T</given-names></name><name><surname>Wagner</surname> <given-names>F</given-names></name><name><surname>Sher</surname> <given-names>N</given-names></name><name><surname>Yanai</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>CEL-Seq: single-cell RNA-Seq by multiplexed linear amplification</article-title><source>Cell Reports</source><volume>2</volume><fpage>666</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2012.08.003</pub-id><pub-id pub-id-type="pmid">22939981</pub-id></element-citation></ref><ref id="bib245"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>B</given-names></name><name><surname>Xing</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>C</given-names></name><name><surname>Gao</surname> <given-names>P</given-names></name><name><surname>Teng</surname> <given-names>L</given-names></name><name><surname>Shan</surname> <given-names>Q</given-names></name><name><surname>Gullicksrud</surname> <given-names>JA</given-names></name><name><surname>Martin</surname> <given-names>MD</given-names></name><name><surname>Yu</surname> <given-names>S</given-names></name><name><surname>Harty</surname> <given-names>JT</given-names></name><name><surname>Badovinac</surname> <given-names>VP</given-names></name><name><surname>Tan</surname> <given-names>K</given-names></name><name><surname>Xue</surname> <given-names>HH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>CD8<sup>+</sup> T cells utilize highly dynamic enhancer repertoires and regulatory circuitry in response to infections</article-title><source>Immunity</source><volume>45</volume><fpage>1341</fpage><lpage>1354</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.11.009</pub-id><pub-id pub-id-type="pmid">27986453</pub-id></element-citation></ref><ref id="bib246"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hellmann</surname> <given-names>MD</given-names></name><name><surname>Nathanson</surname> <given-names>T</given-names></name><name><surname>Rizvi</surname> <given-names>H</given-names></name><name><surname>Creelan</surname> <given-names>BC</given-names></name><name><surname>Sanchez-Vega</surname> <given-names>F</given-names></name><name><surname>Ahuja</surname> <given-names>A</given-names></name><name><surname>Ni</surname> <given-names>A</given-names></name><name><surname>Novik</surname> <given-names>JB</given-names></name><name><surname>Mangarin</surname> <given-names>LMB</given-names></name><name><surname>Abu-Akeel</surname> <given-names>M</given-names></name><name><surname>Liu</surname> <given-names>C</given-names></name><name><surname>Sauter</surname> <given-names>JL</given-names></name><name><surname>Rekhtman</surname> <given-names>N</given-names></name><name><surname>Chang</surname> <given-names>E</given-names></name><name><surname>Callahan</surname> <given-names>MK</given-names></name><name><surname>Chaft</surname> <given-names>JE</given-names></name><name><surname>Voss</surname> <given-names>MH</given-names></name><name><surname>Tenet</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>XM</given-names></name><name><surname>Covello</surname> <given-names>K</given-names></name><name><surname>Renninger</surname> <given-names>A</given-names></name><name><surname>Vitazka</surname> <given-names>P</given-names></name><name><surname>Geese</surname> <given-names>WJ</given-names></name><name><surname>Borghaei</surname> <given-names>H</given-names></name><name><surname>Rudin</surname> <given-names>CM</given-names></name><name><surname>Antonia</surname> <given-names>SJ</given-names></name><name><surname>Swanton</surname> <given-names>C</given-names></name><name><surname>Hammerbacher</surname> <given-names>J</given-names></name><name><surname>Merghoub</surname> <given-names>T</given-names></name><name><surname>McGranahan</surname> <given-names>N</given-names></name><name><surname>Snyder</surname> <given-names>A</given-names></name><name><surname>Wolchok</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genomic features of response to combination immunotherapy in patients with advanced Non-Small-Cell lung Cancer</article-title><source>Cancer Cell</source><volume>33</volume><fpage>843</fpage><lpage>852</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2018.03.018</pub-id><pub-id pub-id-type="pmid">29657128</pub-id></element-citation></ref><ref id="bib247"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helmink</surname> <given-names>BA</given-names></name><name><surname>Reddy</surname> <given-names>SM</given-names></name><name><surname>Gao</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>S</given-names></name><name><surname>Basar</surname> <given-names>R</given-names></name><name><surname>Thakur</surname> <given-names>R</given-names></name><name><surname>Yizhak</surname> <given-names>K</given-names></name><name><surname>Sade-Feldman</surname> <given-names>M</given-names></name><name><surname>Blando</surname> <given-names>J</given-names></name><name><surname>Han</surname> <given-names>G</given-names></name><name><surname>Gopalakrishnan</surname> <given-names>V</given-names></name><name><surname>Xi</surname> <given-names>Y</given-names></name><name><surname>Zhao</surname> <given-names>H</given-names></name><name><surname>Amaria</surname> <given-names>RN</given-names></name><name><surname>Tawbi</surname> <given-names>HA</given-names></name><name><surname>Cogdill</surname> <given-names>AP</given-names></name><name><surname>Liu</surname> <given-names>W</given-names></name><name><surname>LeBleu</surname> <given-names>VS</given-names></name><name><surname>Kugeratski</surname> <given-names>FG</given-names></name><name><surname>Patel</surname> <given-names>S</given-names></name><name><surname>Davies</surname> <given-names>MA</given-names></name><name><surname>Hwu</surname> <given-names>P</given-names></name><name><surname>Lee</surname> <given-names>JE</given-names></name><name><surname>Gershenwald</surname> <given-names>JE</given-names></name><name><surname>Lucci</surname> <given-names>A</given-names></name><name><surname>Arora</surname> <given-names>R</given-names></name><name><surname>Woodman</surname> <given-names>S</given-names></name><name><surname>Keung</surname> <given-names>EZ</given-names></name><name><surname>Gaudreau</surname> <given-names>PO</given-names></name><name><surname>Reuben</surname> <given-names>A</given-names></name><name><surname>Spencer</surname> <given-names>CN</given-names></name><name><surname>Burton</surname> <given-names>EM</given-names></name><name><surname>Haydu</surname> <given-names>LE</given-names></name><name><surname>Lazar</surname> <given-names>AJ</given-names></name><name><surname>Zapassodi</surname> <given-names>R</given-names></name><name><surname>Hudgens</surname> <given-names>CW</given-names></name><name><surname>Ledesma</surname> <given-names>DA</given-names></name><name><surname>Ong</surname> <given-names>S</given-names></name><name><surname>Bailey</surname> <given-names>M</given-names></name><name><surname>Warren</surname> <given-names>S</given-names></name><name><surname>Rao</surname> <given-names>D</given-names></name><name><surname>Krijgsman</surname> <given-names>O</given-names></name><name><surname>Rozeman</surname> <given-names>EA</given-names></name><name><surname>Peeper</surname> <given-names>D</given-names></name><name><surname>Blank</surname> <given-names>CU</given-names></name><name><surname>Schumacher</surname> <given-names>TN</given-names></name><name><surname>Butterfield</surname> <given-names>LH</given-names></name><name><surname>Zelazowska</surname> <given-names>MA</given-names></name><name><surname>McBride</surname> <given-names>KM</given-names></name><name><surname>Kalluri</surname> <given-names>R</given-names></name><name><surname>Allison</surname> <given-names>J</given-names></name><name><surname>Petitprez</surname> <given-names>F</given-names></name><name><surname>Fridman</surname> <given-names>WH</given-names></name><name><surname>Sautès-Fridman</surname> <given-names>C</given-names></name><name><surname>Hacohen</surname> <given-names>N</given-names></name><name><surname>Rezvani</surname> <given-names>K</given-names></name><name><surname>Sharma</surname> <given-names>P</given-names></name><name><surname>Tetzlaff</surname> <given-names>MT</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Wargo</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>B cells and tertiary lymphoid structures promote immunotherapy response</article-title><source>Nature</source><volume>577</volume><fpage>549</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1922-8</pub-id><pub-id pub-id-type="pmid">31942075</pub-id></element-citation></ref><ref id="bib248"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heng</surname> <given-names>TS</given-names></name><name><surname>Painter</surname> <given-names>MW</given-names></name><collab>Immunological Genome Project Consortium</collab></person-group><year iso-8601-date="2008">2008</year><article-title>The immunological genome project: networks of gene expression in immune cells</article-title><source>Nature Immunology</source><volume>9</volume><fpage>1091</fpage><lpage>1094</lpage><pub-id pub-id-type="doi">10.1038/ni1008-1091</pub-id><pub-id pub-id-type="pmid">18800157</pub-id></element-citation></ref><ref id="bib249"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henning</surname> <given-names>AN</given-names></name><name><surname>Roychoudhuri</surname> <given-names>R</given-names></name><name><surname>Restifo</surname> <given-names>NP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Epigenetic control of CD8<sup>+</sup> T cell differentiation</article-title><source>Nature Reviews Immunology</source><volume>18</volume><fpage>340</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1038/nri.2017.146</pub-id><pub-id pub-id-type="pmid">29379213</pub-id></element-citation></ref><ref id="bib250"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herbst</surname> <given-names>RS</given-names></name><name><surname>Soria</surname> <given-names>JC</given-names></name><name><surname>Kowanetz</surname> <given-names>M</given-names></name><name><surname>Fine</surname> <given-names>GD</given-names></name><name><surname>Hamid</surname> <given-names>O</given-names></name><name><surname>Gordon</surname> <given-names>MS</given-names></name><name><surname>Sosman</surname> <given-names>JA</given-names></name><name><surname>McDermott</surname> <given-names>DF</given-names></name><name><surname>Powderly</surname> <given-names>JD</given-names></name><name><surname>Gettinger</surname> <given-names>SN</given-names></name><name><surname>Kohrt</surname> <given-names>HE</given-names></name><name><surname>Horn</surname> <given-names>L</given-names></name><name><surname>Lawrence</surname> <given-names>DP</given-names></name><name><surname>Rost</surname> <given-names>S</given-names></name><name><surname>Leabman</surname> <given-names>M</given-names></name><name><surname>Xiao</surname> <given-names>Y</given-names></name><name><surname>Mokatrin</surname> <given-names>A</given-names></name><name><surname>Koeppen</surname> <given-names>H</given-names></name><name><surname>Hegde</surname> <given-names>PS</given-names></name><name><surname>Mellman</surname> <given-names>I</given-names></name><name><surname>Chen</surname> <given-names>DS</given-names></name><name><surname>Hodi</surname> <given-names>FS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients</article-title><source>Nature</source><volume>515</volume><fpage>563</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1038/nature14011</pub-id><pub-id pub-id-type="pmid">25428504</pub-id></element-citation></ref><ref id="bib251"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewitt</surname> <given-names>SL</given-names></name><name><surname>Farmer</surname> <given-names>D</given-names></name><name><surname>Marszalek</surname> <given-names>K</given-names></name><name><surname>Cadera</surname> <given-names>E</given-names></name><name><surname>Liang</surname> <given-names>HE</given-names></name><name><surname>Xu</surname> <given-names>Y</given-names></name><name><surname>Schlissel</surname> <given-names>MS</given-names></name><name><surname>Skok</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Association between the Igk and Igh immunoglobulin loci mediated by the 3' Igk enhancer induces 'decontraction' of the Igh locus in pre-B cells</article-title><source>Nature Immunology</source><volume>9</volume><fpage>396</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1038/ni1567</pub-id><pub-id pub-id-type="pmid">18297074</pub-id></element-citation></ref><ref id="bib252"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hildner</surname> <given-names>K</given-names></name><name><surname>Edelson</surname> <given-names>BT</given-names></name><name><surname>Purtha</surname> <given-names>WE</given-names></name><name><surname>Diamond</surname> <given-names>M</given-names></name><name><surname>Matsushita</surname> <given-names>H</given-names></name><name><surname>Kohyama</surname> <given-names>M</given-names></name><name><surname>Calderon</surname> <given-names>B</given-names></name><name><surname>Schraml</surname> <given-names>BU</given-names></name><name><surname>Unanue</surname> <given-names>ER</given-names></name><name><surname>Diamond</surname> <given-names>MS</given-names></name><name><surname>Schreiber</surname> <given-names>RD</given-names></name><name><surname>Murphy</surname> <given-names>TL</given-names></name><name><surname>Murphy</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity</article-title><source>Science</source><volume>322</volume><fpage>1097</fpage><lpage>1100</lpage><pub-id pub-id-type="doi">10.1126/science.1164206</pub-id><pub-id pub-id-type="pmid">19008445</pub-id></element-citation></ref><ref id="bib253"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodi</surname> <given-names>FS</given-names></name><name><surname>O'Day</surname> <given-names>SJ</given-names></name><name><surname>McDermott</surname> <given-names>DF</given-names></name><name><surname>Weber</surname> <given-names>RW</given-names></name><name><surname>Sosman</surname> <given-names>JA</given-names></name><name><surname>Haanen</surname> <given-names>JB</given-names></name><name><surname>Gonzalez</surname> <given-names>R</given-names></name><name><surname>Robert</surname> <given-names>C</given-names></name><name><surname>Schadendorf</surname> <given-names>D</given-names></name><name><surname>Hassel</surname> <given-names>JC</given-names></name><name><surname>Akerley</surname> <given-names>W</given-names></name><name><surname>van den Eertwegh</surname> <given-names>AJ</given-names></name><name><surname>Lutzky</surname> <given-names>J</given-names></name><name><surname>Lorigan</surname> <given-names>P</given-names></name><name><surname>Vaubel</surname> <given-names>JM</given-names></name><name><surname>Linette</surname> <given-names>GP</given-names></name><name><surname>Hogg</surname> <given-names>D</given-names></name><name><surname>Ottensmeier</surname> <given-names>CH</given-names></name><name><surname>Lebbé</surname> <given-names>C</given-names></name><name><surname>Peschel</surname> <given-names>C</given-names></name><name><surname>Quirt</surname> <given-names>I</given-names></name><name><surname>Clark</surname> <given-names>JI</given-names></name><name><surname>Wolchok</surname> <given-names>JD</given-names></name><name><surname>Weber</surname> <given-names>JS</given-names></name><name><surname>Tian</surname> <given-names>J</given-names></name><name><surname>Yellin</surname> <given-names>MJ</given-names></name><name><surname>Nichol</surname> <given-names>GM</given-names></name><name><surname>Hoos</surname> <given-names>A</given-names></name><name><surname>Urba</surname> <given-names>WJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Improved survival with ipilimumab in patients with metastatic melanoma</article-title><source>New England Journal of Medicine</source><volume>363</volume><fpage>711</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1003466</pub-id><pub-id pub-id-type="pmid">20525992</pub-id></element-citation></ref><ref id="bib254"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holcombe</surname> <given-names>M</given-names></name><name><surname>Adra</surname> <given-names>S</given-names></name><name><surname>Bicak</surname> <given-names>M</given-names></name><name><surname>Chin</surname> <given-names>S</given-names></name><name><surname>Coakley</surname> <given-names>S</given-names></name><name><surname>Graham</surname> <given-names>AI</given-names></name><name><surname>Green</surname> <given-names>J</given-names></name><name><surname>Greenough</surname> <given-names>C</given-names></name><name><surname>Jackson</surname> <given-names>D</given-names></name><name><surname>Kiran</surname> <given-names>M</given-names></name><name><surname>MacNeil</surname> <given-names>S</given-names></name><name><surname>Maleki-Dizaji</surname> <given-names>A</given-names></name><name><surname>McMinn</surname> <given-names>P</given-names></name><name><surname>Pogson</surname> <given-names>M</given-names></name><name><surname>Poole</surname> <given-names>R</given-names></name><name><surname>Qwarnstrom</surname> <given-names>E</given-names></name><name><surname>Ratnieks</surname> <given-names>F</given-names></name><name><surname>Rolfe</surname> <given-names>MD</given-names></name><name><surname>Smallwood</surname> <given-names>R</given-names></name><name><surname>Sun</surname> <given-names>T</given-names></name><name><surname>Worth</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Modelling complex biological systems using an agent-based approach</article-title><source>Integr. Biol.</source><volume>4</volume><fpage>53</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1039/C1IB00042J</pub-id></element-citation></ref><ref id="bib255"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollern</surname> <given-names>DP</given-names></name><name><surname>Xu</surname> <given-names>N</given-names></name><name><surname>Thennavan</surname> <given-names>A</given-names></name><name><surname>Glodowski</surname> <given-names>C</given-names></name><name><surname>Garcia-Recio</surname> <given-names>S</given-names></name><name><surname>Mott</surname> <given-names>KR</given-names></name><name><surname>He</surname> <given-names>X</given-names></name><name><surname>Garay</surname> <given-names>JP</given-names></name><name><surname>Carey-Ewend</surname> <given-names>K</given-names></name><name><surname>Marron</surname> <given-names>D</given-names></name><name><surname>Ford</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>S</given-names></name><name><surname>Vick</surname> <given-names>SC</given-names></name><name><surname>Martin</surname> <given-names>M</given-names></name><name><surname>Parker</surname> <given-names>JS</given-names></name><name><surname>Vincent</surname> <given-names>BG</given-names></name><name><surname>Serody</surname> <given-names>JS</given-names></name><name><surname>Perou</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast Cancer</article-title><source>Cell</source><volume>179</volume><fpage>1191</fpage><lpage>1206</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.10.028</pub-id><pub-id pub-id-type="pmid">31730857</pub-id></element-citation></ref><ref id="bib256"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname> <given-names>E</given-names></name><name><surname>Wilson</surname> <given-names>ID</given-names></name><name><surname>Nicholson</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Metabolic phenotyping in health and disease</article-title><source>Cell</source><volume>134</volume><fpage>714</fpage><lpage>717</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.08.026</pub-id><pub-id pub-id-type="pmid">18775301</pub-id></element-citation></ref><ref id="bib257"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honda</surname> <given-names>K</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Microbiota in adaptive immune homeostasis and disease</article-title><source>Nature</source><volume>535</volume><fpage>75</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1038/nature18848</pub-id><pub-id pub-id-type="pmid">27383982</pub-id></element-citation></ref><ref id="bib258"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hood</surname> <given-names>L</given-names></name><name><surname>Heath</surname> <given-names>JR</given-names></name><name><surname>Phelps</surname> <given-names>ME</given-names></name><name><surname>Lin</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Systems biology and new technologies enable predictive and preventative medicine</article-title><source>Science</source><volume>306</volume><fpage>640</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1126/science.1104635</pub-id><pub-id pub-id-type="pmid">15499008</pub-id></element-citation></ref><ref id="bib259"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horowitz</surname> <given-names>A</given-names></name><name><surname>Strauss-Albee</surname> <given-names>DM</given-names></name><name><surname>Leipold</surname> <given-names>M</given-names></name><name><surname>Kubo</surname> <given-names>J</given-names></name><name><surname>Nemat-Gorgani</surname> <given-names>N</given-names></name><name><surname>Dogan</surname> <given-names>OC</given-names></name><name><surname>Dekker</surname> <given-names>CL</given-names></name><name><surname>Mackey</surname> <given-names>S</given-names></name><name><surname>Maecker</surname> <given-names>H</given-names></name><name><surname>Swan</surname> <given-names>GE</given-names></name><name><surname>Davis</surname> <given-names>MM</given-names></name><name><surname>Norman</surname> <given-names>PJ</given-names></name><name><surname>Guethlein</surname> <given-names>LA</given-names></name><name><surname>Desai</surname> <given-names>M</given-names></name><name><surname>Parham</surname> <given-names>P</given-names></name><name><surname>Blish</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry</article-title><source>Science Translational Medicine</source><volume>5</volume><elocation-id>208ra145</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3006702</pub-id><pub-id pub-id-type="pmid">24154599</pub-id></element-citation></ref><ref id="bib260"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hozumi</surname> <given-names>N</given-names></name><name><surname>Tonegawa</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1976">1976</year><article-title>Evidence for somatic rearrangement of immunoglobulin genes coding for variable and constant regions</article-title><source>PNAS</source><volume>73</volume><fpage>3628</fpage><lpage>3632</lpage><pub-id pub-id-type="doi">10.1073/pnas.73.10.3628</pub-id><pub-id pub-id-type="pmid">824647</pub-id></element-citation></ref><ref id="bib261"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname> <given-names>J</given-names></name><name><surname>Hodgins</surname> <given-names>JJ</given-names></name><name><surname>Marathe</surname> <given-names>M</given-names></name><name><surname>Nicolai</surname> <given-names>CJ</given-names></name><name><surname>Bourgeois-Daigneault</surname> <given-names>MC</given-names></name><name><surname>Trevino</surname> <given-names>TN</given-names></name><name><surname>Azimi</surname> <given-names>CS</given-names></name><name><surname>Scheer</surname> <given-names>AK</given-names></name><name><surname>Randolph</surname> <given-names>HE</given-names></name><name><surname>Thompson</surname> <given-names>TW</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Iannello</surname> <given-names>A</given-names></name><name><surname>Mathur</surname> <given-names>N</given-names></name><name><surname>Jardine</surname> <given-names>KE</given-names></name><name><surname>Kirn</surname> <given-names>GA</given-names></name><name><surname>Bell</surname> <given-names>JC</given-names></name><name><surname>McBurney</surname> <given-names>MW</given-names></name><name><surname>Raulet</surname> <given-names>DH</given-names></name><name><surname>Ardolino</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade</article-title><source>Journal of Clinical Investigation</source><volume>128</volume><fpage>4654</fpage><lpage>4668</lpage><pub-id pub-id-type="doi">10.1172/JCI99317</pub-id><pub-id pub-id-type="pmid">30198904</pub-id></element-citation></ref><ref id="bib262"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>P</given-names></name><name><surname>Fabyanic</surname> <given-names>E</given-names></name><name><surname>Kwon</surname> <given-names>DY</given-names></name><name><surname>Tang</surname> <given-names>S</given-names></name><name><surname>Zhou</surname> <given-names>Z</given-names></name><name><surname>Wu</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017a</year><article-title>Dissecting Cell-Type composition and Activity-Dependent transcriptional state in mammalian brains by massively parallel Single-Nucleus RNA-Seq</article-title><source>Molecular Cell</source><volume>68</volume><fpage>1006</fpage><lpage>1015</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.11.017</pub-id><pub-id pub-id-type="pmid">29220646</pub-id></element-citation></ref><ref id="bib263"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>Z</given-names></name><name><surname>Ott</surname> <given-names>PA</given-names></name><name><surname>Wu</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2017">2017b</year><article-title>Towards personalized, tumour-specific, therapeutic vaccines for Cancer</article-title><source>Nature Reviews Immunology</source><volume>18</volume><fpage>168</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1038/nri.2017.131</pub-id><pub-id pub-id-type="pmid">29226910</pub-id></element-citation></ref><ref id="bib264"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Fu</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>T</given-names></name><name><surname>Zheng</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>B</given-names></name><name><surname>Gu</surname> <given-names>S</given-names></name><name><surname>Jiang</surname> <given-names>P</given-names></name><name><surname>Fan</surname> <given-names>J</given-names></name><name><surname>Ying</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Carroll</surname> <given-names>MC</given-names></name><name><surname>Wucherpfennig</surname> <given-names>KW</given-names></name><name><surname>Hacohen</surname> <given-names>N</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name><name><surname>Zhang</surname> <given-names>P</given-names></name><name><surname>Liu</surname> <given-names>JS</given-names></name><name><surname>Li</surname> <given-names>B</given-names></name><name><surname>Liu</surname> <given-names>XS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Landscape of B cell immunity and related immune evasion in human cancers</article-title><source>Nature Genetics</source><volume>51</volume><fpage>560</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0339-x</pub-id><pub-id pub-id-type="pmid">30742113</pub-id></element-citation></ref><ref id="bib265"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>A</given-names></name><name><surname>Cheng</surname> <given-names>L</given-names></name><name><surname>He</surname> <given-names>M</given-names></name><name><surname>Nie</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Jiang</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Interleukin-35 on B cell and T cell induction and regulation</article-title><source>Journal of Inflammation</source><volume>14</volume><elocation-id>16</elocation-id><pub-id pub-id-type="doi">10.1186/s12950-017-0164-5</pub-id></element-citation></ref><ref id="bib266"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname> <given-names>JR</given-names></name><name><surname>Roberts</surname> <given-names>N</given-names></name><name><surname>McGowan</surname> <given-names>S</given-names></name><name><surname>Hay</surname> <given-names>D</given-names></name><name><surname>Giannoulatou</surname> <given-names>E</given-names></name><name><surname>Lynch</surname> <given-names>M</given-names></name><name><surname>De Gobbi</surname> <given-names>M</given-names></name><name><surname>Taylor</surname> <given-names>S</given-names></name><name><surname>Gibbons</surname> <given-names>R</given-names></name><name><surname>Higgs</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Analysis of hundreds of cis-regulatory landscapes at high resolution in a single, high-throughput experiment</article-title><source>Nature Genetics</source><volume>46</volume><fpage>205</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1038/ng.2871</pub-id><pub-id pub-id-type="pmid">24413732</pub-id></element-citation></ref><ref id="bib267"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hulett</surname> <given-names>HR</given-names></name><name><surname>Bonner</surname> <given-names>WA</given-names></name><name><surname>Barrett</surname> <given-names>J</given-names></name><name><surname>Herzenberg</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="1969">1969</year><article-title>Cell sorting: automated separation of mammalian cells as a function of intracellular fluorescence</article-title><source>Science</source><volume>166</volume><fpage>747</fpage><lpage>749</lpage><pub-id pub-id-type="doi">10.1126/science.166.3906.747</pub-id><pub-id pub-id-type="pmid">4898615</pub-id></element-citation></ref><ref id="bib268"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hundal</surname> <given-names>J</given-names></name><name><surname>Carreno</surname> <given-names>BM</given-names></name><name><surname>Petti</surname> <given-names>AA</given-names></name><name><surname>Linette</surname> <given-names>GP</given-names></name><name><surname>Griffith</surname> <given-names>OL</given-names></name><name><surname>Mardis</surname> <given-names>ER</given-names></name><name><surname>Griffith</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens</article-title><source>Genome Medicine</source><volume>8</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.1186/s13073-016-0264-5</pub-id></element-citation></ref><ref id="bib269"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ideker</surname> <given-names>T</given-names></name><name><surname>Galitski</surname> <given-names>T</given-names></name><name><surname>Hood</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A new approach to decoding life: systems biology</article-title><source>Annual Review of Genomics and Human Genetics</source><volume>2</volume><fpage>343</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1146/annurev.genom.2.1.343</pub-id><pub-id pub-id-type="pmid">11701654</pub-id></element-citation></ref><ref id="bib270"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ideker</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Integrated Genomic and Proteomic Analyses of a Systematically Perturbed Metabolic Network</article-title><source>Science</source><volume>292</volume><fpage>929</fpage><lpage>934</lpage><pub-id pub-id-type="doi">10.1126/science.292.5518.929</pub-id></element-citation></ref><ref id="bib271"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iida</surname> <given-names>N</given-names></name><name><surname>Dzutsev</surname> <given-names>A</given-names></name><name><surname>Stewart</surname> <given-names>CA</given-names></name><name><surname>Smith</surname> <given-names>L</given-names></name><name><surname>Bouladoux</surname> <given-names>N</given-names></name><name><surname>Weingarten</surname> <given-names>RA</given-names></name><name><surname>Molina</surname> <given-names>DA</given-names></name><name><surname>Salcedo</surname> <given-names>R</given-names></name><name><surname>Back</surname> <given-names>T</given-names></name><name><surname>Cramer</surname> <given-names>S</given-names></name><name><surname>Dai</surname> <given-names>RM</given-names></name><name><surname>Kiu</surname> <given-names>H</given-names></name><name><surname>Cardone</surname> <given-names>M</given-names></name><name><surname>Naik</surname> <given-names>S</given-names></name><name><surname>Patri</surname> <given-names>AK</given-names></name><name><surname>Wang</surname> <given-names>E</given-names></name><name><surname>Marincola</surname> <given-names>FM</given-names></name><name><surname>Frank</surname> <given-names>KM</given-names></name><name><surname>Belkaid</surname> <given-names>Y</given-names></name><name><surname>Trinchieri</surname> <given-names>G</given-names></name><name><surname>Goldszmid</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Commensal Bacteria control Cancer response to therapy by modulating the tumor microenvironment</article-title><source>Science</source><volume>342</volume><fpage>967</fpage><lpage>970</lpage><pub-id pub-id-type="doi">10.1126/science.1240527</pub-id><pub-id pub-id-type="pmid">24264989</pub-id></element-citation></ref><ref id="bib272"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Im</surname> <given-names>SJ</given-names></name><name><surname>Hashimoto</surname> <given-names>M</given-names></name><name><surname>Gerner</surname> <given-names>MY</given-names></name><name><surname>Lee</surname> <given-names>J</given-names></name><name><surname>Kissick</surname> <given-names>HT</given-names></name><name><surname>Burger</surname> <given-names>MC</given-names></name><name><surname>Shan</surname> <given-names>Q</given-names></name><name><surname>Hale</surname> <given-names>JS</given-names></name><name><surname>Lee</surname> <given-names>J</given-names></name><name><surname>Nasti</surname> <given-names>TH</given-names></name><name><surname>Sharpe</surname> <given-names>AH</given-names></name><name><surname>Freeman</surname> <given-names>GJ</given-names></name><name><surname>Germain</surname> <given-names>RN</given-names></name><name><surname>Nakaya</surname> <given-names>HI</given-names></name><name><surname>Xue</surname> <given-names>HH</given-names></name><name><surname>Ahmed</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy</article-title><source>Nature</source><volume>537</volume><fpage>417</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1038/nature19330</pub-id><pub-id pub-id-type="pmid">27501248</pub-id></element-citation></ref><ref id="bib273"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>International Human Genome Sequencing Consortium</collab></person-group><year iso-8601-date="2004">2004</year><article-title>Finishing the euchromatic sequence of the human genome</article-title><source>Nature</source><volume>431</volume><fpage>931</fpage><lpage>945</lpage><pub-id pub-id-type="doi">10.1038/nature03001</pub-id><pub-id pub-id-type="pmid">15496913</pub-id></element-citation></ref><ref id="bib274"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irish</surname> <given-names>JM</given-names></name><name><surname>Doxie</surname> <given-names>DB</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>High-dimensional single-cell cancer biology</article-title><source>Current Topics in Microbiology and Immunology</source><volume>377</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1007/82_2014_367</pub-id><pub-id pub-id-type="pmid">24671264</pub-id></element-citation></ref><ref id="bib275"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname> <given-names>S</given-names></name><name><surname>Kjällquist</surname> <given-names>U</given-names></name><name><surname>Moliner</surname> <given-names>A</given-names></name><name><surname>Zajac</surname> <given-names>P</given-names></name><name><surname>Fan</surname> <given-names>JB</given-names></name><name><surname>Lönnerberg</surname> <given-names>P</given-names></name><name><surname>Linnarsson</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Characterization of the single-cell transcriptional landscape by highly multiplex RNA-seq</article-title><source>Genome Research</source><volume>21</volume><fpage>1160</fpage><lpage>1167</lpage><pub-id pub-id-type="doi">10.1101/gr.110882.110</pub-id><pub-id pub-id-type="pmid">21543516</pub-id></element-citation></ref><ref id="bib276"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanov</surname> <given-names>II</given-names></name><name><surname>Atarashi</surname> <given-names>K</given-names></name><name><surname>Manel</surname> <given-names>N</given-names></name><name><surname>Brodie</surname> <given-names>EL</given-names></name><name><surname>Shima</surname> <given-names>T</given-names></name><name><surname>Karaoz</surname> <given-names>U</given-names></name><name><surname>Wei</surname> <given-names>D</given-names></name><name><surname>Goldfarb</surname> <given-names>KC</given-names></name><name><surname>Santee</surname> <given-names>CA</given-names></name><name><surname>Lynch</surname> <given-names>SV</given-names></name><name><surname>Tanoue</surname> <given-names>T</given-names></name><name><surname>Imaoka</surname> <given-names>A</given-names></name><name><surname>Itoh</surname> <given-names>K</given-names></name><name><surname>Takeda</surname> <given-names>K</given-names></name><name><surname>Umesaki</surname> <given-names>Y</given-names></name><name><surname>Honda</surname> <given-names>K</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Induction of intestinal Th17 cells by segmented filamentous Bacteria</article-title><source>Cell</source><volume>139</volume><fpage>485</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.09.033</pub-id><pub-id pub-id-type="pmid">19836068</pub-id></element-citation></ref><ref id="bib277"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobson</surname> <given-names>A</given-names></name><name><surname>Lam</surname> <given-names>L</given-names></name><name><surname>Rajendram</surname> <given-names>M</given-names></name><name><surname>Tamburini</surname> <given-names>F</given-names></name><name><surname>Honeycutt</surname> <given-names>J</given-names></name><name><surname>Pham</surname> <given-names>T</given-names></name><name><surname>Van Treuren</surname> <given-names>W</given-names></name><name><surname>Pruss</surname> <given-names>K</given-names></name><name><surname>Stabler</surname> <given-names>SR</given-names></name><name><surname>Lugo</surname> <given-names>K</given-names></name><name><surname>Bouley</surname> <given-names>DM</given-names></name><name><surname>Vilches-Moure</surname> <given-names>JG</given-names></name><name><surname>Smith</surname> <given-names>M</given-names></name><name><surname>Sonnenburg</surname> <given-names>JL</given-names></name><name><surname>Bhatt</surname> <given-names>AS</given-names></name><name><surname>Huang</surname> <given-names>KC</given-names></name><name><surname>Monack</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A gut Commensal-Produced metabolite mediates colonization resistance to Salmonella infection</article-title><source>Cell Host &amp; Microbe</source><volume>24</volume><fpage>296</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2018.07.002</pub-id><pub-id pub-id-type="pmid">30057174</pub-id></element-citation></ref><ref id="bib278"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacoby</surname> <given-names>MA</given-names></name><name><surname>Duncavage</surname> <given-names>EJ</given-names></name><name><surname>Walter</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Implications of tumor clonal heterogeneity in the Era of Next-Generation sequencing</article-title><source>Trends in Cancer</source><volume>1</volume><fpage>231</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1016/j.trecan.2015.10.006</pub-id><pub-id pub-id-type="pmid">28741514</pub-id></element-citation></ref><ref id="bib279"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaitin</surname> <given-names>DA</given-names></name><name><surname>Kenigsberg</surname> <given-names>E</given-names></name><name><surname>Keren-Shaul</surname> <given-names>H</given-names></name><name><surname>Elefant</surname> <given-names>N</given-names></name><name><surname>Paul</surname> <given-names>F</given-names></name><name><surname>Zaretsky</surname> <given-names>I</given-names></name><name><surname>Mildner</surname> <given-names>A</given-names></name><name><surname>Cohen</surname> <given-names>N</given-names></name><name><surname>Jung</surname> <given-names>S</given-names></name><name><surname>Tanay</surname> <given-names>A</given-names></name><name><surname>Amit</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types</article-title><source>Science</source><volume>343</volume><fpage>776</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1126/science.1247651</pub-id><pub-id pub-id-type="pmid">24531970</pub-id></element-citation></ref><ref id="bib280"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaitin</surname> <given-names>DA</given-names></name><name><surname>Weiner</surname> <given-names>A</given-names></name><name><surname>Yofe</surname> <given-names>I</given-names></name><name><surname>Lara-Astiaso</surname> <given-names>D</given-names></name><name><surname>Keren-Shaul</surname> <given-names>H</given-names></name><name><surname>David</surname> <given-names>E</given-names></name><name><surname>Salame</surname> <given-names>TM</given-names></name><name><surname>Tanay</surname> <given-names>A</given-names></name><name><surname>van Oudenaarden</surname> <given-names>A</given-names></name><name><surname>Amit</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dissecting immune circuits by linking CRISPR-Pooled screens with Single-Cell RNA-Seq</article-title><source>Cell</source><volume>167</volume><fpage>1883</fpage><lpage>1896</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.11.039</pub-id><pub-id pub-id-type="pmid">27984734</pub-id></element-citation></ref><ref id="bib281"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakubzick</surname> <given-names>C</given-names></name><name><surname>Gautier</surname> <given-names>EL</given-names></name><name><surname>Gibbings</surname> <given-names>SL</given-names></name><name><surname>Sojka</surname> <given-names>DK</given-names></name><name><surname>Schlitzer</surname> <given-names>A</given-names></name><name><surname>Johnson</surname> <given-names>TE</given-names></name><name><surname>Ivanov</surname> <given-names>S</given-names></name><name><surname>Duan</surname> <given-names>Q</given-names></name><name><surname>Bala</surname> <given-names>S</given-names></name><name><surname>Condon</surname> <given-names>T</given-names></name><name><surname>van Rooijen</surname> <given-names>N</given-names></name><name><surname>Grainger</surname> <given-names>JR</given-names></name><name><surname>Belkaid</surname> <given-names>Y</given-names></name><name><surname>Ma'ayan</surname> <given-names>A</given-names></name><name><surname>Riches</surname> <given-names>DW</given-names></name><name><surname>Yokoyama</surname> <given-names>WM</given-names></name><name><surname>Ginhoux</surname> <given-names>F</given-names></name><name><surname>Henson</surname> <given-names>PM</given-names></name><name><surname>Randolph</surname> <given-names>GJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes</article-title><source>Immunity</source><volume>39</volume><fpage>599</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2013.08.007</pub-id><pub-id pub-id-type="pmid">24012416</pub-id></element-citation></ref><ref id="bib282"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeon</surname> <given-names>J</given-names></name><name><surname>Quaranta</surname> <given-names>V</given-names></name><name><surname>Cummings</surname> <given-names>PT</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>An off-lattice hybrid discrete-continuum model of tumor growth and invasion</article-title><source>Biophysical Journal</source><volume>98</volume><fpage>37</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2009.10.002</pub-id><pub-id pub-id-type="pmid">20074513</pub-id></element-citation></ref><ref id="bib283"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>N</given-names></name><name><surname>Schonnesen</surname> <given-names>AA</given-names></name><name><surname>Ma</surname> <given-names>KY</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ushering in integrated T cell repertoire profiling in Cancer</article-title><source>Trends in Cancer</source><volume>5</volume><fpage>85</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.trecan.2018.11.005</pub-id><pub-id pub-id-type="pmid">30755308</pub-id></element-citation></ref><ref id="bib284"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiao</surname> <given-names>Y</given-names></name><name><surname>Torquato</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Emergent behaviors from a cellular automaton model for invasive tumor growth in heterogeneous microenvironments</article-title><source>PLOS Computational Biology</source><volume>7</volume><elocation-id>e1002314</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1002314</pub-id><pub-id pub-id-type="pmid">22215996</pub-id></element-citation></ref><ref id="bib285"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johanson</surname> <given-names>TM</given-names></name><name><surname>Coughlan</surname> <given-names>HD</given-names></name><name><surname>Lun</surname> <given-names>ATL</given-names></name><name><surname>Bediaga</surname> <given-names>NG</given-names></name><name><surname>Naselli</surname> <given-names>G</given-names></name><name><surname>Garnham</surname> <given-names>AL</given-names></name><name><surname>Harrison</surname> <given-names>LC</given-names></name><name><surname>Smyth</surname> <given-names>GK</given-names></name><name><surname>Allan</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genome-wide analysis reveals no evidence of trans chromosomal regulation of mammalian immune development</article-title><source>PLOS Genetics</source><volume>14</volume><elocation-id>e1007431</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007431</pub-id><pub-id pub-id-type="pmid">29883495</pub-id></element-citation></ref><ref id="bib286"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>DS</given-names></name><name><surname>Mortazavi</surname> <given-names>A</given-names></name><name><surname>Myers</surname> <given-names>RM</given-names></name><name><surname>Wold</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Genome-wide mapping of in vivo protein-DNA interactions</article-title><source>Science</source><volume>316</volume><fpage>1497</fpage><lpage>1502</lpage><pub-id pub-id-type="doi">10.1126/science.1141319</pub-id><pub-id pub-id-type="pmid">17540862</pub-id></element-citation></ref><ref id="bib287"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname> <given-names>GW</given-names></name><name><surname>Hill</surname> <given-names>DG</given-names></name><name><surname>Jones</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Understanding immune cells in tertiary lymphoid organ development: it is all starting to come together</article-title><source>Frontiers in Immunology</source><volume>7</volume><elocation-id>401</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2016.00401</pub-id><pub-id pub-id-type="pmid">27752256</pub-id></element-citation></ref><ref id="bib288"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname> <given-names>PA</given-names></name><name><surname>Takai</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The role of DNA methylation in mammalian epigenetics</article-title><source>Science</source><volume>293</volume><fpage>1068</fpage><lpage>1070</lpage><pub-id pub-id-type="doi">10.1126/science.1063852</pub-id><pub-id pub-id-type="pmid">11498573</pub-id></element-citation></ref><ref id="bib289"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname> <given-names>NS</given-names></name><name><surname>Akama-Garren</surname> <given-names>EH</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Lee</surname> <given-names>DY</given-names></name><name><surname>Chang</surname> <given-names>GP</given-names></name><name><surname>Li</surname> <given-names>A</given-names></name><name><surname>DuPage</surname> <given-names>M</given-names></name><name><surname>Tammela</surname> <given-names>T</given-names></name><name><surname>Kerper</surname> <given-names>NR</given-names></name><name><surname>Farago</surname> <given-names>AF</given-names></name><name><surname>Robbins</surname> <given-names>R</given-names></name><name><surname>Crowley</surname> <given-names>DM</given-names></name><name><surname>Bronson</surname> <given-names>RT</given-names></name><name><surname>Jacks</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Regulatory T cells in Tumor-Associated tertiary lymphoid structures suppress Anti-tumor T cell responses</article-title><source>Immunity</source><volume>43</volume><fpage>579</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.08.006</pub-id><pub-id pub-id-type="pmid">26341400</pub-id></element-citation></ref><ref id="bib290"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joyce</surname> <given-names>JA</given-names></name><name><surname>Pollard</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Microenvironmental regulation of metastasis</article-title><source>Nature Reviews Cancer</source><volume>9</volume><fpage>239</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1038/nrc2618</pub-id><pub-id pub-id-type="pmid">19279573</pub-id></element-citation></ref><ref id="bib291"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>June</surname> <given-names>CH</given-names></name><name><surname>O'Connor</surname> <given-names>RS</given-names></name><name><surname>Kawalekar</surname> <given-names>OU</given-names></name><name><surname>Ghassemi</surname> <given-names>S</given-names></name><name><surname>Milone</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>CAR T cell immunotherapy for human cancer</article-title><source>Science</source><volume>359</volume><fpage>1361</fpage><lpage>1365</lpage><pub-id pub-id-type="doi">10.1126/science.aar6711</pub-id><pub-id pub-id-type="pmid">29567707</pub-id></element-citation></ref><ref id="bib292"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname> <given-names>K</given-names></name><name><surname>Heishi</surname> <given-names>T</given-names></name><name><surname>Khan</surname> <given-names>OF</given-names></name><name><surname>Kowalski</surname> <given-names>PS</given-names></name><name><surname>Incio</surname> <given-names>J</given-names></name><name><surname>Rahbari</surname> <given-names>NN</given-names></name><name><surname>Chung</surname> <given-names>E</given-names></name><name><surname>Clark</surname> <given-names>JW</given-names></name><name><surname>Willett</surname> <given-names>CG</given-names></name><name><surname>Luster</surname> <given-names>AD</given-names></name><name><surname>Yun</surname> <given-names>SH</given-names></name><name><surname>Langer</surname> <given-names>R</given-names></name><name><surname>Anderson</surname> <given-names>DG</given-names></name><name><surname>Padera</surname> <given-names>TP</given-names></name><name><surname>Jain</surname> <given-names>RK</given-names></name><name><surname>Fukumura</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy</article-title><source>Journal of Clinical Investigation</source><volume>127</volume><fpage>3039</fpage><lpage>3051</lpage><pub-id pub-id-type="doi">10.1172/JCI93182</pub-id><pub-id pub-id-type="pmid">28691930</pub-id></element-citation></ref><ref id="bib293"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlhofer</surname> <given-names>FM</given-names></name><name><surname>Ribaudo</surname> <given-names>RK</given-names></name><name><surname>Yokoyama</surname> <given-names>WM</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells</article-title><source>Nature</source><volume>358</volume><fpage>66</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1038/358066a0</pub-id><pub-id pub-id-type="pmid">1614533</pub-id></element-citation></ref><ref id="bib294"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katoh</surname> <given-names>H</given-names></name><name><surname>Komura</surname> <given-names>D</given-names></name><name><surname>Konishi</surname> <given-names>H</given-names></name><name><surname>Suzuki</surname> <given-names>R</given-names></name><name><surname>Yamamoto</surname> <given-names>A</given-names></name><name><surname>Kakiuchi</surname> <given-names>M</given-names></name><name><surname>Sato</surname> <given-names>R</given-names></name><name><surname>Ushiku</surname> <given-names>T</given-names></name><name><surname>Yamamoto</surname> <given-names>S</given-names></name><name><surname>Tatsuno</surname> <given-names>K</given-names></name><name><surname>Oshima</surname> <given-names>T</given-names></name><name><surname>Nomura</surname> <given-names>S</given-names></name><name><surname>Seto</surname> <given-names>Y</given-names></name><name><surname>Fukayama</surname> <given-names>M</given-names></name><name><surname>Aburatani</surname> <given-names>H</given-names></name><name><surname>Ishikawa</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Immunogenetic profiling for gastric cancers identifies sulfated glycosaminoglycans as major and functional B cell antigens in human malignancies</article-title><source>Cell Reports</source><volume>20</volume><fpage>1073</fpage><lpage>1087</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.07.016</pub-id><pub-id pub-id-type="pmid">28768193</pub-id></element-citation></ref><ref id="bib295"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufman</surname> <given-names>M</given-names></name><name><surname>Urbain</surname> <given-names>J</given-names></name><name><surname>Thomas</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Towards a logical analysis of the immune response</article-title><source>Journal of Theoretical Biology</source><volume>114</volume><fpage>527</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1016/S0022-5193(85)80042-4</pub-id><pub-id pub-id-type="pmid">3875000</pub-id></element-citation></ref><ref id="bib296"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ke</surname> <given-names>R</given-names></name><name><surname>Mignardi</surname> <given-names>M</given-names></name><name><surname>Pacureanu</surname> <given-names>A</given-names></name><name><surname>Svedlund</surname> <given-names>J</given-names></name><name><surname>Botling</surname> <given-names>J</given-names></name><name><surname>Wählby</surname> <given-names>C</given-names></name><name><surname>Nilsson</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>In situ sequencing for RNA analysis in preserved tissue and cells</article-title><source>Nature Methods</source><volume>10</volume><fpage>857</fpage><lpage>860</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2563</pub-id><pub-id pub-id-type="pmid">23852452</pub-id></element-citation></ref><ref id="bib297"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kenkel</surname> <given-names>JA</given-names></name><name><surname>Tseng</surname> <given-names>WW</given-names></name><name><surname>Davidson</surname> <given-names>MG</given-names></name><name><surname>Tolentino</surname> <given-names>LL</given-names></name><name><surname>Choi</surname> <given-names>O</given-names></name><name><surname>Bhattacharya</surname> <given-names>N</given-names></name><name><surname>Seeley</surname> <given-names>ES</given-names></name><name><surname>Winer</surname> <given-names>DA</given-names></name><name><surname>Reticker-Flynn</surname> <given-names>NE</given-names></name><name><surname>Engleman</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>An immunosuppressive dendritic cell subset accumulates at secondary sites and promotes metastasis in pancreatic Cancer</article-title><source>Cancer Research</source><volume>77</volume><fpage>4158</fpage><lpage>4170</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-16-2212</pub-id><pub-id pub-id-type="pmid">28611041</pub-id></element-citation></ref><ref id="bib298"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keren</surname> <given-names>L</given-names></name><name><surname>Bosse</surname> <given-names>M</given-names></name><name><surname>Marquez</surname> <given-names>D</given-names></name><name><surname>Angoshtari</surname> <given-names>R</given-names></name><name><surname>Jain</surname> <given-names>S</given-names></name><name><surname>Varma</surname> <given-names>S</given-names></name><name><surname>Yang</surname> <given-names>SR</given-names></name><name><surname>Kurian</surname> <given-names>A</given-names></name><name><surname>Van Valen</surname> <given-names>D</given-names></name><name><surname>West</surname> <given-names>R</given-names></name><name><surname>Bendall</surname> <given-names>SC</given-names></name><name><surname>Angelo</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A structured Tumor-Immune microenvironment in triple negative breast Cancer revealed by multiplexed ion beam imaging</article-title><source>Cell</source><volume>174</volume><fpage>1373</fpage><lpage>1387</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.08.039</pub-id><pub-id pub-id-type="pmid">30193111</pub-id></element-citation></ref><ref id="bib299"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keskin</surname> <given-names>DB</given-names></name><name><surname>Anandappa</surname> <given-names>AJ</given-names></name><name><surname>Sun</surname> <given-names>J</given-names></name><name><surname>Tirosh</surname> <given-names>I</given-names></name><name><surname>Mathewson</surname> <given-names>ND</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>Oliveira</surname> <given-names>G</given-names></name><name><surname>Giobbie-Hurder</surname> <given-names>A</given-names></name><name><surname>Felt</surname> <given-names>K</given-names></name><name><surname>Gjini</surname> <given-names>E</given-names></name><name><surname>Shukla</surname> <given-names>SA</given-names></name><name><surname>Hu</surname> <given-names>Z</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Le</surname> <given-names>PM</given-names></name><name><surname>Allesøe</surname> <given-names>RL</given-names></name><name><surname>Richman</surname> <given-names>AR</given-names></name><name><surname>Kowalczyk</surname> <given-names>MS</given-names></name><name><surname>Abdelrahman</surname> <given-names>S</given-names></name><name><surname>Geduldig</surname> <given-names>JE</given-names></name><name><surname>Charbonneau</surname> <given-names>S</given-names></name><name><surname>Pelton</surname> <given-names>K</given-names></name><name><surname>Iorgulescu</surname> <given-names>JB</given-names></name><name><surname>Elagina</surname> <given-names>L</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Olive</surname> <given-names>O</given-names></name><name><surname>McCluskey</surname> <given-names>C</given-names></name><name><surname>Olsen</surname> <given-names>LR</given-names></name><name><surname>Stevens</surname> <given-names>J</given-names></name><name><surname>Lane</surname> <given-names>WJ</given-names></name><name><surname>Salazar</surname> <given-names>AM</given-names></name><name><surname>Daley</surname> <given-names>H</given-names></name><name><surname>Wen</surname> <given-names>PY</given-names></name><name><surname>Chiocca</surname> <given-names>EA</given-names></name><name><surname>Harden</surname> <given-names>M</given-names></name><name><surname>Lennon</surname> <given-names>NJ</given-names></name><name><surname>Gabriel</surname> <given-names>S</given-names></name><name><surname>Getz</surname> <given-names>G</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name><name><surname>Ritz</surname> <given-names>J</given-names></name><name><surname>Neuberg</surname> <given-names>D</given-names></name><name><surname>Rodig</surname> <given-names>SJ</given-names></name><name><surname>Ligon</surname> <given-names>KL</given-names></name><name><surname>Suvà</surname> <given-names>ML</given-names></name><name><surname>Wucherpfennig</surname> <given-names>KW</given-names></name><name><surname>Hacohen</surname> <given-names>N</given-names></name><name><surname>Fritsch</surname> <given-names>EF</given-names></name><name><surname>Livak</surname> <given-names>KJ</given-names></name><name><surname>Ott</surname> <given-names>PA</given-names></name><name><surname>Wu</surname> <given-names>CJ</given-names></name><name><surname>Reardon</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Neoantigen vaccine generates intratumoral T cell responses in phase ib glioblastoma trial</article-title><source>Nature</source><volume>565</volume><fpage>234</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0792-9</pub-id></element-citation></ref><ref id="bib300"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khain</surname> <given-names>E</given-names></name><name><surname>Sander</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Dynamics and pattern formation in invasive tumor growth</article-title><source>Physical Review Letters</source><volume>96</volume><elocation-id>188103</elocation-id><pub-id pub-id-type="doi">10.1103/PhysRevLett.96.188103</pub-id><pub-id pub-id-type="pmid">16712401</pub-id></element-citation></ref><ref id="bib301"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname> <given-names>AR</given-names></name><name><surname>Hams</surname> <given-names>E</given-names></name><name><surname>Floudas</surname> <given-names>A</given-names></name><name><surname>Sparwasser</surname> <given-names>T</given-names></name><name><surname>Weaver</surname> <given-names>CT</given-names></name><name><surname>Fallon</surname> <given-names>PG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>PD-L1hi B cells are critical regulators of humoral immunity</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>5997</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms6997</pub-id><pub-id pub-id-type="pmid">25609381</pub-id></element-citation></ref><ref id="bib302"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname> <given-names>O</given-names></name><name><surname>Giles</surname> <given-names>JR</given-names></name><name><surname>McDonald</surname> <given-names>S</given-names></name><name><surname>Manne</surname> <given-names>S</given-names></name><name><surname>Ngiow</surname> <given-names>SF</given-names></name><name><surname>Patel</surname> <given-names>KP</given-names></name><name><surname>Werner</surname> <given-names>MT</given-names></name><name><surname>Huang</surname> <given-names>AC</given-names></name><name><surname>Alexander</surname> <given-names>KA</given-names></name><name><surname>Wu</surname> <given-names>JE</given-names></name><name><surname>Attanasio</surname> <given-names>J</given-names></name><name><surname>Yan</surname> <given-names>P</given-names></name><name><surname>George</surname> <given-names>SM</given-names></name><name><surname>Bengsch</surname> <given-names>B</given-names></name><name><surname>Staupe</surname> <given-names>RP</given-names></name><name><surname>Donahue</surname> <given-names>G</given-names></name><name><surname>Xu</surname> <given-names>W</given-names></name><name><surname>Amaravadi</surname> <given-names>RK</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Karakousis</surname> <given-names>GC</given-names></name><name><surname>Mitchell</surname> <given-names>TC</given-names></name><name><surname>Schuchter</surname> <given-names>LM</given-names></name><name><surname>Kaye</surname> <given-names>J</given-names></name><name><surname>Berger</surname> <given-names>SL</given-names></name><name><surname>Wherry</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>TOX transcriptionally and epigenetically programs CD8<sup>+</sup> T cell exhaustion</article-title><source>Nature</source><volume>571</volume><fpage>211</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1325-x</pub-id><pub-id pub-id-type="pmid">31207603</pub-id></element-citation></ref><ref id="bib303"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>KT</given-names></name><name><surname>Lee</surname> <given-names>HW</given-names></name><name><surname>Lee</surname> <given-names>HO</given-names></name><name><surname>Song</surname> <given-names>HJ</given-names></name><name><surname>Jeong</surname> <given-names>daE</given-names></name><name><surname>Shin</surname> <given-names>S</given-names></name><name><surname>Kim</surname> <given-names>H</given-names></name><name><surname>Shin</surname> <given-names>Y</given-names></name><name><surname>Nam</surname> <given-names>DH</given-names></name><name><surname>Jeong</surname> <given-names>BC</given-names></name><name><surname>Kirsch</surname> <given-names>DG</given-names></name><name><surname>Joo</surname> <given-names>KM</given-names></name><name><surname>Park</surname> <given-names>WY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Application of single-cell RNA sequencing in optimizing a combinatorial therapeutic strategy in metastatic renal cell carcinoma</article-title><source>Genome Biology</source><volume>17</volume><elocation-id>80</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-016-0945-9</pub-id><pub-id pub-id-type="pmid">27139883</pub-id></element-citation></ref><ref id="bib304"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>N</given-names></name><name><surname>Kim</surname> <given-names>HK</given-names></name><name><surname>Lee</surname> <given-names>K</given-names></name><name><surname>Hong</surname> <given-names>Y</given-names></name><name><surname>Cho</surname> <given-names>JH</given-names></name><name><surname>Choi</surname> <given-names>JW</given-names></name><name><surname>Lee</surname> <given-names>JI</given-names></name><name><surname>Suh</surname> <given-names>YL</given-names></name><name><surname>Ku</surname> <given-names>BM</given-names></name><name><surname>Eum</surname> <given-names>HH</given-names></name><name><surname>Choi</surname> <given-names>S</given-names></name><name><surname>Choi</surname> <given-names>YL</given-names></name><name><surname>Joung</surname> <given-names>JG</given-names></name><name><surname>Park</surname> <given-names>WY</given-names></name><name><surname>Jung</surname> <given-names>HA</given-names></name><name><surname>Sun</surname> <given-names>JM</given-names></name><name><surname>Lee</surname> <given-names>SH</given-names></name><name><surname>Ahn</surname> <given-names>JS</given-names></name><name><surname>Park</surname> <given-names>K</given-names></name><name><surname>Ahn</surname> <given-names>MJ</given-names></name><name><surname>Lee</surname> <given-names>HO</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>2285</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-16164-1</pub-id><pub-id pub-id-type="pmid">32385277</pub-id></element-citation></ref><ref id="bib305"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiselev</surname> <given-names>VY</given-names></name><name><surname>Kirschner</surname> <given-names>K</given-names></name><name><surname>Schaub</surname> <given-names>MT</given-names></name><name><surname>Andrews</surname> <given-names>T</given-names></name><name><surname>Yiu</surname> <given-names>A</given-names></name><name><surname>Chandra</surname> <given-names>T</given-names></name><name><surname>Natarajan</surname> <given-names>KN</given-names></name><name><surname>Reik</surname> <given-names>W</given-names></name><name><surname>Barahona</surname> <given-names>M</given-names></name><name><surname>Green</surname> <given-names>AR</given-names></name><name><surname>Hemberg</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>SC3: consensus clustering of single-cell RNA-seq data</article-title><source>Nature Methods</source><volume>14</volume><fpage>483</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4236</pub-id><pub-id pub-id-type="pmid">28346451</pub-id></element-citation></ref><ref id="bib306"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitamura</surname> <given-names>T</given-names></name><name><surname>Qian</surname> <given-names>BZ</given-names></name><name><surname>Pollard</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Immune cell promotion of metastasis</article-title><source>Nature Reviews Immunology</source><volume>15</volume><fpage>73</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1038/nri3789</pub-id><pub-id pub-id-type="pmid">25614318</pub-id></element-citation></ref><ref id="bib307"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitano</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Systems biology: a brief overview</article-title><source>Science</source><volume>295</volume><fpage>1662</fpage><lpage>1664</lpage><pub-id pub-id-type="doi">10.1126/science.1069492</pub-id><pub-id pub-id-type="pmid">11872829</pub-id></element-citation></ref><ref id="bib308"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname> <given-names>AM</given-names></name><name><surname>Mazutis</surname> <given-names>L</given-names></name><name><surname>Akartuna</surname> <given-names>I</given-names></name><name><surname>Tallapragada</surname> <given-names>N</given-names></name><name><surname>Veres</surname> <given-names>A</given-names></name><name><surname>Li</surname> <given-names>V</given-names></name><name><surname>Peshkin</surname> <given-names>L</given-names></name><name><surname>Weitz</surname> <given-names>DA</given-names></name><name><surname>Kirschner</surname> <given-names>MW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells</article-title><source>Cell</source><volume>161</volume><fpage>1187</fpage><lpage>1201</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.04.044</pub-id><pub-id pub-id-type="pmid">26000487</pub-id></element-citation></ref><ref id="bib309"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Petri nets in systems biology</article-title><source>Software &amp; Systems Modeling</source><volume>14</volume><fpage>703</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1007/s10270-014-0421-5</pub-id></element-citation></ref><ref id="bib310"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kompauer</surname> <given-names>M</given-names></name><name><surname>Heiles</surname> <given-names>S</given-names></name><name><surname>Spengler</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Atmospheric pressure MALDI mass spectrometry imaging of tissues and cells at 1.4-μm lateral resolution</article-title><source>Nature Methods</source><volume>14</volume><fpage>90</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4071</pub-id><pub-id pub-id-type="pmid">27842060</pub-id></element-citation></ref><ref id="bib311"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konermann</surname> <given-names>S</given-names></name><name><surname>Brigham</surname> <given-names>MD</given-names></name><name><surname>Trevino</surname> <given-names>AE</given-names></name><name><surname>Joung</surname> <given-names>J</given-names></name><name><surname>Abudayyeh</surname> <given-names>OO</given-names></name><name><surname>Barcena</surname> <given-names>C</given-names></name><name><surname>Hsu</surname> <given-names>PD</given-names></name><name><surname>Habib</surname> <given-names>N</given-names></name><name><surname>Gootenberg</surname> <given-names>JS</given-names></name><name><surname>Nishimasu</surname> <given-names>H</given-names></name><name><surname>Nureki</surname> <given-names>O</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex</article-title><source>Nature</source><volume>517</volume><fpage>583</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1038/nature14136</pub-id><pub-id pub-id-type="pmid">25494202</pub-id></element-citation></ref><ref id="bib312"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koonin</surname> <given-names>EV</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Comparative genomics, minimal gene-sets and the last universal common ancestor</article-title><source>Nature Reviews Microbiology</source><volume>1</volume><fpage>127</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1038/nrmicro751</pub-id><pub-id pub-id-type="pmid">15035042</pub-id></element-citation></ref><ref id="bib313"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koonin</surname> <given-names>EV</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Orthologs, paralogs, and evolutionary genomics</article-title><source>Annual Review of Genetics</source><volume>39</volume><fpage>309</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1146/annurev.genet.39.073003.114725</pub-id><pub-id pub-id-type="pmid">16285863</pub-id></element-citation></ref><ref id="bib314"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korsunsky</surname> <given-names>I</given-names></name><name><surname>McGovern</surname> <given-names>K</given-names></name><name><surname>LaGatta</surname> <given-names>T</given-names></name><name><surname>Olde Loohuis</surname> <given-names>L</given-names></name><name><surname>Grosso-Applewhite</surname> <given-names>T</given-names></name><name><surname>Griffeth</surname> <given-names>N</given-names></name><name><surname>Mishra</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Systems biology of Cancer: a challenging expedition for clinical and quantitative biologists</article-title><source>Frontiers in Bioengineering and Biotechnology</source><volume>2</volume><elocation-id>27</elocation-id><pub-id pub-id-type="doi">10.3389/fbioe.2014.00027</pub-id><pub-id pub-id-type="pmid">25191654</pub-id></element-citation></ref><ref id="bib315"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kratochvill</surname> <given-names>F</given-names></name><name><surname>Neale</surname> <given-names>G</given-names></name><name><surname>Haverkamp</surname> <given-names>JM</given-names></name><name><surname>Van de Velde</surname> <given-names>LA</given-names></name><name><surname>Smith</surname> <given-names>AM</given-names></name><name><surname>Kawauchi</surname> <given-names>D</given-names></name><name><surname>McEvoy</surname> <given-names>J</given-names></name><name><surname>Roussel</surname> <given-names>MF</given-names></name><name><surname>Dyer</surname> <given-names>MA</given-names></name><name><surname>Qualls</surname> <given-names>JE</given-names></name><name><surname>Murray</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>TNF counterbalances the emergence of M2 tumor macrophages</article-title><source>Cell Reports</source><volume>12</volume><fpage>1902</fpage><lpage>1914</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.08.033</pub-id><pub-id pub-id-type="pmid">26365184</pub-id></element-citation></ref><ref id="bib316"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreeger</surname> <given-names>PK</given-names></name><name><surname>Lauffenburger</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cancer systems biology: a network modeling perspective</article-title><source>Carcinogenesis</source><volume>31</volume><fpage>2</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgp261</pub-id><pub-id pub-id-type="pmid">19861649</pub-id></element-citation></ref><ref id="bib317"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krieg</surname> <given-names>C</given-names></name><name><surname>Nowicka</surname> <given-names>M</given-names></name><name><surname>Guglietta</surname> <given-names>S</given-names></name><name><surname>Schindler</surname> <given-names>S</given-names></name><name><surname>Hartmann</surname> <given-names>FJ</given-names></name><name><surname>Weber</surname> <given-names>LM</given-names></name><name><surname>Dummer</surname> <given-names>R</given-names></name><name><surname>Robinson</surname> <given-names>MD</given-names></name><name><surname>Levesque</surname> <given-names>MP</given-names></name><name><surname>Becher</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy</article-title><source>Nature Medicine</source><volume>24</volume><fpage>144</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1038/nm.4466</pub-id><pub-id pub-id-type="pmid">29309059</pub-id></element-citation></ref><ref id="bib318"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kshitiz</surname></name> <name><surname>Ellison</surname> <given-names>DD</given-names></name><name><surname>Suhail</surname> <given-names>Y</given-names></name><name><surname>Afzal</surname> <given-names>J</given-names></name><name><surname>Woo</surname> <given-names>L</given-names></name><name><surname>Kilic</surname> <given-names>O</given-names></name><name><surname>Spees</surname> <given-names>J</given-names></name><name><surname>Levchenko</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dynamic secretome of bone marrow-derived stromal cells reveals a cardioprotective biochemical cocktail</article-title><source>PNAS</source><volume>116</volume><fpage>14374</fpage><lpage>14383</lpage><pub-id pub-id-type="doi">10.1073/pnas.1902598116</pub-id></element-citation></ref><ref id="bib319"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kveler</surname> <given-names>K</given-names></name><name><surname>Starosvetsky</surname> <given-names>E</given-names></name><name><surname>Ziv-Kenet</surname> <given-names>A</given-names></name><name><surname>Kalugny</surname> <given-names>Y</given-names></name><name><surname>Gorelik</surname> <given-names>Y</given-names></name><name><surname>Shalev-Malul</surname> <given-names>G</given-names></name><name><surname>Aizenbud-Reshef</surname> <given-names>N</given-names></name><name><surname>Dubovik</surname> <given-names>T</given-names></name><name><surname>Briller</surname> <given-names>M</given-names></name><name><surname>Campbell</surname> <given-names>J</given-names></name><name><surname>Rieckmann</surname> <given-names>JC</given-names></name><name><surname>Asbeh</surname> <given-names>N</given-names></name><name><surname>Rimar</surname> <given-names>D</given-names></name><name><surname>Meissner</surname> <given-names>F</given-names></name><name><surname>Wiser</surname> <given-names>J</given-names></name><name><surname>Shen-Orr</surname> <given-names>SS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Immune-centric network of cytokines and cells in disease context identified by computational mining of PubMed</article-title><source>Nature Biotechnology</source><volume>36</volume><fpage>651</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1038/nbt.4152</pub-id><pub-id pub-id-type="pmid">29912209</pub-id></element-citation></ref><ref id="bib320"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labidi-Galy</surname> <given-names>SI</given-names></name><name><surname>Sisirak</surname> <given-names>V</given-names></name><name><surname>Meeus</surname> <given-names>P</given-names></name><name><surname>Gobert</surname> <given-names>M</given-names></name><name><surname>Treilleux</surname> <given-names>I</given-names></name><name><surname>Bajard</surname> <given-names>A</given-names></name><name><surname>Combes</surname> <given-names>JD</given-names></name><name><surname>Faget</surname> <given-names>J</given-names></name><name><surname>Mithieux</surname> <given-names>F</given-names></name><name><surname>Cassignol</surname> <given-names>A</given-names></name><name><surname>Tredan</surname> <given-names>O</given-names></name><name><surname>Durand</surname> <given-names>I</given-names></name><name><surname>Ménétrier-Caux</surname> <given-names>C</given-names></name><name><surname>Caux</surname> <given-names>C</given-names></name><name><surname>Blay</surname> <given-names>JY</given-names></name><name><surname>Ray-Coquard</surname> <given-names>I</given-names></name><name><surname>Bendriss-Vermare</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian Cancer</article-title><source>Cancer Research</source><volume>71</volume><fpage>5423</fpage><lpage>5434</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-11-0367</pub-id><pub-id pub-id-type="pmid">21697280</pub-id></element-citation></ref><ref id="bib321"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacar</surname> <given-names>B</given-names></name><name><surname>Linker</surname> <given-names>SB</given-names></name><name><surname>Jaeger</surname> <given-names>BN</given-names></name><name><surname>Krishnaswami</surname> <given-names>SR</given-names></name><name><surname>Barron</surname> <given-names>JJ</given-names></name><name><surname>Kelder</surname> <given-names>MJE</given-names></name><name><surname>Parylak</surname> <given-names>SL</given-names></name><name><surname>Paquola</surname> <given-names>ACM</given-names></name><name><surname>Venepally</surname> <given-names>P</given-names></name><name><surname>Novotny</surname> <given-names>M</given-names></name><name><surname>O'Connor</surname> <given-names>C</given-names></name><name><surname>Fitzpatrick</surname> <given-names>C</given-names></name><name><surname>Erwin</surname> <given-names>JA</given-names></name><name><surname>Hsu</surname> <given-names>JY</given-names></name><name><surname>Husband</surname> <given-names>D</given-names></name><name><surname>McConnell</surname> <given-names>MJ</given-names></name><name><surname>Lasken</surname> <given-names>R</given-names></name><name><surname>Gage</surname> <given-names>FH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Nuclear RNA-seq of single neurons reveals molecular signatures of activation</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>11022</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms11022</pub-id><pub-id pub-id-type="pmid">27090946</pub-id></element-citation></ref><ref id="bib322"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ladányi</surname> <given-names>A</given-names></name><name><surname>Kiss</surname> <given-names>J</given-names></name><name><surname>Somlai</surname> <given-names>B</given-names></name><name><surname>Gilde</surname> <given-names>K</given-names></name><name><surname>Fejős</surname> <given-names>Z</given-names></name><name><surname>Mohos</surname> <given-names>A</given-names></name><name><surname>Gaudi</surname> <given-names>I</given-names></name><name><surname>Tímár</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Density of DC-LAMP+ mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor</article-title><source>Cancer Immunology, Immunotherapy</source><volume>56</volume><fpage>1459</fpage><lpage>1469</lpage><pub-id pub-id-type="doi">10.1007/s00262-007-0286-3</pub-id></element-citation></ref><ref id="bib323"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Linton</surname> <given-names>LM</given-names></name><name><surname>Birren</surname> <given-names>B</given-names></name><name><surname>Nusbaum</surname> <given-names>C</given-names></name><name><surname>Zody</surname> <given-names>MC</given-names></name><name><surname>Baldwin</surname> <given-names>J</given-names></name><name><surname>Devon</surname> <given-names>K</given-names></name><name><surname>Dewar</surname> <given-names>K</given-names></name><name><surname>Doyle</surname> <given-names>M</given-names></name><name><surname>FitzHugh</surname> <given-names>W</given-names></name><name><surname>Funke</surname> <given-names>R</given-names></name><name><surname>Gage</surname> <given-names>D</given-names></name><name><surname>Harris</surname> <given-names>K</given-names></name><name><surname>Heaford</surname> <given-names>A</given-names></name><name><surname>Howland</surname> <given-names>J</given-names></name><name><surname>Kann</surname> <given-names>L</given-names></name><name><surname>Lehoczky</surname> <given-names>J</given-names></name><name><surname>LeVine</surname> <given-names>R</given-names></name><name><surname>McEwan</surname> <given-names>P</given-names></name><name><surname>McKernan</surname> <given-names>K</given-names></name><name><surname>Meldrim</surname> <given-names>J</given-names></name><name><surname>Mesirov</surname> <given-names>JP</given-names></name><name><surname>Miranda</surname> <given-names>C</given-names></name><name><surname>Morris</surname> <given-names>W</given-names></name><name><surname>Naylor</surname> <given-names>J</given-names></name><name><surname>Raymond</surname> <given-names>C</given-names></name><name><surname>Rosetti</surname> <given-names>M</given-names></name><name><surname>Santos</surname> <given-names>R</given-names></name><name><surname>Sheridan</surname> <given-names>A</given-names></name><name><surname>Sougnez</surname> <given-names>C</given-names></name><name><surname>Stange-Thomann</surname> <given-names>Y</given-names></name><name><surname>Stojanovic</surname> <given-names>N</given-names></name><name><surname>Subramanian</surname> <given-names>A</given-names></name><name><surname>Wyman</surname> <given-names>D</given-names></name><name><surname>Rogers</surname> <given-names>J</given-names></name><name><surname>Sulston</surname> <given-names>J</given-names></name><name><surname>Ainscough</surname> <given-names>R</given-names></name><name><surname>Beck</surname> <given-names>S</given-names></name><name><surname>Bentley</surname> <given-names>D</given-names></name><name><surname>Burton</surname> <given-names>J</given-names></name><name><surname>Clee</surname> <given-names>C</given-names></name><name><surname>Carter</surname> <given-names>N</given-names></name><name><surname>Coulson</surname> <given-names>A</given-names></name><name><surname>Deadman</surname> <given-names>R</given-names></name><name><surname>Deloukas</surname> <given-names>P</given-names></name><name><surname>Dunham</surname> <given-names>A</given-names></name><name><surname>Dunham</surname> <given-names>I</given-names></name><name><surname>Durbin</surname> <given-names>R</given-names></name><name><surname>French</surname> <given-names>L</given-names></name><name><surname>Grafham</surname> <given-names>D</given-names></name><name><surname>Gregory</surname> <given-names>S</given-names></name><name><surname>Hubbard</surname> <given-names>T</given-names></name><name><surname>Humphray</surname> <given-names>S</given-names></name><name><surname>Hunt</surname> <given-names>A</given-names></name><name><surname>Jones</surname> <given-names>M</given-names></name><name><surname>Lloyd</surname> <given-names>C</given-names></name><name><surname>McMurray</surname> <given-names>A</given-names></name><name><surname>Matthews</surname> <given-names>L</given-names></name><name><surname>Mercer</surname> <given-names>S</given-names></name><name><surname>Milne</surname> <given-names>S</given-names></name><name><surname>Mullikin</surname> <given-names>JC</given-names></name><name><surname>Mungall</surname> <given-names>A</given-names></name><name><surname>Plumb</surname> <given-names>R</given-names></name><name><surname>Ross</surname> <given-names>M</given-names></name><name><surname>Shownkeen</surname> <given-names>R</given-names></name><name><surname>Sims</surname> <given-names>S</given-names></name><name><surname>Waterston</surname> <given-names>RH</given-names></name><name><surname>Wilson</surname> <given-names>RK</given-names></name><name><surname>Hillier</surname> <given-names>LW</given-names></name><name><surname>McPherson</surname> <given-names>JD</given-names></name><name><surname>Marra</surname> <given-names>MA</given-names></name><name><surname>Mardis</surname> <given-names>ER</given-names></name><name><surname>Fulton</surname> <given-names>LA</given-names></name><name><surname>Chinwalla</surname> <given-names>AT</given-names></name><name><surname>Pepin</surname> <given-names>KH</given-names></name><name><surname>Gish</surname> <given-names>WR</given-names></name><name><surname>Chissoe</surname> <given-names>SL</given-names></name><name><surname>Wendl</surname> <given-names>MC</given-names></name><name><surname>Delehaunty</surname> <given-names>KD</given-names></name><name><surname>Miner</surname> <given-names>TL</given-names></name><name><surname>Delehaunty</surname> <given-names>A</given-names></name><name><surname>Kramer</surname> <given-names>JB</given-names></name><name><surname>Cook</surname> <given-names>LL</given-names></name><name><surname>Fulton</surname> <given-names>RS</given-names></name><name><surname>Johnson</surname> <given-names>DL</given-names></name><name><surname>Minx</surname> <given-names>PJ</given-names></name><name><surname>Clifton</surname> <given-names>SW</given-names></name><name><surname>Hawkins</surname> <given-names>T</given-names></name><name><surname>Branscomb</surname> <given-names>E</given-names></name><name><surname>Predki</surname> <given-names>P</given-names></name><name><surname>Richardson</surname> <given-names>P</given-names></name><name><surname>Wenning</surname> <given-names>S</given-names></name><name><surname>Slezak</surname> <given-names>T</given-names></name><name><surname>Doggett</surname> <given-names>N</given-names></name><name><surname>Cheng</surname> <given-names>JF</given-names></name><name><surname>Olsen</surname> <given-names>A</given-names></name><name><surname>Lucas</surname> <given-names>S</given-names></name><name><surname>Elkin</surname> <given-names>C</given-names></name><name><surname>Uberbacher</surname> <given-names>E</given-names></name><name><surname>Frazier</surname> <given-names>M</given-names></name><name><surname>Gibbs</surname> <given-names>RA</given-names></name><name><surname>Muzny</surname> <given-names>DM</given-names></name><name><surname>Scherer</surname> <given-names>SE</given-names></name><name><surname>Bouck</surname> <given-names>JB</given-names></name><name><surname>Sodergren</surname> <given-names>EJ</given-names></name><name><surname>Worley</surname> <given-names>KC</given-names></name><name><surname>Rives</surname> <given-names>CM</given-names></name><name><surname>Gorrell</surname> <given-names>JH</given-names></name><name><surname>Metzker</surname> <given-names>ML</given-names></name><name><surname>Naylor</surname> <given-names>SL</given-names></name><name><surname>Kucherlapati</surname> <given-names>RS</given-names></name><name><surname>Nelson</surname> <given-names>DL</given-names></name><name><surname>Weinstock</surname> <given-names>GM</given-names></name><name><surname>Sakaki</surname> <given-names>Y</given-names></name><name><surname>Fujiyama</surname> <given-names>A</given-names></name><name><surname>Hattori</surname> <given-names>M</given-names></name><name><surname>Yada</surname> <given-names>T</given-names></name><name><surname>Toyoda</surname> <given-names>A</given-names></name><name><surname>Itoh</surname> <given-names>T</given-names></name><name><surname>Kawagoe</surname> <given-names>C</given-names></name><name><surname>Watanabe</surname> <given-names>H</given-names></name><name><surname>Totoki</surname> <given-names>Y</given-names></name><name><surname>Taylor</surname> <given-names>T</given-names></name><name><surname>Weissenbach</surname> <given-names>J</given-names></name><name><surname>Heilig</surname> <given-names>R</given-names></name><name><surname>Saurin</surname> <given-names>W</given-names></name><name><surname>Artiguenave</surname> <given-names>F</given-names></name><name><surname>Brottier</surname> <given-names>P</given-names></name><name><surname>Bruls</surname> <given-names>T</given-names></name><name><surname>Pelletier</surname> <given-names>E</given-names></name><name><surname>Robert</surname> <given-names>C</given-names></name><name><surname>Wincker</surname> <given-names>P</given-names></name><name><surname>Smith</surname> <given-names>DR</given-names></name><name><surname>Doucette-Stamm</surname> <given-names>L</given-names></name><name><surname>Rubenfield</surname> <given-names>M</given-names></name><name><surname>Weinstock</surname> <given-names>K</given-names></name><name><surname>Lee</surname> <given-names>HM</given-names></name><name><surname>Dubois</surname> <given-names>J</given-names></name><name><surname>Rosenthal</surname> <given-names>A</given-names></name><name><surname>Platzer</surname> <given-names>M</given-names></name><name><surname>Nyakatura</surname> <given-names>G</given-names></name><name><surname>Taudien</surname> <given-names>S</given-names></name><name><surname>Rump</surname> <given-names>A</given-names></name><name><surname>Yang</surname> <given-names>H</given-names></name><name><surname>Yu</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Huang</surname> <given-names>G</given-names></name><name><surname>Gu</surname> <given-names>J</given-names></name><name><surname>Hood</surname> <given-names>L</given-names></name><name><surname>Rowen</surname> <given-names>L</given-names></name><name><surname>Madan</surname> <given-names>A</given-names></name><name><surname>Qin</surname> <given-names>S</given-names></name><name><surname>Davis</surname> <given-names>RW</given-names></name><name><surname>Federspiel</surname> <given-names>NA</given-names></name><name><surname>Abola</surname> <given-names>AP</given-names></name><name><surname>Proctor</surname> <given-names>MJ</given-names></name><name><surname>Myers</surname> <given-names>RM</given-names></name><name><surname>Schmutz</surname> <given-names>J</given-names></name><name><surname>Dickson</surname> <given-names>M</given-names></name><name><surname>Grimwood</surname> <given-names>J</given-names></name><name><surname>Cox</surname> <given-names>DR</given-names></name><name><surname>Olson</surname> <given-names>MV</given-names></name><name><surname>Kaul</surname> <given-names>R</given-names></name><name><surname>Raymond</surname> <given-names>C</given-names></name><name><surname>Shimizu</surname> <given-names>N</given-names></name><name><surname>Kawasaki</surname> <given-names>K</given-names></name><name><surname>Minoshima</surname> <given-names>S</given-names></name><name><surname>Evans</surname> <given-names>GA</given-names></name><name><surname>Athanasiou</surname> <given-names>M</given-names></name><name><surname>Schultz</surname> <given-names>R</given-names></name><name><surname>Roe</surname> <given-names>BA</given-names></name><name><surname>Chen</surname> <given-names>F</given-names></name><name><surname>Pan</surname> <given-names>H</given-names></name><name><surname>Ramser</surname> <given-names>J</given-names></name><name><surname>Lehrach</surname> <given-names>H</given-names></name><name><surname>Reinhardt</surname> <given-names>R</given-names></name><name><surname>McCombie</surname> <given-names>WR</given-names></name><name><surname>de la Bastide</surname> <given-names>M</given-names></name><name><surname>Dedhia</surname> <given-names>N</given-names></name><name><surname>Blöcker</surname> <given-names>H</given-names></name><name><surname>Hornischer</surname> <given-names>K</given-names></name><name><surname>Nordsiek</surname> <given-names>G</given-names></name><name><surname>Agarwala</surname> <given-names>R</given-names></name><name><surname>Aravind</surname> <given-names>L</given-names></name><name><surname>Bailey</surname> <given-names>JA</given-names></name><name><surname>Bateman</surname> <given-names>A</given-names></name><name><surname>Batzoglou</surname> <given-names>S</given-names></name><name><surname>Birney</surname> <given-names>E</given-names></name><name><surname>Bork</surname> <given-names>P</given-names></name><name><surname>Brown</surname> <given-names>DG</given-names></name><name><surname>Burge</surname> <given-names>CB</given-names></name><name><surname>Cerutti</surname> <given-names>L</given-names></name><name><surname>Chen</surname> <given-names>HC</given-names></name><name><surname>Church</surname> <given-names>D</given-names></name><name><surname>Clamp</surname> <given-names>M</given-names></name><name><surname>Copley</surname> <given-names>RR</given-names></name><name><surname>Doerks</surname> <given-names>T</given-names></name><name><surname>Eddy</surname> <given-names>SR</given-names></name><name><surname>Eichler</surname> <given-names>EE</given-names></name><name><surname>Furey</surname> <given-names>TS</given-names></name><name><surname>Galagan</surname> <given-names>J</given-names></name><name><surname>Gilbert</surname> <given-names>JG</given-names></name><name><surname>Harmon</surname> <given-names>C</given-names></name><name><surname>Hayashizaki</surname> <given-names>Y</given-names></name><name><surname>Haussler</surname> <given-names>D</given-names></name><name><surname>Hermjakob</surname> <given-names>H</given-names></name><name><surname>Hokamp</surname> <given-names>K</given-names></name><name><surname>Jang</surname> <given-names>W</given-names></name><name><surname>Johnson</surname> <given-names>LS</given-names></name><name><surname>Jones</surname> <given-names>TA</given-names></name><name><surname>Kasif</surname> <given-names>S</given-names></name><name><surname>Kaspryzk</surname> <given-names>A</given-names></name><name><surname>Kennedy</surname> <given-names>S</given-names></name><name><surname>Kent</surname> <given-names>WJ</given-names></name><name><surname>Kitts</surname> <given-names>P</given-names></name><name><surname>Koonin</surname> <given-names>EV</given-names></name><name><surname>Korf</surname> <given-names>I</given-names></name><name><surname>Kulp</surname> <given-names>D</given-names></name><name><surname>Lancet</surname> <given-names>D</given-names></name><name><surname>Lowe</surname> <given-names>TM</given-names></name><name><surname>McLysaght</surname> <given-names>A</given-names></name><name><surname>Mikkelsen</surname> <given-names>T</given-names></name><name><surname>Moran</surname> <given-names>JV</given-names></name><name><surname>Mulder</surname> <given-names>N</given-names></name><name><surname>Pollara</surname> <given-names>VJ</given-names></name><name><surname>Ponting</surname> <given-names>CP</given-names></name><name><surname>Schuler</surname> <given-names>G</given-names></name><name><surname>Schultz</surname> <given-names>J</given-names></name><name><surname>Slater</surname> <given-names>G</given-names></name><name><surname>Smit</surname> <given-names>AF</given-names></name><name><surname>Stupka</surname> <given-names>E</given-names></name><name><surname>Szustakowki</surname> <given-names>J</given-names></name><name><surname>Thierry-Mieg</surname> <given-names>D</given-names></name><name><surname>Thierry-Mieg</surname> <given-names>J</given-names></name><name><surname>Wagner</surname> <given-names>L</given-names></name><name><surname>Wallis</surname> <given-names>J</given-names></name><name><surname>Wheeler</surname> <given-names>R</given-names></name><name><surname>Williams</surname> <given-names>A</given-names></name><name><surname>Wolf</surname> <given-names>YI</given-names></name><name><surname>Wolfe</surname> <given-names>KH</given-names></name><name><surname>Yang</surname> <given-names>SP</given-names></name><name><surname>Yeh</surname> <given-names>RF</given-names></name><name><surname>Collins</surname> <given-names>F</given-names></name><name><surname>Guyer</surname> <given-names>MS</given-names></name><name><surname>Peterson</surname> <given-names>J</given-names></name><name><surname>Felsenfeld</surname> <given-names>A</given-names></name><name><surname>Wetterstrand</surname> <given-names>KA</given-names></name><name><surname>Patrinos</surname> <given-names>A</given-names></name><name><surname>Morgan</surname> <given-names>MJ</given-names></name><name><surname>de Jong</surname> <given-names>P</given-names></name><name><surname>Catanese</surname> <given-names>JJ</given-names></name><name><surname>Osoegawa</surname> <given-names>K</given-names></name><name><surname>Shizuya</surname> <given-names>H</given-names></name><name><surname>Choi</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>YJ</given-names></name><name><surname>Szustakowki</surname> <given-names>J</given-names></name><collab>International Human Genome Sequencing Consortium</collab></person-group><year iso-8601-date="2001">2001</year><article-title>Initial sequencing and analysis of the human genome</article-title><source>Nature</source><volume>409</volume><fpage>860</fpage><lpage>921</lpage><pub-id pub-id-type="doi">10.1038/35057062</pub-id><pub-id pub-id-type="pmid">11237011</pub-id></element-citation></ref><ref id="bib324"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanier</surname> <given-names>LL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>NK cell recognition</article-title><source>Annual Review of Immunology</source><volume>23</volume><fpage>225</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.23.021704.115526</pub-id><pub-id pub-id-type="pmid">15771571</pub-id></element-citation></ref><ref id="bib325"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latonen</surname> <given-names>L</given-names></name><name><surname>Afyounian</surname> <given-names>E</given-names></name><name><surname>Jylhä</surname> <given-names>A</given-names></name><name><surname>Nättinen</surname> <given-names>J</given-names></name><name><surname>Aapola</surname> <given-names>U</given-names></name><name><surname>Annala</surname> <given-names>M</given-names></name><name><surname>Kivinummi</surname> <given-names>KK</given-names></name><name><surname>Tammela</surname> <given-names>TTL</given-names></name><name><surname>Beuerman</surname> <given-names>RW</given-names></name><name><surname>Uusitalo</surname> <given-names>H</given-names></name><name><surname>Nykter</surname> <given-names>M</given-names></name><name><surname>Visakorpi</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Integrative proteomics in prostate Cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>1176</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-03573-6</pub-id><pub-id pub-id-type="pmid">29563510</pub-id></element-citation></ref><ref id="bib326"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavin</surname> <given-names>Y</given-names></name><name><surname>Winter</surname> <given-names>D</given-names></name><name><surname>Blecher-Gonen</surname> <given-names>R</given-names></name><name><surname>David</surname> <given-names>E</given-names></name><name><surname>Keren-Shaul</surname> <given-names>H</given-names></name><name><surname>Merad</surname> <given-names>M</given-names></name><name><surname>Jung</surname> <given-names>S</given-names></name><name><surname>Amit</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment</article-title><source>Cell</source><volume>159</volume><fpage>1312</fpage><lpage>1326</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.11.018</pub-id><pub-id pub-id-type="pmid">25480296</pub-id></element-citation></ref><ref id="bib327"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavin</surname> <given-names>Y</given-names></name><name><surname>Kobayashi</surname> <given-names>S</given-names></name><name><surname>Leader</surname> <given-names>A</given-names></name><name><surname>Amir</surname> <given-names>ED</given-names></name><name><surname>Elefant</surname> <given-names>N</given-names></name><name><surname>Bigenwald</surname> <given-names>C</given-names></name><name><surname>Remark</surname> <given-names>R</given-names></name><name><surname>Sweeney</surname> <given-names>R</given-names></name><name><surname>Becker</surname> <given-names>CD</given-names></name><name><surname>Levine</surname> <given-names>JH</given-names></name><name><surname>Meinhof</surname> <given-names>K</given-names></name><name><surname>Chow</surname> <given-names>A</given-names></name><name><surname>Kim-Shulze</surname> <given-names>S</given-names></name><name><surname>Wolf</surname> <given-names>A</given-names></name><name><surname>Medaglia</surname> <given-names>C</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Rytlewski</surname> <given-names>JA</given-names></name><name><surname>Emerson</surname> <given-names>RO</given-names></name><name><surname>Solovyov</surname> <given-names>A</given-names></name><name><surname>Greenbaum</surname> <given-names>BD</given-names></name><name><surname>Sanders</surname> <given-names>C</given-names></name><name><surname>Vignali</surname> <given-names>M</given-names></name><name><surname>Beasley</surname> <given-names>MB</given-names></name><name><surname>Flores</surname> <given-names>R</given-names></name><name><surname>Gnjatic</surname> <given-names>S</given-names></name><name><surname>Pe'er</surname> <given-names>D</given-names></name><name><surname>Rahman</surname> <given-names>A</given-names></name><name><surname>Amit</surname> <given-names>I</given-names></name><name><surname>Merad</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Innate immune landscape in early lung adenocarcinoma by paired Single-Cell analyses</article-title><source>Cell</source><volume>169</volume><fpage>750</fpage><lpage>765</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.04.014</pub-id><pub-id pub-id-type="pmid">28475900</pub-id></element-citation></ref><ref id="bib328"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname> <given-names>MS</given-names></name><name><surname>Stojanov</surname> <given-names>P</given-names></name><name><surname>Mermel</surname> <given-names>CH</given-names></name><name><surname>Robinson</surname> <given-names>JT</given-names></name><name><surname>Garraway</surname> <given-names>LA</given-names></name><name><surname>Golub</surname> <given-names>TR</given-names></name><name><surname>Meyerson</surname> <given-names>M</given-names></name><name><surname>Gabriel</surname> <given-names>SB</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Getz</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Discovery and saturation analysis of Cancer genes across 21 tumour types</article-title><source>Nature</source><volume>505</volume><fpage>495</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1038/nature12912</pub-id><pub-id pub-id-type="pmid">24390350</pub-id></element-citation></ref><ref id="bib329"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>JW</given-names></name><name><surname>Epardaud</surname> <given-names>M</given-names></name><name><surname>Sun</surname> <given-names>J</given-names></name><name><surname>Becker</surname> <given-names>JE</given-names></name><name><surname>Cheng</surname> <given-names>AC</given-names></name><name><surname>Yonekura</surname> <given-names>AR</given-names></name><name><surname>Heath</surname> <given-names>JK</given-names></name><name><surname>Turley</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self</article-title><source>Nature Immunology</source><volume>8</volume><fpage>181</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1038/ni1427</pub-id><pub-id pub-id-type="pmid">17195844</pub-id></element-citation></ref><ref id="bib330"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>JH</given-names></name><name><surname>Daugharthy</surname> <given-names>ER</given-names></name><name><surname>Scheiman</surname> <given-names>J</given-names></name><name><surname>Kalhor</surname> <given-names>R</given-names></name><name><surname>Yang</surname> <given-names>JL</given-names></name><name><surname>Ferrante</surname> <given-names>TC</given-names></name><name><surname>Terry</surname> <given-names>R</given-names></name><name><surname>Jeanty</surname> <given-names>SS</given-names></name><name><surname>Li</surname> <given-names>C</given-names></name><name><surname>Amamoto</surname> <given-names>R</given-names></name><name><surname>Peters</surname> <given-names>DT</given-names></name><name><surname>Turczyk</surname> <given-names>BM</given-names></name><name><surname>Marblestone</surname> <given-names>AH</given-names></name><name><surname>Inverso</surname> <given-names>SA</given-names></name><name><surname>Bernard</surname> <given-names>A</given-names></name><name><surname>Mali</surname> <given-names>P</given-names></name><name><surname>Rios</surname> <given-names>X</given-names></name><name><surname>Aach</surname> <given-names>J</given-names></name><name><surname>Church</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Highly multiplexed subcellular RNA sequencing in situ</article-title><source>Science</source><volume>343</volume><fpage>1360</fpage><lpage>1363</lpage><pub-id pub-id-type="doi">10.1126/science.1250212</pub-id><pub-id pub-id-type="pmid">24578530</pub-id></element-citation></ref><ref id="bib331"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letort</surname> <given-names>G</given-names></name><name><surname>Montagud</surname> <given-names>A</given-names></name><name><surname>Stoll</surname> <given-names>G</given-names></name><name><surname>Heiland</surname> <given-names>R</given-names></name><name><surname>Barillot</surname> <given-names>E</given-names></name><name><surname>Macklin</surname> <given-names>P</given-names></name><name><surname>Zinovyev</surname> <given-names>A</given-names></name><name><surname>Calzone</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>PhysiBoSS: a multi-scale agent-based modelling framework integrating physical dimension and cell signalling</article-title><source>Bioinformatics</source><volume>35</volume><fpage>1188</fpage><lpage>1196</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty766</pub-id><pub-id pub-id-type="pmid">30169736</pub-id></element-citation></ref><ref id="bib332"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lettice</surname> <given-names>LA</given-names></name><name><surname>Heaney</surname> <given-names>SJ</given-names></name><name><surname>Purdie</surname> <given-names>LA</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>de Beer</surname> <given-names>P</given-names></name><name><surname>Oostra</surname> <given-names>BA</given-names></name><name><surname>Goode</surname> <given-names>D</given-names></name><name><surname>Elgar</surname> <given-names>G</given-names></name><name><surname>Hill</surname> <given-names>RE</given-names></name><name><surname>de Graaff</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>A long-range shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly</article-title><source>Human Molecular Genetics</source><volume>12</volume><fpage>1725</fpage><lpage>1735</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddg180</pub-id><pub-id pub-id-type="pmid">12837695</pub-id></element-citation></ref><ref id="bib333"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levesque</surname> <given-names>MJ</given-names></name><name><surname>Raj</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Single-chromosome transcriptional profiling reveals chromosomal gene expression regulation</article-title><source>Nature Methods</source><volume>10</volume><fpage>246</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2372</pub-id><pub-id pub-id-type="pmid">23416756</pub-id></element-citation></ref><ref id="bib334"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname> <given-names>JH</given-names></name><name><surname>Simonds</surname> <given-names>EF</given-names></name><name><surname>Bendall</surname> <given-names>SC</given-names></name><name><surname>Davis</surname> <given-names>KL</given-names></name><name><surname>Amir</surname> <given-names>AD</given-names></name><name><surname>Tadmor</surname> <given-names>MD</given-names></name><name><surname>Litvin</surname> <given-names>O</given-names></name><name><surname>Fienberg</surname> <given-names>HG</given-names></name><name><surname>Jager</surname> <given-names>A</given-names></name><name><surname>Zunder</surname> <given-names>ER</given-names></name><name><surname>Finck</surname> <given-names>R</given-names></name><name><surname>Gedman</surname> <given-names>AL</given-names></name><name><surname>Radtke</surname> <given-names>I</given-names></name><name><surname>Downing</surname> <given-names>JR</given-names></name><name><surname>Pe'er</surname> <given-names>D</given-names></name><name><surname>Nolan</surname> <given-names>GP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Data-Driven phenotypic dissection of AML reveals Progenitor-like cells that correlate with prognosis</article-title><source>Cell</source><volume>162</volume><fpage>184</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.05.047</pub-id><pub-id pub-id-type="pmid">26095251</pub-id></element-citation></ref><ref id="bib335"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname> <given-names>CE</given-names></name><name><surname>Pollard</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Distinct role of macrophages in different tumor microenvironments</article-title><source>Cancer Research</source><volume>66</volume><fpage>605</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-4005</pub-id><pub-id pub-id-type="pmid">16423985</pub-id></element-citation></ref><ref id="bib336"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>G</given-names></name><name><surname>Zan</surname> <given-names>H</given-names></name><name><surname>Xu</surname> <given-names>Z</given-names></name><name><surname>Casali</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Epigenetics of the antibody response</article-title><source>Trends in Immunology</source><volume>34</volume><fpage>460</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1016/j.it.2013.03.006</pub-id><pub-id pub-id-type="pmid">23643790</pub-id></element-citation></ref><ref id="bib337"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>B</given-names></name><name><surname>Li</surname> <given-names>T</given-names></name><name><surname>Pignon</surname> <given-names>JC</given-names></name><name><surname>Wang</surname> <given-names>B</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Shukla</surname> <given-names>SA</given-names></name><name><surname>Dou</surname> <given-names>R</given-names></name><name><surname>Chen</surname> <given-names>Q</given-names></name><name><surname>Hodi</surname> <given-names>FS</given-names></name><name><surname>Choueiri</surname> <given-names>TK</given-names></name><name><surname>Wu</surname> <given-names>C</given-names></name><name><surname>Hacohen</surname> <given-names>N</given-names></name><name><surname>Signoretti</surname> <given-names>S</given-names></name><name><surname>Liu</surname> <given-names>JS</given-names></name><name><surname>Liu</surname> <given-names>XS</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>Landscape of tumor-infiltrating T cell repertoire of human cancers</article-title><source>Nature Genetics</source><volume>48</volume><fpage>725</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1038/ng.3581</pub-id><pub-id pub-id-type="pmid">27240091</pub-id></element-citation></ref><ref id="bib338"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>B</given-names></name><name><surname>Severson</surname> <given-names>E</given-names></name><name><surname>Pignon</surname> <given-names>JC</given-names></name><name><surname>Zhao</surname> <given-names>H</given-names></name><name><surname>Li</surname> <given-names>T</given-names></name><name><surname>Novak</surname> <given-names>J</given-names></name><name><surname>Jiang</surname> <given-names>P</given-names></name><name><surname>Shen</surname> <given-names>H</given-names></name><name><surname>Aster</surname> <given-names>JC</given-names></name><name><surname>Rodig</surname> <given-names>S</given-names></name><name><surname>Signoretti</surname> <given-names>S</given-names></name><name><surname>Liu</surname> <given-names>JS</given-names></name><name><surname>Liu</surname> <given-names>XS</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>Comprehensive analyses of tumor immunity: implications for Cancer immunotherapy</article-title><source>Genome Biology</source><volume>17</volume><elocation-id>174</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-016-1028-7</pub-id><pub-id pub-id-type="pmid">27549193</pub-id></element-citation></ref><ref id="bib339"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>van der Leun</surname> <given-names>AM</given-names></name><name><surname>Yofe</surname> <given-names>I</given-names></name><name><surname>Lubling</surname> <given-names>Y</given-names></name><name><surname>Gelbard-Solodkin</surname> <given-names>D</given-names></name><name><surname>van Akkooi</surname> <given-names>ACJ</given-names></name><name><surname>van den Braber</surname> <given-names>M</given-names></name><name><surname>Rozeman</surname> <given-names>EA</given-names></name><name><surname>Haanen</surname> <given-names>J</given-names></name><name><surname>Blank</surname> <given-names>CU</given-names></name><name><surname>Horlings</surname> <given-names>HM</given-names></name><name><surname>David</surname> <given-names>E</given-names></name><name><surname>Baran</surname> <given-names>Y</given-names></name><name><surname>Bercovich</surname> <given-names>A</given-names></name><name><surname>Lifshitz</surname> <given-names>A</given-names></name><name><surname>Schumacher</surname> <given-names>TN</given-names></name><name><surname>Tanay</surname> <given-names>A</given-names></name><name><surname>Amit</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma</article-title><source>Cell</source><volume>176</volume><fpage>775</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.11.043</pub-id><pub-id pub-id-type="pmid">30595452</pub-id></element-citation></ref><ref id="bib340"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liarski</surname> <given-names>VM</given-names></name><name><surname>Sibley</surname> <given-names>A</given-names></name><name><surname>van Panhuys</surname> <given-names>N</given-names></name><name><surname>Ai</surname> <given-names>J</given-names></name><name><surname>Chang</surname> <given-names>A</given-names></name><name><surname>Kennedy</surname> <given-names>D</given-names></name><name><surname>Merolle</surname> <given-names>M</given-names></name><name><surname>Germain</surname> <given-names>RN</given-names></name><name><surname>Giger</surname> <given-names>ML</given-names></name><name><surname>Clark</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Quantifying in situ adaptive immune cell cognate interactions in humans</article-title><source>Nature Immunology</source><volume>20</volume><fpage>503</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1038/s41590-019-0315-3</pub-id><pub-id pub-id-type="pmid">30778242</pub-id></element-citation></ref><ref id="bib341"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liau</surname> <given-names>B</given-names></name><name><surname>Tan</surname> <given-names>B</given-names></name><name><surname>Teo</surname> <given-names>G</given-names></name><name><surname>Zhang</surname> <given-names>P</given-names></name><name><surname>Choo</surname> <given-names>A</given-names></name><name><surname>Rudd</surname> <given-names>PM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Shotgun glycomics identifies Tumor-Associated glycan ligands bound by an ovarian Carcinoma-Specific monoclonal antibody</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>14489</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-15123-z</pub-id><pub-id pub-id-type="pmid">29101385</pub-id></element-citation></ref><ref id="bib342"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lieberman-Aiden</surname> <given-names>E</given-names></name><name><surname>van Berkum</surname> <given-names>NL</given-names></name><name><surname>Williams</surname> <given-names>L</given-names></name><name><surname>Imakaev</surname> <given-names>M</given-names></name><name><surname>Ragoczy</surname> <given-names>T</given-names></name><name><surname>Telling</surname> <given-names>A</given-names></name><name><surname>Amit</surname> <given-names>I</given-names></name><name><surname>Lajoie</surname> <given-names>BR</given-names></name><name><surname>Sabo</surname> <given-names>PJ</given-names></name><name><surname>Dorschner</surname> <given-names>MO</given-names></name><name><surname>Sandstrom</surname> <given-names>R</given-names></name><name><surname>Bernstein</surname> <given-names>B</given-names></name><name><surname>Bender</surname> <given-names>MA</given-names></name><name><surname>Groudine</surname> <given-names>M</given-names></name><name><surname>Gnirke</surname> <given-names>A</given-names></name><name><surname>Stamatoyannopoulos</surname> <given-names>J</given-names></name><name><surname>Mirny</surname> <given-names>LA</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Dekker</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Comprehensive mapping of long-range interactions reveals folding principles of the human genome</article-title><source>Science</source><volume>326</volume><fpage>289</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1126/science.1181369</pub-id><pub-id pub-id-type="pmid">19815776</pub-id></element-citation></ref><ref id="bib343"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lifson</surname> <given-names>JD</given-names></name><name><surname>Engleman</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Role of CD4 in normal immunity and HIV infection</article-title><source>Immunological Reviews</source><volume>109</volume><fpage>93</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1111/j.1600-065X.1989.tb00021.x</pub-id><pub-id pub-id-type="pmid">2475427</pub-id></element-citation></ref><ref id="bib344"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>CY</given-names></name><name><surname>Lovén</surname> <given-names>J</given-names></name><name><surname>Rahl</surname> <given-names>PB</given-names></name><name><surname>Paranal</surname> <given-names>RM</given-names></name><name><surname>Burge</surname> <given-names>CB</given-names></name><name><surname>Bradner</surname> <given-names>JE</given-names></name><name><surname>Lee</surname> <given-names>TI</given-names></name><name><surname>Young</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Transcriptional amplification in tumor cells with elevated c-Myc</article-title><source>Cell</source><volume>151</volume><fpage>56</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.08.026</pub-id><pub-id pub-id-type="pmid">23021215</pub-id></element-citation></ref><ref id="bib345"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>JR</given-names></name><name><surname>Fallahi-Sichani</surname> <given-names>M</given-names></name><name><surname>Sorger</surname> <given-names>PK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Highly multiplexed imaging of single cells using a high-throughput cyclic immunofluorescence method</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>8390</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms9390</pub-id><pub-id pub-id-type="pmid">26399630</pub-id></element-citation></ref><ref id="bib346"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname> <given-names>JQ</given-names></name><name><surname>Li</surname> <given-names>T</given-names></name><name><surname>Hu</surname> <given-names>JF</given-names></name><name><surname>Vu</surname> <given-names>TH</given-names></name><name><surname>Chen</surname> <given-names>HL</given-names></name><name><surname>Qiu</surname> <given-names>XW</given-names></name><name><surname>Cherry</surname> <given-names>AM</given-names></name><name><surname>Hoffman</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>CTCF mediates interchromosomal colocalization between <italic>Igf2/H19</italic> and <italic>Wsb1/Nf1</italic></article-title><source>Science</source><volume>312</volume><fpage>269</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1126/science.1123191</pub-id><pub-id pub-id-type="pmid">16614224</pub-id></element-citation></ref><ref id="bib347"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linnemann</surname> <given-names>C</given-names></name><name><surname>Heemskerk</surname> <given-names>B</given-names></name><name><surname>Kvistborg</surname> <given-names>P</given-names></name><name><surname>Kluin</surname> <given-names>RJ</given-names></name><name><surname>Bolotin</surname> <given-names>DA</given-names></name><name><surname>Chen</surname> <given-names>X</given-names></name><name><surname>Bresser</surname> <given-names>K</given-names></name><name><surname>Nieuwland</surname> <given-names>M</given-names></name><name><surname>Schotte</surname> <given-names>R</given-names></name><name><surname>Michels</surname> <given-names>S</given-names></name><name><surname>Gomez-Eerland</surname> <given-names>R</given-names></name><name><surname>Jahn</surname> <given-names>L</given-names></name><name><surname>Hombrink</surname> <given-names>P</given-names></name><name><surname>Legrand</surname> <given-names>N</given-names></name><name><surname>Shu</surname> <given-names>CJ</given-names></name><name><surname>Mamedov</surname> <given-names>IZ</given-names></name><name><surname>Velds</surname> <given-names>A</given-names></name><name><surname>Blank</surname> <given-names>CU</given-names></name><name><surname>Haanen</surname> <given-names>JB</given-names></name><name><surname>Turchaninova</surname> <given-names>MA</given-names></name><name><surname>Kerkhoven</surname> <given-names>RM</given-names></name><name><surname>Spits</surname> <given-names>H</given-names></name><name><surname>Hadrup</surname> <given-names>SR</given-names></name><name><surname>Heemskerk</surname> <given-names>MH</given-names></name><name><surname>Blankenstein</surname> <given-names>T</given-names></name><name><surname>Chudakov</surname> <given-names>DM</given-names></name><name><surname>Bendle</surname> <given-names>GM</given-names></name><name><surname>Schumacher</surname> <given-names>TN</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>High-throughput identification of antigen-specific TCRs by TCR gene capture</article-title><source>Nature Medicine</source><volume>19</volume><fpage>1534</fpage><lpage>1541</lpage><pub-id pub-id-type="doi">10.1038/nm.3359</pub-id><pub-id pub-id-type="pmid">24121928</pub-id></element-citation></ref><ref id="bib348"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lister</surname> <given-names>R</given-names></name><name><surname>Pelizzola</surname> <given-names>M</given-names></name><name><surname>Dowen</surname> <given-names>RH</given-names></name><name><surname>Hawkins</surname> <given-names>RD</given-names></name><name><surname>Hon</surname> <given-names>G</given-names></name><name><surname>Tonti-Filippini</surname> <given-names>J</given-names></name><name><surname>Nery</surname> <given-names>JR</given-names></name><name><surname>Lee</surname> <given-names>L</given-names></name><name><surname>Ye</surname> <given-names>Z</given-names></name><name><surname>Ngo</surname> <given-names>QM</given-names></name><name><surname>Edsall</surname> <given-names>L</given-names></name><name><surname>Antosiewicz-Bourget</surname> <given-names>J</given-names></name><name><surname>Stewart</surname> <given-names>R</given-names></name><name><surname>Ruotti</surname> <given-names>V</given-names></name><name><surname>Millar</surname> <given-names>AH</given-names></name><name><surname>Thomson</surname> <given-names>JA</given-names></name><name><surname>Ren</surname> <given-names>B</given-names></name><name><surname>Ecker</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Human DNA methylomes at base resolution show widespread epigenomic differences</article-title><source>Nature</source><volume>462</volume><fpage>315</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1038/nature08514</pub-id><pub-id pub-id-type="pmid">19829295</pub-id></element-citation></ref><ref id="bib349"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>K</given-names></name><name><surname>Victora</surname> <given-names>GD</given-names></name><name><surname>Schwickert</surname> <given-names>TA</given-names></name><name><surname>Guermonprez</surname> <given-names>P</given-names></name><name><surname>Meredith</surname> <given-names>MM</given-names></name><name><surname>Yao</surname> <given-names>K</given-names></name><name><surname>Chu</surname> <given-names>FF</given-names></name><name><surname>Randolph</surname> <given-names>GJ</given-names></name><name><surname>Rudensky</surname> <given-names>AY</given-names></name><name><surname>Nussenzweig</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>In vivo analysis of dendritic cell development and homeostasis</article-title><source>Science</source><volume>324</volume><fpage>392</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1126/science.1170540</pub-id><pub-id pub-id-type="pmid">19286519</pub-id></element-citation></ref><ref id="bib350"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Gerner</surname> <given-names>MY</given-names></name><name><surname>Van Panhuys</surname> <given-names>N</given-names></name><name><surname>Levine</surname> <given-names>AG</given-names></name><name><surname>Rudensky</surname> <given-names>AY</given-names></name><name><surname>Germain</surname> <given-names>RN</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Immune homeostasis enforced by co-localized effector and regulatory T cells</article-title><source>Nature</source><volume>528</volume><fpage>225</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1038/nature16169</pub-id></element-citation></ref><ref id="bib351"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>S</given-names></name><name><surname>Zhu</surname> <given-names>Y</given-names></name><name><surname>Lin</surname> <given-names>LW</given-names></name><name><surname>Ding</surname> <given-names>SK</given-names></name><name><surname>Lin</surname> <given-names>XC</given-names></name><name><surname>Zhong</surname> <given-names>KL</given-names></name><name><surname>Pan</surname> <given-names>K</given-names></name><name><surname>Dai</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The composition and variation of the BCR CDR3s in gastric cancer</article-title><source>Oncology Letters</source><volume>16</volume><fpage>239</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.3892/ol.2018.8677</pub-id><pub-id pub-id-type="pmid">29928407</pub-id></element-citation></ref><ref id="bib352"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Lu</surname> <given-names>H</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Yan</surname> <given-names>X</given-names></name><name><surname>Xiao</surname> <given-names>M</given-names></name><name><surname>Hao</surname> <given-names>J</given-names></name><name><surname>Alekseev</surname> <given-names>A</given-names></name><name><surname>Khong</surname> <given-names>H</given-names></name><name><surname>Chen</surname> <given-names>T</given-names></name><name><surname>Huang</surname> <given-names>R</given-names></name><name><surname>Wu</surname> <given-names>J</given-names></name><name><surname>Zhao</surname> <given-names>Q</given-names></name><name><surname>Wu</surname> <given-names>Q</given-names></name><name><surname>Xu</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Jin</surname> <given-names>W</given-names></name><name><surname>Yu</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Wei</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>A</given-names></name><name><surname>Zhong</surname> <given-names>B</given-names></name><name><surname>Ni</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Nurieva</surname> <given-names>R</given-names></name><name><surname>Ye</surname> <given-names>L</given-names></name><name><surname>Tian</surname> <given-names>Q</given-names></name><name><surname>Bian</surname> <given-names>XW</given-names></name><name><surname>Dong</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction</article-title><source>Nature</source><volume>567</volume><fpage>525</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-0979-8</pub-id><pub-id pub-id-type="pmid">30814730</pub-id></element-citation></ref><ref id="bib353"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>XS</given-names></name><name><surname>Mardis</surname> <given-names>ER</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Applications of immunogenomics to Cancer</article-title><source>Cell</source><volume>168</volume><fpage>600</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.01.014</pub-id><pub-id pub-id-type="pmid">28187283</pub-id></element-citation></ref><ref id="bib354"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname> <given-names>SA</given-names></name><name><surname>Thorpe</surname> <given-names>J</given-names></name><name><surname>DeBerg</surname> <given-names>HA</given-names></name><name><surname>Gersuk</surname> <given-names>V</given-names></name><name><surname>Eddy</surname> <given-names>J</given-names></name><name><surname>Harris</surname> <given-names>KM</given-names></name><name><surname>Ehlers</surname> <given-names>M</given-names></name><name><surname>Herold</surname> <given-names>KC</given-names></name><name><surname>Nepom</surname> <given-names>GT</given-names></name><name><surname>Linsley</surname> <given-names>PS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes</article-title><source>Science Immunology</source><volume>1</volume><elocation-id>eaai7793</elocation-id><pub-id pub-id-type="doi">10.1126/sciimmunol.aai7793</pub-id><pub-id pub-id-type="pmid">28664195</pub-id></element-citation></ref><ref id="bib355"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lubeck</surname> <given-names>E</given-names></name><name><surname>Coskun</surname> <given-names>AF</given-names></name><name><surname>Zhiyentayev</surname> <given-names>T</given-names></name><name><surname>Ahmad</surname> <given-names>M</given-names></name><name><surname>Cai</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Single-cell in situ RNA profiling by sequential hybridization</article-title><source>Nature Methods</source><volume>11</volume><fpage>360</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2892</pub-id><pub-id pub-id-type="pmid">24681720</pub-id></element-citation></ref><ref id="bib356"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lubeck</surname> <given-names>E</given-names></name><name><surname>Cai</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Single-cell systems biology by super-resolution imaging and combinatorial labeling</article-title><source>Nature Methods</source><volume>9</volume><fpage>743</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2069</pub-id><pub-id pub-id-type="pmid">22660740</pub-id></element-citation></ref><ref id="bib357"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Łuksza</surname> <given-names>M</given-names></name><name><surname>Riaz</surname> <given-names>N</given-names></name><name><surname>Makarov</surname> <given-names>V</given-names></name><name><surname>Balachandran</surname> <given-names>VP</given-names></name><name><surname>Hellmann</surname> <given-names>MD</given-names></name><name><surname>Solovyov</surname> <given-names>A</given-names></name><name><surname>Rizvi</surname> <given-names>NA</given-names></name><name><surname>Merghoub</surname> <given-names>T</given-names></name><name><surname>Levine</surname> <given-names>AJ</given-names></name><name><surname>Chan</surname> <given-names>TA</given-names></name><name><surname>Wolchok</surname> <given-names>JD</given-names></name><name><surname>Greenbaum</surname> <given-names>BD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy</article-title><source>Nature</source><volume>551</volume><fpage>517</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1038/nature24473</pub-id><pub-id pub-id-type="pmid">29132144</pub-id></element-citation></ref><ref id="bib358"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lund</surname> <given-names>AW</given-names></name><name><surname>Duraes</surname> <given-names>FV</given-names></name><name><surname>Hirosue</surname> <given-names>S</given-names></name><name><surname>Raghavan</surname> <given-names>VR</given-names></name><name><surname>Nembrini</surname> <given-names>C</given-names></name><name><surname>Thomas</surname> <given-names>SN</given-names></name><name><surname>Issa</surname> <given-names>A</given-names></name><name><surname>Hugues</surname> <given-names>S</given-names></name><name><surname>Swartz</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics</article-title><source>Cell Reports</source><volume>1</volume><fpage>191</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2012.01.005</pub-id><pub-id pub-id-type="pmid">22832193</pub-id></element-citation></ref><ref id="bib359"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lund</surname> <given-names>AW</given-names></name><name><surname>Wagner</surname> <given-names>M</given-names></name><name><surname>Fankhauser</surname> <given-names>M</given-names></name><name><surname>Steinskog</surname> <given-names>ES</given-names></name><name><surname>Broggi</surname> <given-names>MA</given-names></name><name><surname>Spranger</surname> <given-names>S</given-names></name><name><surname>Gajewski</surname> <given-names>TF</given-names></name><name><surname>Alitalo</surname> <given-names>K</given-names></name><name><surname>Eikesdal</surname> <given-names>HP</given-names></name><name><surname>Wiig</surname> <given-names>H</given-names></name><name><surname>Swartz</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Lymphatic vessels regulate immune microenvironments in human and murine melanoma</article-title><source>Journal of Clinical Investigation</source><volume>126</volume><fpage>3389</fpage><lpage>3402</lpage><pub-id pub-id-type="doi">10.1172/JCI79434</pub-id><pub-id pub-id-type="pmid">27525437</pub-id></element-citation></ref><ref id="bib360"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lundegaard</surname> <given-names>C</given-names></name><name><surname>Lund</surname> <given-names>O</given-names></name><name><surname>Nielsen</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers</article-title><source>Bioinformatics</source><volume>24</volume><fpage>1397</fpage><lpage>1398</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btn128</pub-id><pub-id pub-id-type="pmid">18413329</pub-id></element-citation></ref><ref id="bib361"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>C</given-names></name><name><surname>Fan</surname> <given-names>R</given-names></name><name><surname>Ahmad</surname> <given-names>H</given-names></name><name><surname>Shi</surname> <given-names>Q</given-names></name><name><surname>Comin-Anduix</surname> <given-names>B</given-names></name><name><surname>Chodon</surname> <given-names>T</given-names></name><name><surname>Koya</surname> <given-names>RC</given-names></name><name><surname>Liu</surname> <given-names>CC</given-names></name><name><surname>Kwong</surname> <given-names>GA</given-names></name><name><surname>Radu</surname> <given-names>CG</given-names></name><name><surname>Ribas</surname> <given-names>A</given-names></name><name><surname>Heath</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells</article-title><source>Nature Medicine</source><volume>17</volume><fpage>738</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1038/nm.2375</pub-id><pub-id pub-id-type="pmid">21602800</pub-id></element-citation></ref><ref id="bib362"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maaten</surname> <given-names>L</given-names></name><name><surname>Hinton</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Visualizing data using t-SNE</article-title><source>Journal of Machine Learning Research</source><volume>9</volume><fpage>2579</fpage><lpage>2605</lpage></element-citation></ref><ref id="bib363"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname> <given-names>D</given-names></name><name><surname>Costa</surname> <given-names>RS</given-names></name><name><surname>Rocha</surname> <given-names>M</given-names></name><name><surname>Ferreira</surname> <given-names>EC</given-names></name><name><surname>Tidor</surname> <given-names>B</given-names></name><name><surname>Rocha</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Modeling formalisms in systems biology</article-title><source>AMB Express</source><volume>1</volume><elocation-id>45</elocation-id><pub-id pub-id-type="doi">10.1186/2191-0855-1-45</pub-id><pub-id pub-id-type="pmid">22141422</pub-id></element-citation></ref><ref id="bib364"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macosko</surname> <given-names>EZ</given-names></name><name><surname>Basu</surname> <given-names>A</given-names></name><name><surname>Satija</surname> <given-names>R</given-names></name><name><surname>Nemesh</surname> <given-names>J</given-names></name><name><surname>Shekhar</surname> <given-names>K</given-names></name><name><surname>Goldman</surname> <given-names>M</given-names></name><name><surname>Tirosh</surname> <given-names>I</given-names></name><name><surname>Bialas</surname> <given-names>AR</given-names></name><name><surname>Kamitaki</surname> <given-names>N</given-names></name><name><surname>Martersteck</surname> <given-names>EM</given-names></name><name><surname>Trombetta</surname> <given-names>JJ</given-names></name><name><surname>Weitz</surname> <given-names>DA</given-names></name><name><surname>Sanes</surname> <given-names>JR</given-names></name><name><surname>Shalek</surname> <given-names>AK</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name><name><surname>McCarroll</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Highly parallel Genome-wide expression profiling of individual cells using nanoliter droplets</article-title><source>Cell</source><volume>161</volume><fpage>1202</fpage><lpage>1214</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.05.002</pub-id><pub-id pub-id-type="pmid">26000488</pub-id></element-citation></ref><ref id="bib365"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mai</surname> <given-names>Z</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Boolean network-based analysis of the apoptosis network: irreversible apoptosis and stable surviving</article-title><source>Journal of Theoretical Biology</source><volume>259</volume><fpage>760</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.1016/j.jtbi.2009.04.024</pub-id><pub-id pub-id-type="pmid">19422837</pub-id></element-citation></ref><ref id="bib366"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mak</surname> <given-names>IW</given-names></name><name><surname>Evaniew</surname> <given-names>N</given-names></name><name><surname>Ghert</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Lost in translation: animal models and clinical trials in Cancer treatment</article-title><source>American Journal of Translational Research</source><volume>6</volume><fpage>114</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">24489990</pub-id></element-citation></ref><ref id="bib367"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makridakis</surname> <given-names>M</given-names></name><name><surname>Vlahou</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Secretome proteomics for discovery of cancer biomarkers</article-title><source>Journal of Proteomics</source><volume>73</volume><fpage>2291</fpage><lpage>2305</lpage><pub-id pub-id-type="doi">10.1016/j.jprot.2010.07.001</pub-id><pub-id pub-id-type="pmid">20637910</pub-id></element-citation></ref><ref id="bib368"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mallet</surname> <given-names>DG</given-names></name><name><surname>De Pillis</surname> <given-names>LG</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A cellular automata model of tumor-immune system interactions</article-title><source>Journal of Theoretical Biology</source><volume>239</volume><fpage>334</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1016/j.jtbi.2005.08.002</pub-id><pub-id pub-id-type="pmid">16169016</pub-id></element-citation></ref><ref id="bib369"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malmberg</surname> <given-names>KJ</given-names></name><name><surname>Carlsten</surname> <given-names>M</given-names></name><name><surname>Björklund</surname> <given-names>A</given-names></name><name><surname>Sohlberg</surname> <given-names>E</given-names></name><name><surname>Bryceson</surname> <given-names>YT</given-names></name><name><surname>Ljunggren</surname> <given-names>HG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Natural killer cell-mediated immunosurveillance of human Cancer</article-title><source>Seminars in Immunology</source><volume>31</volume><fpage>20</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.smim.2017.08.002</pub-id><pub-id pub-id-type="pmid">28888619</pub-id></element-citation></ref><ref id="bib370"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandelboim</surname> <given-names>O</given-names></name><name><surname>Berke</surname> <given-names>G</given-names></name><name><surname>Fridkin</surname> <given-names>M</given-names></name><name><surname>Feldman</surname> <given-names>M</given-names></name><name><surname>Eisenstein</surname> <given-names>M</given-names></name><name><surname>Eisenbach</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma</article-title><source>Nature</source><volume>369</volume><fpage>67</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1038/369067a0</pub-id><pub-id pub-id-type="pmid">8164742</pub-id></element-citation></ref><ref id="bib371"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandelboim</surname> <given-names>O</given-names></name><name><surname>Vadai</surname> <given-names>E</given-names></name><name><surname>Fridkin</surname> <given-names>M</given-names></name><name><surname>Katz-Hillel</surname> <given-names>A</given-names></name><name><surname>Feldman</surname> <given-names>M</given-names></name><name><surname>Berke</surname> <given-names>G</given-names></name><name><surname>Eisenbach</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides</article-title><source>Nature Medicine</source><volume>1</volume><fpage>1179</fpage><lpage>1183</lpage><pub-id pub-id-type="doi">10.1038/nm1195-1179</pub-id><pub-id pub-id-type="pmid">7584991</pub-id></element-citation></ref><ref id="bib372"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandruzzato</surname> <given-names>S</given-names></name><name><surname>Brandau</surname> <given-names>S</given-names></name><name><surname>Britten</surname> <given-names>CM</given-names></name><name><surname>Bronte</surname> <given-names>V</given-names></name><name><surname>Damuzzo</surname> <given-names>V</given-names></name><name><surname>Gouttefangeas</surname> <given-names>C</given-names></name><name><surname>Maurer</surname> <given-names>D</given-names></name><name><surname>Ottensmeier</surname> <given-names>C</given-names></name><name><surname>van der Burg</surname> <given-names>SH</given-names></name><name><surname>Welters</surname> <given-names>MJP</given-names></name><name><surname>Walter</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study</article-title><source>Cancer Immunology, Immunotherapy</source><volume>65</volume><fpage>161</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1007/s00262-015-1782-5</pub-id></element-citation></ref><ref id="bib373"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mantovani</surname> <given-names>A</given-names></name><name><surname>Sica</surname> <given-names>A</given-names></name><name><surname>Sozzani</surname> <given-names>S</given-names></name><name><surname>Allavena</surname> <given-names>P</given-names></name><name><surname>Vecchi</surname> <given-names>A</given-names></name><name><surname>Locati</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The chemokine system in diverse forms of macrophage activation and polarization</article-title><source>Trends in Immunology</source><volume>25</volume><fpage>677</fpage><lpage>686</lpage><pub-id pub-id-type="doi">10.1016/j.it.2004.09.015</pub-id><pub-id pub-id-type="pmid">15530839</pub-id></element-citation></ref><ref id="bib374"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcus</surname> <given-names>A</given-names></name><name><surname>Gowen</surname> <given-names>BG</given-names></name><name><surname>Thompson</surname> <given-names>TW</given-names></name><name><surname>Iannello</surname> <given-names>A</given-names></name><name><surname>Ardolino</surname> <given-names>M</given-names></name><name><surname>Deng</surname> <given-names>W</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Shifrin</surname> <given-names>N</given-names></name><name><surname>Raulet</surname> <given-names>DH</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Recognition of tumors by the innate immune system and natural killer cells</article-title><source>Advances in Immunology</source><volume>122</volume><fpage>91</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-800267-4.00003-1</pub-id><pub-id pub-id-type="pmid">24507156</pub-id></element-citation></ref><ref id="bib375"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname> <given-names>FO</given-names></name><name><surname>Gordon</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The M1 and M2 paradigm of macrophage activation: time for reassessment</article-title><source>F1000Prime Reports</source><volume>6</volume><elocation-id>13</elocation-id><pub-id pub-id-type="doi">10.12703/P6-13</pub-id><pub-id pub-id-type="pmid">24669294</pub-id></element-citation></ref><ref id="bib376"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Materi</surname> <given-names>W</given-names></name><name><surname>Wishart</surname> <given-names>DS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Computational systems biology in Cancer: modeling methods and applications</article-title><source>Gene Regulation and Systems Biology</source><volume>1</volume><elocation-id>117762500700100</elocation-id><pub-id pub-id-type="doi">10.1177/117762500700100010</pub-id></element-citation></ref><ref id="bib377"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matson</surname> <given-names>V</given-names></name><name><surname>Fessler</surname> <given-names>J</given-names></name><name><surname>Bao</surname> <given-names>R</given-names></name><name><surname>Chongsuwat</surname> <given-names>T</given-names></name><name><surname>Zha</surname> <given-names>Y</given-names></name><name><surname>Alegre</surname> <given-names>ML</given-names></name><name><surname>Luke</surname> <given-names>JJ</given-names></name><name><surname>Gajewski</surname> <given-names>TF</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients</article-title><source>Science</source><volume>359</volume><fpage>104</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1126/science.aao3290</pub-id><pub-id pub-id-type="pmid">29302014</pub-id></element-citation></ref><ref id="bib378"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsushita</surname> <given-names>H</given-names></name><name><surname>Vesely</surname> <given-names>MD</given-names></name><name><surname>Koboldt</surname> <given-names>DC</given-names></name><name><surname>Rickert</surname> <given-names>CG</given-names></name><name><surname>Uppaluri</surname> <given-names>R</given-names></name><name><surname>Magrini</surname> <given-names>VJ</given-names></name><name><surname>Arthur</surname> <given-names>CD</given-names></name><name><surname>White</surname> <given-names>JM</given-names></name><name><surname>Chen</surname> <given-names>YS</given-names></name><name><surname>Shea</surname> <given-names>LK</given-names></name><name><surname>Hundal</surname> <given-names>J</given-names></name><name><surname>Wendl</surname> <given-names>MC</given-names></name><name><surname>Demeter</surname> <given-names>R</given-names></name><name><surname>Wylie</surname> <given-names>T</given-names></name><name><surname>Allison</surname> <given-names>JP</given-names></name><name><surname>Smyth</surname> <given-names>MJ</given-names></name><name><surname>Old</surname> <given-names>LJ</given-names></name><name><surname>Mardis</surname> <given-names>ER</given-names></name><name><surname>Schreiber</surname> <given-names>RD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting</article-title><source>Nature</source><volume>482</volume><fpage>400</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1038/nature10755</pub-id><pub-id pub-id-type="pmid">22318521</pub-id></element-citation></ref><ref id="bib379"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matzavinos</surname> <given-names>A</given-names></name><name><surname>Chaplain</surname> <given-names>MA</given-names></name><name><surname>Kuznetsov</surname> <given-names>VA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Mathematical modelling of the spatio-temporal response of cytotoxic T-lymphocytes to a solid tumour</article-title><source>Mathematical Medicine and Biology</source><volume>21</volume><fpage>1</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1093/imammb/21.1.1</pub-id><pub-id pub-id-type="pmid">15065736</pub-id></element-citation></ref><ref id="bib380"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazmanian</surname> <given-names>SK</given-names></name><name><surname>Liu</surname> <given-names>CH</given-names></name><name><surname>Tzianabos</surname> <given-names>AO</given-names></name><name><surname>Kasper</surname> <given-names>DL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>An immunomodulatory molecule of symbiotic Bacteria directs maturation of the host immune system</article-title><source>Cell</source><volume>122</volume><fpage>107</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.05.007</pub-id><pub-id pub-id-type="pmid">16009137</pub-id></element-citation></ref><ref id="bib381"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGranahan</surname> <given-names>N</given-names></name><name><surname>Furness</surname> <given-names>AJ</given-names></name><name><surname>Rosenthal</surname> <given-names>R</given-names></name><name><surname>Ramskov</surname> <given-names>S</given-names></name><name><surname>Lyngaa</surname> <given-names>R</given-names></name><name><surname>Saini</surname> <given-names>SK</given-names></name><name><surname>Jamal-Hanjani</surname> <given-names>M</given-names></name><name><surname>Wilson</surname> <given-names>GA</given-names></name><name><surname>Birkbak</surname> <given-names>NJ</given-names></name><name><surname>Hiley</surname> <given-names>CT</given-names></name><name><surname>Watkins</surname> <given-names>TB</given-names></name><name><surname>Shafi</surname> <given-names>S</given-names></name><name><surname>Murugaesu</surname> <given-names>N</given-names></name><name><surname>Mitter</surname> <given-names>R</given-names></name><name><surname>Akarca</surname> <given-names>AU</given-names></name><name><surname>Linares</surname> <given-names>J</given-names></name><name><surname>Marafioti</surname> <given-names>T</given-names></name><name><surname>Henry</surname> <given-names>JY</given-names></name><name><surname>Van Allen</surname> <given-names>EM</given-names></name><name><surname>Miao</surname> <given-names>D</given-names></name><name><surname>Schilling</surname> <given-names>B</given-names></name><name><surname>Schadendorf</surname> <given-names>D</given-names></name><name><surname>Garraway</surname> <given-names>LA</given-names></name><name><surname>Makarov</surname> <given-names>V</given-names></name><name><surname>Rizvi</surname> <given-names>NA</given-names></name><name><surname>Snyder</surname> <given-names>A</given-names></name><name><surname>Hellmann</surname> <given-names>MD</given-names></name><name><surname>Merghoub</surname> <given-names>T</given-names></name><name><surname>Wolchok</surname> <given-names>JD</given-names></name><name><surname>Shukla</surname> <given-names>SA</given-names></name><name><surname>Wu</surname> <given-names>CJ</given-names></name><name><surname>Peggs</surname> <given-names>KS</given-names></name><name><surname>Chan</surname> <given-names>TA</given-names></name><name><surname>Hadrup</surname> <given-names>SR</given-names></name><name><surname>Quezada</surname> <given-names>SA</given-names></name><name><surname>Swanton</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade</article-title><source>Science</source><volume>351</volume><fpage>1463</fpage><lpage>1469</lpage><pub-id pub-id-type="doi">10.1126/science.aaf1490</pub-id><pub-id pub-id-type="pmid">26940869</pub-id></element-citation></ref><ref id="bib382"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>McInnes</surname> <given-names>L</given-names></name><name><surname>Healy</surname> <given-names>J</given-names></name><name><surname>Melville</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Umap: uniform manifold approximation and projection for dimension reduction</article-title><source>arXiv</source><ext-link ext-link-type="uri" xlink:href="https://arxiv.org/abs/1802.03426">https://arxiv.org/abs/1802.03426</ext-link></element-citation></ref><ref id="bib383"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLane</surname> <given-names>LM</given-names></name><name><surname>Abdel-Hakeem</surname> <given-names>MS</given-names></name><name><surname>Wherry</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>CD8 T cell exhaustion during chronic viral infection and Cancer</article-title><source>Annual Review of Immunology</source><volume>37</volume><fpage>457</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-041015-055318</pub-id><pub-id pub-id-type="pmid">30676822</pub-id></element-citation></ref><ref id="bib384"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meissner</surname> <given-names>A</given-names></name><name><surname>Gnirke</surname> <given-names>A</given-names></name><name><surname>Bell</surname> <given-names>GW</given-names></name><name><surname>Ramsahoye</surname> <given-names>B</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Jaenisch</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis</article-title><source>Nucleic Acids Research</source><volume>33</volume><fpage>5868</fpage><lpage>5877</lpage><pub-id pub-id-type="doi">10.1093/nar/gki901</pub-id><pub-id pub-id-type="pmid">16224102</pub-id></element-citation></ref><ref id="bib385"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meissner</surname> <given-names>F</given-names></name><name><surname>Scheltema</surname> <given-names>RA</given-names></name><name><surname>Mollenkopf</surname> <given-names>HJ</given-names></name><name><surname>Mann</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Direct proteomic quantification of the secretome of activated immune cells</article-title><source>Science</source><volume>340</volume><fpage>475</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1126/science.1232578</pub-id><pub-id pub-id-type="pmid">23620052</pub-id></element-citation></ref><ref id="bib386"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mempel</surname> <given-names>TR</given-names></name><name><surname>Henrickson</surname> <given-names>SE</given-names></name><name><surname>Von Andrian</surname> <given-names>UH</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases</article-title><source>Nature</source><volume>427</volume><fpage>154</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1038/nature02238</pub-id><pub-id pub-id-type="pmid">14712275</pub-id></element-citation></ref><ref id="bib387"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merad</surname> <given-names>M</given-names></name><name><surname>Manz</surname> <given-names>MG</given-names></name><name><surname>Karsunky</surname> <given-names>H</given-names></name><name><surname>Wagers</surname> <given-names>A</given-names></name><name><surname>Peters</surname> <given-names>W</given-names></name><name><surname>Charo</surname> <given-names>I</given-names></name><name><surname>Weissman</surname> <given-names>IL</given-names></name><name><surname>Cyster</surname> <given-names>JG</given-names></name><name><surname>Engleman</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Langerhans cells renew in the skin throughout life under steady-state conditions</article-title><source>Nature Immunology</source><volume>3</volume><fpage>1135</fpage><lpage>1141</lpage><pub-id pub-id-type="doi">10.1038/ni852</pub-id><pub-id pub-id-type="pmid">12415265</pub-id></element-citation></ref><ref id="bib388"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merad</surname> <given-names>M</given-names></name><name><surname>Sathe</surname> <given-names>P</given-names></name><name><surname>Helft</surname> <given-names>J</given-names></name><name><surname>Miller</surname> <given-names>J</given-names></name><name><surname>Mortha</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting</article-title><source>Annual Review of Immunology</source><volume>31</volume><fpage>563</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-020711-074950</pub-id><pub-id pub-id-type="pmid">23516985</pub-id></element-citation></ref><ref id="bib389"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mertins</surname> <given-names>P</given-names></name><name><surname>Mani</surname> <given-names>DR</given-names></name><name><surname>Ruggles</surname> <given-names>KV</given-names></name><name><surname>Gillette</surname> <given-names>MA</given-names></name><name><surname>Clauser</surname> <given-names>KR</given-names></name><name><surname>Wang</surname> <given-names>P</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Qiao</surname> <given-names>JW</given-names></name><name><surname>Cao</surname> <given-names>S</given-names></name><name><surname>Petralia</surname> <given-names>F</given-names></name><name><surname>Kawaler</surname> <given-names>E</given-names></name><name><surname>Mundt</surname> <given-names>F</given-names></name><name><surname>Krug</surname> <given-names>K</given-names></name><name><surname>Tu</surname> <given-names>Z</given-names></name><name><surname>Lei</surname> <given-names>JT</given-names></name><name><surname>Gatza</surname> <given-names>ML</given-names></name><name><surname>Wilkerson</surname> <given-names>M</given-names></name><name><surname>Perou</surname> <given-names>CM</given-names></name><name><surname>Yellapantula</surname> <given-names>V</given-names></name><name><surname>Huang</surname> <given-names>KL</given-names></name><name><surname>Lin</surname> <given-names>C</given-names></name><name><surname>McLellan</surname> <given-names>MD</given-names></name><name><surname>Yan</surname> <given-names>P</given-names></name><name><surname>Davies</surname> <given-names>SR</given-names></name><name><surname>Townsend</surname> <given-names>RR</given-names></name><name><surname>Skates</surname> <given-names>SJ</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>B</given-names></name><name><surname>Kinsinger</surname> <given-names>CR</given-names></name><name><surname>Mesri</surname> <given-names>M</given-names></name><name><surname>Rodriguez</surname> <given-names>H</given-names></name><name><surname>Ding</surname> <given-names>L</given-names></name><name><surname>Paulovich</surname> <given-names>AG</given-names></name><name><surname>Fenyö</surname> <given-names>D</given-names></name><name><surname>Ellis</surname> <given-names>MJ</given-names></name><name><surname>Carr</surname> <given-names>SA</given-names></name><collab>NCI CPTAC</collab></person-group><year iso-8601-date="2016">2016</year><article-title>Proteogenomics connects somatic mutations to signalling in breast Cancer</article-title><source>Nature</source><volume>534</volume><fpage>55</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1038/nature18003</pub-id><pub-id pub-id-type="pmid">27251275</pub-id></element-citation></ref><ref id="bib390"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mestas</surname> <given-names>J</given-names></name><name><surname>Hughes</surname> <given-names>CC</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Of mice and not men: differences between mouse and human immunology</article-title><source>The Journal of Immunology</source><volume>172</volume><fpage>2731</fpage><lpage>2738</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.5.2731</pub-id><pub-id pub-id-type="pmid">14978070</pub-id></element-citation></ref><ref id="bib391"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname> <given-names>AS</given-names></name><name><surname>Heiser</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Systems biology approaches to measure and model phenotypic heterogeneity in cancer</article-title><source>Current Opinion in Systems Biology</source><volume>17</volume><fpage>35</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.coisb.2019.09.002</pub-id></element-citation></ref><ref id="bib392"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michor</surname> <given-names>F</given-names></name><name><surname>Hughes</surname> <given-names>TP</given-names></name><name><surname>Iwasa</surname> <given-names>Y</given-names></name><name><surname>Branford</surname> <given-names>S</given-names></name><name><surname>Shah</surname> <given-names>NP</given-names></name><name><surname>Sawyers</surname> <given-names>CL</given-names></name><name><surname>Nowak</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Dynamics of chronic myeloid leukaemia</article-title><source>Nature</source><volume>435</volume><fpage>1267</fpage><lpage>1270</lpage><pub-id pub-id-type="doi">10.1038/nature03669</pub-id><pub-id pub-id-type="pmid">15988530</pub-id></element-citation></ref><ref id="bib393"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mielle</surname> <given-names>J</given-names></name><name><surname>Audo</surname> <given-names>R</given-names></name><name><surname>Hahne</surname> <given-names>M</given-names></name><name><surname>Macia</surname> <given-names>L</given-names></name><name><surname>Combe</surname> <given-names>B</given-names></name><name><surname>Morel</surname> <given-names>J</given-names></name><name><surname>Daien</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>IL-10 producing B cells ability to induce regulatory T cells is maintained in rheumatoid arthritis</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>961</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.00961</pub-id><pub-id pub-id-type="pmid">29774031</pub-id></element-citation></ref><ref id="bib394"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>MJ</given-names></name><name><surname>Wei</surname> <given-names>SH</given-names></name><name><surname>Parker</surname> <given-names>I</given-names></name><name><surname>Cahalan</surname> <given-names>MD</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Two-photon imaging of lymphocyte motility and antigen response in intact lymph node</article-title><source>Science</source><volume>296</volume><fpage>1869</fpage><lpage>1873</lpage><pub-id pub-id-type="doi">10.1126/science.1070051</pub-id><pub-id pub-id-type="pmid">12016203</pub-id></element-citation></ref><ref id="bib395"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname> <given-names>CD</given-names></name><name><surname>Kincaid</surname> <given-names>K</given-names></name><name><surname>Alt</surname> <given-names>JM</given-names></name><name><surname>Heilman</surname> <given-names>MJ</given-names></name><name><surname>Hill</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>M-1/M-2 macrophages and the Th1/Th2 paradigm</article-title><source>The Journal of Immunology</source><volume>164</volume><fpage>6166</fpage><lpage>6173</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.164.12.6166</pub-id><pub-id pub-id-type="pmid">10843666</pub-id></element-citation></ref><ref id="bib396"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mistry</surname> <given-names>AM</given-names></name><name><surname>Greenplate</surname> <given-names>AR</given-names></name><name><surname>Ihrie</surname> <given-names>RA</given-names></name><name><surname>Irish</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Beyond the message: advantages of snapshot proteomics with single-cell mass cytometry in solid tumors</article-title><source>The FEBS Journal</source><volume>286</volume><fpage>1523</fpage><lpage>1539</lpage><pub-id pub-id-type="doi">10.1111/febs.14730</pub-id><pub-id pub-id-type="pmid">30549207</pub-id></element-citation></ref><ref id="bib397"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname> <given-names>D</given-names></name><name><surname>Chintala</surname> <given-names>S</given-names></name><name><surname>Dey</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Plasmacytoid dendritic cell in immunity and cancer</article-title><source>Journal of Neuroimmunology</source><volume>322</volume><fpage>63</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.jneuroim.2018.06.012</pub-id><pub-id pub-id-type="pmid">30049538</pub-id></element-citation></ref><ref id="bib398"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montfort</surname> <given-names>A</given-names></name><name><surname>Pearce</surname> <given-names>O</given-names></name><name><surname>Maniati</surname> <given-names>E</given-names></name><name><surname>Vincent</surname> <given-names>BG</given-names></name><name><surname>Bixby</surname> <given-names>L</given-names></name><name><surname>Böhm</surname> <given-names>S</given-names></name><name><surname>Dowe</surname> <given-names>T</given-names></name><name><surname>Wilkes</surname> <given-names>EH</given-names></name><name><surname>Chakravarty</surname> <given-names>P</given-names></name><name><surname>Thompson</surname> <given-names>R</given-names></name><name><surname>Topping</surname> <given-names>J</given-names></name><name><surname>Cutillas</surname> <given-names>PR</given-names></name><name><surname>Lockley</surname> <given-names>M</given-names></name><name><surname>Serody</surname> <given-names>JS</given-names></name><name><surname>Capasso</surname> <given-names>M</given-names></name><name><surname>Balkwill</surname> <given-names>FR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A strong B-cell response is part of the immune landscape in human High-Grade serous ovarian metastases</article-title><source>Clinical Cancer Research</source><volume>23</volume><fpage>250</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-16-0081</pub-id><pub-id pub-id-type="pmid">27354470</pub-id></element-citation></ref><ref id="bib399"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moretta</surname> <given-names>A</given-names></name><name><surname>Bottino</surname> <given-names>C</given-names></name><name><surname>Pende</surname> <given-names>D</given-names></name><name><surname>Tripodi</surname> <given-names>G</given-names></name><name><surname>Tambussi</surname> <given-names>G</given-names></name><name><surname>Viale</surname> <given-names>O</given-names></name><name><surname>Orengo</surname> <given-names>A</given-names></name><name><surname>Barbaresi</surname> <given-names>M</given-names></name><name><surname>Merli</surname> <given-names>A</given-names></name><name><surname>Ciccone</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition</article-title><source>The Journal of Experimental Medicine</source><volume>172</volume><fpage>1589</fpage><lpage>1598</lpage><pub-id pub-id-type="doi">10.1084/jem.172.6.1589</pub-id><pub-id pub-id-type="pmid">2147946</pub-id></element-citation></ref><ref id="bib400"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mose</surname> <given-names>LE</given-names></name><name><surname>Selitsky</surname> <given-names>SR</given-names></name><name><surname>Bixby</surname> <given-names>LM</given-names></name><name><surname>Marron</surname> <given-names>DL</given-names></name><name><surname>Iglesia</surname> <given-names>MD</given-names></name><name><surname>Serody</surname> <given-names>JS</given-names></name><name><surname>Perou</surname> <given-names>CM</given-names></name><name><surname>Vincent</surname> <given-names>BG</given-names></name><name><surname>Parker</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V'DJer</article-title><source>Bioinformatics</source><volume>32</volume><fpage>3729</fpage><lpage>3734</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btw526</pub-id><pub-id pub-id-type="pmid">27559159</pub-id></element-citation></ref><ref id="bib401"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosser</surname> <given-names>DM</given-names></name><name><surname>Edwards</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Exploring the full spectrum of macrophage activation</article-title><source>Nature Reviews Immunology</source><volume>8</volume><fpage>958</fpage><lpage>969</lpage><pub-id pub-id-type="doi">10.1038/nri2448</pub-id><pub-id pub-id-type="pmid">19029990</pub-id></element-citation></ref><ref id="bib402"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller</surname> <given-names>S</given-names></name><name><surname>Kohanbash</surname> <given-names>G</given-names></name><name><surname>Liu</surname> <given-names>SJ</given-names></name><name><surname>Alvarado</surname> <given-names>B</given-names></name><name><surname>Carrera</surname> <given-names>D</given-names></name><name><surname>Bhaduri</surname> <given-names>A</given-names></name><name><surname>Watchmaker</surname> <given-names>PB</given-names></name><name><surname>Yagnik</surname> <given-names>G</given-names></name><name><surname>Di Lullo</surname> <given-names>E</given-names></name><name><surname>Malatesta</surname> <given-names>M</given-names></name><name><surname>Amankulor</surname> <given-names>NM</given-names></name><name><surname>Kriegstein</surname> <given-names>AR</given-names></name><name><surname>Lim</surname> <given-names>DA</given-names></name><name><surname>Aghi</surname> <given-names>M</given-names></name><name><surname>Okada</surname> <given-names>H</given-names></name><name><surname>Diaz</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment</article-title><source>Genome Biology</source><volume>18</volume><elocation-id>234</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-017-1362-4</pub-id><pub-id pub-id-type="pmid">29262845</pub-id></element-citation></ref><ref id="bib403"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mumbach</surname> <given-names>MR</given-names></name><name><surname>Rubin</surname> <given-names>AJ</given-names></name><name><surname>Flynn</surname> <given-names>RA</given-names></name><name><surname>Dai</surname> <given-names>C</given-names></name><name><surname>Khavari</surname> <given-names>PA</given-names></name><name><surname>Greenleaf</surname> <given-names>WJ</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>HiChIP: efficient and sensitive analysis of protein-directed genome architecture</article-title><source>Nature Methods</source><volume>13</volume><fpage>919</fpage><lpage>922</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3999</pub-id><pub-id pub-id-type="pmid">27643841</pub-id></element-citation></ref><ref id="bib404"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mumbach</surname> <given-names>MR</given-names></name><name><surname>Satpathy</surname> <given-names>AT</given-names></name><name><surname>Boyle</surname> <given-names>EA</given-names></name><name><surname>Dai</surname> <given-names>C</given-names></name><name><surname>Gowen</surname> <given-names>BG</given-names></name><name><surname>Cho</surname> <given-names>SW</given-names></name><name><surname>Nguyen</surname> <given-names>ML</given-names></name><name><surname>Rubin</surname> <given-names>AJ</given-names></name><name><surname>Granja</surname> <given-names>JM</given-names></name><name><surname>Kazane</surname> <given-names>KR</given-names></name><name><surname>Wei</surname> <given-names>Y</given-names></name><name><surname>Nguyen</surname> <given-names>T</given-names></name><name><surname>Greenside</surname> <given-names>PG</given-names></name><name><surname>Corces</surname> <given-names>MR</given-names></name><name><surname>Tycko</surname> <given-names>J</given-names></name><name><surname>Simeonov</surname> <given-names>DR</given-names></name><name><surname>Suliman</surname> <given-names>N</given-names></name><name><surname>Li</surname> <given-names>R</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Flynn</surname> <given-names>RA</given-names></name><name><surname>Kundaje</surname> <given-names>A</given-names></name><name><surname>Khavari</surname> <given-names>PA</given-names></name><name><surname>Marson</surname> <given-names>A</given-names></name><name><surname>Corn</surname> <given-names>JE</given-names></name><name><surname>Quertermous</surname> <given-names>T</given-names></name><name><surname>Greenleaf</surname> <given-names>WJ</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Enhancer connectome in primary human cells identifies target genes of disease-associated DNA elements</article-title><source>Nature Genetics</source><volume>49</volume><fpage>1602</fpage><lpage>1612</lpage><pub-id pub-id-type="doi">10.1038/ng.3963</pub-id><pub-id pub-id-type="pmid">28945252</pub-id></element-citation></ref><ref id="bib405"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname> <given-names>TL</given-names></name><name><surname>Tussiwand</surname> <given-names>R</given-names></name><name><surname>Murphy</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Specificity through cooperation: batf-irf interactions control immune-regulatory networks</article-title><source>Nature Reviews Immunology</source><volume>13</volume><fpage>499</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1038/nri3470</pub-id><pub-id pub-id-type="pmid">23787991</pub-id></element-citation></ref><ref id="bib406"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname> <given-names>PJ</given-names></name><name><surname>Allen</surname> <given-names>JE</given-names></name><name><surname>Biswas</surname> <given-names>SK</given-names></name><name><surname>Fisher</surname> <given-names>EA</given-names></name><name><surname>Gilroy</surname> <given-names>DW</given-names></name><name><surname>Goerdt</surname> <given-names>S</given-names></name><name><surname>Gordon</surname> <given-names>S</given-names></name><name><surname>Hamilton</surname> <given-names>JA</given-names></name><name><surname>Ivashkiv</surname> <given-names>LB</given-names></name><name><surname>Lawrence</surname> <given-names>T</given-names></name><name><surname>Locati</surname> <given-names>M</given-names></name><name><surname>Mantovani</surname> <given-names>A</given-names></name><name><surname>Martinez</surname> <given-names>FO</given-names></name><name><surname>Mege</surname> <given-names>JL</given-names></name><name><surname>Mosser</surname> <given-names>DM</given-names></name><name><surname>Natoli</surname> <given-names>G</given-names></name><name><surname>Saeij</surname> <given-names>JP</given-names></name><name><surname>Schultze</surname> <given-names>JL</given-names></name><name><surname>Shirey</surname> <given-names>KA</given-names></name><name><surname>Sica</surname> <given-names>A</given-names></name><name><surname>Suttles</surname> <given-names>J</given-names></name><name><surname>Udalova</surname> <given-names>I</given-names></name><name><surname>van Ginderachter</surname> <given-names>JA</given-names></name><name><surname>Vogel</surname> <given-names>SN</given-names></name><name><surname>Wynn</surname> <given-names>TA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Macrophage activation and polarization: nomenclature and experimental guidelines</article-title><source>Immunity</source><volume>41</volume><fpage>14</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.06.008</pub-id><pub-id pub-id-type="pmid">25035950</pub-id></element-citation></ref><ref id="bib407"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname> <given-names>PJ</given-names></name><name><surname>Wynn</surname> <given-names>TA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Protective and pathogenic functions of macrophage subsets</article-title><source>Nature Reviews Immunology</source><volume>11</volume><fpage>723</fpage><lpage>737</lpage><pub-id pub-id-type="doi">10.1038/nri3073</pub-id><pub-id pub-id-type="pmid">21997792</pub-id></element-citation></ref><ref id="bib408"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mustafa</surname> <given-names>SA</given-names></name><name><surname>Hoheisel</surname> <given-names>JD</given-names></name><name><surname>Alhamdani</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Secretome profiling with antibody microarrays</article-title><source>Molecular BioSystems</source><volume>7</volume><fpage>1795</fpage><lpage>1801</lpage><pub-id pub-id-type="doi">10.1039/c1mb05071k</pub-id><pub-id pub-id-type="pmid">21505656</pub-id></element-citation></ref><ref id="bib409"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naba</surname> <given-names>A</given-names></name><name><surname>Clauser</surname> <given-names>KR</given-names></name><name><surname>Hoersch</surname> <given-names>S</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>Carr</surname> <given-names>SA</given-names></name><name><surname>Hynes</surname> <given-names>RO</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices</article-title><source>Molecular &amp; Cellular Proteomics : MCP</source><volume>11</volume><elocation-id>M111.014647</elocation-id><pub-id pub-id-type="doi">10.1074/mcp.M111.014647</pub-id><pub-id pub-id-type="pmid">22159717</pub-id></element-citation></ref><ref id="bib410"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagano</surname> <given-names>T</given-names></name><name><surname>Lubling</surname> <given-names>Y</given-names></name><name><surname>Stevens</surname> <given-names>TJ</given-names></name><name><surname>Schoenfelder</surname> <given-names>S</given-names></name><name><surname>Yaffe</surname> <given-names>E</given-names></name><name><surname>Dean</surname> <given-names>W</given-names></name><name><surname>Laue</surname> <given-names>ED</given-names></name><name><surname>Tanay</surname> <given-names>A</given-names></name><name><surname>Fraser</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Single-cell Hi-C reveals cell-to-cell variability in chromosome structure</article-title><source>Nature</source><volume>502</volume><fpage>59</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1038/nature12593</pub-id><pub-id pub-id-type="pmid">24067610</pub-id></element-citation></ref><ref id="bib411"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naik</surname> <given-names>SH</given-names></name><name><surname>Sathe</surname> <given-names>P</given-names></name><name><surname>Park</surname> <given-names>HY</given-names></name><name><surname>Metcalf</surname> <given-names>D</given-names></name><name><surname>Proietto</surname> <given-names>AI</given-names></name><name><surname>Dakic</surname> <given-names>A</given-names></name><name><surname>Carotta</surname> <given-names>S</given-names></name><name><surname>O'Keeffe</surname> <given-names>M</given-names></name><name><surname>Bahlo</surname> <given-names>M</given-names></name><name><surname>Papenfuss</surname> <given-names>A</given-names></name><name><surname>Kwak</surname> <given-names>JY</given-names></name><name><surname>Wu</surname> <given-names>L</given-names></name><name><surname>Shortman</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo</article-title><source>Nature Immunology</source><volume>8</volume><fpage>1217</fpage><lpage>1226</lpage><pub-id pub-id-type="doi">10.1038/ni1522</pub-id><pub-id pub-id-type="pmid">17922015</pub-id></element-citation></ref><ref id="bib412"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Nature Biotechnology</collab></person-group><year iso-8601-date="2012">2012</year><article-title>What happened to personalized medicine?</article-title><source>Nature Biotechnology</source><volume>30</volume><elocation-id>1</elocation-id><pub-id pub-id-type="doi">10.1038/nbt.2096</pub-id><pub-id pub-id-type="pmid">22231070</pub-id></element-citation></ref><ref id="bib413"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navin</surname> <given-names>N</given-names></name><name><surname>Kendall</surname> <given-names>J</given-names></name><name><surname>Troge</surname> <given-names>J</given-names></name><name><surname>Andrews</surname> <given-names>P</given-names></name><name><surname>Rodgers</surname> <given-names>L</given-names></name><name><surname>McIndoo</surname> <given-names>J</given-names></name><name><surname>Cook</surname> <given-names>K</given-names></name><name><surname>Stepansky</surname> <given-names>A</given-names></name><name><surname>Levy</surname> <given-names>D</given-names></name><name><surname>Esposito</surname> <given-names>D</given-names></name><name><surname>Muthuswamy</surname> <given-names>L</given-names></name><name><surname>Krasnitz</surname> <given-names>A</given-names></name><name><surname>McCombie</surname> <given-names>WR</given-names></name><name><surname>Hicks</surname> <given-names>J</given-names></name><name><surname>Wigler</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Tumour evolution inferred by single-cell sequencing</article-title><source>Nature</source><volume>472</volume><fpage>90</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1038/nature09807</pub-id><pub-id pub-id-type="pmid">21399628</pub-id></element-citation></ref><ref id="bib414"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newell</surname> <given-names>EW</given-names></name><name><surname>Sigal</surname> <given-names>N</given-names></name><name><surname>Nair</surname> <given-names>N</given-names></name><name><surname>Kidd</surname> <given-names>BA</given-names></name><name><surname>Greenberg</surname> <given-names>HB</given-names></name><name><surname>Davis</surname> <given-names>MM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization</article-title><source>Nature Biotechnology</source><volume>31</volume><fpage>623</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1038/nbt.2593</pub-id><pub-id pub-id-type="pmid">23748502</pub-id></element-citation></ref><ref id="bib415"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newell</surname> <given-names>EW</given-names></name><name><surname>Davis</surname> <given-names>MM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells</article-title><source>Nature Biotechnology</source><volume>32</volume><fpage>149</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1038/nbt.2783</pub-id><pub-id pub-id-type="pmid">24441473</pub-id></element-citation></ref><ref id="bib416"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname> <given-names>AM</given-names></name><name><surname>Liu</surname> <given-names>CL</given-names></name><name><surname>Green</surname> <given-names>MR</given-names></name><name><surname>Gentles</surname> <given-names>AJ</given-names></name><name><surname>Feng</surname> <given-names>W</given-names></name><name><surname>Xu</surname> <given-names>Y</given-names></name><name><surname>Hoang</surname> <given-names>CD</given-names></name><name><surname>Diehn</surname> <given-names>M</given-names></name><name><surname>Alizadeh</surname> <given-names>AA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Robust enumeration of cell subsets from tissue expression profiles</article-title><source>Nature Methods</source><volume>12</volume><fpage>453</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3337</pub-id><pub-id pub-id-type="pmid">25822800</pub-id></element-citation></ref><ref id="bib417"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname> <given-names>AM</given-names></name><name><surname>Steen</surname> <given-names>CB</given-names></name><name><surname>Liu</surname> <given-names>CL</given-names></name><name><surname>Gentles</surname> <given-names>AJ</given-names></name><name><surname>Chaudhuri</surname> <given-names>AA</given-names></name><name><surname>Scherer</surname> <given-names>F</given-names></name><name><surname>Khodadoust</surname> <given-names>MS</given-names></name><name><surname>Esfahani</surname> <given-names>MS</given-names></name><name><surname>Luca</surname> <given-names>BA</given-names></name><name><surname>Steiner</surname> <given-names>D</given-names></name><name><surname>Diehn</surname> <given-names>M</given-names></name><name><surname>Alizadeh</surname> <given-names>AA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Determining cell type abundance and expression from bulk tissues with digital cytometry</article-title><source>Nature Biotechnology</source><volume>37</volume><fpage>773</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1038/s41587-019-0114-2</pub-id><pub-id pub-id-type="pmid">31061481</pub-id></element-citation></ref><ref id="bib418"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neyt</surname> <given-names>K</given-names></name><name><surname>Perros</surname> <given-names>F</given-names></name><name><surname>GeurtsvanKessel</surname> <given-names>CH</given-names></name><name><surname>Hammad</surname> <given-names>H</given-names></name><name><surname>Lambrecht</surname> <given-names>BN</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Tertiary lymphoid organs in infection and autoimmunity</article-title><source>Trends in Immunology</source><volume>33</volume><fpage>297</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1016/j.it.2012.04.006</pub-id><pub-id pub-id-type="pmid">22622061</pub-id></element-citation></ref><ref id="bib419"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nghiem</surname> <given-names>PT</given-names></name><name><surname>Bhatia</surname> <given-names>S</given-names></name><name><surname>Lipson</surname> <given-names>EJ</given-names></name><name><surname>Kudchadkar</surname> <given-names>RR</given-names></name><name><surname>Miller</surname> <given-names>NJ</given-names></name><name><surname>Annamalai</surname> <given-names>L</given-names></name><name><surname>Berry</surname> <given-names>S</given-names></name><name><surname>Chartash</surname> <given-names>EK</given-names></name><name><surname>Daud</surname> <given-names>A</given-names></name><name><surname>Fling</surname> <given-names>SP</given-names></name><name><surname>Friedlander</surname> <given-names>PA</given-names></name><name><surname>Kluger</surname> <given-names>HM</given-names></name><name><surname>Kohrt</surname> <given-names>HE</given-names></name><name><surname>Lundgren</surname> <given-names>L</given-names></name><name><surname>Margolin</surname> <given-names>K</given-names></name><name><surname>Mitchell</surname> <given-names>A</given-names></name><name><surname>Olencki</surname> <given-names>T</given-names></name><name><surname>Pardoll</surname> <given-names>DM</given-names></name><name><surname>Reddy</surname> <given-names>SA</given-names></name><name><surname>Shantha</surname> <given-names>EM</given-names></name><name><surname>Sharfman</surname> <given-names>WH</given-names></name><name><surname>Sharon</surname> <given-names>E</given-names></name><name><surname>Shemanski</surname> <given-names>LR</given-names></name><name><surname>Shinohara</surname> <given-names>MM</given-names></name><name><surname>Sunshine</surname> <given-names>JC</given-names></name><name><surname>Taube</surname> <given-names>JM</given-names></name><name><surname>Thompson</surname> <given-names>JA</given-names></name><name><surname>Townson</surname> <given-names>SM</given-names></name><name><surname>Yearley</surname> <given-names>JH</given-names></name><name><surname>Topalian</surname> <given-names>SL</given-names></name><name><surname>Cheever</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>PD-1 blockade with pembrolizumab in advanced Merkel-Cell carcinoma</article-title><source>New England Journal of Medicine</source><volume>374</volume><fpage>2542</fpage><lpage>2552</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1603702</pub-id><pub-id pub-id-type="pmid">27093365</pub-id></element-citation></ref><ref id="bib420"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nichols</surname> <given-names>LA</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Colella</surname> <given-names>TA</given-names></name><name><surname>Bennett</surname> <given-names>CL</given-names></name><name><surname>Clausen</surname> <given-names>BE</given-names></name><name><surname>Engelhard</surname> <given-names>VH</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Deletional self-tolerance to a melanocyte/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes</article-title><source>The Journal of Immunology</source><volume>179</volume><fpage>993</fpage><lpage>1003</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.179.2.993</pub-id><pub-id pub-id-type="pmid">17617591</pub-id></element-citation></ref><ref id="bib421"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholson</surname> <given-names>JK</given-names></name><name><surname>Connelly</surname> <given-names>J</given-names></name><name><surname>Lindon</surname> <given-names>JC</given-names></name><name><surname>Holmes</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Metabonomics: a platform for studying drug toxicity and gene function</article-title><source>Nature Reviews Drug Discovery</source><volume>1</volume><fpage>153</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1038/nrd728</pub-id><pub-id pub-id-type="pmid">12120097</pub-id></element-citation></ref><ref id="bib422"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholson</surname> <given-names>JK</given-names></name><name><surname>Lindon</surname> <given-names>JC</given-names></name><name><surname>Lindon, Metabonomics</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Metabonomics</article-title><source>Nature</source><volume>455</volume><fpage>1054</fpage><lpage>1056</lpage><pub-id pub-id-type="doi">10.1038/4551054a</pub-id></element-citation></ref><ref id="bib423"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nie</surname> <given-names>Z</given-names></name><name><surname>Hu</surname> <given-names>G</given-names></name><name><surname>Wei</surname> <given-names>G</given-names></name><name><surname>Cui</surname> <given-names>K</given-names></name><name><surname>Yamane</surname> <given-names>A</given-names></name><name><surname>Resch</surname> <given-names>W</given-names></name><name><surname>Wang</surname> <given-names>R</given-names></name><name><surname>Green</surname> <given-names>DR</given-names></name><name><surname>Tessarollo</surname> <given-names>L</given-names></name><name><surname>Casellas</surname> <given-names>R</given-names></name><name><surname>Zhao</surname> <given-names>K</given-names></name><name><surname>Levens</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells</article-title><source>Cell</source><volume>151</volume><fpage>68</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.08.033</pub-id><pub-id pub-id-type="pmid">23021216</pub-id></element-citation></ref><ref id="bib424"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishino</surname> <given-names>M</given-names></name><name><surname>Ramaiya</surname> <given-names>NH</given-names></name><name><surname>Hatabu</surname> <given-names>H</given-names></name><name><surname>Hodi</surname> <given-names>FS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Monitoring immune-checkpoint blockade: response evaluation and biomarker development</article-title><source>Nature Reviews Clinical Oncology</source><volume>14</volume><fpage>655</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1038/nrclinonc.2017.88</pub-id><pub-id pub-id-type="pmid">28653677</pub-id></element-citation></ref><ref id="bib425"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Northrup</surname> <given-names>DL</given-names></name><name><surname>Zhao</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Application of ChIP-Seq and related techniques to the study of immune function</article-title><source>Immunity</source><volume>34</volume><fpage>830</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.06.002</pub-id><pub-id pub-id-type="pmid">21703538</pub-id></element-citation></ref><ref id="bib426"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norton</surname> <given-names>KA</given-names></name><name><surname>Gong</surname> <given-names>C</given-names></name><name><surname>Jamalian</surname> <given-names>S</given-names></name><name><surname>Popel</surname> <given-names>AS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Multiscale Agent-Based and hybrid modeling of the tumor immune microenvironment</article-title><source>Processes</source><volume>7</volume><elocation-id>37</elocation-id><pub-id pub-id-type="doi">10.3390/pr7010037</pub-id><pub-id pub-id-type="pmid">30701168</pub-id></element-citation></ref><ref id="bib427"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norton</surname> <given-names>L</given-names></name><name><surname>Simon</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="1977">1977</year><article-title>Growth curve of an experimental solid tumor following radiotherapy</article-title><source>JNCI: Journal of the National Cancer Institute</source><volume>58</volume><fpage>1735</fpage><lpage>1741</lpage><pub-id pub-id-type="doi">10.1093/jnci/58.6.1735</pub-id></element-citation></ref><ref id="bib428"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowak</surname> <given-names>MA</given-names></name><name><surname>Sigmund</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Evolutionary dynamics of biological games</article-title><source>Science</source><volume>303</volume><fpage>793</fpage><lpage>799</lpage><pub-id pub-id-type="doi">10.1126/science.1093411</pub-id><pub-id pub-id-type="pmid">14764867</pub-id></element-citation></ref><ref id="bib429"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowicki</surname> <given-names>TS</given-names></name><name><surname>Berent-Maoz</surname> <given-names>B</given-names></name><name><surname>Cheung-Lau</surname> <given-names>G</given-names></name><name><surname>Huang</surname> <given-names>RR</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Tsoi</surname> <given-names>J</given-names></name><name><surname>Kaplan-Lefko</surname> <given-names>P</given-names></name><name><surname>Cabrera</surname> <given-names>P</given-names></name><name><surname>Tran</surname> <given-names>J</given-names></name><name><surname>Pang</surname> <given-names>J</given-names></name><name><surname>Macabali</surname> <given-names>M</given-names></name><name><surname>Garcilazo</surname> <given-names>IP</given-names></name><name><surname>Carretero</surname> <given-names>IB</given-names></name><name><surname>Kalbasi</surname> <given-names>A</given-names></name><name><surname>Cochran</surname> <given-names>AJ</given-names></name><name><surname>Grasso</surname> <given-names>CS</given-names></name><name><surname>Hu-Lieskovan</surname> <given-names>S</given-names></name><name><surname>Chmielowski</surname> <given-names>B</given-names></name><name><surname>Comin-Anduix</surname> <given-names>B</given-names></name><name><surname>Singh</surname> <given-names>A</given-names></name><name><surname>Ribas</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A pilot trial of the combination of transgenic NY-ESO-1-reactive adoptive cellular therapy with dendritic cell vaccination with or without ipilimumab</article-title><source>Clinical Cancer Research</source><volume>25</volume><fpage>2096</fpage><lpage>2108</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-18-3496</pub-id><pub-id pub-id-type="pmid">30573690</pub-id></element-citation></ref><ref id="bib430"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noy</surname> <given-names>R</given-names></name><name><surname>Pollard</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Tumor-associated macrophages: from mechanisms to therapy</article-title><source>Immunity</source><volume>41</volume><fpage>49</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.06.010</pub-id><pub-id pub-id-type="pmid">25035953</pub-id></element-citation></ref><ref id="bib431"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nozawa</surname> <given-names>H</given-names></name><name><surname>Chiu</surname> <given-names>C</given-names></name><name><surname>Hanahan</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis</article-title><source>PNAS</source><volume>103</volume><fpage>12493</fpage><lpage>12498</lpage><pub-id pub-id-type="doi">10.1073/pnas.0601807103</pub-id><pub-id pub-id-type="pmid">16891410</pub-id></element-citation></ref><ref id="bib432"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nyhus</surname> <given-names>JK</given-names></name><name><surname>Wolford</surname> <given-names>CC</given-names></name><name><surname>Friece</surname> <given-names>CR</given-names></name><name><surname>Nelson</surname> <given-names>MB</given-names></name><name><surname>Sampsel</surname> <given-names>JW</given-names></name><name><surname>Barbera-Guillem</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>IgG-recognizing shed tumor-associated antigens can promote tumor invasion and metastasis</article-title><source>Cancer Immunology, Immunotherapy</source><volume>50</volume><fpage>361</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1007/s002620100206</pub-id><pub-id pub-id-type="pmid">11676396</pub-id></element-citation></ref><ref id="bib433"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odell</surname> <given-names>GM</given-names></name><name><surname>Foe</surname> <given-names>VE</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>An agent-based model contrasts opposite effects of dynamic and stable microtubules on cleavage furrow positioning</article-title><source>Journal of Cell Biology</source><volume>183</volume><fpage>471</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1083/jcb.200807129</pub-id><pub-id pub-id-type="pmid">18955556</pub-id></element-citation></ref><ref id="bib434"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olive</surname> <given-names>KP</given-names></name><name><surname>Jacobetz</surname> <given-names>MA</given-names></name><name><surname>Davidson</surname> <given-names>CJ</given-names></name><name><surname>Gopinathan</surname> <given-names>A</given-names></name><name><surname>McIntyre</surname> <given-names>D</given-names></name><name><surname>Honess</surname> <given-names>D</given-names></name><name><surname>Madhu</surname> <given-names>B</given-names></name><name><surname>Goldgraben</surname> <given-names>MA</given-names></name><name><surname>Caldwell</surname> <given-names>ME</given-names></name><name><surname>Allard</surname> <given-names>D</given-names></name><name><surname>Frese</surname> <given-names>KK</given-names></name><name><surname>DeNicola</surname> <given-names>G</given-names></name><name><surname>Feig</surname> <given-names>C</given-names></name><name><surname>Combs</surname> <given-names>C</given-names></name><name><surname>Winter</surname> <given-names>SP</given-names></name><name><surname>Ireland-Zecchini</surname> <given-names>H</given-names></name><name><surname>Reichelt</surname> <given-names>S</given-names></name><name><surname>Howat</surname> <given-names>WJ</given-names></name><name><surname>Chang</surname> <given-names>A</given-names></name><name><surname>Dhara</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Ruckert</surname> <given-names>F</given-names></name><name><surname>Grutzmann</surname> <given-names>R</given-names></name><name><surname>Pilarsky</surname> <given-names>C</given-names></name><name><surname>Izeradjene</surname> <given-names>K</given-names></name><name><surname>Hingorani</surname> <given-names>SR</given-names></name><name><surname>Huang</surname> <given-names>P</given-names></name><name><surname>Davies</surname> <given-names>SE</given-names></name><name><surname>Plunkett</surname> <given-names>W</given-names></name><name><surname>Egorin</surname> <given-names>M</given-names></name><name><surname>Hruban</surname> <given-names>RH</given-names></name><name><surname>Whitebread</surname> <given-names>N</given-names></name><name><surname>McGovern</surname> <given-names>K</given-names></name><name><surname>Adams</surname> <given-names>J</given-names></name><name><surname>Iacobuzio-Donahue</surname> <given-names>C</given-names></name><name><surname>Griffiths</surname> <given-names>J</given-names></name><name><surname>Tuveson</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic Cancer</article-title><source>Science</source><volume>324</volume><fpage>1457</fpage><lpage>1461</lpage><pub-id pub-id-type="doi">10.1126/science.1171362</pub-id></element-citation></ref><ref id="bib435"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olkhanud</surname> <given-names>PB</given-names></name><name><surname>Damdinsuren</surname> <given-names>B</given-names></name><name><surname>Bodogai</surname> <given-names>M</given-names></name><name><surname>Gress</surname> <given-names>RE</given-names></name><name><surname>Sen</surname> <given-names>R</given-names></name><name><surname>Wejksza</surname> <given-names>K</given-names></name><name><surname>Malchinkhuu</surname> <given-names>E</given-names></name><name><surname>Wersto</surname> <given-names>RP</given-names></name><name><surname>Biragyn</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Tumor-evoked regulatory B cells promote breast Cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells</article-title><source>Cancer Research</source><volume>71</volume><fpage>3505</fpage><lpage>3515</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-10-4316</pub-id><pub-id pub-id-type="pmid">21444674</pub-id></element-citation></ref><ref id="bib436"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olson</surname> <given-names>B</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>ET</given-names></name><name><surname>Patnaik</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mouse models for Cancer immunotherapy research</article-title><source>Cancer Discovery</source><volume>8</volume><fpage>1358</fpage><lpage>1365</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-18-0044</pub-id><pub-id pub-id-type="pmid">30309862</pub-id></element-citation></ref><ref id="bib437"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onai</surname> <given-names>N</given-names></name><name><surname>Obata-Onai</surname> <given-names>A</given-names></name><name><surname>Schmid</surname> <given-names>MA</given-names></name><name><surname>Ohteki</surname> <given-names>T</given-names></name><name><surname>Jarrossay</surname> <given-names>D</given-names></name><name><surname>Manz</surname> <given-names>MG</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow</article-title><source>Nature Immunology</source><volume>8</volume><fpage>1207</fpage><lpage>1216</lpage><pub-id pub-id-type="doi">10.1038/ni1518</pub-id><pub-id pub-id-type="pmid">17922016</pub-id></element-citation></ref><ref id="bib438"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ott</surname> <given-names>PA</given-names></name><name><surname>Hu</surname> <given-names>Z</given-names></name><name><surname>Keskin</surname> <given-names>DB</given-names></name><name><surname>Shukla</surname> <given-names>SA</given-names></name><name><surname>Sun</surname> <given-names>J</given-names></name><name><surname>Bozym</surname> <given-names>DJ</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Luoma</surname> <given-names>A</given-names></name><name><surname>Giobbie-Hurder</surname> <given-names>A</given-names></name><name><surname>Peter</surname> <given-names>L</given-names></name><name><surname>Chen</surname> <given-names>C</given-names></name><name><surname>Olive</surname> <given-names>O</given-names></name><name><surname>Carter</surname> <given-names>TA</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>Lieb</surname> <given-names>DJ</given-names></name><name><surname>Eisenhaure</surname> <given-names>T</given-names></name><name><surname>Gjini</surname> <given-names>E</given-names></name><name><surname>Stevens</surname> <given-names>J</given-names></name><name><surname>Lane</surname> <given-names>WJ</given-names></name><name><surname>Javeri</surname> <given-names>I</given-names></name><name><surname>Nellaiappan</surname> <given-names>K</given-names></name><name><surname>Salazar</surname> <given-names>AM</given-names></name><name><surname>Daley</surname> <given-names>H</given-names></name><name><surname>Seaman</surname> <given-names>M</given-names></name><name><surname>Buchbinder</surname> <given-names>EI</given-names></name><name><surname>Yoon</surname> <given-names>CH</given-names></name><name><surname>Harden</surname> <given-names>M</given-names></name><name><surname>Lennon</surname> <given-names>N</given-names></name><name><surname>Gabriel</surname> <given-names>S</given-names></name><name><surname>Rodig</surname> <given-names>SJ</given-names></name><name><surname>Barouch</surname> <given-names>DH</given-names></name><name><surname>Aster</surname> <given-names>JC</given-names></name><name><surname>Getz</surname> <given-names>G</given-names></name><name><surname>Wucherpfennig</surname> <given-names>K</given-names></name><name><surname>Neuberg</surname> <given-names>D</given-names></name><name><surname>Ritz</surname> <given-names>J</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Fritsch</surname> <given-names>EF</given-names></name><name><surname>Hacohen</surname> <given-names>N</given-names></name><name><surname>Wu</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>An immunogenic personal neoantigen vaccine for patients with melanoma</article-title><source>Nature</source><volume>547</volume><fpage>217</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1038/nature22991</pub-id></element-citation></ref><ref id="bib439"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owen</surname> <given-names>MR</given-names></name><name><surname>Sherratt</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Modelling the macrophage invasion of tumours: effects on growth and composition</article-title><source>Mathematical Medicine and Biology</source><volume>15</volume><fpage>165</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1093/imammb/15.2.165</pub-id></element-citation></ref><ref id="bib440"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozik</surname> <given-names>J</given-names></name><name><surname>Collier</surname> <given-names>N</given-names></name><name><surname>Wozniak</surname> <given-names>JM</given-names></name><name><surname>Macal</surname> <given-names>C</given-names></name><name><surname>Cockrell</surname> <given-names>C</given-names></name><name><surname>Friedman</surname> <given-names>SH</given-names></name><name><surname>Ghaffarizadeh</surname> <given-names>A</given-names></name><name><surname>Heiland</surname> <given-names>R</given-names></name><name><surname>An</surname> <given-names>G</given-names></name><name><surname>Macklin</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow</article-title><source>BMC Bioinformatics</source><volume>19</volume><elocation-id>483</elocation-id><pub-id pub-id-type="doi">10.1186/s12859-018-2510-x</pub-id><pub-id pub-id-type="pmid">30577742</pub-id></element-citation></ref><ref id="bib441"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacheco</surname> <given-names>JM</given-names></name><name><surname>Santos</surname> <given-names>FC</given-names></name><name><surname>Dingli</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The ecology of cancer from an evolutionary game theory perspective</article-title><source>Interface Focus</source><volume>4</volume><fpage>20140019</fpage><pub-id pub-id-type="doi">10.1098/rsfs.2014.0019</pub-id><pub-id pub-id-type="pmid">25097748</pub-id></element-citation></ref><ref id="bib442"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname> <given-names>DB</given-names></name><name><surname>Yuan</surname> <given-names>J</given-names></name><name><surname>Redmond</surname> <given-names>D</given-names></name><name><surname>Wen</surname> <given-names>YH</given-names></name><name><surname>Durack</surname> <given-names>JC</given-names></name><name><surname>Emerson</surname> <given-names>R</given-names></name><name><surname>Solomon</surname> <given-names>S</given-names></name><name><surname>Dong</surname> <given-names>Z</given-names></name><name><surname>Wong</surname> <given-names>P</given-names></name><name><surname>Comstock</surname> <given-names>C</given-names></name><name><surname>Diab</surname> <given-names>A</given-names></name><name><surname>Sung</surname> <given-names>J</given-names></name><name><surname>Maybody</surname> <given-names>M</given-names></name><name><surname>Morris</surname> <given-names>E</given-names></name><name><surname>Brogi</surname> <given-names>E</given-names></name><name><surname>Morrow</surname> <given-names>M</given-names></name><name><surname>Sacchini</surname> <given-names>V</given-names></name><name><surname>Elemento</surname> <given-names>O</given-names></name><name><surname>Robins</surname> <given-names>H</given-names></name><name><surname>Patil</surname> <given-names>S</given-names></name><name><surname>Allison</surname> <given-names>JP</given-names></name><name><surname>Wolchok</surname> <given-names>JD</given-names></name><name><surname>Hudis</surname> <given-names>C</given-names></name><name><surname>Norton</surname> <given-names>L</given-names></name><name><surname>McArthur</surname> <given-names>HL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Deep sequencing of T-cell receptor DNA as a biomarker of clonally expanded TILs in breast Cancer after immunotherapy</article-title><source>Cancer Immunology Research</source><volume>4</volume><fpage>835</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1158/2326-6066.CIR-16-0013</pub-id><pub-id pub-id-type="pmid">27587469</pub-id></element-citation></ref><ref id="bib443"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paley</surname> <given-names>MA</given-names></name><name><surname>Kroy</surname> <given-names>DC</given-names></name><name><surname>Odorizzi</surname> <given-names>PM</given-names></name><name><surname>Johnnidis</surname> <given-names>JB</given-names></name><name><surname>Dolfi</surname> <given-names>DV</given-names></name><name><surname>Barnett</surname> <given-names>BE</given-names></name><name><surname>Bikoff</surname> <given-names>EK</given-names></name><name><surname>Robertson</surname> <given-names>EJ</given-names></name><name><surname>Lauer</surname> <given-names>GM</given-names></name><name><surname>Reiner</surname> <given-names>SL</given-names></name><name><surname>Wherry</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection</article-title><source>Science</source><volume>338</volume><fpage>1220</fpage><lpage>1225</lpage><pub-id pub-id-type="doi">10.1126/science.1229620</pub-id><pub-id pub-id-type="pmid">23197535</pub-id></element-citation></ref><ref id="bib444"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pappalardo</surname> <given-names>F</given-names></name><name><surname>Martinez Forero</surname> <given-names>I</given-names></name><name><surname>Pennisi</surname> <given-names>M</given-names></name><name><surname>Palazon</surname> <given-names>A</given-names></name><name><surname>Melero</surname> <given-names>I</given-names></name><name><surname>Motta</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>SimB16: modeling induced immune system response against B16-melanoma</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e26523</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0026523</pub-id><pub-id pub-id-type="pmid">22028894</pub-id></element-citation></ref><ref id="bib445"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardoll</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The blockade of immune checkpoints in cancer immunotherapy</article-title><source>Nature Reviews Cancer</source><volume>12</volume><fpage>252</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1038/nrc3239</pub-id><pub-id pub-id-type="pmid">22437870</pub-id></element-citation></ref><ref id="bib446"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>DS</given-names></name><name><surname>Robertson-Tessi</surname> <given-names>M</given-names></name><name><surname>Luddy</surname> <given-names>KA</given-names></name><name><surname>Maini</surname> <given-names>PK</given-names></name><name><surname>Bonsall</surname> <given-names>MB</given-names></name><name><surname>Gatenby</surname> <given-names>RA</given-names></name><name><surname>Anderson</surname> <given-names>ARA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The goldilocks window of personalized chemotherapy: getting the immune response just right</article-title><source>Cancer Research</source><volume>79</volume><fpage>5302</fpage><lpage>5315</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-18-3712</pub-id><pub-id pub-id-type="pmid">31387920</pub-id></element-citation></ref><ref id="bib447"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parkhurst</surname> <given-names>MR</given-names></name><name><surname>Robbins</surname> <given-names>PF</given-names></name><name><surname>Tran</surname> <given-names>E</given-names></name><name><surname>Prickett</surname> <given-names>TD</given-names></name><name><surname>Gartner</surname> <given-names>JJ</given-names></name><name><surname>Jia</surname> <given-names>L</given-names></name><name><surname>Ivey</surname> <given-names>G</given-names></name><name><surname>Li</surname> <given-names>YF</given-names></name><name><surname>El-Gamil</surname> <given-names>M</given-names></name><name><surname>Lalani</surname> <given-names>A</given-names></name><name><surname>Crystal</surname> <given-names>JS</given-names></name><name><surname>Sachs</surname> <given-names>A</given-names></name><name><surname>Groh</surname> <given-names>E</given-names></name><name><surname>Ray</surname> <given-names>S</given-names></name><name><surname>Ngo</surname> <given-names>LT</given-names></name><name><surname>Kivitz</surname> <given-names>S</given-names></name><name><surname>Pasetto</surname> <given-names>A</given-names></name><name><surname>Yossef</surname> <given-names>R</given-names></name><name><surname>Lowery</surname> <given-names>FJ</given-names></name><name><surname>Goff</surname> <given-names>SL</given-names></name><name><surname>Lo</surname> <given-names>W</given-names></name><name><surname>Cafri</surname> <given-names>G</given-names></name><name><surname>Deniger</surname> <given-names>DC</given-names></name><name><surname>Malekzadeh</surname> <given-names>P</given-names></name><name><surname>Ahmadzadeh</surname> <given-names>M</given-names></name><name><surname>Wunderlich</surname> <given-names>JR</given-names></name><name><surname>Somerville</surname> <given-names>RPT</given-names></name><name><surname>Rosenberg</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Unique neoantigens arise from somatic mutations in patients with gastrointestinal cancers</article-title><source>Cancer Discovery</source><volume>9</volume><fpage>1022</fpage><lpage>1035</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-18-1494</pub-id><pub-id pub-id-type="pmid">31164343</pub-id></element-citation></ref><ref id="bib448"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parnas</surname> <given-names>O</given-names></name><name><surname>Jovanovic</surname> <given-names>M</given-names></name><name><surname>Eisenhaure</surname> <given-names>TM</given-names></name><name><surname>Herbst</surname> <given-names>RH</given-names></name><name><surname>Dixit</surname> <given-names>A</given-names></name><name><surname>Ye</surname> <given-names>CJ</given-names></name><name><surname>Przybylski</surname> <given-names>D</given-names></name><name><surname>Platt</surname> <given-names>RJ</given-names></name><name><surname>Tirosh</surname> <given-names>I</given-names></name><name><surname>Sanjana</surname> <given-names>NE</given-names></name><name><surname>Shalem</surname> <given-names>O</given-names></name><name><surname>Satija</surname> <given-names>R</given-names></name><name><surname>Raychowdhury</surname> <given-names>R</given-names></name><name><surname>Mertins</surname> <given-names>P</given-names></name><name><surname>Carr</surname> <given-names>SA</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name><name><surname>Hacohen</surname> <given-names>N</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A Genome-wide CRISPR screen in primary immune cells to dissect regulatory networks</article-title><source>Cell</source><volume>162</volume><fpage>675</fpage><lpage>686</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.06.059</pub-id><pub-id pub-id-type="pmid">26189680</pub-id></element-citation></ref><ref id="bib449"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pauken</surname> <given-names>KE</given-names></name><name><surname>Sammons</surname> <given-names>MA</given-names></name><name><surname>Odorizzi</surname> <given-names>PM</given-names></name><name><surname>Manne</surname> <given-names>S</given-names></name><name><surname>Godec</surname> <given-names>J</given-names></name><name><surname>Khan</surname> <given-names>O</given-names></name><name><surname>Drake</surname> <given-names>AM</given-names></name><name><surname>Chen</surname> <given-names>Z</given-names></name><name><surname>Sen</surname> <given-names>DR</given-names></name><name><surname>Kurachi</surname> <given-names>M</given-names></name><name><surname>Barnitz</surname> <given-names>RA</given-names></name><name><surname>Bartman</surname> <given-names>C</given-names></name><name><surname>Bengsch</surname> <given-names>B</given-names></name><name><surname>Huang</surname> <given-names>AC</given-names></name><name><surname>Schenkel</surname> <given-names>JM</given-names></name><name><surname>Vahedi</surname> <given-names>G</given-names></name><name><surname>Haining</surname> <given-names>WN</given-names></name><name><surname>Berger</surname> <given-names>SL</given-names></name><name><surname>Wherry</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade</article-title><source>Science</source><volume>354</volume><fpage>1160</fpage><lpage>1165</lpage><pub-id pub-id-type="doi">10.1126/science.aaf2807</pub-id><pub-id pub-id-type="pmid">27789795</pub-id></element-citation></ref><ref id="bib450"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pauken</surname> <given-names>KE</given-names></name><name><surname>Wherry</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Overcoming T cell exhaustion in infection and cancer</article-title><source>Trends in Immunology</source><volume>36</volume><fpage>265</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1016/j.it.2015.02.008</pub-id><pub-id pub-id-type="pmid">25797516</pub-id></element-citation></ref><ref id="bib451"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearson</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="1901">1901</year><article-title>LIII. On lines and planes of closest fit to systems of points in space</article-title><source>The London, Edinburgh, and Dublin Philosophical Magazine and Journal of Science</source><volume>2</volume><fpage>559</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1080/14786440109462720</pub-id></element-citation></ref><ref id="bib452"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pech</surname> <given-names>MF</given-names></name><name><surname>Fong</surname> <given-names>LE</given-names></name><name><surname>Villalta</surname> <given-names>JE</given-names></name><name><surname>Chan</surname> <given-names>LJ</given-names></name><name><surname>Kharbanda</surname> <given-names>S</given-names></name><name><surname>O'Brien</surname> <given-names>JJ</given-names></name><name><surname>McAllister</surname> <given-names>FE</given-names></name><name><surname>Firestone</surname> <given-names>AJ</given-names></name><name><surname>Jan</surname> <given-names>CH</given-names></name><name><surname>Settleman</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance</article-title><source>eLife</source><volume>8</volume><elocation-id>e47362</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.47362</pub-id><pub-id pub-id-type="pmid">31452512</pub-id></element-citation></ref><ref id="bib453"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname> <given-names>D</given-names></name><name><surname>Kryczek</surname> <given-names>I</given-names></name><name><surname>Nagarsheth</surname> <given-names>N</given-names></name><name><surname>Zhao</surname> <given-names>L</given-names></name><name><surname>Wei</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>W</given-names></name><name><surname>Sun</surname> <given-names>Y</given-names></name><name><surname>Zhao</surname> <given-names>E</given-names></name><name><surname>Vatan</surname> <given-names>L</given-names></name><name><surname>Szeliga</surname> <given-names>W</given-names></name><name><surname>Kotarski</surname> <given-names>J</given-names></name><name><surname>Tarkowski</surname> <given-names>R</given-names></name><name><surname>Dou</surname> <given-names>Y</given-names></name><name><surname>Cho</surname> <given-names>K</given-names></name><name><surname>Hensley-Alford</surname> <given-names>S</given-names></name><name><surname>Munkarah</surname> <given-names>A</given-names></name><name><surname>Liu</surname> <given-names>R</given-names></name><name><surname>Zou</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy</article-title><source>Nature</source><volume>527</volume><fpage>249</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1038/nature15520</pub-id><pub-id pub-id-type="pmid">26503055</pub-id></element-citation></ref><ref id="bib454"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname> <given-names>C</given-names></name><name><surname>Gimenez-Xavier</surname> <given-names>P</given-names></name><name><surname>Pros</surname> <given-names>E</given-names></name><name><surname>Pajares</surname> <given-names>MJ</given-names></name><name><surname>Moro</surname> <given-names>M</given-names></name><name><surname>Gomez</surname> <given-names>A</given-names></name><name><surname>Navarro</surname> <given-names>A</given-names></name><name><surname>Condom</surname> <given-names>E</given-names></name><name><surname>Moran</surname> <given-names>S</given-names></name><name><surname>Gomez-Lopez</surname> <given-names>G</given-names></name><name><surname>Graña</surname> <given-names>O</given-names></name><name><surname>Rubio-Camarillo</surname> <given-names>M</given-names></name><name><surname>Martinez-Martí</surname> <given-names>A</given-names></name><name><surname>Yokota</surname> <given-names>J</given-names></name><name><surname>Carretero</surname> <given-names>J</given-names></name><name><surname>Galbis</surname> <given-names>JM</given-names></name><name><surname>Nadal</surname> <given-names>E</given-names></name><name><surname>Pisano</surname> <given-names>D</given-names></name><name><surname>Sozzi</surname> <given-names>G</given-names></name><name><surname>Felip</surname> <given-names>E</given-names></name><name><surname>Montuenga</surname> <given-names>LM</given-names></name><name><surname>Roz</surname> <given-names>L</given-names></name><name><surname>Villanueva</surname> <given-names>A</given-names></name><name><surname>Sanchez-Cespedes</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genomic profiling of Patient-Derived xenografts for lung Cancer identifies <italic>B2M</italic> Inactivation Impairing Immunorecognition</article-title><source>Clinical Cancer Research</source><volume>23</volume><fpage>3203</fpage><lpage>3213</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-16-1946-T</pub-id><pub-id pub-id-type="pmid">28302866</pub-id></element-citation></ref><ref id="bib455"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perros</surname> <given-names>F</given-names></name><name><surname>Dorfmüller</surname> <given-names>P</given-names></name><name><surname>Montani</surname> <given-names>D</given-names></name><name><surname>Hammad</surname> <given-names>H</given-names></name><name><surname>Waelput</surname> <given-names>W</given-names></name><name><surname>Girerd</surname> <given-names>B</given-names></name><name><surname>Raymond</surname> <given-names>N</given-names></name><name><surname>Mercier</surname> <given-names>O</given-names></name><name><surname>Mussot</surname> <given-names>S</given-names></name><name><surname>Cohen-Kaminsky</surname> <given-names>S</given-names></name><name><surname>Humbert</surname> <given-names>M</given-names></name><name><surname>Lambrecht</surname> <given-names>BN</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>185</volume><fpage>311</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1164/rccm.201105-0927OC</pub-id><pub-id pub-id-type="pmid">22108206</pub-id></element-citation></ref><ref id="bib456"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname> <given-names>C</given-names></name><name><surname>Bell</surname> <given-names>R</given-names></name><name><surname>Klag</surname> <given-names>KA</given-names></name><name><surname>Lee</surname> <given-names>SH</given-names></name><name><surname>Soto</surname> <given-names>R</given-names></name><name><surname>Ghazaryan</surname> <given-names>A</given-names></name><name><surname>Buhrke</surname> <given-names>K</given-names></name><name><surname>Ekiz</surname> <given-names>HA</given-names></name><name><surname>Ost</surname> <given-names>KS</given-names></name><name><surname>Boudina</surname> <given-names>S</given-names></name><name><surname>O'Connell</surname> <given-names>RM</given-names></name><name><surname>Cox</surname> <given-names>JE</given-names></name><name><surname>Villanueva</surname> <given-names>CJ</given-names></name><name><surname>Stephens</surname> <given-names>WZ</given-names></name><name><surname>Round</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>T cell-mediated regulation of the Microbiota protects against obesity</article-title><source>Science</source><volume>365</volume><elocation-id>eaat9351</elocation-id><pub-id pub-id-type="doi">10.1126/science.aat9351</pub-id><pub-id pub-id-type="pmid">31346040</pub-id></element-citation></ref><ref id="bib457"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Petri</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="1962">1962</year><source>Kommunikation Mit Automaten</source><publisher-name>Mathematisches Institut der Universität Bonn</publisher-name></element-citation></ref><ref id="bib458"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philip</surname> <given-names>M</given-names></name><name><surname>Fairchild</surname> <given-names>L</given-names></name><name><surname>Sun</surname> <given-names>L</given-names></name><name><surname>Horste</surname> <given-names>EL</given-names></name><name><surname>Camara</surname> <given-names>S</given-names></name><name><surname>Shakiba</surname> <given-names>M</given-names></name><name><surname>Scott</surname> <given-names>AC</given-names></name><name><surname>Viale</surname> <given-names>A</given-names></name><name><surname>Lauer</surname> <given-names>P</given-names></name><name><surname>Merghoub</surname> <given-names>T</given-names></name><name><surname>Hellmann</surname> <given-names>MD</given-names></name><name><surname>Wolchok</surname> <given-names>JD</given-names></name><name><surname>Leslie</surname> <given-names>CS</given-names></name><name><surname>Schietinger</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Chromatin states define tumour-specific T cell dysfunction and reprogramming</article-title><source>Nature</source><volume>545</volume><fpage>452</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1038/nature22367</pub-id><pub-id pub-id-type="pmid">28514453</pub-id></element-citation></ref><ref id="bib459"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philip</surname> <given-names>M</given-names></name><name><surname>Schietinger</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Heterogeneity and fate choice: t cell exhaustion in Cancer and chronic infections</article-title><source>Current Opinion in Immunology</source><volume>58</volume><fpage>98</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2019.04.014</pub-id><pub-id pub-id-type="pmid">31181510</pub-id></element-citation></ref><ref id="bib460"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piccard</surname> <given-names>H</given-names></name><name><surname>Muschel</surname> <given-names>RJ</given-names></name><name><surname>Opdenakker</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>On the dual roles and polarized phenotypes of neutrophils in tumor development and progression</article-title><source>Critical Reviews in Oncology/Hematology</source><volume>82</volume><fpage>296</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1016/j.critrevonc.2011.06.004</pub-id><pub-id pub-id-type="pmid">21798756</pub-id></element-citation></ref><ref id="bib461"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piccolo</surname> <given-names>V</given-names></name><name><surname>Curina</surname> <given-names>A</given-names></name><name><surname>Genua</surname> <given-names>M</given-names></name><name><surname>Ghisletti</surname> <given-names>S</given-names></name><name><surname>Simonatto</surname> <given-names>M</given-names></name><name><surname>Sabò</surname> <given-names>A</given-names></name><name><surname>Amati</surname> <given-names>B</given-names></name><name><surname>Ostuni</surname> <given-names>R</given-names></name><name><surname>Natoli</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Opposing macrophage polarization programs show extensive epigenomic and transcriptional cross-talk</article-title><source>Nature Immunology</source><volume>18</volume><fpage>530</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1038/ni.3710</pub-id><pub-id pub-id-type="pmid">28288101</pub-id></element-citation></ref><ref id="bib462"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitzalis</surname> <given-names>C</given-names></name><name><surname>Jones</surname> <given-names>GW</given-names></name><name><surname>Bombardieri</surname> <given-names>M</given-names></name><name><surname>Jones</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Ectopic lymphoid-like structures in infection, cancer and autoimmunity</article-title><source>Nature Reviews Immunology</source><volume>14</volume><fpage>447</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1038/nri3700</pub-id><pub-id pub-id-type="pmid">24948366</pub-id></element-citation></ref><ref id="bib463"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pogson</surname> <given-names>M</given-names></name><name><surname>Holcombe</surname> <given-names>M</given-names></name><name><surname>Smallwood</surname> <given-names>R</given-names></name><name><surname>Qwarnstrom</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Introducing spatial information into predictive NF-kappaB modelling--an agent-based approach</article-title><source>PLOS ONE</source><volume>3</volume><elocation-id>e2367</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0002367</pub-id><pub-id pub-id-type="pmid">18523553</pub-id></element-citation></ref><ref id="bib464"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poleszczuk</surname> <given-names>J</given-names></name><name><surname>Macklin</surname> <given-names>P</given-names></name><name><surname>Enderling</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Agent-Based modeling of Cancer stem cell driven solid tumor growth</article-title><source>Methods in Molecular Biology</source><volume>1516</volume><fpage>335</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1007/7651_2016_346</pub-id><pub-id pub-id-type="pmid">27044046</pub-id></element-citation></ref><ref id="bib465"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porter</surname> <given-names>DL</given-names></name><name><surname>Levine</surname> <given-names>BL</given-names></name><name><surname>Kalos</surname> <given-names>M</given-names></name><name><surname>Bagg</surname> <given-names>A</given-names></name><name><surname>June</surname> <given-names>CH</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia</article-title><source>New England Journal of Medicine</source><volume>365</volume><fpage>725</fpage><lpage>733</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1103849</pub-id><pub-id pub-id-type="pmid">21830940</pub-id></element-citation></ref><ref id="bib466"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pourhasanzade</surname> <given-names>F</given-names></name><name><surname>Sabzpoushan</surname> <given-names>SH</given-names></name><name><surname>Alizadeh</surname> <given-names>AM</given-names></name><name><surname>Esmati</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>An agent-based model of avascular tumor growth: immune response tendency to prevent Cancer development</article-title><source>Simulation</source><volume>93</volume><fpage>641</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1177/0037549717699072</pub-id></element-citation></ref><ref id="bib467"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poussin</surname> <given-names>C</given-names></name><name><surname>Mathis</surname> <given-names>C</given-names></name><name><surname>Alexopoulos</surname> <given-names>LG</given-names></name><name><surname>Messinis</surname> <given-names>DE</given-names></name><name><surname>Dulize</surname> <given-names>RH</given-names></name><name><surname>Belcastro</surname> <given-names>V</given-names></name><name><surname>Melas</surname> <given-names>IN</given-names></name><name><surname>Sakellaropoulos</surname> <given-names>T</given-names></name><name><surname>Rhrissorrakrai</surname> <given-names>K</given-names></name><name><surname>Bilal</surname> <given-names>E</given-names></name><name><surname>Meyer</surname> <given-names>P</given-names></name><name><surname>Talikka</surname> <given-names>M</given-names></name><name><surname>Boué</surname> <given-names>S</given-names></name><name><surname>Norel</surname> <given-names>R</given-names></name><name><surname>Rice</surname> <given-names>JJ</given-names></name><name><surname>Stolovitzky</surname> <given-names>G</given-names></name><name><surname>Ivanov</surname> <given-names>NV</given-names></name><name><surname>Peitsch</surname> <given-names>MC</given-names></name><name><surname>Hoeng</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The species translation challenge-a systems biology perspective on human and rat bronchial epithelial cells</article-title><source>Scientific Data</source><volume>1</volume><elocation-id>140009</elocation-id><pub-id pub-id-type="doi">10.1038/sdata.2014.9</pub-id><pub-id pub-id-type="pmid">25977767</pub-id></element-citation></ref><ref id="bib468"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Prabhakaran</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dirichlet process mixture model for correcting technical variation insingle-cell gene expression data</article-title><conf-name>International Conference on Machine Learning</conf-name></element-citation></ref><ref id="bib469"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pritchard</surname> <given-names>AL</given-names></name><name><surname>Hastie</surname> <given-names>ML</given-names></name><name><surname>Neller</surname> <given-names>M</given-names></name><name><surname>Gorman</surname> <given-names>JJ</given-names></name><name><surname>Schmidt</surname> <given-names>CW</given-names></name><name><surname>Hayward</surname> <given-names>NK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Exploration of peptides bound to MHC class I molecules in melanoma</article-title><source>Pigment Cell &amp; Melanoma Research</source><volume>28</volume><fpage>281</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1111/pcmr.12357</pub-id><pub-id pub-id-type="pmid">25645385</pub-id></element-citation></ref><ref id="bib470"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pucci</surname> <given-names>F</given-names></name><name><surname>Garris</surname> <given-names>C</given-names></name><name><surname>Lai</surname> <given-names>CP</given-names></name><name><surname>Newton</surname> <given-names>A</given-names></name><name><surname>Pfirschke</surname> <given-names>C</given-names></name><name><surname>Engblom</surname> <given-names>C</given-names></name><name><surname>Alvarez</surname> <given-names>D</given-names></name><name><surname>Sprachman</surname> <given-names>M</given-names></name><name><surname>Evavold</surname> <given-names>C</given-names></name><name><surname>Magnuson</surname> <given-names>A</given-names></name><name><surname>von Andrian</surname> <given-names>UH</given-names></name><name><surname>Glatz</surname> <given-names>K</given-names></name><name><surname>Breakefield</surname> <given-names>XO</given-names></name><name><surname>Mempel</surname> <given-names>TR</given-names></name><name><surname>Weissleder</surname> <given-names>R</given-names></name><name><surname>Pittet</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions</article-title><source>Science</source><volume>352</volume><fpage>242</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1126/science.aaf1328</pub-id><pub-id pub-id-type="pmid">26989197</pub-id></element-citation></ref><ref id="bib471"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puram</surname> <given-names>SV</given-names></name><name><surname>Tirosh</surname> <given-names>I</given-names></name><name><surname>Parikh</surname> <given-names>AS</given-names></name><name><surname>Patel</surname> <given-names>AP</given-names></name><name><surname>Yizhak</surname> <given-names>K</given-names></name><name><surname>Gillespie</surname> <given-names>S</given-names></name><name><surname>Rodman</surname> <given-names>C</given-names></name><name><surname>Luo</surname> <given-names>CL</given-names></name><name><surname>Mroz</surname> <given-names>EA</given-names></name><name><surname>Emerick</surname> <given-names>KS</given-names></name><name><surname>Deschler</surname> <given-names>DG</given-names></name><name><surname>Varvares</surname> <given-names>MA</given-names></name><name><surname>Mylvaganam</surname> <given-names>R</given-names></name><name><surname>Rozenblatt-Rosen</surname> <given-names>O</given-names></name><name><surname>Rocco</surname> <given-names>JW</given-names></name><name><surname>Faquin</surname> <given-names>WC</given-names></name><name><surname>Lin</surname> <given-names>DT</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name><name><surname>Bernstein</surname> <given-names>BE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Single-Cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck Cancer</article-title><source>Cell</source><volume>171</volume><fpage>1611</fpage><lpage>1624</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.10.044</pub-id><pub-id pub-id-type="pmid">29198524</pub-id></element-citation></ref><ref id="bib472"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname> <given-names>BZ</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Kitamura</surname> <given-names>T</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Campion</surname> <given-names>LR</given-names></name><name><surname>Kaiser</surname> <given-names>EA</given-names></name><name><surname>Snyder</surname> <given-names>LA</given-names></name><name><surname>Pollard</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis</article-title><source>Nature</source><volume>475</volume><fpage>222</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1038/nature10138</pub-id><pub-id pub-id-type="pmid">21654748</pub-id></element-citation></ref><ref id="bib473"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname> <given-names>BZ</given-names></name><name><surname>Pollard</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Macrophage diversity enhances tumor progression and metastasis</article-title><source>Cell</source><volume>141</volume><fpage>39</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.03.014</pub-id><pub-id pub-id-type="pmid">20371344</pub-id></element-citation></ref><ref id="bib474"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname> <given-names>Z</given-names></name><name><surname>Richter</surname> <given-names>G</given-names></name><name><surname>Schüler</surname> <given-names>T</given-names></name><name><surname>Ibe</surname> <given-names>S</given-names></name><name><surname>Cao</surname> <given-names>X</given-names></name><name><surname>Blankenstein</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>B cells inhibit induction of T cell-dependent tumor immunity</article-title><source>Nature Medicine</source><volume>4</volume><fpage>627</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1038/nm0598-627</pub-id><pub-id pub-id-type="pmid">9585241</pub-id></element-citation></ref><ref id="bib475"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname> <given-names>P</given-names></name><name><surname>Simonds</surname> <given-names>EF</given-names></name><name><surname>Bendall</surname> <given-names>SC</given-names></name><name><surname>Gibbs</surname> <given-names>KD</given-names></name><name><surname>Bruggner</surname> <given-names>RV</given-names></name><name><surname>Linderman</surname> <given-names>MD</given-names></name><name><surname>Sachs</surname> <given-names>K</given-names></name><name><surname>Nolan</surname> <given-names>GP</given-names></name><name><surname>Plevritis</surname> <given-names>SK</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE</article-title><source>Nature Biotechnology</source><volume>29</volume><fpage>886</fpage><lpage>891</lpage><pub-id pub-id-type="doi">10.1038/nbt.1991</pub-id><pub-id pub-id-type="pmid">21964415</pub-id></element-citation></ref><ref id="bib476"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Qiu</surname> <given-names>S</given-names></name><name><surname>Hong</surname> <given-names>R</given-names></name><name><surname>Zhuang</surname> <given-names>Z</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Zhu</surname> <given-names>L</given-names></name><name><surname>Lin</surname> <given-names>X</given-names></name><name><surname>Zheng</surname> <given-names>Q</given-names></name><name><surname>Liu</surname> <given-names>S</given-names></name><name><surname>Zhang</surname> <given-names>K</given-names></name><name><surname>Huang</surname> <given-names>M</given-names></name><name><surname>Lee</surname> <given-names>K</given-names></name><name><surname>Lu</surname> <given-names>Q</given-names></name><name><surname>Xia</surname> <given-names>W</given-names></name><name><surname>Xu</surname> <given-names>F</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Tang</surname> <given-names>J</given-names></name><name><surname>Xiao</surname> <given-names>X</given-names></name><name><surname>Wei</surname> <given-names>W</given-names></name><name><surname>Yuan</surname> <given-names>Z</given-names></name><name><surname>Shi</surname> <given-names>Y</given-names></name><name><surname>Hou</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Yang</surname> <given-names>H</given-names></name><name><surname>Zhan</surname> <given-names>Q</given-names></name><name><surname>Li</surname> <given-names>B</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A Single-Cell immune atlas of triple negative breast Cancer reveals novel immune cell subsets.</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/566968</pub-id></element-citation></ref><ref id="bib477"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quon</surname> <given-names>G</given-names></name><name><surname>Haider</surname> <given-names>S</given-names></name><name><surname>Deshwar</surname> <given-names>AG</given-names></name><name><surname>Cui</surname> <given-names>A</given-names></name><name><surname>Boutros</surname> <given-names>PC</given-names></name><name><surname>Morris</surname> <given-names>Q</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Computational purification of individual tumor gene expression profiles leads to significant improvements in prognostic prediction</article-title><source>Genome Medicine</source><volume>5</volume><elocation-id>29</elocation-id><pub-id pub-id-type="doi">10.1186/gm433</pub-id><pub-id pub-id-type="pmid">23537167</pub-id></element-citation></ref><ref id="bib478"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Racle</surname> <given-names>J</given-names></name><name><surname>de Jonge</surname> <given-names>K</given-names></name><name><surname>Baumgaertner</surname> <given-names>P</given-names></name><name><surname>Speiser</surname> <given-names>DE</given-names></name><name><surname>Gfeller</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data</article-title><source>eLife</source><volume>6</volume><elocation-id>e26476</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.26476</pub-id><pub-id pub-id-type="pmid">29130882</pub-id></element-citation></ref><ref id="bib479"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajasagi</surname> <given-names>M</given-names></name><name><surname>Shukla</surname> <given-names>SA</given-names></name><name><surname>Fritsch</surname> <given-names>EF</given-names></name><name><surname>Keskin</surname> <given-names>DB</given-names></name><name><surname>DeLuca</surname> <given-names>D</given-names></name><name><surname>Carmona</surname> <given-names>E</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Sougnez</surname> <given-names>C</given-names></name><name><surname>Cibulskis</surname> <given-names>K</given-names></name><name><surname>Sidney</surname> <given-names>J</given-names></name><name><surname>Stevenson</surname> <given-names>K</given-names></name><name><surname>Ritz</surname> <given-names>J</given-names></name><name><surname>Neuberg</surname> <given-names>D</given-names></name><name><surname>Brusic</surname> <given-names>V</given-names></name><name><surname>Gabriel</surname> <given-names>S</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Getz</surname> <given-names>G</given-names></name><name><surname>Hacohen</surname> <given-names>N</given-names></name><name><surname>Wu</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia</article-title><source>Blood</source><volume>124</volume><fpage>453</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1182/blood-2014-04-567933</pub-id><pub-id pub-id-type="pmid">24891321</pub-id></element-citation></ref><ref id="bib480"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramani</surname> <given-names>V</given-names></name><name><surname>Deng</surname> <given-names>X</given-names></name><name><surname>Qiu</surname> <given-names>R</given-names></name><name><surname>Gunderson</surname> <given-names>KL</given-names></name><name><surname>Steemers</surname> <given-names>FJ</given-names></name><name><surname>Disteche</surname> <given-names>CM</given-names></name><name><surname>Noble</surname> <given-names>WS</given-names></name><name><surname>Duan</surname> <given-names>Z</given-names></name><name><surname>Shendure</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Massively multiplex single-cell Hi-C</article-title><source>Nature Methods</source><volume>14</volume><fpage>263</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4155</pub-id><pub-id pub-id-type="pmid">28135255</pub-id></element-citation></ref><ref id="bib481"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramsköld</surname> <given-names>D</given-names></name><name><surname>Luo</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>YC</given-names></name><name><surname>Li</surname> <given-names>R</given-names></name><name><surname>Deng</surname> <given-names>Q</given-names></name><name><surname>Faridani</surname> <given-names>OR</given-names></name><name><surname>Daniels</surname> <given-names>GA</given-names></name><name><surname>Khrebtukova</surname> <given-names>I</given-names></name><name><surname>Loring</surname> <given-names>JF</given-names></name><name><surname>Laurent</surname> <given-names>LC</given-names></name><name><surname>Schroth</surname> <given-names>GP</given-names></name><name><surname>Sandberg</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells</article-title><source>Nature Biotechnology</source><volume>30</volume><fpage>777</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1038/nbt.2282</pub-id><pub-id pub-id-type="pmid">22820318</pub-id></element-citation></ref><ref id="bib482"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname> <given-names>SS</given-names></name><name><surname>Huntley</surname> <given-names>MH</given-names></name><name><surname>Durand</surname> <given-names>NC</given-names></name><name><surname>Stamenova</surname> <given-names>EK</given-names></name><name><surname>Bochkov</surname> <given-names>ID</given-names></name><name><surname>Robinson</surname> <given-names>JT</given-names></name><name><surname>Sanborn</surname> <given-names>AL</given-names></name><name><surname>Machol</surname> <given-names>I</given-names></name><name><surname>Omer</surname> <given-names>AD</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Aiden</surname> <given-names>EL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A 3D map of the human genome at Kilobase resolution reveals principles of chromatin looping</article-title><source>Cell</source><volume>159</volume><fpage>1665</fpage><lpage>1680</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.11.021</pub-id><pub-id pub-id-type="pmid">25497547</pub-id></element-citation></ref><ref id="bib483"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinartz</surname> <given-names>S</given-names></name><name><surname>Schumann</surname> <given-names>T</given-names></name><name><surname>Finkernagel</surname> <given-names>F</given-names></name><name><surname>Wortmann</surname> <given-names>A</given-names></name><name><surname>Jansen</surname> <given-names>JM</given-names></name><name><surname>Meissner</surname> <given-names>W</given-names></name><name><surname>Krause</surname> <given-names>M</given-names></name><name><surname>Schwörer</surname> <given-names>AM</given-names></name><name><surname>Wagner</surname> <given-names>U</given-names></name><name><surname>Müller-Brüsselbach</surname> <given-names>S</given-names></name><name><surname>Müller</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse</article-title><source>International Journal of Cancer</source><volume>134</volume><fpage>32</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1002/ijc.28335</pub-id><pub-id pub-id-type="pmid">23784932</pub-id></element-citation></ref><ref id="bib484"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renner</surname> <given-names>K</given-names></name><name><surname>Singer</surname> <given-names>K</given-names></name><name><surname>Koehl</surname> <given-names>GE</given-names></name><name><surname>Geissler</surname> <given-names>EK</given-names></name><name><surname>Peter</surname> <given-names>K</given-names></name><name><surname>Siska</surname> <given-names>PJ</given-names></name><name><surname>Kreutz</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Metabolic hallmarks of tumor and immune cells in the tumor microenvironment</article-title><source>Frontiers in Immunology</source><volume>8</volume><elocation-id>248</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2017.00248</pub-id><pub-id pub-id-type="pmid">28337200</pub-id></element-citation></ref><ref id="bib485"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Restifo</surname> <given-names>NP</given-names></name><name><surname>Dudley</surname> <given-names>ME</given-names></name><name><surname>Rosenberg</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Adoptive immunotherapy for cancer: harnessing the T cell response</article-title><source>Nature Reviews Immunology</source><volume>12</volume><fpage>269</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1038/nri3191</pub-id><pub-id pub-id-type="pmid">22437939</pub-id></element-citation></ref><ref id="bib486"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Reticker-Flynn</surname> <given-names>NE</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Basto</surname> <given-names>PA</given-names></name><name><surname>Bejnood</surname> <given-names>A</given-names></name><name><surname>Martins</surname> <given-names>MM</given-names></name><name><surname>Kenkel</surname> <given-names>JA</given-names></name><name><surname>Linde</surname> <given-names>IL</given-names></name><name><surname>Bagchi</surname> <given-names>S</given-names></name><name><surname>Yuan</surname> <given-names>R</given-names></name><name><surname>Cheng</surname> <given-names>J</given-names></name><name><surname>Tolentino</surname> <given-names>LL</given-names></name><name><surname>Choi</surname> <given-names>O</given-names></name><name><surname>Wu</surname> <given-names>N</given-names></name><name><surname>Chang</surname> <given-names>S</given-names></name><name><surname>Kong</surname> <given-names>C</given-names></name><name><surname>Gentles</surname> <given-names>AJ</given-names></name><name><surname>Sunwoo</surname> <given-names>JB</given-names></name><name><surname>Plevritis</surname> <given-names>SK</given-names></name><name><surname>Engleman</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Lymph node colonization alters the systemic immune response to enable metastasis to distant tissues</article-title><source>SSRN Electronic Journal</source><pub-id pub-id-type="doi">10.2139/ssrn.3624427</pub-id></element-citation></ref><ref id="bib487"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reticker-Flynn</surname> <given-names>NE</given-names></name><name><surname>Bhatia</surname> <given-names>SN</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Aberrant glycosylation promotes lung Cancer metastasis through adhesion to galectins in the metastatic niche</article-title><source>Cancer Discovery</source><volume>5</volume><fpage>168</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-13-0760</pub-id><pub-id pub-id-type="pmid">25421439</pub-id></element-citation></ref><ref id="bib488"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reticker-Flynn</surname> <given-names>NE</given-names></name><name><surname>Engleman</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A gut punch fights cancer and infection</article-title><source>Nature</source><volume>565</volume><fpage>573</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1038/d41586-019-00133-w</pub-id><pub-id pub-id-type="pmid">30683936</pub-id></element-citation></ref><ref id="bib489"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhrissorrakrai</surname> <given-names>K</given-names></name><name><surname>Belcastro</surname> <given-names>V</given-names></name><name><surname>Bilal</surname> <given-names>E</given-names></name><name><surname>Norel</surname> <given-names>R</given-names></name><name><surname>Poussin</surname> <given-names>C</given-names></name><name><surname>Mathis</surname> <given-names>C</given-names></name><name><surname>Dulize</surname> <given-names>RH</given-names></name><name><surname>Ivanov</surname> <given-names>NV</given-names></name><name><surname>Alexopoulos</surname> <given-names>L</given-names></name><name><surname>Rice</surname> <given-names>JJ</given-names></name><name><surname>Peitsch</surname> <given-names>MC</given-names></name><name><surname>Stolovitzky</surname> <given-names>G</given-names></name><name><surname>Meyer</surname> <given-names>P</given-names></name><name><surname>Hoeng</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Understanding the limits of animal models as predictors of human biology: lessons learned from the sbv IMPROVER species translation challenge</article-title><source>Bioinformatics</source><volume>31</volume><fpage>471</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu611</pub-id><pub-id pub-id-type="pmid">25236459</pub-id></element-citation></ref><ref id="bib490"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname> <given-names>DM</given-names></name><name><surname>Hettinger</surname> <given-names>J</given-names></name><name><surname>Feuerer</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Monocytes and macrophages in Cancer: development and functions</article-title><source>Cancer Microenvironment</source><volume>6</volume><fpage>179</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1007/s12307-012-0123-x</pub-id><pub-id pub-id-type="pmid">23179263</pub-id></element-citation></ref><ref id="bib491"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ridaura</surname> <given-names>VK</given-names></name><name><surname>Faith</surname> <given-names>JJ</given-names></name><name><surname>Rey</surname> <given-names>FE</given-names></name><name><surname>Cheng</surname> <given-names>J</given-names></name><name><surname>Duncan</surname> <given-names>AE</given-names></name><name><surname>Kau</surname> <given-names>AL</given-names></name><name><surname>Griffin</surname> <given-names>NW</given-names></name><name><surname>Lombard</surname> <given-names>V</given-names></name><name><surname>Henrissat</surname> <given-names>B</given-names></name><name><surname>Bain</surname> <given-names>JR</given-names></name><name><surname>Muehlbauer</surname> <given-names>MJ</given-names></name><name><surname>Ilkayeva</surname> <given-names>O</given-names></name><name><surname>Semenkovich</surname> <given-names>CF</given-names></name><name><surname>Funai</surname> <given-names>K</given-names></name><name><surname>Hayashi</surname> <given-names>DK</given-names></name><name><surname>Lyle</surname> <given-names>BJ</given-names></name><name><surname>Martini</surname> <given-names>MC</given-names></name><name><surname>Ursell</surname> <given-names>LK</given-names></name><name><surname>Clemente</surname> <given-names>JC</given-names></name><name><surname>Van Treuren</surname> <given-names>W</given-names></name><name><surname>Walters</surname> <given-names>WA</given-names></name><name><surname>Knight</surname> <given-names>R</given-names></name><name><surname>Newgard</surname> <given-names>CB</given-names></name><name><surname>Heath</surname> <given-names>AC</given-names></name><name><surname>Gordon</surname> <given-names>JI</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Gut Microbiota from twins discordant for obesity modulate metabolism in mice</article-title><source>Science</source><volume>341</volume><elocation-id>1241214</elocation-id><pub-id pub-id-type="doi">10.1126/science.1241214</pub-id><pub-id pub-id-type="pmid">24009397</pub-id></element-citation></ref><ref id="bib492"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizvi</surname> <given-names>NA</given-names></name><name><surname>Hellmann</surname> <given-names>MD</given-names></name><name><surname>Snyder</surname> <given-names>A</given-names></name><name><surname>Kvistborg</surname> <given-names>P</given-names></name><name><surname>Makarov</surname> <given-names>V</given-names></name><name><surname>Havel</surname> <given-names>JJ</given-names></name><name><surname>Lee</surname> <given-names>W</given-names></name><name><surname>Yuan</surname> <given-names>J</given-names></name><name><surname>Wong</surname> <given-names>P</given-names></name><name><surname>Ho</surname> <given-names>TS</given-names></name><name><surname>Miller</surname> <given-names>ML</given-names></name><name><surname>Rekhtman</surname> <given-names>N</given-names></name><name><surname>Moreira</surname> <given-names>AL</given-names></name><name><surname>Ibrahim</surname> <given-names>F</given-names></name><name><surname>Bruggeman</surname> <given-names>C</given-names></name><name><surname>Gasmi</surname> <given-names>B</given-names></name><name><surname>Zappasodi</surname> <given-names>R</given-names></name><name><surname>Maeda</surname> <given-names>Y</given-names></name><name><surname>Sander</surname> <given-names>C</given-names></name><name><surname>Garon</surname> <given-names>EB</given-names></name><name><surname>Merghoub</surname> <given-names>T</given-names></name><name><surname>Wolchok</surname> <given-names>JD</given-names></name><name><surname>Schumacher</surname> <given-names>TN</given-names></name><name><surname>Chan</surname> <given-names>TA</given-names></name></person-group><year iso-8601-date="2015">2015a</year><article-title>Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer</article-title><source>Science</source><volume>348</volume><fpage>124</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1126/science.aaa1348</pub-id><pub-id pub-id-type="pmid">25765070</pub-id></element-citation></ref><ref id="bib493"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizvi</surname> <given-names>NA</given-names></name><name><surname>Mazières</surname> <given-names>J</given-names></name><name><surname>Planchard</surname> <given-names>D</given-names></name><name><surname>Stinchcombe</surname> <given-names>TE</given-names></name><name><surname>Dy</surname> <given-names>GK</given-names></name><name><surname>Antonia</surname> <given-names>SJ</given-names></name><name><surname>Horn</surname> <given-names>L</given-names></name><name><surname>Lena</surname> <given-names>H</given-names></name><name><surname>Minenza</surname> <given-names>E</given-names></name><name><surname>Mennecier</surname> <given-names>B</given-names></name><name><surname>Otterson</surname> <given-names>GA</given-names></name><name><surname>Campos</surname> <given-names>LT</given-names></name><name><surname>Gandara</surname> <given-names>DR</given-names></name><name><surname>Levy</surname> <given-names>BP</given-names></name><name><surname>Nair</surname> <given-names>SG</given-names></name><name><surname>Zalcman</surname> <given-names>G</given-names></name><name><surname>Wolf</surname> <given-names>J</given-names></name><name><surname>Souquet</surname> <given-names>PJ</given-names></name><name><surname>Baldini</surname> <given-names>E</given-names></name><name><surname>Cappuzzo</surname> <given-names>F</given-names></name><name><surname>Chouaid</surname> <given-names>C</given-names></name><name><surname>Dowlati</surname> <given-names>A</given-names></name><name><surname>Sanborn</surname> <given-names>R</given-names></name><name><surname>Lopez-Chavez</surname> <given-names>A</given-names></name><name><surname>Grohe</surname> <given-names>C</given-names></name><name><surname>Huber</surname> <given-names>RM</given-names></name><name><surname>Harbison</surname> <given-names>CT</given-names></name><name><surname>Baudelet</surname> <given-names>C</given-names></name><name><surname>Lestini</surname> <given-names>BJ</given-names></name><name><surname>Ramalingam</surname> <given-names>SS</given-names></name></person-group><year iso-8601-date="2015">2015b</year><article-title>Activity and safety of Nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial</article-title><source>The Lancet Oncology</source><volume>16</volume><fpage>257</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1016/S1470-2045(15)70054-9</pub-id><pub-id pub-id-type="pmid">25704439</pub-id></element-citation></ref><ref id="bib494"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robert</surname> <given-names>C</given-names></name><name><surname>Long</surname> <given-names>GV</given-names></name><name><surname>Brady</surname> <given-names>B</given-names></name><name><surname>Dutriaux</surname> <given-names>C</given-names></name><name><surname>Maio</surname> <given-names>M</given-names></name><name><surname>Mortier</surname> <given-names>L</given-names></name><name><surname>Hassel</surname> <given-names>JC</given-names></name><name><surname>Rutkowski</surname> <given-names>P</given-names></name><name><surname>McNeil</surname> <given-names>C</given-names></name><name><surname>Kalinka-Warzocha</surname> <given-names>E</given-names></name><name><surname>Savage</surname> <given-names>KJ</given-names></name><name><surname>Hernberg</surname> <given-names>MM</given-names></name><name><surname>Lebbé</surname> <given-names>C</given-names></name><name><surname>Charles</surname> <given-names>J</given-names></name><name><surname>Mihalcioiu</surname> <given-names>C</given-names></name><name><surname>Chiarion-Sileni</surname> <given-names>V</given-names></name><name><surname>Mauch</surname> <given-names>C</given-names></name><name><surname>Cognetti</surname> <given-names>F</given-names></name><name><surname>Arance</surname> <given-names>A</given-names></name><name><surname>Schmidt</surname> <given-names>H</given-names></name><name><surname>Schadendorf</surname> <given-names>D</given-names></name><name><surname>Gogas</surname> <given-names>H</given-names></name><name><surname>Lundgren-Eriksson</surname> <given-names>L</given-names></name><name><surname>Horak</surname> <given-names>C</given-names></name><name><surname>Sharkey</surname> <given-names>B</given-names></name><name><surname>Waxman</surname> <given-names>IM</given-names></name><name><surname>Atkinson</surname> <given-names>V</given-names></name><name><surname>Ascierto</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Nivolumab in previously untreated melanoma without <italic>BRAF</italic> mutation</article-title><source>The New England Journal of Medicine</source><volume>372</volume><fpage>320</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1412082</pub-id><pub-id pub-id-type="pmid">25399552</pub-id></element-citation></ref><ref id="bib495"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname> <given-names>EW</given-names></name><name><surname>Broz</surname> <given-names>ML</given-names></name><name><surname>Binnewies</surname> <given-names>M</given-names></name><name><surname>Headley</surname> <given-names>MB</given-names></name><name><surname>Nelson</surname> <given-names>AE</given-names></name><name><surname>Wolf</surname> <given-names>DM</given-names></name><name><surname>Kaisho</surname> <given-names>T</given-names></name><name><surname>Bogunovic</surname> <given-names>D</given-names></name><name><surname>Bhardwaj</surname> <given-names>N</given-names></name><name><surname>Krummel</surname> <given-names>MF</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Critical role for CD103(+)/CD141(+) Dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma</article-title><source>Cancer Cell</source><volume>30</volume><fpage>324</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2016.06.003</pub-id><pub-id pub-id-type="pmid">27424807</pub-id></element-citation></ref><ref id="bib496"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname> <given-names>RM</given-names></name><name><surname>Suarez-Alvarez</surname> <given-names>B</given-names></name><name><surname>Lavín</surname> <given-names>JL</given-names></name><name><surname>Mosén-Ansorena</surname> <given-names>D</given-names></name><name><surname>Baragaño Raneros</surname> <given-names>A</given-names></name><name><surname>Márquez-Kisinousky</surname> <given-names>L</given-names></name><name><surname>Aransay</surname> <given-names>AM</given-names></name><name><surname>Lopez-Larrea</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Epigenetic networks regulate the transcriptional program in memory and terminally differentiated CD8<sup>+</sup> T cells</article-title><source>The Journal of Immunology</source><volume>198</volume><fpage>937</fpage><lpage>949</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1601102</pub-id><pub-id pub-id-type="pmid">27974453</pub-id></element-citation></ref><ref id="bib497"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohaan</surname> <given-names>MW</given-names></name><name><surname>van den Berg</surname> <given-names>JH</given-names></name><name><surname>Kvistborg</surname> <given-names>P</given-names></name><name><surname>Haanen</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option</article-title><source>Journal for ImmunoTherapy of Cancer</source><volume>6</volume><elocation-id>102</elocation-id><pub-id pub-id-type="doi">10.1186/s40425-018-0391-1</pub-id><pub-id pub-id-type="pmid">30285902</pub-id></element-citation></ref><ref id="bib498"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname> <given-names>SA</given-names></name><name><surname>Packard</surname> <given-names>BS</given-names></name><name><surname>Aebersold</surname> <given-names>PM</given-names></name><name><surname>Solomon</surname> <given-names>D</given-names></name><name><surname>Topalian</surname> <given-names>SL</given-names></name><name><surname>Toy</surname> <given-names>ST</given-names></name><name><surname>Simon</surname> <given-names>P</given-names></name><name><surname>Lotze</surname> <given-names>MT</given-names></name><name><surname>Yang</surname> <given-names>JC</given-names></name><name><surname>Seipp</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report</article-title><source>New England Journal of Medicine</source><volume>319</volume><fpage>1676</fpage><lpage>1680</lpage><pub-id pub-id-type="doi">10.1056/NEJM198812223192527</pub-id><pub-id pub-id-type="pmid">3264384</pub-id></element-citation></ref><ref id="bib499"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname> <given-names>SA</given-names></name><name><surname>Restifo</surname> <given-names>NP</given-names></name><name><surname>Yang</surname> <given-names>JC</given-names></name><name><surname>Morgan</surname> <given-names>RA</given-names></name><name><surname>Dudley</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Adoptive cell transfer: a clinical path to effective cancer immunotherapy</article-title><source>Nature Reviews Cancer</source><volume>8</volume><fpage>299</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1038/nrc2355</pub-id><pub-id pub-id-type="pmid">18354418</pub-id></element-citation></ref><ref id="bib500"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname> <given-names>SA</given-names></name><name><surname>Restifo</surname> <given-names>NP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Adoptive cell transfer as personalized immunotherapy for human cancer</article-title><source>Science</source><volume>348</volume><fpage>62</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1126/science.aaa4967</pub-id><pub-id pub-id-type="pmid">25838374</pub-id></element-citation></ref><ref id="bib501"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosser</surname> <given-names>EC</given-names></name><name><surname>Mauri</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Regulatory B cells: origin, phenotype, and function</article-title><source>Immunity</source><volume>42</volume><fpage>607</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.04.005</pub-id><pub-id pub-id-type="pmid">25902480</pub-id></element-citation></ref><ref id="bib502"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotem</surname> <given-names>A</given-names></name><name><surname>Ram</surname> <given-names>O</given-names></name><name><surname>Shoresh</surname> <given-names>N</given-names></name><name><surname>Sperling</surname> <given-names>RA</given-names></name><name><surname>Goren</surname> <given-names>A</given-names></name><name><surname>Weitz</surname> <given-names>DA</given-names></name><name><surname>Bernstein</surname> <given-names>BE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Single-cell ChIP-seq reveals cell subpopulations defined by chromatin state</article-title><source>Nature Biotechnology</source><volume>33</volume><fpage>1165</fpage><lpage>1172</lpage><pub-id pub-id-type="doi">10.1038/nbt.3383</pub-id><pub-id pub-id-type="pmid">26458175</pub-id></element-citation></ref><ref id="bib503"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Routy</surname> <given-names>B</given-names></name><name><surname>Le Chatelier</surname> <given-names>E</given-names></name><name><surname>Derosa</surname> <given-names>L</given-names></name><name><surname>Duong</surname> <given-names>CPM</given-names></name><name><surname>Alou</surname> <given-names>MT</given-names></name><name><surname>Daillère</surname> <given-names>R</given-names></name><name><surname>Fluckiger</surname> <given-names>A</given-names></name><name><surname>Messaoudene</surname> <given-names>M</given-names></name><name><surname>Rauber</surname> <given-names>C</given-names></name><name><surname>Roberti</surname> <given-names>MP</given-names></name><name><surname>Fidelle</surname> <given-names>M</given-names></name><name><surname>Flament</surname> <given-names>C</given-names></name><name><surname>Poirier-Colame</surname> <given-names>V</given-names></name><name><surname>Opolon</surname> <given-names>P</given-names></name><name><surname>Klein</surname> <given-names>C</given-names></name><name><surname>Iribarren</surname> <given-names>K</given-names></name><name><surname>Mondragón</surname> <given-names>L</given-names></name><name><surname>Jacquelot</surname> <given-names>N</given-names></name><name><surname>Qu</surname> <given-names>B</given-names></name><name><surname>Ferrere</surname> <given-names>G</given-names></name><name><surname>Clémenson</surname> <given-names>C</given-names></name><name><surname>Mezquita</surname> <given-names>L</given-names></name><name><surname>Masip</surname> <given-names>JR</given-names></name><name><surname>Naltet</surname> <given-names>C</given-names></name><name><surname>Brosseau</surname> <given-names>S</given-names></name><name><surname>Kaderbhai</surname> <given-names>C</given-names></name><name><surname>Richard</surname> <given-names>C</given-names></name><name><surname>Rizvi</surname> <given-names>H</given-names></name><name><surname>Levenez</surname> <given-names>F</given-names></name><name><surname>Galleron</surname> <given-names>N</given-names></name><name><surname>Quinquis</surname> <given-names>B</given-names></name><name><surname>Pons</surname> <given-names>N</given-names></name><name><surname>Ryffel</surname> <given-names>B</given-names></name><name><surname>Minard-Colin</surname> <given-names>V</given-names></name><name><surname>Gonin</surname> <given-names>P</given-names></name><name><surname>Soria</surname> <given-names>JC</given-names></name><name><surname>Deutsch</surname> <given-names>E</given-names></name><name><surname>Loriot</surname> <given-names>Y</given-names></name><name><surname>Ghiringhelli</surname> <given-names>F</given-names></name><name><surname>Zalcman</surname> <given-names>G</given-names></name><name><surname>Goldwasser</surname> <given-names>F</given-names></name><name><surname>Escudier</surname> <given-names>B</given-names></name><name><surname>Hellmann</surname> <given-names>MD</given-names></name><name><surname>Eggermont</surname> <given-names>A</given-names></name><name><surname>Raoult</surname> <given-names>D</given-names></name><name><surname>Albiges</surname> <given-names>L</given-names></name><name><surname>Kroemer</surname> <given-names>G</given-names></name><name><surname>Zitvogel</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors</article-title><source>Science</source><volume>359</volume><fpage>91</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1126/science.aan3706</pub-id><pub-id pub-id-type="pmid">29097494</pub-id></element-citation></ref><ref id="bib504"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russ</surname> <given-names>BE</given-names></name><name><surname>Olshanksy</surname> <given-names>M</given-names></name><name><surname>Smallwood</surname> <given-names>HS</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Denton</surname> <given-names>AE</given-names></name><name><surname>Prier</surname> <given-names>JE</given-names></name><name><surname>Stock</surname> <given-names>AT</given-names></name><name><surname>Croom</surname> <given-names>HA</given-names></name><name><surname>Cullen</surname> <given-names>JG</given-names></name><name><surname>Nguyen</surname> <given-names>ML</given-names></name><name><surname>Rowe</surname> <given-names>S</given-names></name><name><surname>Olson</surname> <given-names>MR</given-names></name><name><surname>Finkelstein</surname> <given-names>DB</given-names></name><name><surname>Kelso</surname> <given-names>A</given-names></name><name><surname>Thomas</surname> <given-names>PG</given-names></name><name><surname>Speed</surname> <given-names>TP</given-names></name><name><surname>Rao</surname> <given-names>S</given-names></name><name><surname>Turner</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Distinct epigenetic signatures delineate transcriptional programs during virus-specific CD8(+) T cell differentiation</article-title><source>Immunity</source><volume>41</volume><fpage>853</fpage><lpage>865</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.11.001</pub-id><pub-id pub-id-type="pmid">25517617</pub-id></element-citation></ref><ref id="bib505"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabò</surname> <given-names>A</given-names></name><name><surname>Kress</surname> <given-names>TR</given-names></name><name><surname>Pelizzola</surname> <given-names>M</given-names></name><name><surname>de Pretis</surname> <given-names>S</given-names></name><name><surname>Gorski</surname> <given-names>MM</given-names></name><name><surname>Tesi</surname> <given-names>A</given-names></name><name><surname>Morelli</surname> <given-names>MJ</given-names></name><name><surname>Bora</surname> <given-names>P</given-names></name><name><surname>Doni</surname> <given-names>M</given-names></name><name><surname>Verrecchia</surname> <given-names>A</given-names></name><name><surname>Tonelli</surname> <given-names>C</given-names></name><name><surname>Fagà</surname> <given-names>G</given-names></name><name><surname>Bianchi</surname> <given-names>V</given-names></name><name><surname>Ronchi</surname> <given-names>A</given-names></name><name><surname>Low</surname> <given-names>D</given-names></name><name><surname>Müller</surname> <given-names>H</given-names></name><name><surname>Guccione</surname> <given-names>E</given-names></name><name><surname>Campaner</surname> <given-names>S</given-names></name><name><surname>Amati</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Selective transcriptional regulation by myc in cellular growth control and lymphomagenesis</article-title><source>Nature</source><volume>511</volume><fpage>488</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1038/nature13537</pub-id><pub-id pub-id-type="pmid">25043028</pub-id></element-citation></ref><ref id="bib506"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sackmann</surname> <given-names>A</given-names></name><name><surname>Heiner</surname> <given-names>M</given-names></name><name><surname>Koch</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Application of Petri net based analysis techniques to signal transduction pathways</article-title><source>BMC Bioinformatics</source><volume>7</volume><elocation-id>482</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-7-482</pub-id></element-citation></ref><ref id="bib507"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sade-Feldman</surname> <given-names>M</given-names></name><name><surname>Jiao</surname> <given-names>YJ</given-names></name><name><surname>Chen</surname> <given-names>JH</given-names></name><name><surname>Rooney</surname> <given-names>MS</given-names></name><name><surname>Barzily-Rokni</surname> <given-names>M</given-names></name><name><surname>Eliane</surname> <given-names>J-P</given-names></name><name><surname>Bjorgaard</surname> <given-names>SL</given-names></name><name><surname>Hammond</surname> <given-names>MR</given-names></name><name><surname>Vitzthum</surname> <given-names>H</given-names></name><name><surname>Blackmon</surname> <given-names>SM</given-names></name><name><surname>Frederick</surname> <given-names>DT</given-names></name><name><surname>Hazar-Rethinam</surname> <given-names>M</given-names></name><name><surname>Nadres</surname> <given-names>BA</given-names></name><name><surname>Van Seventer</surname> <given-names>EE</given-names></name><name><surname>Shukla</surname> <given-names>SA</given-names></name><name><surname>Yizhak</surname> <given-names>K</given-names></name><name><surname>Ray</surname> <given-names>JP</given-names></name><name><surname>Rosebrock</surname> <given-names>D</given-names></name><name><surname>Livitz</surname> <given-names>D</given-names></name><name><surname>Adalsteinsson</surname> <given-names>V</given-names></name><name><surname>Getz</surname> <given-names>G</given-names></name><name><surname>Duncan</surname> <given-names>LM</given-names></name><name><surname>Li</surname> <given-names>B</given-names></name><name><surname>Corcoran</surname> <given-names>RB</given-names></name><name><surname>Lawrence</surname> <given-names>DP</given-names></name><name><surname>Stemmer-Rachamimov</surname> <given-names>A</given-names></name><name><surname>Boland</surname> <given-names>GM</given-names></name><name><surname>Landau</surname> <given-names>DA</given-names></name><name><surname>Flaherty</surname> <given-names>KT</given-names></name><name><surname>Sullivan</surname> <given-names>RJ</given-names></name><name><surname>Hacohen</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Resistance to checkpoint blockade therapy through inactivation of antigen presentation</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>1136</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-01062-w</pub-id></element-citation></ref><ref id="bib508"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sade-Feldman</surname> <given-names>M</given-names></name><name><surname>Yizhak</surname> <given-names>K</given-names></name><name><surname>Bjorgaard</surname> <given-names>SL</given-names></name><name><surname>Ray</surname> <given-names>JP</given-names></name><name><surname>de Boer</surname> <given-names>CG</given-names></name><name><surname>Jenkins</surname> <given-names>RW</given-names></name><name><surname>Lieb</surname> <given-names>DJ</given-names></name><name><surname>Chen</surname> <given-names>JH</given-names></name><name><surname>Frederick</surname> <given-names>DT</given-names></name><name><surname>Barzily-Rokni</surname> <given-names>M</given-names></name><name><surname>Freeman</surname> <given-names>SS</given-names></name><name><surname>Reuben</surname> <given-names>A</given-names></name><name><surname>Hoover</surname> <given-names>PJ</given-names></name><name><surname>Villani</surname> <given-names>A-C</given-names></name><name><surname>Ivanova</surname> <given-names>E</given-names></name><name><surname>Portell</surname> <given-names>A</given-names></name><name><surname>Lizotte</surname> <given-names>PH</given-names></name><name><surname>Aref</surname> <given-names>AR</given-names></name><name><surname>Eliane</surname> <given-names>J-P</given-names></name><name><surname>Hammond</surname> <given-names>MR</given-names></name><name><surname>Vitzthum</surname> <given-names>H</given-names></name><name><surname>Blackmon</surname> <given-names>SM</given-names></name><name><surname>Li</surname> <given-names>B</given-names></name><name><surname>Gopalakrishnan</surname> <given-names>V</given-names></name><name><surname>Reddy</surname> <given-names>SM</given-names></name><name><surname>Cooper</surname> <given-names>ZA</given-names></name><name><surname>Paweletz</surname> <given-names>CP</given-names></name><name><surname>Barbie</surname> <given-names>DA</given-names></name><name><surname>Stemmer-Rachamimov</surname> <given-names>A</given-names></name><name><surname>Flaherty</surname> <given-names>KT</given-names></name><name><surname>Wargo</surname> <given-names>JA</given-names></name><name><surname>Boland</surname> <given-names>GM</given-names></name><name><surname>Sullivan</surname> <given-names>RJ</given-names></name><name><surname>Getz</surname> <given-names>G</given-names></name><name><surname>Hacohen</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma</article-title><source>Cell</source><volume>175</volume><fpage>998</fpage><lpage>1013</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.10.038</pub-id></element-citation></ref><ref id="bib509"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saez-Rodriguez</surname> <given-names>J</given-names></name><name><surname>Simeoni</surname> <given-names>L</given-names></name><name><surname>Lindquist</surname> <given-names>JA</given-names></name><name><surname>Hemenway</surname> <given-names>R</given-names></name><name><surname>Bommhardt</surname> <given-names>U</given-names></name><name><surname>Arndt</surname> <given-names>B</given-names></name><name><surname>Haus</surname> <given-names>UU</given-names></name><name><surname>Weismantel</surname> <given-names>R</given-names></name><name><surname>Gilles</surname> <given-names>ED</given-names></name><name><surname>Klamt</surname> <given-names>S</given-names></name><name><surname>Schraven</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>A logical model provides insights into T cell receptor signaling</article-title><source>PLOS Computational Biology</source><volume>3</volume><elocation-id>e163</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.0030163</pub-id><pub-id pub-id-type="pmid">17722974</pub-id></element-citation></ref><ref id="bib510"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahin</surname> <given-names>U</given-names></name><name><surname>Derhovanessian</surname> <given-names>E</given-names></name><name><surname>Miller</surname> <given-names>M</given-names></name><name><surname>Kloke</surname> <given-names>BP</given-names></name><name><surname>Simon</surname> <given-names>P</given-names></name><name><surname>Löwer</surname> <given-names>M</given-names></name><name><surname>Bukur</surname> <given-names>V</given-names></name><name><surname>Tadmor</surname> <given-names>AD</given-names></name><name><surname>Luxemburger</surname> <given-names>U</given-names></name><name><surname>Schrörs</surname> <given-names>B</given-names></name><name><surname>Omokoko</surname> <given-names>T</given-names></name><name><surname>Vormehr</surname> <given-names>M</given-names></name><name><surname>Albrecht</surname> <given-names>C</given-names></name><name><surname>Paruzynski</surname> <given-names>A</given-names></name><name><surname>Kuhn</surname> <given-names>AN</given-names></name><name><surname>Buck</surname> <given-names>J</given-names></name><name><surname>Heesch</surname> <given-names>S</given-names></name><name><surname>Schreeb</surname> <given-names>KH</given-names></name><name><surname>Müller</surname> <given-names>F</given-names></name><name><surname>Ortseifer</surname> <given-names>I</given-names></name><name><surname>Vogler</surname> <given-names>I</given-names></name><name><surname>Godehardt</surname> <given-names>E</given-names></name><name><surname>Attig</surname> <given-names>S</given-names></name><name><surname>Rae</surname> <given-names>R</given-names></name><name><surname>Breitkreuz</surname> <given-names>A</given-names></name><name><surname>Tolliver</surname> <given-names>C</given-names></name><name><surname>Suchan</surname> <given-names>M</given-names></name><name><surname>Martic</surname> <given-names>G</given-names></name><name><surname>Hohberger</surname> <given-names>A</given-names></name><name><surname>Sorn</surname> <given-names>P</given-names></name><name><surname>Diekmann</surname> <given-names>J</given-names></name><name><surname>Ciesla</surname> <given-names>J</given-names></name><name><surname>Waksmann</surname> <given-names>O</given-names></name><name><surname>Brück</surname> <given-names>AK</given-names></name><name><surname>Witt</surname> <given-names>M</given-names></name><name><surname>Zillgen</surname> <given-names>M</given-names></name><name><surname>Rothermel</surname> <given-names>A</given-names></name><name><surname>Kasemann</surname> <given-names>B</given-names></name><name><surname>Langer</surname> <given-names>D</given-names></name><name><surname>Bolte</surname> <given-names>S</given-names></name><name><surname>Diken</surname> <given-names>M</given-names></name><name><surname>Kreiter</surname> <given-names>S</given-names></name><name><surname>Nemecek</surname> <given-names>R</given-names></name><name><surname>Gebhardt</surname> <given-names>C</given-names></name><name><surname>Grabbe</surname> <given-names>S</given-names></name><name><surname>Höller</surname> <given-names>C</given-names></name><name><surname>Utikal</surname> <given-names>J</given-names></name><name><surname>Huber</surname> <given-names>C</given-names></name><name><surname>Loquai</surname> <given-names>C</given-names></name><name><surname>Türeci</surname> <given-names>Ö</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against Cancer</article-title><source>Nature</source><volume>547</volume><fpage>222</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1038/nature23003</pub-id><pub-id pub-id-type="pmid">28678784</pub-id></element-citation></ref><ref id="bib511"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salmon</surname> <given-names>H</given-names></name><name><surname>Idoyaga</surname> <given-names>J</given-names></name><name><surname>Rahman</surname> <given-names>A</given-names></name><name><surname>Leboeuf</surname> <given-names>M</given-names></name><name><surname>Remark</surname> <given-names>R</given-names></name><name><surname>Jordan</surname> <given-names>S</given-names></name><name><surname>Casanova-Acebes</surname> <given-names>M</given-names></name><name><surname>Khudoynazarova</surname> <given-names>M</given-names></name><name><surname>Agudo</surname> <given-names>J</given-names></name><name><surname>Tung</surname> <given-names>N</given-names></name><name><surname>Chakarov</surname> <given-names>S</given-names></name><name><surname>Rivera</surname> <given-names>C</given-names></name><name><surname>Hogstad</surname> <given-names>B</given-names></name><name><surname>Bosenberg</surname> <given-names>M</given-names></name><name><surname>Hashimoto</surname> <given-names>D</given-names></name><name><surname>Gnjatic</surname> <given-names>S</given-names></name><name><surname>Bhardwaj</surname> <given-names>N</given-names></name><name><surname>Palucka</surname> <given-names>AK</given-names></name><name><surname>Brown</surname> <given-names>BD</given-names></name><name><surname>Brody</surname> <given-names>J</given-names></name><name><surname>Ginhoux</surname> <given-names>F</given-names></name><name><surname>Merad</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Expansion and activation of CD103(+) Dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition</article-title><source>Immunity</source><volume>44</volume><fpage>924</fpage><lpage>938</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.03.012</pub-id><pub-id pub-id-type="pmid">27096321</pub-id></element-citation></ref><ref id="bib512"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samusik</surname> <given-names>N</given-names></name><name><surname>Good</surname> <given-names>Z</given-names></name><name><surname>Spitzer</surname> <given-names>MH</given-names></name><name><surname>Davis</surname> <given-names>KL</given-names></name><name><surname>Nolan</surname> <given-names>GP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Automated mapping of phenotype space with single-cell data</article-title><source>Nature Methods</source><volume>13</volume><fpage>493</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3863</pub-id><pub-id pub-id-type="pmid">27183440</pub-id></element-citation></ref><ref id="bib513"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez-Vega</surname> <given-names>F</given-names></name><name><surname>Mina</surname> <given-names>M</given-names></name><name><surname>Armenia</surname> <given-names>J</given-names></name><name><surname>Chatila</surname> <given-names>WK</given-names></name><name><surname>Luna</surname> <given-names>A</given-names></name><name><surname>La</surname> <given-names>KC</given-names></name><name><surname>Dimitriadoy</surname> <given-names>S</given-names></name><name><surname>Liu</surname> <given-names>DL</given-names></name><name><surname>Kantheti</surname> <given-names>HS</given-names></name><name><surname>Saghafinia</surname> <given-names>S</given-names></name><name><surname>Chakravarty</surname> <given-names>D</given-names></name><name><surname>Daian</surname> <given-names>F</given-names></name><name><surname>Gao</surname> <given-names>Q</given-names></name><name><surname>Bailey</surname> <given-names>MH</given-names></name><name><surname>Liang</surname> <given-names>WW</given-names></name><name><surname>Foltz</surname> <given-names>SM</given-names></name><name><surname>Shmulevich</surname> <given-names>I</given-names></name><name><surname>Ding</surname> <given-names>L</given-names></name><name><surname>Heins</surname> <given-names>Z</given-names></name><name><surname>Ochoa</surname> <given-names>A</given-names></name><name><surname>Gross</surname> <given-names>B</given-names></name><name><surname>Gao</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Kundra</surname> <given-names>R</given-names></name><name><surname>Kandoth</surname> <given-names>C</given-names></name><name><surname>Bahceci</surname> <given-names>I</given-names></name><name><surname>Dervishi</surname> <given-names>L</given-names></name><name><surname>Dogrusoz</surname> <given-names>U</given-names></name><name><surname>Zhou</surname> <given-names>W</given-names></name><name><surname>Shen</surname> <given-names>H</given-names></name><name><surname>Laird</surname> <given-names>PW</given-names></name><name><surname>Way</surname> <given-names>GP</given-names></name><name><surname>Greene</surname> <given-names>CS</given-names></name><name><surname>Liang</surname> <given-names>H</given-names></name><name><surname>Xiao</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name><name><surname>Iavarone</surname> <given-names>A</given-names></name><name><surname>Berger</surname> <given-names>AH</given-names></name><name><surname>Bivona</surname> <given-names>TG</given-names></name><name><surname>Lazar</surname> <given-names>AJ</given-names></name><name><surname>Hammer</surname> <given-names>GD</given-names></name><name><surname>Giordano</surname> <given-names>T</given-names></name><name><surname>Kwong</surname> <given-names>LN</given-names></name><name><surname>McArthur</surname> <given-names>G</given-names></name><name><surname>Huang</surname> <given-names>C</given-names></name><name><surname>Tward</surname> <given-names>AD</given-names></name><name><surname>Frederick</surname> <given-names>MJ</given-names></name><name><surname>McCormick</surname> <given-names>F</given-names></name><name><surname>Meyerson</surname> <given-names>M</given-names></name><name><surname>Van Allen</surname> <given-names>EM</given-names></name><name><surname>Cherniack</surname> <given-names>AD</given-names></name><name><surname>Ciriello</surname> <given-names>G</given-names></name><name><surname>Sander</surname> <given-names>C</given-names></name><name><surname>Schultz</surname> <given-names>N</given-names></name><collab>Cancer Genome Atlas Research Network</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Oncogenic signaling pathways in the Cancer genome atlas</article-title><source>Cell</source><volume>173</volume><fpage>321</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.03.035</pub-id><pub-id pub-id-type="pmid">29625050</pub-id></element-citation></ref><ref id="bib514"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarnaik</surname> <given-names>A</given-names></name><name><surname>Khushalani</surname> <given-names>NI</given-names></name><name><surname>Chesney</surname> <given-names>JA</given-names></name><name><surname>Lewis</surname> <given-names>KD</given-names></name><name><surname>Medina</surname> <given-names>TM</given-names></name><name><surname>Kluger</surname> <given-names>HM</given-names></name><name><surname>Thomas</surname> <given-names>SS</given-names></name><name><surname>Domingo Musibay</surname> <given-names>E</given-names></name><name><surname>Pavlick</surname> <given-names>AC</given-names></name><name><surname>Whitman</surname> <given-names>ED</given-names></name><name><surname>Martin-Algarra</surname> <given-names>S</given-names></name><name><surname>Corrie</surname> <given-names>PG</given-names></name><name><surname>Lutzky</surname> <given-names>J</given-names></name><name><surname>Hamid</surname> <given-names>O</given-names></name><name><surname>Wu</surname> <given-names>R</given-names></name><name><surname>Shi</surname> <given-names>W</given-names></name><name><surname>Fardis</surname> <given-names>M</given-names></name><name><surname>Weber</surname> <given-names>JS</given-names></name><name><surname>Larkin</surname> <given-names>JMG</given-names></name><name><surname>Kirkwood</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Long-term follow up of lifileucel (LN-144) cryopreserved autologous tumor infiltrating lymphocyte therapy in patients with advanced melanoma progressed on multiple prior therapies</article-title><source>Journal of Clinical Oncology</source><volume>38</volume><elocation-id>10006</elocation-id><pub-id pub-id-type="doi">10.1200/JCO.2020.38.15_suppl.10006</pub-id></element-citation></ref><ref id="bib515"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satomaa</surname> <given-names>T</given-names></name><name><surname>Heiskanen</surname> <given-names>A</given-names></name><name><surname>Leonardsson</surname> <given-names>I</given-names></name><name><surname>Angström</surname> <given-names>J</given-names></name><name><surname>Olonen</surname> <given-names>A</given-names></name><name><surname>Blomqvist</surname> <given-names>M</given-names></name><name><surname>Salovuori</surname> <given-names>N</given-names></name><name><surname>Haglund</surname> <given-names>C</given-names></name><name><surname>Teneberg</surname> <given-names>S</given-names></name><name><surname>Natunen</surname> <given-names>J</given-names></name><name><surname>Carpén</surname> <given-names>O</given-names></name><name><surname>Saarinen</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Analysis of the human Cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens</article-title><source>Cancer Research</source><volume>69</volume><fpage>5811</fpage><lpage>5819</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-0289</pub-id><pub-id pub-id-type="pmid">19584298</pub-id></element-citation></ref><ref id="bib516"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satpathy</surname> <given-names>AT</given-names></name><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Albring</surname> <given-names>JC</given-names></name><name><surname>Murphy</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Re(de)fining the dendritic cell lineage</article-title><source>Nature Immunology</source><volume>13</volume><fpage>1145</fpage><lpage>1154</lpage><pub-id pub-id-type="doi">10.1038/ni.2467</pub-id><pub-id pub-id-type="pmid">23160217</pub-id></element-citation></ref><ref id="bib517"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satpathy</surname> <given-names>AT</given-names></name><name><surname>Saligrama</surname> <given-names>N</given-names></name><name><surname>Buenrostro</surname> <given-names>JD</given-names></name><name><surname>Wei</surname> <given-names>Y</given-names></name><name><surname>Wu</surname> <given-names>B</given-names></name><name><surname>Rubin</surname> <given-names>AJ</given-names></name><name><surname>Granja</surname> <given-names>JM</given-names></name><name><surname>Lareau</surname> <given-names>CA</given-names></name><name><surname>Li</surname> <given-names>R</given-names></name><name><surname>Qi</surname> <given-names>Y</given-names></name><name><surname>Parker</surname> <given-names>KR</given-names></name><name><surname>Mumbach</surname> <given-names>MR</given-names></name><name><surname>Serratelli</surname> <given-names>WS</given-names></name><name><surname>Gennert</surname> <given-names>DG</given-names></name><name><surname>Schep</surname> <given-names>AN</given-names></name><name><surname>Corces</surname> <given-names>MR</given-names></name><name><surname>Khodadoust</surname> <given-names>MS</given-names></name><name><surname>Kim</surname> <given-names>YH</given-names></name><name><surname>Khavari</surname> <given-names>PA</given-names></name><name><surname>Greenleaf</surname> <given-names>WJ</given-names></name><name><surname>Davis</surname> <given-names>MM</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Transcript-indexed ATAC-seq for precision immune profiling</article-title><source>Nature Medicine</source><volume>24</volume><fpage>580</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1038/s41591-018-0008-8</pub-id><pub-id pub-id-type="pmid">29686426</pub-id></element-citation></ref><ref id="bib518"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satpathy</surname> <given-names>AT</given-names></name><name><surname>Granja</surname> <given-names>JM</given-names></name><name><surname>Yost</surname> <given-names>KE</given-names></name><name><surname>Qi</surname> <given-names>Y</given-names></name><name><surname>Meschi</surname> <given-names>F</given-names></name><name><surname>McDermott</surname> <given-names>GP</given-names></name><name><surname>Olsen</surname> <given-names>BN</given-names></name><name><surname>Mumbach</surname> <given-names>MR</given-names></name><name><surname>Pierce</surname> <given-names>SE</given-names></name><name><surname>Corces</surname> <given-names>MR</given-names></name><name><surname>Shah</surname> <given-names>P</given-names></name><name><surname>Bell</surname> <given-names>JC</given-names></name><name><surname>Jhutty</surname> <given-names>D</given-names></name><name><surname>Nemec</surname> <given-names>CM</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Yin</surname> <given-names>Y</given-names></name><name><surname>Giresi</surname> <given-names>PG</given-names></name><name><surname>Chang</surname> <given-names>ALS</given-names></name><name><surname>Zheng</surname> <given-names>GXY</given-names></name><name><surname>Greenleaf</surname> <given-names>WJ</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion</article-title><source>Nature Biotechnology</source><volume>37</volume><fpage>925</fpage><lpage>936</lpage><pub-id pub-id-type="doi">10.1038/s41587-019-0206-z</pub-id><pub-id pub-id-type="pmid">31375813</pub-id></element-citation></ref><ref id="bib519"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sautès-Fridman</surname> <given-names>C</given-names></name><name><surname>Lawand</surname> <given-names>M</given-names></name><name><surname>Giraldo</surname> <given-names>NA</given-names></name><name><surname>Kaplon</surname> <given-names>H</given-names></name><name><surname>Germain</surname> <given-names>C</given-names></name><name><surname>Fridman</surname> <given-names>WH</given-names></name><name><surname>Dieu-Nosjean</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Tertiary lymphoid structures in cancers: prognostic value, regulation, and manipulation for therapeutic intervention</article-title><source>Frontiers in Immunology</source><volume>7</volume><elocation-id>407</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2016.00407</pub-id><pub-id pub-id-type="pmid">27752258</pub-id></element-citation></ref><ref id="bib520"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sautès-Fridman</surname> <given-names>C</given-names></name><name><surname>Petitprez</surname> <given-names>F</given-names></name><name><surname>Calderaro</surname> <given-names>J</given-names></name><name><surname>Fridman</surname> <given-names>WH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Tertiary lymphoid structures in the era of Cancer immunotherapy</article-title><source>Nature Reviews Cancer</source><volume>19</volume><fpage>307</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1038/s41568-019-0144-6</pub-id><pub-id pub-id-type="pmid">31092904</pub-id></element-citation></ref><ref id="bib521"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savas</surname> <given-names>P</given-names></name><name><surname>Virassamy</surname> <given-names>B</given-names></name><name><surname>Ye</surname> <given-names>C</given-names></name><name><surname>Salim</surname> <given-names>A</given-names></name><name><surname>Mintoff</surname> <given-names>CP</given-names></name><name><surname>Caramia</surname> <given-names>F</given-names></name><name><surname>Salgado</surname> <given-names>R</given-names></name><name><surname>Byrne</surname> <given-names>DJ</given-names></name><name><surname>Teo</surname> <given-names>ZL</given-names></name><name><surname>Dushyanthen</surname> <given-names>S</given-names></name><name><surname>Byrne</surname> <given-names>A</given-names></name><name><surname>Wein</surname> <given-names>L</given-names></name><name><surname>Luen</surname> <given-names>SJ</given-names></name><name><surname>Poliness</surname> <given-names>C</given-names></name><name><surname>Nightingale</surname> <given-names>SS</given-names></name><name><surname>Skandarajah</surname> <given-names>AS</given-names></name><name><surname>Gyorki</surname> <given-names>DE</given-names></name><name><surname>Thornton</surname> <given-names>CM</given-names></name><name><surname>Beavis</surname> <given-names>PA</given-names></name><name><surname>Fox</surname> <given-names>SB</given-names></name><name><surname>Darcy</surname> <given-names>PK</given-names></name><name><surname>Speed</surname> <given-names>TP</given-names></name><name><surname>Mackay</surname> <given-names>LK</given-names></name><name><surname>Neeson</surname> <given-names>PJ</given-names></name><name><surname>Loi</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Single-cell profiling of breast Cancer T cells reveals a tissue-resident memory subset associated with improved prognosis</article-title><source>Nature Medicine</source><volume>24</volume><fpage>986</fpage><lpage>993</lpage><pub-id pub-id-type="doi">10.1038/s41591-018-0078-7</pub-id></element-citation></ref><ref id="bib522"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scharer</surname> <given-names>CD</given-names></name><name><surname>Bally</surname> <given-names>AP</given-names></name><name><surname>Gandham</surname> <given-names>B</given-names></name><name><surname>Boss</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cutting edge: chromatin accessibility programs CD8 T cell memory</article-title><source>The Journal of Immunology</source><volume>198</volume><fpage>2238</fpage><lpage>2243</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1602086</pub-id><pub-id pub-id-type="pmid">28179496</pub-id></element-citation></ref><ref id="bib523"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schelker</surname> <given-names>M</given-names></name><name><surname>Feau</surname> <given-names>S</given-names></name><name><surname>Du</surname> <given-names>J</given-names></name><name><surname>Ranu</surname> <given-names>N</given-names></name><name><surname>Klipp</surname> <given-names>E</given-names></name><name><surname>MacBeath</surname> <given-names>G</given-names></name><name><surname>Schoeberl</surname> <given-names>B</given-names></name><name><surname>Raue</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Estimation of immune cell content in tumour tissue using single-cell RNA-seq data</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>2032</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-02289-3</pub-id><pub-id pub-id-type="pmid">29230012</pub-id></element-citation></ref><ref id="bib524"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheper</surname> <given-names>W</given-names></name><name><surname>Kelderman</surname> <given-names>S</given-names></name><name><surname>Fanchi</surname> <given-names>LF</given-names></name><name><surname>Linnemann</surname> <given-names>C</given-names></name><name><surname>Bendle</surname> <given-names>G</given-names></name><name><surname>de Rooij</surname> <given-names>MAJ</given-names></name><name><surname>Hirt</surname> <given-names>C</given-names></name><name><surname>Mezzadra</surname> <given-names>R</given-names></name><name><surname>Slagter</surname> <given-names>M</given-names></name><name><surname>Dijkstra</surname> <given-names>K</given-names></name><name><surname>Kluin</surname> <given-names>RJC</given-names></name><name><surname>Snaebjornsson</surname> <given-names>P</given-names></name><name><surname>Milne</surname> <given-names>K</given-names></name><name><surname>Nelson</surname> <given-names>BH</given-names></name><name><surname>Zijlmans</surname> <given-names>H</given-names></name><name><surname>Kenter</surname> <given-names>G</given-names></name><name><surname>Voest</surname> <given-names>EE</given-names></name><name><surname>Haanen</surname> <given-names>J</given-names></name><name><surname>Schumacher</surname> <given-names>TN</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers</article-title><source>Nature Medicine</source><volume>25</volume><fpage>89</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1038/s41591-018-0266-5</pub-id><pub-id pub-id-type="pmid">30510250</pub-id></element-citation></ref><ref id="bib525"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schietinger</surname> <given-names>A</given-names></name><name><surname>Philip</surname> <given-names>M</given-names></name><name><surname>Krisnawan</surname> <given-names>VE</given-names></name><name><surname>Chiu</surname> <given-names>EY</given-names></name><name><surname>Delrow</surname> <given-names>JJ</given-names></name><name><surname>Basom</surname> <given-names>RS</given-names></name><name><surname>Lauer</surname> <given-names>P</given-names></name><name><surname>Brockstedt</surname> <given-names>DG</given-names></name><name><surname>Knoblaugh</surname> <given-names>SE</given-names></name><name><surname>Hämmerling</surname> <given-names>GJ</given-names></name><name><surname>Schell</surname> <given-names>TD</given-names></name><name><surname>Garbi</surname> <given-names>N</given-names></name><name><surname>Greenberg</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Tumor-Specific T cell dysfunction is a dynamic Antigen-Driven differentiation program initiated early during tumorigenesis</article-title><source>Immunity</source><volume>45</volume><fpage>389</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.07.011</pub-id><pub-id pub-id-type="pmid">27521269</pub-id></element-citation></ref><ref id="bib526"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schietinger</surname> <given-names>A</given-names></name><name><surname>Greenberg</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Tolerance and exhaustion: defining mechanisms of T cell dysfunction</article-title><source>Trends in Immunology</source><volume>35</volume><fpage>51</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.it.2013.10.001</pub-id></element-citation></ref><ref id="bib527"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schioppa</surname> <given-names>T</given-names></name><name><surname>Moore</surname> <given-names>R</given-names></name><name><surname>Thompson</surname> <given-names>RG</given-names></name><name><surname>Rosser</surname> <given-names>EC</given-names></name><name><surname>Kulbe</surname> <given-names>H</given-names></name><name><surname>Nedospasov</surname> <given-names>S</given-names></name><name><surname>Mauri</surname> <given-names>C</given-names></name><name><surname>Coussens</surname> <given-names>LM</given-names></name><name><surname>Balkwill</surname> <given-names>FR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis</article-title><source>PNAS</source><volume>108</volume><fpage>10662</fpage><lpage>10667</lpage><pub-id pub-id-type="doi">10.1073/pnas.1100994108</pub-id><pub-id pub-id-type="pmid">21670304</pub-id></element-citation></ref><ref id="bib528"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidl</surname> <given-names>C</given-names></name><name><surname>Delacher</surname> <given-names>M</given-names></name><name><surname>Huehn</surname> <given-names>J</given-names></name><name><surname>Feuerer</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Epigenetic mechanisms regulating T-cell responses</article-title><source>Journal of Allergy and Clinical Immunology</source><volume>142</volume><fpage>728</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2018.07.014</pub-id><pub-id pub-id-type="pmid">30195378</pub-id></element-citation></ref><ref id="bib529"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname> <given-names>RD</given-names></name><name><surname>Old</surname> <given-names>LJ</given-names></name><name><surname>Smyth</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion</article-title><source>Science</source><volume>331</volume><fpage>1565</fpage><lpage>1570</lpage><pub-id pub-id-type="doi">10.1126/science.1203486</pub-id><pub-id pub-id-type="pmid">21436444</pub-id></element-citation></ref><ref id="bib530"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schubert</surname> <given-names>W</given-names></name><name><surname>Bonnekoh</surname> <given-names>B</given-names></name><name><surname>Pommer</surname> <given-names>AJ</given-names></name><name><surname>Philipsen</surname> <given-names>L</given-names></name><name><surname>Böckelmann</surname> <given-names>R</given-names></name><name><surname>Malykh</surname> <given-names>Y</given-names></name><name><surname>Gollnick</surname> <given-names>H</given-names></name><name><surname>Friedenberger</surname> <given-names>M</given-names></name><name><surname>Bode</surname> <given-names>M</given-names></name><name><surname>Dress</surname> <given-names>AW</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Analyzing proteome topology and function by automated multidimensional fluorescence microscopy</article-title><source>Nature Biotechnology</source><volume>24</volume><fpage>1270</fpage><lpage>1278</lpage><pub-id pub-id-type="doi">10.1038/nbt1250</pub-id><pub-id pub-id-type="pmid">17013374</pub-id></element-citation></ref><ref id="bib531"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schumacher</surname> <given-names>TN</given-names></name><name><surname>Schreiber</surname> <given-names>RD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Neoantigens in cancer immunotherapy</article-title><source>Science</source><volume>348</volume><fpage>69</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1126/science.aaa4971</pub-id><pub-id pub-id-type="pmid">25838375</pub-id></element-citation></ref><ref id="bib532"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname> <given-names>AC</given-names></name><name><surname>Dündar</surname> <given-names>F</given-names></name><name><surname>Zumbo</surname> <given-names>P</given-names></name><name><surname>Chandran</surname> <given-names>SS</given-names></name><name><surname>Klebanoff</surname> <given-names>CA</given-names></name><name><surname>Shakiba</surname> <given-names>M</given-names></name><name><surname>Trivedi</surname> <given-names>P</given-names></name><name><surname>Menocal</surname> <given-names>L</given-names></name><name><surname>Appleby</surname> <given-names>H</given-names></name><name><surname>Camara</surname> <given-names>S</given-names></name><name><surname>Zamarin</surname> <given-names>D</given-names></name><name><surname>Walther</surname> <given-names>T</given-names></name><name><surname>Snyder</surname> <given-names>A</given-names></name><name><surname>Femia</surname> <given-names>MR</given-names></name><name><surname>Comen</surname> <given-names>EA</given-names></name><name><surname>Wen</surname> <given-names>HY</given-names></name><name><surname>Hellmann</surname> <given-names>MD</given-names></name><name><surname>Anandasabapathy</surname> <given-names>N</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Altorki</surname> <given-names>NK</given-names></name><name><surname>Lauer</surname> <given-names>P</given-names></name><name><surname>Levy</surname> <given-names>O</given-names></name><name><surname>Glickman</surname> <given-names>MS</given-names></name><name><surname>Kaye</surname> <given-names>J</given-names></name><name><surname>Betel</surname> <given-names>D</given-names></name><name><surname>Philip</surname> <given-names>M</given-names></name><name><surname>Schietinger</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>TOX is a critical regulator of tumour-specific T cell differentiation</article-title><source>Nature</source><volume>571</volume><fpage>270</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1324-y</pub-id><pub-id pub-id-type="pmid">31207604</pub-id></element-citation></ref><ref id="bib533"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>See</surname> <given-names>P</given-names></name><name><surname>Dutertre</surname> <given-names>CA</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Günther</surname> <given-names>P</given-names></name><name><surname>McGovern</surname> <given-names>N</given-names></name><name><surname>Irac</surname> <given-names>SE</given-names></name><name><surname>Gunawan</surname> <given-names>M</given-names></name><name><surname>Beyer</surname> <given-names>M</given-names></name><name><surname>Händler</surname> <given-names>K</given-names></name><name><surname>Duan</surname> <given-names>K</given-names></name><name><surname>Sumatoh</surname> <given-names>HRB</given-names></name><name><surname>Ruffin</surname> <given-names>N</given-names></name><name><surname>Jouve</surname> <given-names>M</given-names></name><name><surname>Gea-Mallorquí</surname> <given-names>E</given-names></name><name><surname>Hennekam</surname> <given-names>RCM</given-names></name><name><surname>Lim</surname> <given-names>T</given-names></name><name><surname>Yip</surname> <given-names>CC</given-names></name><name><surname>Wen</surname> <given-names>M</given-names></name><name><surname>Malleret</surname> <given-names>B</given-names></name><name><surname>Low</surname> <given-names>I</given-names></name><name><surname>Shadan</surname> <given-names>NB</given-names></name><name><surname>Fen</surname> <given-names>CFS</given-names></name><name><surname>Tay</surname> <given-names>A</given-names></name><name><surname>Lum</surname> <given-names>J</given-names></name><name><surname>Zolezzi</surname> <given-names>F</given-names></name><name><surname>Larbi</surname> <given-names>A</given-names></name><name><surname>Poidinger</surname> <given-names>M</given-names></name><name><surname>Chan</surname> <given-names>JKY</given-names></name><name><surname>Chen</surname> <given-names>Q</given-names></name><name><surname>Rénia</surname> <given-names>L</given-names></name><name><surname>Haniffa</surname> <given-names>M</given-names></name><name><surname>Benaroch</surname> <given-names>P</given-names></name><name><surname>Schlitzer</surname> <given-names>A</given-names></name><name><surname>Schultze</surname> <given-names>JL</given-names></name><name><surname>Newell</surname> <given-names>EW</given-names></name><name><surname>Ginhoux</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mapping the human DC lineage through the integration of high-dimensional techniques</article-title><source>Science</source><volume>356</volume><elocation-id>eaag3009</elocation-id><pub-id pub-id-type="doi">10.1126/science.aag3009</pub-id><pub-id pub-id-type="pmid">28473638</pub-id></element-citation></ref><ref id="bib534"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seiden</surname> <given-names>PE</given-names></name><name><surname>Celada</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>A model for simulating cognate recognition and response in the immune system</article-title><source>Journal of Theoretical Biology</source><volume>158</volume><fpage>329</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1016/S0022-5193(05)80737-4</pub-id><pub-id pub-id-type="pmid">1287364</pub-id></element-citation></ref><ref id="bib535"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname> <given-names>DR</given-names></name><name><surname>Kaminski</surname> <given-names>J</given-names></name><name><surname>Barnitz</surname> <given-names>RA</given-names></name><name><surname>Kurachi</surname> <given-names>M</given-names></name><name><surname>Gerdemann</surname> <given-names>U</given-names></name><name><surname>Yates</surname> <given-names>KB</given-names></name><name><surname>Tsao</surname> <given-names>HW</given-names></name><name><surname>Godec</surname> <given-names>J</given-names></name><name><surname>LaFleur</surname> <given-names>MW</given-names></name><name><surname>Brown</surname> <given-names>FD</given-names></name><name><surname>Tonnerre</surname> <given-names>P</given-names></name><name><surname>Chung</surname> <given-names>RT</given-names></name><name><surname>Tully</surname> <given-names>DC</given-names></name><name><surname>Allen</surname> <given-names>TM</given-names></name><name><surname>Frahm</surname> <given-names>N</given-names></name><name><surname>Lauer</surname> <given-names>GM</given-names></name><name><surname>Wherry</surname> <given-names>EJ</given-names></name><name><surname>Yosef</surname> <given-names>N</given-names></name><name><surname>Haining</surname> <given-names>WN</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The epigenetic landscape of T cell exhaustion</article-title><source>Science</source><volume>354</volume><fpage>1165</fpage><lpage>1169</lpage><pub-id pub-id-type="doi">10.1126/science.aae0491</pub-id><pub-id pub-id-type="pmid">27789799</pub-id></element-citation></ref><ref id="bib536"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname> <given-names>H</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>González-Avalos</surname> <given-names>E</given-names></name><name><surname>Samaniego-Castruita</surname> <given-names>D</given-names></name><name><surname>Das</surname> <given-names>A</given-names></name><name><surname>Wang</surname> <given-names>YH</given-names></name><name><surname>López-Moyado</surname> <given-names>IF</given-names></name><name><surname>Georges</surname> <given-names>RO</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Onodera</surname> <given-names>A</given-names></name><name><surname>Wu</surname> <given-names>CJ</given-names></name><name><surname>Lu</surname> <given-names>LF</given-names></name><name><surname>Hogan</surname> <given-names>PG</given-names></name><name><surname>Bhandoola</surname> <given-names>A</given-names></name><name><surname>Rao</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8<sup>+</sup> T cell exhaustion</article-title><source>PNAS</source><volume>116</volume><fpage>12410</fpage><lpage>12415</lpage><pub-id pub-id-type="doi">10.1073/pnas.1905675116</pub-id><pub-id pub-id-type="pmid">31152140</pub-id></element-citation></ref><ref id="bib537"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serbina</surname> <given-names>NV</given-names></name><name><surname>Pamer</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2</article-title><source>Nature Immunology</source><volume>7</volume><fpage>311</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1038/ni1309</pub-id><pub-id pub-id-type="pmid">16462739</pub-id></element-citation></ref><ref id="bib538"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shafer</surname> <given-names>MER</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cross-Species analysis of Single-Cell transcriptomic data</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>7</volume><elocation-id>175</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2019.00175</pub-id><pub-id pub-id-type="pmid">31552245</pub-id></element-citation></ref><ref id="bib539"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname> <given-names>S</given-names></name><name><surname>Divekar</surname> <given-names>AA</given-names></name><name><surname>Hilchey</surname> <given-names>SP</given-names></name><name><surname>Cho</surname> <given-names>HM</given-names></name><name><surname>Newman</surname> <given-names>CL</given-names></name><name><surname>Shin</surname> <given-names>SU</given-names></name><name><surname>Nechustan</surname> <given-names>H</given-names></name><name><surname>Challita-Eid</surname> <given-names>PM</given-names></name><name><surname>Segal</surname> <given-names>BM</given-names></name><name><surname>Yi</surname> <given-names>KH</given-names></name><name><surname>Rosenblatt</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells</article-title><source>International Journal of Cancer</source><volume>117</volume><fpage>574</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1002/ijc.21177</pub-id><pub-id pub-id-type="pmid">15912532</pub-id></element-citation></ref><ref id="bib540"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shalek</surname> <given-names>AK</given-names></name><name><surname>Satija</surname> <given-names>R</given-names></name><name><surname>Adiconis</surname> <given-names>X</given-names></name><name><surname>Gertner</surname> <given-names>RS</given-names></name><name><surname>Gaublomme</surname> <given-names>JT</given-names></name><name><surname>Raychowdhury</surname> <given-names>R</given-names></name><name><surname>Schwartz</surname> <given-names>S</given-names></name><name><surname>Yosef</surname> <given-names>N</given-names></name><name><surname>Malboeuf</surname> <given-names>C</given-names></name><name><surname>Lu</surname> <given-names>D</given-names></name><name><surname>Trombetta</surname> <given-names>JJ</given-names></name><name><surname>Gennert</surname> <given-names>D</given-names></name><name><surname>Gnirke</surname> <given-names>A</given-names></name><name><surname>Goren</surname> <given-names>A</given-names></name><name><surname>Hacohen</surname> <given-names>N</given-names></name><name><surname>Levin</surname> <given-names>JZ</given-names></name><name><surname>Park</surname> <given-names>H</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Single-cell transcriptomics reveals bimodality in expression and splicing in immune cells</article-title><source>Nature</source><volume>498</volume><fpage>236</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1038/nature12172</pub-id><pub-id pub-id-type="pmid">23685454</pub-id></element-citation></ref><ref id="bib541"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shalek</surname> <given-names>AK</given-names></name><name><surname>Benson</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Single-cell analyses to tailor treatments</article-title><source>Science Translational Medicine</source><volume>9</volume><elocation-id>eaan4730</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aan4730</pub-id><pub-id pub-id-type="pmid">28931656</pub-id></element-citation></ref><ref id="bib542"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shalem</surname> <given-names>O</given-names></name><name><surname>Sanjana</surname> <given-names>NE</given-names></name><name><surname>Hartenian</surname> <given-names>E</given-names></name><name><surname>Shi</surname> <given-names>X</given-names></name><name><surname>Scott</surname> <given-names>DA</given-names></name><name><surname>Mikkelsen</surname> <given-names>TS</given-names></name><name><surname>Heckl</surname> <given-names>D</given-names></name><name><surname>Ebert</surname> <given-names>BL</given-names></name><name><surname>Root</surname> <given-names>DE</given-names></name><name><surname>Doench</surname> <given-names>JG</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Genome-Scale CRISPR-Cas9 knockout screening in human cells</article-title><source>Science</source><volume>343</volume><fpage>84</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1126/science.1247005</pub-id></element-citation></ref><ref id="bib543"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname> <given-names>P</given-names></name><name><surname>Allison</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The future of immune checkpoint therapy</article-title><source>Science</source><volume>348</volume><fpage>56</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1126/science.aaa8172</pub-id><pub-id pub-id-type="pmid">25838373</pub-id></element-citation></ref><ref id="bib544"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shay</surname> <given-names>T</given-names></name><name><surname>Kang</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Immunological Genome Project and systems immunology</article-title><source>Trends in Immunology</source><volume>34</volume><fpage>602</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1016/j.it.2013.03.004</pub-id></element-citation></ref><ref id="bib545"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen-Orr</surname> <given-names>SS</given-names></name><name><surname>Tibshirani</surname> <given-names>R</given-names></name><name><surname>Khatri</surname> <given-names>P</given-names></name><name><surname>Bodian</surname> <given-names>DL</given-names></name><name><surname>Staedtler</surname> <given-names>F</given-names></name><name><surname>Perry</surname> <given-names>NM</given-names></name><name><surname>Hastie</surname> <given-names>T</given-names></name><name><surname>Sarwal</surname> <given-names>MM</given-names></name><name><surname>Davis</surname> <given-names>MM</given-names></name><name><surname>Butte</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cell type-specific gene expression differences in complex tissues</article-title><source>Nature Methods</source><volume>7</volume><fpage>287</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1439</pub-id><pub-id pub-id-type="pmid">20208531</pub-id></element-citation></ref><ref id="bib546"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen-Orr</surname> <given-names>SS</given-names></name><name><surname>Gaujoux</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Computational deconvolution: extracting cell type-specific information from heterogeneous samples</article-title><source>Current Opinion in Immunology</source><volume>25</volume><fpage>571</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2013.09.015</pub-id></element-citation></ref><ref id="bib547"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shifrut</surname> <given-names>E</given-names></name><name><surname>Carnevale</surname> <given-names>J</given-names></name><name><surname>Tobin</surname> <given-names>V</given-names></name><name><surname>Roth</surname> <given-names>TL</given-names></name><name><surname>Woo</surname> <given-names>JM</given-names></name><name><surname>Bui</surname> <given-names>CT</given-names></name><name><surname>Li</surname> <given-names>PJ</given-names></name><name><surname>Diolaiti</surname> <given-names>ME</given-names></name><name><surname>Ashworth</surname> <given-names>A</given-names></name><name><surname>Marson</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genome-wide CRISPR screens in primary human T cells reveal key regulators of immune function</article-title><source>Cell</source><volume>175</volume><fpage>1958</fpage><lpage>1971</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.10.024</pub-id><pub-id pub-id-type="pmid">30449619</pub-id></element-citation></ref><ref id="bib548"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname> <given-names>HY</given-names></name><name><surname>Sciumè</surname> <given-names>G</given-names></name><name><surname>Mikami</surname> <given-names>Y</given-names></name><name><surname>Guo</surname> <given-names>L</given-names></name><name><surname>Sun</surname> <given-names>HW</given-names></name><name><surname>Brooks</surname> <given-names>SR</given-names></name><name><surname>Urban</surname> <given-names>JF</given-names></name><name><surname>Davis</surname> <given-names>FP</given-names></name><name><surname>Kanno</surname> <given-names>Y</given-names></name><name><surname>O'Shea</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Developmental acquisition of regulomes underlies innate lymphoid cell functionality</article-title><source>Cell</source><volume>165</volume><fpage>1120</fpage><lpage>1133</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.04.029</pub-id><pub-id pub-id-type="pmid">27156451</pub-id></element-citation></ref><ref id="bib549"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shurin</surname> <given-names>GV</given-names></name><name><surname>Ma</surname> <given-names>Y</given-names></name><name><surname>Shurin</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Immunosuppressive mechanisms of regulatory dendritic cells in Cancer</article-title><source>Cancer Microenvironment</source><volume>6</volume><fpage>159</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1007/s12307-013-0133-3</pub-id><pub-id pub-id-type="pmid">23749739</pub-id></element-citation></ref><ref id="bib550"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simoni</surname> <given-names>Y</given-names></name><name><surname>Becht</surname> <given-names>E</given-names></name><name><surname>Fehlings</surname> <given-names>M</given-names></name><name><surname>Loh</surname> <given-names>CY</given-names></name><name><surname>Koo</surname> <given-names>SL</given-names></name><name><surname>Teng</surname> <given-names>KWW</given-names></name><name><surname>Yeong</surname> <given-names>JPS</given-names></name><name><surname>Nahar</surname> <given-names>R</given-names></name><name><surname>Zhang</surname> <given-names>T</given-names></name><name><surname>Kared</surname> <given-names>H</given-names></name><name><surname>Duan</surname> <given-names>K</given-names></name><name><surname>Ang</surname> <given-names>N</given-names></name><name><surname>Poidinger</surname> <given-names>M</given-names></name><name><surname>Lee</surname> <given-names>YY</given-names></name><name><surname>Larbi</surname> <given-names>A</given-names></name><name><surname>Khng</surname> <given-names>AJ</given-names></name><name><surname>Tan</surname> <given-names>E</given-names></name><name><surname>Fu</surname> <given-names>C</given-names></name><name><surname>Mathew</surname> <given-names>R</given-names></name><name><surname>Teo</surname> <given-names>M</given-names></name><name><surname>Lim</surname> <given-names>WT</given-names></name><name><surname>Toh</surname> <given-names>CK</given-names></name><name><surname>Ong</surname> <given-names>BH</given-names></name><name><surname>Koh</surname> <given-names>T</given-names></name><name><surname>Hillmer</surname> <given-names>AM</given-names></name><name><surname>Takano</surname> <given-names>A</given-names></name><name><surname>Lim</surname> <given-names>TKH</given-names></name><name><surname>Tan</surname> <given-names>EH</given-names></name><name><surname>Zhai</surname> <given-names>W</given-names></name><name><surname>Tan</surname> <given-names>DSW</given-names></name><name><surname>Tan</surname> <given-names>IB</given-names></name><name><surname>Newell</surname> <given-names>EW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Bystander CD8<sup>+</sup> T cells are abundant and phenotypically distinct in human tumour infiltrates</article-title><source>Nature</source><volume>557</volume><fpage>575</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0130-2</pub-id><pub-id pub-id-type="pmid">29769722</pub-id></element-citation></ref><ref id="bib551"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simonis</surname> <given-names>M</given-names></name><name><surname>Klous</surname> <given-names>P</given-names></name><name><surname>Splinter</surname> <given-names>E</given-names></name><name><surname>Moshkin</surname> <given-names>Y</given-names></name><name><surname>Willemsen</surname> <given-names>R</given-names></name><name><surname>de Wit</surname> <given-names>E</given-names></name><name><surname>van Steensel</surname> <given-names>B</given-names></name><name><surname>de Laat</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture-on-chip (4C)</article-title><source>Nature Genetics</source><volume>38</volume><fpage>1348</fpage><lpage>1354</lpage><pub-id pub-id-type="doi">10.1038/ng1896</pub-id><pub-id pub-id-type="pmid">17033623</pub-id></element-citation></ref><ref id="bib552"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sims</surname> <given-names>JS</given-names></name><name><surname>Grinshpun</surname> <given-names>B</given-names></name><name><surname>Feng</surname> <given-names>Y</given-names></name><name><surname>Ung</surname> <given-names>TH</given-names></name><name><surname>Neira</surname> <given-names>JA</given-names></name><name><surname>Samanamud</surname> <given-names>JL</given-names></name><name><surname>Canoll</surname> <given-names>P</given-names></name><name><surname>Shen</surname> <given-names>Y</given-names></name><name><surname>Sims</surname> <given-names>PA</given-names></name><name><surname>Bruce</surname> <given-names>JN</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Diversity and divergence of the glioma-infiltrating T-cell receptor repertoire</article-title><source>PNAS</source><volume>113</volume><fpage>E3529</fpage><lpage>E3537</lpage><pub-id pub-id-type="doi">10.1073/pnas.1601012113</pub-id><pub-id pub-id-type="pmid">27261081</pub-id></element-citation></ref><ref id="bib553"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singhal</surname> <given-names>S</given-names></name><name><surname>Bhojnagarwala</surname> <given-names>PS</given-names></name><name><surname>O'Brien</surname> <given-names>S</given-names></name><name><surname>Moon</surname> <given-names>EK</given-names></name><name><surname>Garfall</surname> <given-names>AL</given-names></name><name><surname>Rao</surname> <given-names>AS</given-names></name><name><surname>Quatromoni</surname> <given-names>JG</given-names></name><name><surname>Stephen</surname> <given-names>TL</given-names></name><name><surname>Litzky</surname> <given-names>L</given-names></name><name><surname>Deshpande</surname> <given-names>C</given-names></name><name><surname>Feldman</surname> <given-names>MD</given-names></name><name><surname>Hancock</surname> <given-names>WW</given-names></name><name><surname>Conejo-Garcia</surname> <given-names>JR</given-names></name><name><surname>Albelda</surname> <given-names>SM</given-names></name><name><surname>Eruslanov</surname> <given-names>EB</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Origin and role of a subset of Tumor-Associated neutrophils with Antigen-Presenting cell features in Early-Stage human lung Cancer</article-title><source>Cancer Cell</source><volume>30</volume><fpage>120</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2016.06.001</pub-id><pub-id pub-id-type="pmid">27374224</pub-id></element-citation></ref><ref id="bib554"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sisirak</surname> <given-names>V</given-names></name><name><surname>Faget</surname> <given-names>J</given-names></name><name><surname>Gobert</surname> <given-names>M</given-names></name><name><surname>Goutagny</surname> <given-names>N</given-names></name><name><surname>Vey</surname> <given-names>N</given-names></name><name><surname>Treilleux</surname> <given-names>I</given-names></name><name><surname>Renaudineau</surname> <given-names>S</given-names></name><name><surname>Poyet</surname> <given-names>G</given-names></name><name><surname>Labidi-Galy</surname> <given-names>SI</given-names></name><name><surname>Goddard-Leon</surname> <given-names>S</given-names></name><name><surname>Durand</surname> <given-names>I</given-names></name><name><surname>Le Mercier</surname> <given-names>I</given-names></name><name><surname>Bajard</surname> <given-names>A</given-names></name><name><surname>Bachelot</surname> <given-names>T</given-names></name><name><surname>Puisieux</surname> <given-names>A</given-names></name><name><surname>Puisieux</surname> <given-names>I</given-names></name><name><surname>Blay</surname> <given-names>JY</given-names></name><name><surname>Ménétrier-Caux</surname> <given-names>C</given-names></name><name><surname>Caux</surname> <given-names>C</given-names></name><name><surname>Bendriss-Vermare</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast Cancer progression</article-title><source>Cancer Research</source><volume>72</volume><fpage>5188</fpage><lpage>5197</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-11-3468</pub-id><pub-id pub-id-type="pmid">22836755</pub-id></element-citation></ref><ref id="bib555"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sivan</surname> <given-names>A</given-names></name><name><surname>Corrales</surname> <given-names>L</given-names></name><name><surname>Hubert</surname> <given-names>N</given-names></name><name><surname>Williams</surname> <given-names>JB</given-names></name><name><surname>Aquino-Michaels</surname> <given-names>K</given-names></name><name><surname>Earley</surname> <given-names>ZM</given-names></name><name><surname>Benyamin</surname> <given-names>FW</given-names></name><name><surname>Lei</surname> <given-names>YM</given-names></name><name><surname>Jabri</surname> <given-names>B</given-names></name><name><surname>Alegre</surname> <given-names>ML</given-names></name><name><surname>Chang</surname> <given-names>EB</given-names></name><name><surname>Gajewski</surname> <given-names>TF</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy</article-title><source>Science</source><volume>350</volume><fpage>1084</fpage><lpage>1089</lpage><pub-id pub-id-type="doi">10.1126/science.aac4255</pub-id><pub-id pub-id-type="pmid">26541606</pub-id></element-citation></ref><ref id="bib556"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skene</surname> <given-names>PJ</given-names></name><name><surname>Henikoff</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites</article-title><source>eLife</source><volume>6</volume><elocation-id>e21856</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.21856</pub-id><pub-id pub-id-type="pmid">28079019</pub-id></element-citation></ref><ref id="bib557"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smallwood</surname> <given-names>SA</given-names></name><name><surname>Lee</surname> <given-names>HJ</given-names></name><name><surname>Angermueller</surname> <given-names>C</given-names></name><name><surname>Krueger</surname> <given-names>F</given-names></name><name><surname>Saadeh</surname> <given-names>H</given-names></name><name><surname>Peat</surname> <given-names>J</given-names></name><name><surname>Andrews</surname> <given-names>SR</given-names></name><name><surname>Stegle</surname> <given-names>O</given-names></name><name><surname>Reik</surname> <given-names>W</given-names></name><name><surname>Kelsey</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Single-cell genome-wide bisulfite sequencing for assessing epigenetic heterogeneity</article-title><source>Nature Methods</source><volume>11</volume><fpage>817</fpage><lpage>820</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3035</pub-id><pub-id pub-id-type="pmid">25042786</pub-id></element-citation></ref><ref id="bib558"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snyder</surname> <given-names>A</given-names></name><name><surname>Makarov</surname> <given-names>V</given-names></name><name><surname>Merghoub</surname> <given-names>T</given-names></name><name><surname>Yuan</surname> <given-names>J</given-names></name><name><surname>Zaretsky</surname> <given-names>JM</given-names></name><name><surname>Desrichard</surname> <given-names>A</given-names></name><name><surname>Walsh</surname> <given-names>LA</given-names></name><name><surname>Postow</surname> <given-names>MA</given-names></name><name><surname>Wong</surname> <given-names>P</given-names></name><name><surname>Ho</surname> <given-names>TS</given-names></name><name><surname>Hollmann</surname> <given-names>TJ</given-names></name><name><surname>Bruggeman</surname> <given-names>C</given-names></name><name><surname>Kannan</surname> <given-names>K</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Elipenahli</surname> <given-names>C</given-names></name><name><surname>Liu</surname> <given-names>C</given-names></name><name><surname>Harbison</surname> <given-names>CT</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Ribas</surname> <given-names>A</given-names></name><name><surname>Wolchok</surname> <given-names>JD</given-names></name><name><surname>Chan</surname> <given-names>TA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Genetic basis for clinical response to CTLA-4 blockade in melanoma</article-title><source>New England Journal of Medicine</source><volume>371</volume><fpage>2189</fpage><lpage>2199</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1406498</pub-id></element-citation></ref><ref id="bib559"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soheilypour</surname> <given-names>M</given-names></name><name><surname>Mofrad</surname> <given-names>MRK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Agent‐based modeling in molecular systems biology</article-title><source>BioEssays</source><volume>40</volume><elocation-id>1800020</elocation-id><pub-id pub-id-type="doi">10.1002/bies.201800020</pub-id></element-citation></ref><ref id="bib560"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>X</given-names></name><name><surname>Lasanajak</surname> <given-names>Y</given-names></name><name><surname>Xia</surname> <given-names>B</given-names></name><name><surname>Heimburg-Molinaro</surname> <given-names>J</given-names></name><name><surname>Rhea</surname> <given-names>JM</given-names></name><name><surname>Ju</surname> <given-names>H</given-names></name><name><surname>Zhao</surname> <given-names>C</given-names></name><name><surname>Molinaro</surname> <given-names>RJ</given-names></name><name><surname>Cummings</surname> <given-names>RD</given-names></name><name><surname>Smith</surname> <given-names>DF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Shotgun glycomics: a microarray strategy for functional glycomics</article-title><source>Nature Methods</source><volume>8</volume><fpage>85</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1540</pub-id><pub-id pub-id-type="pmid">21131969</pub-id></element-citation></ref><ref id="bib561"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spektor</surname> <given-names>R</given-names></name><name><surname>Tippens</surname> <given-names>ND</given-names></name><name><surname>Mimoso</surname> <given-names>CA</given-names></name><name><surname>Soloway</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>methyl-ATAC-seq measures DNA methylation at accessible chromatin</article-title><source>Genome Research</source><volume>29</volume><fpage>969</fpage><lpage>977</lpage><pub-id pub-id-type="doi">10.1101/gr.245399.118</pub-id><pub-id pub-id-type="pmid">31160376</pub-id></element-citation></ref><ref id="bib562"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spitzer</surname> <given-names>MH</given-names></name><name><surname>Gherardini</surname> <given-names>PF</given-names></name><name><surname>Fragiadakis</surname> <given-names>GK</given-names></name><name><surname>Bhattacharya</surname> <given-names>N</given-names></name><name><surname>Yuan</surname> <given-names>RT</given-names></name><name><surname>Hotson</surname> <given-names>AN</given-names></name><name><surname>Finck</surname> <given-names>R</given-names></name><name><surname>Carmi</surname> <given-names>Y</given-names></name><name><surname>Zunder</surname> <given-names>ER</given-names></name><name><surname>Fantl</surname> <given-names>WJ</given-names></name><name><surname>Bendall</surname> <given-names>SC</given-names></name><name><surname>Engleman</surname> <given-names>EG</given-names></name><name><surname>Nolan</surname> <given-names>GP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>IMMUNOLOGY. An interactive reference framework for modeling a dynamic immune system</article-title><source>Science</source><volume>349</volume><elocation-id>1259425</elocation-id><pub-id pub-id-type="doi">10.1126/science.1259425</pub-id><pub-id pub-id-type="pmid">26160952</pub-id></element-citation></ref><ref id="bib563"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spitzer</surname> <given-names>MH</given-names></name><name><surname>Carmi</surname> <given-names>Y</given-names></name><name><surname>Reticker-Flynn</surname> <given-names>NE</given-names></name><name><surname>Kwek</surname> <given-names>SS</given-names></name><name><surname>Madhireddy</surname> <given-names>D</given-names></name><name><surname>Martins</surname> <given-names>MM</given-names></name><name><surname>Gherardini</surname> <given-names>PF</given-names></name><name><surname>Prestwood</surname> <given-names>TR</given-names></name><name><surname>Chabon</surname> <given-names>J</given-names></name><name><surname>Bendall</surname> <given-names>SC</given-names></name><name><surname>Fong</surname> <given-names>L</given-names></name><name><surname>Nolan</surname> <given-names>GP</given-names></name><name><surname>Engleman</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Systemic immunity is required for effective Cancer immunotherapy</article-title><source>Cell</source><volume>168</volume><fpage>487</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.12.022</pub-id><pub-id pub-id-type="pmid">28111070</pub-id></element-citation></ref><ref id="bib564"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stacker</surname> <given-names>SA</given-names></name><name><surname>Williams</surname> <given-names>SP</given-names></name><name><surname>Karnezis</surname> <given-names>T</given-names></name><name><surname>Shayan</surname> <given-names>R</given-names></name><name><surname>Fox</surname> <given-names>SB</given-names></name><name><surname>Achen</surname> <given-names>MG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Lymphangiogenesis and lymphatic vessel remodelling in Cancer</article-title><source>Nature Reviews Cancer</source><volume>14</volume><fpage>159</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1038/nrc3677</pub-id><pub-id pub-id-type="pmid">24561443</pub-id></element-citation></ref><ref id="bib565"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanková</surname> <given-names>K</given-names></name><name><surname>Brown</surname> <given-names>JS</given-names></name><name><surname>Dalton</surname> <given-names>WS</given-names></name><name><surname>Gatenby</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Optimizing Cancer treatment using game theory: a review</article-title><source>JAMA Oncology</source><volume>5</volume><fpage>96</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1001/jamaoncol.2018.3395</pub-id><pub-id pub-id-type="pmid">30098166</pub-id></element-citation></ref><ref id="bib566"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Starnes</surname> <given-names>CO</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Coley's toxins in perspective</article-title><source>Nature</source><volume>357</volume><fpage>11</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1038/357011a0</pub-id></element-citation></ref><ref id="bib567"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stegle</surname> <given-names>O</given-names></name><name><surname>Teichmann</surname> <given-names>SA</given-names></name><name><surname>Marioni</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Computational and analytical challenges in single-cell transcriptomics</article-title><source>Nature Reviews Genetics</source><volume>16</volume><fpage>133</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1038/nrg3833</pub-id></element-citation></ref><ref id="bib568"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname> <given-names>M</given-names></name><name><surname>Keshav</surname> <given-names>S</given-names></name><name><surname>Harris</surname> <given-names>N</given-names></name><name><surname>Gordon</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation</article-title><source>The Journal of Experimental Medicine</source><volume>176</volume><fpage>287</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1084/jem.176.1.287</pub-id><pub-id pub-id-type="pmid">1613462</pub-id></element-citation></ref><ref id="bib569"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinman</surname> <given-names>RM</given-names></name><name><surname>Cohn</surname> <given-names>ZA</given-names></name></person-group><year iso-8601-date="1973">1973</year><article-title>Identification of a novel cell type in peripheral lymphoid organs of mice. I. morphology, quantitation, tissue distribution</article-title><source>The Journal of Experimental Medicine</source><volume>137</volume><fpage>1142</fpage><lpage>1162</lpage><pub-id pub-id-type="doi">10.1084/jem.137.5.1142</pub-id><pub-id pub-id-type="pmid">4573839</pub-id></element-citation></ref><ref id="bib570"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname> <given-names>TJ</given-names></name><name><surname>Lando</surname> <given-names>D</given-names></name><name><surname>Basu</surname> <given-names>S</given-names></name><name><surname>Atkinson</surname> <given-names>LP</given-names></name><name><surname>Cao</surname> <given-names>Y</given-names></name><name><surname>Lee</surname> <given-names>SF</given-names></name><name><surname>Leeb</surname> <given-names>M</given-names></name><name><surname>Wohlfahrt</surname> <given-names>KJ</given-names></name><name><surname>Boucher</surname> <given-names>W</given-names></name><name><surname>O'Shaughnessy-Kirwan</surname> <given-names>A</given-names></name><name><surname>Cramard</surname> <given-names>J</given-names></name><name><surname>Faure</surname> <given-names>AJ</given-names></name><name><surname>Ralser</surname> <given-names>M</given-names></name><name><surname>Blanco</surname> <given-names>E</given-names></name><name><surname>Morey</surname> <given-names>L</given-names></name><name><surname>Sansó</surname> <given-names>M</given-names></name><name><surname>Palayret</surname> <given-names>MGS</given-names></name><name><surname>Lehner</surname> <given-names>B</given-names></name><name><surname>Di Croce</surname> <given-names>L</given-names></name><name><surname>Wutz</surname> <given-names>A</given-names></name><name><surname>Hendrich</surname> <given-names>B</given-names></name><name><surname>Klenerman</surname> <given-names>D</given-names></name><name><surname>Laue</surname> <given-names>ED</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>3d structures of individual mammalian genomes studied by single-cell Hi-C</article-title><source>Nature</source><volume>544</volume><fpage>59</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1038/nature21429</pub-id><pub-id pub-id-type="pmid">28289288</pub-id></element-citation></ref><ref id="bib571"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoll</surname> <given-names>S</given-names></name><name><surname>Delon</surname> <given-names>J</given-names></name><name><surname>Brotz</surname> <given-names>TM</given-names></name><name><surname>Germain</surname> <given-names>RN</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Dynamic imaging of T cell-dendritic cell interactions in lymph nodes</article-title><source>Science</source><volume>296</volume><fpage>1873</fpage><lpage>1876</lpage><pub-id pub-id-type="doi">10.1126/science.1071065</pub-id><pub-id pub-id-type="pmid">12052961</pub-id></element-citation></ref><ref id="bib572"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoll</surname> <given-names>G</given-names></name><name><surname>Viara</surname> <given-names>E</given-names></name><name><surname>Barillot</surname> <given-names>E</given-names></name><name><surname>Calzone</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Continuous time boolean modeling for biological signaling: application of Gillespie algorithm</article-title><source>BMC Systems Biology</source><volume>6</volume><elocation-id>116</elocation-id><pub-id pub-id-type="doi">10.1186/1752-0509-6-116</pub-id><pub-id pub-id-type="pmid">22932419</pub-id></element-citation></ref><ref id="bib573"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strahl</surname> <given-names>BD</given-names></name><name><surname>Allis</surname> <given-names>CD</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The language of covalent histone modifications</article-title><source>Nature</source><volume>403</volume><fpage>41</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1038/47412</pub-id><pub-id pub-id-type="pmid">10638745</pub-id></element-citation></ref><ref id="bib574"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stratton</surname> <given-names>MR</given-names></name><name><surname>Campbell</surname> <given-names>PJ</given-names></name><name><surname>Futreal</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The cancer genome</article-title><source>Nature</source><volume>458</volume><fpage>719</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1038/nature07943</pub-id><pub-id pub-id-type="pmid">19360079</pub-id></element-citation></ref><ref id="bib575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname> <given-names>T</given-names></name><name><surname>Butler</surname> <given-names>A</given-names></name><name><surname>Hoffman</surname> <given-names>P</given-names></name><name><surname>Hafemeister</surname> <given-names>C</given-names></name><name><surname>Papalexi</surname> <given-names>E</given-names></name><name><surname>Mauck</surname> <given-names>WM</given-names></name><name><surname>Hao</surname> <given-names>Y</given-names></name><name><surname>Stoeckius</surname> <given-names>M</given-names></name><name><surname>Smibert</surname> <given-names>P</given-names></name><name><surname>Satija</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Comprehensive Integration of Single-Cell Data</article-title><source>Cell</source><volume>177</volume><fpage>1888</fpage><lpage>1902</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id></element-citation></ref><ref id="bib576"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname> <given-names>T</given-names></name><name><surname>Satija</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Integrative single-cell analysis</article-title><source>Nature Reviews Genetics</source><volume>20</volume><fpage>257</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1038/s41576-019-0093-7</pub-id></element-citation></ref><ref id="bib577"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suhail</surname> <given-names>Y</given-names></name><name><surname>Cain</surname> <given-names>MP</given-names></name><name><surname>Vanaja</surname> <given-names>K</given-names></name><name><surname>Kurywchak</surname> <given-names>PA</given-names></name><name><surname>Levchenko</surname> <given-names>A</given-names></name><name><surname>Kalluri</surname> <given-names>R</given-names></name><name><surname>Kshitiz</surname></name> </person-group><year iso-8601-date="2019">2019</year><article-title>Systems Biology of Cancer Metastasis</article-title><source>Cell Systems</source><volume>9</volume><fpage>109</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2019.07.003</pub-id></element-citation></ref><ref id="bib578"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>C</given-names></name><name><surname>Li</surname> <given-names>T</given-names></name><name><surname>Song</surname> <given-names>X</given-names></name><name><surname>Huang</surname> <given-names>L</given-names></name><name><surname>Zang</surname> <given-names>Q</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Bi</surname> <given-names>N</given-names></name><name><surname>Jiao</surname> <given-names>G</given-names></name><name><surname>Hao</surname> <given-names>Y</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>R</given-names></name><name><surname>Luo</surname> <given-names>Z</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Song</surname> <given-names>Y</given-names></name><name><surname>He</surname> <given-names>J</given-names></name><name><surname>Abliz</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Spatially resolved metabolomics to discover tumor-associated metabolic alterations</article-title><source>PNAS</source><volume>116</volume><fpage>52</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1073/pnas.1808950116</pub-id><pub-id pub-id-type="pmid">30559182</pub-id></element-citation></ref><ref id="bib579"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suvà</surname> <given-names>ML</given-names></name><name><surname>Riggi</surname> <given-names>N</given-names></name><name><surname>Bernstein</surname> <given-names>BE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Epigenetic reprogramming in cancer</article-title><source>Science</source><volume>339</volume><fpage>1567</fpage><lpage>1570</lpage><pub-id pub-id-type="doi">10.1126/science.1230184</pub-id><pub-id pub-id-type="pmid">23539597</pub-id></element-citation></ref><ref id="bib580"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swadling</surname> <given-names>L</given-names></name><name><surname>Capone</surname> <given-names>S</given-names></name><name><surname>Antrobus</surname> <given-names>RD</given-names></name><name><surname>Brown</surname> <given-names>A</given-names></name><name><surname>Richardson</surname> <given-names>R</given-names></name><name><surname>Newell</surname> <given-names>EW</given-names></name><name><surname>Halliday</surname> <given-names>J</given-names></name><name><surname>Kelly</surname> <given-names>C</given-names></name><name><surname>Bowen</surname> <given-names>D</given-names></name><name><surname>Fergusson</surname> <given-names>J</given-names></name><name><surname>Kurioka</surname> <given-names>A</given-names></name><name><surname>Ammendola</surname> <given-names>V</given-names></name><name><surname>Del Sorbo</surname> <given-names>M</given-names></name><name><surname>Grazioli</surname> <given-names>F</given-names></name><name><surname>Esposito</surname> <given-names>ML</given-names></name><name><surname>Siani</surname> <given-names>L</given-names></name><name><surname>Traboni</surname> <given-names>C</given-names></name><name><surname>Hill</surname> <given-names>A</given-names></name><name><surname>Colloca</surname> <given-names>S</given-names></name><name><surname>Davis</surname> <given-names>M</given-names></name><name><surname>Nicosia</surname> <given-names>A</given-names></name><name><surname>Cortese</surname> <given-names>R</given-names></name><name><surname>Folgori</surname> <given-names>A</given-names></name><name><surname>Klenerman</surname> <given-names>P</given-names></name><name><surname>Barnes</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory</article-title><source>Science Translational Medicine</source><volume>6</volume><elocation-id>261ra153</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3009185</pub-id><pub-id pub-id-type="pmid">25378645</pub-id></element-citation></ref><ref id="bib581"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swaminathan</surname> <given-names>J</given-names></name><name><surname>Boulgakov</surname> <given-names>AA</given-names></name><name><surname>Hernandez</surname> <given-names>ET</given-names></name><name><surname>Bardo</surname> <given-names>AM</given-names></name><name><surname>Bachman</surname> <given-names>JL</given-names></name><name><surname>Marotta</surname> <given-names>J</given-names></name><name><surname>Johnson</surname> <given-names>AM</given-names></name><name><surname>Anslyn</surname> <given-names>EV</given-names></name><name><surname>Marcotte</surname> <given-names>EM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Highly parallel single-molecule identification of proteins in zeptomole-scale mixtures</article-title><source>Nature Biotechnology</source><volume>36</volume><fpage>1076</fpage><lpage>1082</lpage><pub-id pub-id-type="doi">10.1038/nbt.4278</pub-id></element-citation></ref><ref id="bib582"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swartz</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Immunomodulatory roles of lymphatic vessels in Cancer progression</article-title><source>Cancer Immunology Research</source><volume>2</volume><fpage>701</fpage><lpage>707</lpage><pub-id pub-id-type="doi">10.1158/2326-6066.CIR-14-0115</pub-id><pub-id pub-id-type="pmid">25092811</pub-id></element-citation></ref><ref id="bib583"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szczerba</surname> <given-names>BM</given-names></name><name><surname>Castro-Giner</surname> <given-names>F</given-names></name><name><surname>Vetter</surname> <given-names>M</given-names></name><name><surname>Krol</surname> <given-names>I</given-names></name><name><surname>Gkountela</surname> <given-names>S</given-names></name><name><surname>Landin</surname> <given-names>J</given-names></name><name><surname>Scheidmann</surname> <given-names>MC</given-names></name><name><surname>Donato</surname> <given-names>C</given-names></name><name><surname>Scherrer</surname> <given-names>R</given-names></name><name><surname>Singer</surname> <given-names>J</given-names></name><name><surname>Beisel</surname> <given-names>C</given-names></name><name><surname>Kurzeder</surname> <given-names>C</given-names></name><name><surname>Heinzelmann-Schwarz</surname> <given-names>V</given-names></name><name><surname>Rochlitz</surname> <given-names>C</given-names></name><name><surname>Weber</surname> <given-names>WP</given-names></name><name><surname>Beerenwinkel</surname> <given-names>N</given-names></name><name><surname>Aceto</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Neutrophils escort circulating tumour cells to enable cell cycle progression</article-title><source>Nature</source><volume>566</volume><fpage>553</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-0915-y</pub-id></element-citation></ref><ref id="bib584"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tammela</surname> <given-names>T</given-names></name><name><surname>Alitalo</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Lymphangiogenesis: molecular mechanisms and future promise</article-title><source>Cell</source><volume>140</volume><fpage>460</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.01.045</pub-id><pub-id pub-id-type="pmid">20178740</pub-id></element-citation></ref><ref id="bib585"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname> <given-names>TT</given-names></name><name><surname>Coussens</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Humoral immunity, inflammation and Cancer</article-title><source>Current Opinion in Immunology</source><volume>19</volume><fpage>209</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2007.01.001</pub-id><pub-id pub-id-type="pmid">17276050</pub-id></element-citation></ref><ref id="bib586"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname> <given-names>F</given-names></name><name><surname>Barbacioru</surname> <given-names>C</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Nordman</surname> <given-names>E</given-names></name><name><surname>Lee</surname> <given-names>C</given-names></name><name><surname>Xu</surname> <given-names>N</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Bodeau</surname> <given-names>J</given-names></name><name><surname>Tuch</surname> <given-names>BB</given-names></name><name><surname>Siddiqui</surname> <given-names>A</given-names></name><name><surname>Lao</surname> <given-names>K</given-names></name><name><surname>Surani</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>mRNA-Seq whole-transcriptome analysis of a single cell</article-title><source>Nature Methods</source><volume>6</volume><fpage>377</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1315</pub-id><pub-id pub-id-type="pmid">19349980</pub-id></element-citation></ref><ref id="bib587"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname> <given-names>F</given-names></name><name><surname>Barbacioru</surname> <given-names>C</given-names></name><name><surname>Nordman</surname> <given-names>E</given-names></name><name><surname>Li</surname> <given-names>B</given-names></name><name><surname>Xu</surname> <given-names>N</given-names></name><name><surname>Bashkirov</surname> <given-names>VI</given-names></name><name><surname>Lao</surname> <given-names>K</given-names></name><name><surname>Surani</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>RNA-Seq analysis to capture the transcriptome landscape of a single cell</article-title><source>Nature Protocols</source><volume>5</volume><fpage>516</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1038/nprot.2009.236</pub-id><pub-id pub-id-type="pmid">20203668</pub-id></element-citation></ref><ref id="bib588"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanoue</surname> <given-names>T</given-names></name><name><surname>Morita</surname> <given-names>S</given-names></name><name><surname>Plichta</surname> <given-names>DR</given-names></name><name><surname>Skelly</surname> <given-names>AN</given-names></name><name><surname>Suda</surname> <given-names>W</given-names></name><name><surname>Sugiura</surname> <given-names>Y</given-names></name><name><surname>Narushima</surname> <given-names>S</given-names></name><name><surname>Vlamakis</surname> <given-names>H</given-names></name><name><surname>Motoo</surname> <given-names>I</given-names></name><name><surname>Sugita</surname> <given-names>K</given-names></name><name><surname>Shiota</surname> <given-names>A</given-names></name><name><surname>Takeshita</surname> <given-names>K</given-names></name><name><surname>Yasuma-Mitobe</surname> <given-names>K</given-names></name><name><surname>Riethmacher</surname> <given-names>D</given-names></name><name><surname>Kaisho</surname> <given-names>T</given-names></name><name><surname>Norman</surname> <given-names>JM</given-names></name><name><surname>Mucida</surname> <given-names>D</given-names></name><name><surname>Suematsu</surname> <given-names>M</given-names></name><name><surname>Yaguchi</surname> <given-names>T</given-names></name><name><surname>Bucci</surname> <given-names>V</given-names></name><name><surname>Inoue</surname> <given-names>T</given-names></name><name><surname>Kawakami</surname> <given-names>Y</given-names></name><name><surname>Olle</surname> <given-names>B</given-names></name><name><surname>Roberts</surname> <given-names>B</given-names></name><name><surname>Hattori</surname> <given-names>M</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name><name><surname>Atarashi</surname> <given-names>K</given-names></name><name><surname>Honda</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A defined commensal consortium elicits CD8 T cells and anti-cancer immunity</article-title><source>Nature</source><volume>565</volume><fpage>600</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-0878-z</pub-id><pub-id pub-id-type="pmid">30675064</pub-id></element-citation></ref><ref id="bib589"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tariq</surname> <given-names>MA</given-names></name><name><surname>Kim</surname> <given-names>HJ</given-names></name><name><surname>Jejelowo</surname> <given-names>O</given-names></name><name><surname>Pourmand</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Whole-transcriptome RNAseq analysis from minute amount of total RNA</article-title><source>Nucleic Acids Research</source><volume>39</volume><elocation-id>e120</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkr547</pub-id><pub-id pub-id-type="pmid">21737426</pub-id></element-citation></ref><ref id="bib590"><element-citation publication-type="web"><person-group person-group-type="author"><collab>The Cancer Genome Atlas</collab></person-group><year iso-8601-date="2006">2006</year><article-title>The Cancer genome atlas program</article-title><ext-link ext-link-type="uri" xlink:href="https://www.cancer.gov/tcga">https://www.cancer.gov/tcga</ext-link><date-in-citation iso-8601-date="2019-11-15">November 15, 2019</date-in-citation></element-citation></ref><ref id="bib591"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="1973">1973</year><article-title>Boolean formalization of genetic control circuits</article-title><source>Journal of Theoretical Biology</source><volume>42</volume><fpage>563</fpage><lpage>585</lpage><pub-id pub-id-type="doi">10.1016/0022-5193(73)90247-6</pub-id><pub-id pub-id-type="pmid">4588055</pub-id></element-citation></ref><ref id="bib592"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorsen</surname> <given-names>T</given-names></name><name><surname>Roberts</surname> <given-names>RW</given-names></name><name><surname>Arnold</surname> <given-names>FH</given-names></name><name><surname>Quake</surname> <given-names>SR</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Dynamic pattern formation in a vesicle-generating microfluidic device</article-title><source>Physical Review Letters</source><volume>86</volume><fpage>4163</fpage><lpage>4166</lpage><pub-id pub-id-type="doi">10.1103/PhysRevLett.86.4163</pub-id><pub-id pub-id-type="pmid">11328121</pub-id></element-citation></ref><ref id="bib593"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorsen</surname> <given-names>T</given-names></name><name><surname>Maerkl</surname> <given-names>SJ</given-names></name><name><surname>Quake</surname> <given-names>SR</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Microfluidic large-scale integration</article-title><source>Science</source><volume>298</volume><fpage>580</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1126/science.1076996</pub-id><pub-id pub-id-type="pmid">12351675</pub-id></element-citation></ref><ref id="bib594"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorsson</surname> <given-names>V</given-names></name><name><surname>Gibbs</surname> <given-names>DL</given-names></name><name><surname>Brown</surname> <given-names>SD</given-names></name><name><surname>Wolf</surname> <given-names>D</given-names></name><name><surname>Bortone</surname> <given-names>DS</given-names></name><name><surname>Ou Yang</surname> <given-names>TH</given-names></name><name><surname>Porta-Pardo</surname> <given-names>E</given-names></name><name><surname>Gao</surname> <given-names>GF</given-names></name><name><surname>Plaisier</surname> <given-names>CL</given-names></name><name><surname>Eddy</surname> <given-names>JA</given-names></name><name><surname>Ziv</surname> <given-names>E</given-names></name><name><surname>Culhane</surname> <given-names>AC</given-names></name><name><surname>Paull</surname> <given-names>EO</given-names></name><name><surname>Sivakumar</surname> <given-names>IKA</given-names></name><name><surname>Gentles</surname> <given-names>AJ</given-names></name><name><surname>Malhotra</surname> <given-names>R</given-names></name><name><surname>Farshidfar</surname> <given-names>F</given-names></name><name><surname>Colaprico</surname> <given-names>A</given-names></name><name><surname>Parker</surname> <given-names>JS</given-names></name><name><surname>Mose</surname> <given-names>LE</given-names></name><name><surname>Vo</surname> <given-names>NS</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Rader</surname> <given-names>J</given-names></name><name><surname>Dhankani</surname> <given-names>V</given-names></name><name><surname>Reynolds</surname> <given-names>SM</given-names></name><name><surname>Bowlby</surname> <given-names>R</given-names></name><name><surname>Califano</surname> <given-names>A</given-names></name><name><surname>Cherniack</surname> <given-names>AD</given-names></name><name><surname>Anastassiou</surname> <given-names>D</given-names></name><name><surname>Bedognetti</surname> <given-names>D</given-names></name><name><surname>Mokrab</surname> <given-names>Y</given-names></name><name><surname>Newman</surname> <given-names>AM</given-names></name><name><surname>Rao</surname> <given-names>A</given-names></name><name><surname>Chen</surname> <given-names>K</given-names></name><name><surname>Krasnitz</surname> <given-names>A</given-names></name><name><surname>Hu</surname> <given-names>H</given-names></name><name><surname>Malta</surname> <given-names>TM</given-names></name><name><surname>Noushmehr</surname> <given-names>H</given-names></name><name><surname>Pedamallu</surname> <given-names>CS</given-names></name><name><surname>Bullman</surname> <given-names>S</given-names></name><name><surname>Ojesina</surname> <given-names>AI</given-names></name><name><surname>Lamb</surname> <given-names>A</given-names></name><name><surname>Zhou</surname> <given-names>W</given-names></name><name><surname>Shen</surname> <given-names>H</given-names></name><name><surname>Choueiri</surname> <given-names>TK</given-names></name><name><surname>Weinstein</surname> <given-names>JN</given-names></name><name><surname>Guinney</surname> <given-names>J</given-names></name><name><surname>Saltz</surname> <given-names>J</given-names></name><name><surname>Holt</surname> <given-names>RA</given-names></name><name><surname>Rabkin</surname> <given-names>CS</given-names></name><name><surname>Lazar</surname> <given-names>AJ</given-names></name><name><surname>Serody</surname> <given-names>JS</given-names></name><name><surname>Demicco</surname> <given-names>EG</given-names></name><name><surname>Disis</surname> <given-names>ML</given-names></name><name><surname>Vincent</surname> <given-names>BG</given-names></name><name><surname>Shmulevich</surname> <given-names>I</given-names></name><collab>Cancer Genome Atlas Research Network</collab></person-group><year iso-8601-date="2018">2018</year><article-title>The immune landscape of Cancer</article-title><source>Immunity</source><volume>48</volume><fpage>812</fpage><lpage>830</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2018.03.023</pub-id><pub-id pub-id-type="pmid">29628290</pub-id></element-citation></ref><ref id="bib595"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thul</surname> <given-names>PJ</given-names></name><name><surname>Åkesson</surname> <given-names>L</given-names></name><name><surname>Wiking</surname> <given-names>M</given-names></name><name><surname>Mahdessian</surname> <given-names>D</given-names></name><name><surname>Geladaki</surname> <given-names>A</given-names></name><name><surname>Ait Blal</surname> <given-names>H</given-names></name><name><surname>Alm</surname> <given-names>T</given-names></name><name><surname>Asplund</surname> <given-names>A</given-names></name><name><surname>Björk</surname> <given-names>L</given-names></name><name><surname>Breckels</surname> <given-names>LM</given-names></name><name><surname>Bäckström</surname> <given-names>A</given-names></name><name><surname>Danielsson</surname> <given-names>F</given-names></name><name><surname>Fagerberg</surname> <given-names>L</given-names></name><name><surname>Fall</surname> <given-names>J</given-names></name><name><surname>Gatto</surname> <given-names>L</given-names></name><name><surname>Gnann</surname> <given-names>C</given-names></name><name><surname>Hober</surname> <given-names>S</given-names></name><name><surname>Hjelmare</surname> <given-names>M</given-names></name><name><surname>Johansson</surname> <given-names>F</given-names></name><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Lindskog</surname> <given-names>C</given-names></name><name><surname>Mulder</surname> <given-names>J</given-names></name><name><surname>Mulvey</surname> <given-names>CM</given-names></name><name><surname>Nilsson</surname> <given-names>P</given-names></name><name><surname>Oksvold</surname> <given-names>P</given-names></name><name><surname>Rockberg</surname> <given-names>J</given-names></name><name><surname>Schutten</surname> <given-names>R</given-names></name><name><surname>Schwenk</surname> <given-names>JM</given-names></name><name><surname>Sivertsson</surname> <given-names>Å</given-names></name><name><surname>Sjöstedt</surname> <given-names>E</given-names></name><name><surname>Skogs</surname> <given-names>M</given-names></name><name><surname>Stadler</surname> <given-names>C</given-names></name><name><surname>Sullivan</surname> <given-names>DP</given-names></name><name><surname>Tegel</surname> <given-names>H</given-names></name><name><surname>Winsnes</surname> <given-names>C</given-names></name><name><surname>Zhang</surname> <given-names>C</given-names></name><name><surname>Zwahlen</surname> <given-names>M</given-names></name><name><surname>Mardinoglu</surname> <given-names>A</given-names></name><name><surname>Pontén</surname> <given-names>F</given-names></name><name><surname>von Feilitzen</surname> <given-names>K</given-names></name><name><surname>Lilley</surname> <given-names>KS</given-names></name><name><surname>Uhlén</surname> <given-names>M</given-names></name><name><surname>Lundberg</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A subcellular map of the human proteome</article-title><source>Science</source><volume>356</volume><elocation-id>eaal3321</elocation-id><pub-id pub-id-type="doi">10.1126/science.aal3321</pub-id><pub-id pub-id-type="pmid">28495876</pub-id></element-citation></ref><ref id="bib596"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thurman</surname> <given-names>RE</given-names></name><name><surname>Rynes</surname> <given-names>E</given-names></name><name><surname>Humbert</surname> <given-names>R</given-names></name><name><surname>Vierstra</surname> <given-names>J</given-names></name><name><surname>Maurano</surname> <given-names>MT</given-names></name><name><surname>Haugen</surname> <given-names>E</given-names></name><name><surname>Sheffield</surname> <given-names>NC</given-names></name><name><surname>Stergachis</surname> <given-names>AB</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Vernot</surname> <given-names>B</given-names></name><name><surname>Garg</surname> <given-names>K</given-names></name><name><surname>John</surname> <given-names>S</given-names></name><name><surname>Sandstrom</surname> <given-names>R</given-names></name><name><surname>Bates</surname> <given-names>D</given-names></name><name><surname>Boatman</surname> <given-names>L</given-names></name><name><surname>Canfield</surname> <given-names>TK</given-names></name><name><surname>Diegel</surname> <given-names>M</given-names></name><name><surname>Dunn</surname> <given-names>D</given-names></name><name><surname>Ebersol</surname> <given-names>AK</given-names></name><name><surname>Frum</surname> <given-names>T</given-names></name><name><surname>Giste</surname> <given-names>E</given-names></name><name><surname>Johnson</surname> <given-names>AK</given-names></name><name><surname>Johnson</surname> <given-names>EM</given-names></name><name><surname>Kutyavin</surname> <given-names>T</given-names></name><name><surname>Lajoie</surname> <given-names>B</given-names></name><name><surname>Lee</surname> <given-names>BK</given-names></name><name><surname>Lee</surname> <given-names>K</given-names></name><name><surname>London</surname> <given-names>D</given-names></name><name><surname>Lotakis</surname> <given-names>D</given-names></name><name><surname>Neph</surname> <given-names>S</given-names></name><name><surname>Neri</surname> <given-names>F</given-names></name><name><surname>Nguyen</surname> <given-names>ED</given-names></name><name><surname>Qu</surname> <given-names>H</given-names></name><name><surname>Reynolds</surname> <given-names>AP</given-names></name><name><surname>Roach</surname> <given-names>V</given-names></name><name><surname>Safi</surname> <given-names>A</given-names></name><name><surname>Sanchez</surname> <given-names>ME</given-names></name><name><surname>Sanyal</surname> <given-names>A</given-names></name><name><surname>Shafer</surname> <given-names>A</given-names></name><name><surname>Simon</surname> <given-names>JM</given-names></name><name><surname>Song</surname> <given-names>L</given-names></name><name><surname>Vong</surname> <given-names>S</given-names></name><name><surname>Weaver</surname> <given-names>M</given-names></name><name><surname>Yan</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Lenhard</surname> <given-names>B</given-names></name><name><surname>Tewari</surname> <given-names>M</given-names></name><name><surname>Dorschner</surname> <given-names>MO</given-names></name><name><surname>Hansen</surname> <given-names>RS</given-names></name><name><surname>Navas</surname> <given-names>PA</given-names></name><name><surname>Stamatoyannopoulos</surname> <given-names>G</given-names></name><name><surname>Iyer</surname> <given-names>VR</given-names></name><name><surname>Lieb</surname> <given-names>JD</given-names></name><name><surname>Sunyaev</surname> <given-names>SR</given-names></name><name><surname>Akey</surname> <given-names>JM</given-names></name><name><surname>Sabo</surname> <given-names>PJ</given-names></name><name><surname>Kaul</surname> <given-names>R</given-names></name><name><surname>Furey</surname> <given-names>TS</given-names></name><name><surname>Dekker</surname> <given-names>J</given-names></name><name><surname>Crawford</surname> <given-names>GE</given-names></name><name><surname>Stamatoyannopoulos</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The accessible chromatin landscape of the human genome</article-title><source>Nature</source><volume>489</volume><fpage>75</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1038/nature11232</pub-id><pub-id pub-id-type="pmid">22955617</pub-id></element-citation></ref><ref id="bib597"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tice</surname> <given-names>JD</given-names></name><name><surname>Song</surname> <given-names>H</given-names></name><name><surname>Lyon</surname> <given-names>AD</given-names></name><name><surname>Ismagilov</surname> <given-names>RF</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Formation of droplets and mixing in multiphase microfluidics at low values of the Reynolds and the capillary numbers</article-title><source>Langmuir</source><volume>19</volume><fpage>9127</fpage><lpage>9133</lpage><pub-id pub-id-type="doi">10.1021/la030090w</pub-id></element-citation></ref><ref id="bib598"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tirosh</surname> <given-names>I</given-names></name><name><surname>Izar</surname> <given-names>B</given-names></name><name><surname>Prakadan</surname> <given-names>SM</given-names></name><name><surname>Wadsworth</surname> <given-names>MH</given-names></name><name><surname>Treacy</surname> <given-names>D</given-names></name><name><surname>Trombetta</surname> <given-names>JJ</given-names></name><name><surname>Rotem</surname> <given-names>A</given-names></name><name><surname>Rodman</surname> <given-names>C</given-names></name><name><surname>Lian</surname> <given-names>C</given-names></name><name><surname>Murphy</surname> <given-names>G</given-names></name><name><surname>Fallahi-Sichani</surname> <given-names>M</given-names></name><name><surname>Dutton-Regester</surname> <given-names>K</given-names></name><name><surname>Lin</surname> <given-names>JR</given-names></name><name><surname>Cohen</surname> <given-names>O</given-names></name><name><surname>Shah</surname> <given-names>P</given-names></name><name><surname>Lu</surname> <given-names>D</given-names></name><name><surname>Genshaft</surname> <given-names>AS</given-names></name><name><surname>Hughes</surname> <given-names>TK</given-names></name><name><surname>Ziegler</surname> <given-names>CG</given-names></name><name><surname>Kazer</surname> <given-names>SW</given-names></name><name><surname>Gaillard</surname> <given-names>A</given-names></name><name><surname>Kolb</surname> <given-names>KE</given-names></name><name><surname>Villani</surname> <given-names>AC</given-names></name><name><surname>Johannessen</surname> <given-names>CM</given-names></name><name><surname>Andreev</surname> <given-names>AY</given-names></name><name><surname>Van Allen</surname> <given-names>EM</given-names></name><name><surname>Bertagnolli</surname> <given-names>M</given-names></name><name><surname>Sorger</surname> <given-names>PK</given-names></name><name><surname>Sullivan</surname> <given-names>RJ</given-names></name><name><surname>Flaherty</surname> <given-names>KT</given-names></name><name><surname>Frederick</surname> <given-names>DT</given-names></name><name><surname>Jané-Valbuena</surname> <given-names>J</given-names></name><name><surname>Yoon</surname> <given-names>CH</given-names></name><name><surname>Rozenblatt-Rosen</surname> <given-names>O</given-names></name><name><surname>Shalek</surname> <given-names>AK</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name><name><surname>Garraway</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq</article-title><source>Science</source><volume>352</volume><fpage>189</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1126/science.aad0501</pub-id><pub-id pub-id-type="pmid">27124452</pub-id></element-citation></ref><ref id="bib599"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tjalsma</surname> <given-names>H</given-names></name><name><surname>Bolhuis</surname> <given-names>A</given-names></name><name><surname>Jongbloed</surname> <given-names>JD</given-names></name><name><surname>Bron</surname> <given-names>S</given-names></name><name><surname>van Dijl</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Signal peptide-dependent protein transport in <italic>Bacillus subtilis</italic>: a genome-based survey of the secretome</article-title><source>Microbiology and Molecular Biology Reviews</source><volume>64</volume><fpage>515</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1128/MMBR.64.3.515-547.2000</pub-id><pub-id pub-id-type="pmid">10974125</pub-id></element-citation></ref><ref id="bib600"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Topalian</surname> <given-names>SL</given-names></name><name><surname>Hodi</surname> <given-names>FS</given-names></name><name><surname>Brahmer</surname> <given-names>JR</given-names></name><name><surname>Gettinger</surname> <given-names>SN</given-names></name><name><surname>Smith</surname> <given-names>DC</given-names></name><name><surname>McDermott</surname> <given-names>DF</given-names></name><name><surname>Powderly</surname> <given-names>JD</given-names></name><name><surname>Carvajal</surname> <given-names>RD</given-names></name><name><surname>Sosman</surname> <given-names>JA</given-names></name><name><surname>Atkins</surname> <given-names>MB</given-names></name><name><surname>Leming</surname> <given-names>PD</given-names></name><name><surname>Spigel</surname> <given-names>DR</given-names></name><name><surname>Antonia</surname> <given-names>SJ</given-names></name><name><surname>Horn</surname> <given-names>L</given-names></name><name><surname>Drake</surname> <given-names>CG</given-names></name><name><surname>Pardoll</surname> <given-names>DM</given-names></name><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Sharfman</surname> <given-names>WH</given-names></name><name><surname>Anders</surname> <given-names>RA</given-names></name><name><surname>Taube</surname> <given-names>JM</given-names></name><name><surname>McMiller</surname> <given-names>TL</given-names></name><name><surname>Xu</surname> <given-names>H</given-names></name><name><surname>Korman</surname> <given-names>AJ</given-names></name><name><surname>Jure-Kunkel</surname> <given-names>M</given-names></name><name><surname>Agrawal</surname> <given-names>S</given-names></name><name><surname>McDonald</surname> <given-names>D</given-names></name><name><surname>Kollia</surname> <given-names>GD</given-names></name><name><surname>Gupta</surname> <given-names>A</given-names></name><name><surname>Wigginton</surname> <given-names>JM</given-names></name><name><surname>Sznol</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Safety, activity, and immune correlates of anti-PD-1 antibody in Cancer</article-title><source>New England Journal of Medicine</source><volume>366</volume><fpage>2443</fpage><lpage>2454</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1200690</pub-id><pub-id pub-id-type="pmid">22658127</pub-id></element-citation></ref><ref id="bib601"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tosches</surname> <given-names>MA</given-names></name><name><surname>Yamawaki</surname> <given-names>TM</given-names></name><name><surname>Naumann</surname> <given-names>RK</given-names></name><name><surname>Jacobi</surname> <given-names>AA</given-names></name><name><surname>Tushev</surname> <given-names>G</given-names></name><name><surname>Laurent</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Evolution of pallium, Hippocampus, and cortical cell types revealed by single-cell transcriptomics in reptiles</article-title><source>Science</source><volume>360</volume><fpage>881</fpage><lpage>888</lpage><pub-id pub-id-type="doi">10.1126/science.aar4237</pub-id></element-citation></ref><ref id="bib602"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname> <given-names>E</given-names></name><name><surname>Turcotte</surname> <given-names>S</given-names></name><name><surname>Gros</surname> <given-names>A</given-names></name><name><surname>Robbins</surname> <given-names>PF</given-names></name><name><surname>Lu</surname> <given-names>YC</given-names></name><name><surname>Dudley</surname> <given-names>ME</given-names></name><name><surname>Wunderlich</surname> <given-names>JR</given-names></name><name><surname>Somerville</surname> <given-names>RP</given-names></name><name><surname>Hogan</surname> <given-names>K</given-names></name><name><surname>Hinrichs</surname> <given-names>CS</given-names></name><name><surname>Parkhurst</surname> <given-names>MR</given-names></name><name><surname>Yang</surname> <given-names>JC</given-names></name><name><surname>Rosenberg</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial Cancer</article-title><source>Science</source><volume>344</volume><fpage>641</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1126/science.1251102</pub-id><pub-id pub-id-type="pmid">24812403</pub-id></element-citation></ref><ref id="bib603"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname> <given-names>E</given-names></name><name><surname>Robbins</surname> <given-names>PF</given-names></name><name><surname>Lu</surname> <given-names>YC</given-names></name><name><surname>Prickett</surname> <given-names>TD</given-names></name><name><surname>Gartner</surname> <given-names>JJ</given-names></name><name><surname>Jia</surname> <given-names>L</given-names></name><name><surname>Pasetto</surname> <given-names>A</given-names></name><name><surname>Zheng</surname> <given-names>Z</given-names></name><name><surname>Ray</surname> <given-names>S</given-names></name><name><surname>Groh</surname> <given-names>EM</given-names></name><name><surname>Kriley</surname> <given-names>IR</given-names></name><name><surname>Rosenberg</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>T-Cell transfer therapy targeting mutant KRAS in Cancer</article-title><source>New England Journal of Medicine</source><volume>375</volume><fpage>2255</fpage><lpage>2262</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1609279</pub-id><pub-id pub-id-type="pmid">27959684</pub-id></element-citation></ref><ref id="bib604"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsou</surname> <given-names>CL</given-names></name><name><surname>Peters</surname> <given-names>W</given-names></name><name><surname>Si</surname> <given-names>Y</given-names></name><name><surname>Slaymaker</surname> <given-names>S</given-names></name><name><surname>Aslanian</surname> <given-names>AM</given-names></name><name><surname>Weisberg</surname> <given-names>SP</given-names></name><name><surname>Mack</surname> <given-names>M</given-names></name><name><surname>Charo</surname> <given-names>IF</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites</article-title><source>Journal of Clinical Investigation</source><volume>117</volume><fpage>902</fpage><lpage>909</lpage><pub-id pub-id-type="doi">10.1172/JCI29919</pub-id><pub-id pub-id-type="pmid">17364026</pub-id></element-citation></ref><ref id="bib605"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsujikawa</surname> <given-names>T</given-names></name><name><surname>Kumar</surname> <given-names>S</given-names></name><name><surname>Borkar</surname> <given-names>RN</given-names></name><name><surname>Azimi</surname> <given-names>V</given-names></name><name><surname>Thibault</surname> <given-names>G</given-names></name><name><surname>Chang</surname> <given-names>YH</given-names></name><name><surname>Balter</surname> <given-names>A</given-names></name><name><surname>Kawashima</surname> <given-names>R</given-names></name><name><surname>Choe</surname> <given-names>G</given-names></name><name><surname>Sauer</surname> <given-names>D</given-names></name><name><surname>El Rassi</surname> <given-names>E</given-names></name><name><surname>Clayburgh</surname> <given-names>DR</given-names></name><name><surname>Kulesz-Martin</surname> <given-names>MF</given-names></name><name><surname>Lutz</surname> <given-names>ER</given-names></name><name><surname>Zheng</surname> <given-names>L</given-names></name><name><surname>Jaffee</surname> <given-names>EM</given-names></name><name><surname>Leyshock</surname> <given-names>P</given-names></name><name><surname>Margolin</surname> <given-names>AA</given-names></name><name><surname>Mori</surname> <given-names>M</given-names></name><name><surname>Gray</surname> <given-names>JW</given-names></name><name><surname>Flint</surname> <given-names>PW</given-names></name><name><surname>Coussens</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Quantitative multiplex immunohistochemistry reveals Myeloid-Inflamed Tumor-Immune complexity associated with poor prognosis</article-title><source>Cell Reports</source><volume>19</volume><fpage>203</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.03.037</pub-id><pub-id pub-id-type="pmid">28380359</pub-id></element-citation></ref><ref id="bib606"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tumeh</surname> <given-names>PC</given-names></name><name><surname>Harview</surname> <given-names>CL</given-names></name><name><surname>Yearley</surname> <given-names>JH</given-names></name><name><surname>Shintaku</surname> <given-names>IP</given-names></name><name><surname>Taylor</surname> <given-names>EJ</given-names></name><name><surname>Robert</surname> <given-names>L</given-names></name><name><surname>Chmielowski</surname> <given-names>B</given-names></name><name><surname>Spasic</surname> <given-names>M</given-names></name><name><surname>Henry</surname> <given-names>G</given-names></name><name><surname>Ciobanu</surname> <given-names>V</given-names></name><name><surname>West</surname> <given-names>AN</given-names></name><name><surname>Carmona</surname> <given-names>M</given-names></name><name><surname>Kivork</surname> <given-names>C</given-names></name><name><surname>Seja</surname> <given-names>E</given-names></name><name><surname>Cherry</surname> <given-names>G</given-names></name><name><surname>Gutierrez</surname> <given-names>AJ</given-names></name><name><surname>Grogan</surname> <given-names>TR</given-names></name><name><surname>Mateus</surname> <given-names>C</given-names></name><name><surname>Tomasic</surname> <given-names>G</given-names></name><name><surname>Glaspy</surname> <given-names>JA</given-names></name><name><surname>Emerson</surname> <given-names>RO</given-names></name><name><surname>Robins</surname> <given-names>H</given-names></name><name><surname>Pierce</surname> <given-names>RH</given-names></name><name><surname>Elashoff</surname> <given-names>DA</given-names></name><name><surname>Robert</surname> <given-names>C</given-names></name><name><surname>Ribas</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>PD-1 blockade induces responses by inhibiting adaptive immune resistance</article-title><source>Nature</source><volume>515</volume><fpage>568</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1038/nature13954</pub-id><pub-id pub-id-type="pmid">25428505</pub-id></element-citation></ref><ref id="bib607"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turing</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="1952">1952</year><article-title>The chemical basis of morphogenesis</article-title><source>Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences</source><volume>237</volume><fpage>37</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1098/rstb.1952.0012</pub-id></element-citation></ref><ref id="bib608"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turley</surname> <given-names>SJ</given-names></name><name><surname>Fletcher</surname> <given-names>AL</given-names></name><name><surname>Elpek</surname> <given-names>KG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs</article-title><source>Nature Reviews Immunology</source><volume>10</volume><fpage>813</fpage><lpage>825</lpage><pub-id pub-id-type="doi">10.1038/nri2886</pub-id></element-citation></ref><ref id="bib609"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unger</surname> <given-names>MA</given-names></name><name><surname>Chou</surname> <given-names>HP</given-names></name><name><surname>Thorsen</surname> <given-names>T</given-names></name><name><surname>Scherer</surname> <given-names>A</given-names></name><name><surname>Quake</surname> <given-names>SR</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Monolithic microfabricated valves and pumps by multilayer soft lithography</article-title><source>Science</source><volume>288</volume><fpage>113</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1126/science.288.5463.113</pub-id><pub-id pub-id-type="pmid">10753110</pub-id></element-citation></ref><ref id="bib610"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utzschneider</surname> <given-names>DT</given-names></name><name><surname>Charmoy</surname> <given-names>M</given-names></name><name><surname>Chennupati</surname> <given-names>V</given-names></name><name><surname>Pousse</surname> <given-names>L</given-names></name><name><surname>Ferreira</surname> <given-names>DP</given-names></name><name><surname>Calderon-Copete</surname> <given-names>S</given-names></name><name><surname>Danilo</surname> <given-names>M</given-names></name><name><surname>Alfei</surname> <given-names>F</given-names></name><name><surname>Hofmann</surname> <given-names>M</given-names></name><name><surname>Wieland</surname> <given-names>D</given-names></name><name><surname>Pradervand</surname> <given-names>S</given-names></name><name><surname>Thimme</surname> <given-names>R</given-names></name><name><surname>Zehn</surname> <given-names>D</given-names></name><name><surname>Held</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>T cell factor 1-Expressing Memory-like CD8(+) T cells sustain the immune response to chronic viral infections</article-title><source>Immunity</source><volume>45</volume><fpage>415</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.07.021</pub-id><pub-id pub-id-type="pmid">27533016</pub-id></element-citation></ref><ref id="bib611"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vahedi</surname> <given-names>G</given-names></name><name><surname>Kanno</surname> <given-names>Y</given-names></name><name><surname>Furumoto</surname> <given-names>Y</given-names></name><name><surname>Jiang</surname> <given-names>K</given-names></name><name><surname>Parker</surname> <given-names>SC</given-names></name><name><surname>Erdos</surname> <given-names>MR</given-names></name><name><surname>Davis</surname> <given-names>SR</given-names></name><name><surname>Roychoudhuri</surname> <given-names>R</given-names></name><name><surname>Restifo</surname> <given-names>NP</given-names></name><name><surname>Gadina</surname> <given-names>M</given-names></name><name><surname>Tang</surname> <given-names>Z</given-names></name><name><surname>Ruan</surname> <given-names>Y</given-names></name><name><surname>Collins</surname> <given-names>FS</given-names></name><name><surname>Sartorelli</surname> <given-names>V</given-names></name><name><surname>O'Shea</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Super-enhancers delineate disease-associated regulatory nodes in T cells</article-title><source>Nature</source><volume>520</volume><fpage>558</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1038/nature14154</pub-id><pub-id pub-id-type="pmid">25686607</pub-id></element-citation></ref><ref id="bib612"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallania</surname> <given-names>F</given-names></name><name><surname>Tam</surname> <given-names>A</given-names></name><name><surname>Lofgren</surname> <given-names>S</given-names></name><name><surname>Schaffert</surname> <given-names>S</given-names></name><name><surname>Azad</surname> <given-names>TD</given-names></name><name><surname>Bongen</surname> <given-names>E</given-names></name><name><surname>Haynes</surname> <given-names>W</given-names></name><name><surname>Alsup</surname> <given-names>M</given-names></name><name><surname>Alonso</surname> <given-names>M</given-names></name><name><surname>Davis</surname> <given-names>M</given-names></name><name><surname>Engleman</surname> <given-names>E</given-names></name><name><surname>Khatri</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Leveraging heterogeneity across multiple datasets increases cell-mixture deconvolution accuracy and reduces biological and technical biases</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>4735</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-07242-6</pub-id><pub-id pub-id-type="pmid">30413720</pub-id></element-citation></ref><ref id="bib613"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Brink</surname> <given-names>SC</given-names></name><name><surname>Sage</surname> <given-names>F</given-names></name><name><surname>Vértesy</surname> <given-names>Á</given-names></name><name><surname>Spanjaard</surname> <given-names>B</given-names></name><name><surname>Peterson-Maduro</surname> <given-names>J</given-names></name><name><surname>Baron</surname> <given-names>CS</given-names></name><name><surname>Robin</surname> <given-names>C</given-names></name><name><surname>van Oudenaarden</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Single-cell sequencing reveals dissociation-induced gene expression in tissue subpopulations</article-title><source>Nature Methods</source><volume>14</volume><fpage>935</fpage><lpage>936</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4437</pub-id><pub-id pub-id-type="pmid">28960196</pub-id></element-citation></ref><ref id="bib614"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Dijk</surname> <given-names>D</given-names></name><name><surname>Sharma</surname> <given-names>R</given-names></name><name><surname>Nainys</surname> <given-names>J</given-names></name><name><surname>Yim</surname> <given-names>K</given-names></name><name><surname>Kathail</surname> <given-names>P</given-names></name><name><surname>Carr</surname> <given-names>AJ</given-names></name><name><surname>Burdziak</surname> <given-names>C</given-names></name><name><surname>Moon</surname> <given-names>KR</given-names></name><name><surname>Chaffer</surname> <given-names>CL</given-names></name><name><surname>Pattabiraman</surname> <given-names>D</given-names></name><name><surname>Bierie</surname> <given-names>B</given-names></name><name><surname>Mazutis</surname> <given-names>L</given-names></name><name><surname>Wolf</surname> <given-names>G</given-names></name><name><surname>Krishnaswamy</surname> <given-names>S</given-names></name><name><surname>Pe'er</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Recovering gene interactions from Single-Cell data using data diffusion</article-title><source>Cell</source><volume>174</volume><fpage>716</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.05.061</pub-id><pub-id pub-id-type="pmid">29961576</pub-id></element-citation></ref><ref id="bib615"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Gassen</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data</article-title><source>Cytometry Part A</source><volume>87</volume><fpage>636</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1002/cyto.a.22625</pub-id></element-citation></ref><ref id="bib616"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Nood</surname> <given-names>E</given-names></name><name><surname>Vrieze</surname> <given-names>A</given-names></name><name><surname>Nieuwdorp</surname> <given-names>M</given-names></name><name><surname>Fuentes</surname> <given-names>S</given-names></name><name><surname>Zoetendal</surname> <given-names>EG</given-names></name><name><surname>de Vos</surname> <given-names>WM</given-names></name><name><surname>Visser</surname> <given-names>CE</given-names></name><name><surname>Kuijper</surname> <given-names>EJ</given-names></name><name><surname>Bartelsman</surname> <given-names>JF</given-names></name><name><surname>Tijssen</surname> <given-names>JG</given-names></name><name><surname>Speelman</surname> <given-names>P</given-names></name><name><surname>Dijkgraaf</surname> <given-names>MG</given-names></name><name><surname>Keller</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Duodenal infusion of donor feces for recurrent <italic>Clostridium difficile</italic></article-title><source>New England Journal of Medicine</source><volume>368</volume><fpage>407</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1205037</pub-id><pub-id pub-id-type="pmid">23323867</pub-id></element-citation></ref><ref id="bib617"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venter</surname> <given-names>JC</given-names></name><name><surname>Adams</surname> <given-names>MD</given-names></name><name><surname>Myers</surname> <given-names>EW</given-names></name><name><surname>Li</surname> <given-names>PW</given-names></name><name><surname>Mural</surname> <given-names>RJ</given-names></name><name><surname>Sutton</surname> <given-names>GG</given-names></name><name><surname>Smith</surname> <given-names>HO</given-names></name><name><surname>Yandell</surname> <given-names>M</given-names></name><name><surname>Evans</surname> <given-names>CA</given-names></name><name><surname>Holt</surname> <given-names>RA</given-names></name><name><surname>Gocayne</surname> <given-names>JD</given-names></name><name><surname>Amanatides</surname> <given-names>P</given-names></name><name><surname>Ballew</surname> <given-names>RM</given-names></name><name><surname>Huson</surname> <given-names>DH</given-names></name><name><surname>Wortman</surname> <given-names>JR</given-names></name><name><surname>Zhang</surname> <given-names>Q</given-names></name><name><surname>Kodira</surname> <given-names>CD</given-names></name><name><surname>Zheng</surname> <given-names>XH</given-names></name><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Skupski</surname> <given-names>M</given-names></name><name><surname>Subramanian</surname> <given-names>G</given-names></name><name><surname>Thomas</surname> <given-names>PD</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Gabor Miklos</surname> <given-names>GL</given-names></name><name><surname>Nelson</surname> <given-names>C</given-names></name><name><surname>Broder</surname> <given-names>S</given-names></name><name><surname>Clark</surname> <given-names>AG</given-names></name><name><surname>Nadeau</surname> <given-names>J</given-names></name><name><surname>McKusick</surname> <given-names>VA</given-names></name><name><surname>Zinder</surname> <given-names>N</given-names></name><name><surname>Levine</surname> <given-names>AJ</given-names></name><name><surname>Roberts</surname> <given-names>RJ</given-names></name><name><surname>Simon</surname> <given-names>M</given-names></name><name><surname>Slayman</surname> <given-names>C</given-names></name><name><surname>Hunkapiller</surname> <given-names>M</given-names></name><name><surname>Bolanos</surname> <given-names>R</given-names></name><name><surname>Delcher</surname> <given-names>A</given-names></name><name><surname>Dew</surname> <given-names>I</given-names></name><name><surname>Fasulo</surname> <given-names>D</given-names></name><name><surname>Flanigan</surname> <given-names>M</given-names></name><name><surname>Florea</surname> <given-names>L</given-names></name><name><surname>Halpern</surname> <given-names>A</given-names></name><name><surname>Hannenhalli</surname> <given-names>S</given-names></name><name><surname>Kravitz</surname> <given-names>S</given-names></name><name><surname>Levy</surname> <given-names>S</given-names></name><name><surname>Mobarry</surname> <given-names>C</given-names></name><name><surname>Reinert</surname> <given-names>K</given-names></name><name><surname>Remington</surname> <given-names>K</given-names></name><name><surname>Abu-Threideh</surname> <given-names>J</given-names></name><name><surname>Beasley</surname> <given-names>E</given-names></name><name><surname>Biddick</surname> <given-names>K</given-names></name><name><surname>Bonazzi</surname> <given-names>V</given-names></name><name><surname>Brandon</surname> <given-names>R</given-names></name><name><surname>Cargill</surname> <given-names>M</given-names></name><name><surname>Chandramouliswaran</surname> <given-names>I</given-names></name><name><surname>Charlab</surname> <given-names>R</given-names></name><name><surname>Chaturvedi</surname> <given-names>K</given-names></name><name><surname>Deng</surname> <given-names>Z</given-names></name><name><surname>Di Francesco</surname> <given-names>V</given-names></name><name><surname>Dunn</surname> <given-names>P</given-names></name><name><surname>Eilbeck</surname> <given-names>K</given-names></name><name><surname>Evangelista</surname> <given-names>C</given-names></name><name><surname>Gabrielian</surname> <given-names>AE</given-names></name><name><surname>Gan</surname> <given-names>W</given-names></name><name><surname>Ge</surname> <given-names>W</given-names></name><name><surname>Gong</surname> <given-names>F</given-names></name><name><surname>Gu</surname> <given-names>Z</given-names></name><name><surname>Guan</surname> <given-names>P</given-names></name><name><surname>Heiman</surname> <given-names>TJ</given-names></name><name><surname>Higgins</surname> <given-names>ME</given-names></name><name><surname>Ji</surname> <given-names>RR</given-names></name><name><surname>Ke</surname> <given-names>Z</given-names></name><name><surname>Ketchum</surname> <given-names>KA</given-names></name><name><surname>Lai</surname> <given-names>Z</given-names></name><name><surname>Lei</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>Z</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Liang</surname> <given-names>Y</given-names></name><name><surname>Lin</surname> <given-names>X</given-names></name><name><surname>Lu</surname> <given-names>F</given-names></name><name><surname>Merkulov</surname> <given-names>GV</given-names></name><name><surname>Milshina</surname> <given-names>N</given-names></name><name><surname>Moore</surname> <given-names>HM</given-names></name><name><surname>Naik</surname> <given-names>AK</given-names></name><name><surname>Narayan</surname> <given-names>VA</given-names></name><name><surname>Neelam</surname> <given-names>B</given-names></name><name><surname>Nusskern</surname> <given-names>D</given-names></name><name><surname>Rusch</surname> <given-names>DB</given-names></name><name><surname>Salzberg</surname> <given-names>S</given-names></name><name><surname>Shao</surname> <given-names>W</given-names></name><name><surname>Shue</surname> <given-names>B</given-names></name><name><surname>Sun</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Wang</surname> <given-names>A</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Wei</surname> <given-names>M</given-names></name><name><surname>Wides</surname> <given-names>R</given-names></name><name><surname>Xiao</surname> <given-names>C</given-names></name><name><surname>Yan</surname> <given-names>C</given-names></name><name><surname>Yao</surname> <given-names>A</given-names></name><name><surname>Ye</surname> <given-names>J</given-names></name><name><surname>Zhan</surname> <given-names>M</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Zhao</surname> <given-names>Q</given-names></name><name><surname>Zheng</surname> <given-names>L</given-names></name><name><surname>Zhong</surname> <given-names>F</given-names></name><name><surname>Zhong</surname> <given-names>W</given-names></name><name><surname>Zhu</surname> <given-names>S</given-names></name><name><surname>Zhao</surname> <given-names>S</given-names></name><name><surname>Gilbert</surname> <given-names>D</given-names></name><name><surname>Baumhueter</surname> <given-names>S</given-names></name><name><surname>Spier</surname> <given-names>G</given-names></name><name><surname>Carter</surname> <given-names>C</given-names></name><name><surname>Cravchik</surname> <given-names>A</given-names></name><name><surname>Woodage</surname> <given-names>T</given-names></name><name><surname>Ali</surname> <given-names>F</given-names></name><name><surname>An</surname> <given-names>H</given-names></name><name><surname>Awe</surname> <given-names>A</given-names></name><name><surname>Baldwin</surname> <given-names>D</given-names></name><name><surname>Baden</surname> <given-names>H</given-names></name><name><surname>Barnstead</surname> <given-names>M</given-names></name><name><surname>Barrow</surname> <given-names>I</given-names></name><name><surname>Beeson</surname> <given-names>K</given-names></name><name><surname>Busam</surname> <given-names>D</given-names></name><name><surname>Carver</surname> <given-names>A</given-names></name><name><surname>Center</surname> <given-names>A</given-names></name><name><surname>Cheng</surname> <given-names>ML</given-names></name><name><surname>Curry</surname> <given-names>L</given-names></name><name><surname>Danaher</surname> <given-names>S</given-names></name><name><surname>Davenport</surname> <given-names>L</given-names></name><name><surname>Desilets</surname> <given-names>R</given-names></name><name><surname>Dietz</surname> <given-names>S</given-names></name><name><surname>Dodson</surname> <given-names>K</given-names></name><name><surname>Doup</surname> <given-names>L</given-names></name><name><surname>Ferriera</surname> <given-names>S</given-names></name><name><surname>Garg</surname> <given-names>N</given-names></name><name><surname>Gluecksmann</surname> <given-names>A</given-names></name><name><surname>Hart</surname> <given-names>B</given-names></name><name><surname>Haynes</surname> <given-names>J</given-names></name><name><surname>Haynes</surname> <given-names>C</given-names></name><name><surname>Heiner</surname> <given-names>C</given-names></name><name><surname>Hladun</surname> <given-names>S</given-names></name><name><surname>Hostin</surname> <given-names>D</given-names></name><name><surname>Houck</surname> <given-names>J</given-names></name><name><surname>Howland</surname> <given-names>T</given-names></name><name><surname>Ibegwam</surname> <given-names>C</given-names></name><name><surname>Johnson</surname> <given-names>J</given-names></name><name><surname>Kalush</surname> <given-names>F</given-names></name><name><surname>Kline</surname> <given-names>L</given-names></name><name><surname>Koduru</surname> <given-names>S</given-names></name><name><surname>Love</surname> <given-names>A</given-names></name><name><surname>Mann</surname> <given-names>F</given-names></name><name><surname>May</surname> <given-names>D</given-names></name><name><surname>McCawley</surname> <given-names>S</given-names></name><name><surname>McIntosh</surname> <given-names>T</given-names></name><name><surname>McMullen</surname> <given-names>I</given-names></name><name><surname>Moy</surname> <given-names>M</given-names></name><name><surname>Moy</surname> <given-names>L</given-names></name><name><surname>Murphy</surname> <given-names>B</given-names></name><name><surname>Nelson</surname> <given-names>K</given-names></name><name><surname>Pfannkoch</surname> <given-names>C</given-names></name><name><surname>Pratts</surname> <given-names>E</given-names></name><name><surname>Puri</surname> <given-names>V</given-names></name><name><surname>Qureshi</surname> <given-names>H</given-names></name><name><surname>Reardon</surname> <given-names>M</given-names></name><name><surname>Rodriguez</surname> <given-names>R</given-names></name><name><surname>Rogers</surname> <given-names>YH</given-names></name><name><surname>Romblad</surname> <given-names>D</given-names></name><name><surname>Ruhfel</surname> <given-names>B</given-names></name><name><surname>Scott</surname> <given-names>R</given-names></name><name><surname>Sitter</surname> <given-names>C</given-names></name><name><surname>Smallwood</surname> <given-names>M</given-names></name><name><surname>Stewart</surname> <given-names>E</given-names></name><name><surname>Strong</surname> <given-names>R</given-names></name><name><surname>Suh</surname> <given-names>E</given-names></name><name><surname>Thomas</surname> <given-names>R</given-names></name><name><surname>Tint</surname> <given-names>NN</given-names></name><name><surname>Tse</surname> <given-names>S</given-names></name><name><surname>Vech</surname> <given-names>C</given-names></name><name><surname>Wang</surname> <given-names>G</given-names></name><name><surname>Wetter</surname> <given-names>J</given-names></name><name><surname>Williams</surname> <given-names>S</given-names></name><name><surname>Williams</surname> <given-names>M</given-names></name><name><surname>Windsor</surname> <given-names>S</given-names></name><name><surname>Winn-Deen</surname> <given-names>E</given-names></name><name><surname>Wolfe</surname> <given-names>K</given-names></name><name><surname>Zaveri</surname> <given-names>J</given-names></name><name><surname>Zaveri</surname> <given-names>K</given-names></name><name><surname>Abril</surname> <given-names>JF</given-names></name><name><surname>Guigó</surname> <given-names>R</given-names></name><name><surname>Campbell</surname> <given-names>MJ</given-names></name><name><surname>Sjolander</surname> <given-names>KV</given-names></name><name><surname>Karlak</surname> <given-names>B</given-names></name><name><surname>Kejariwal</surname> <given-names>A</given-names></name><name><surname>Mi</surname> <given-names>H</given-names></name><name><surname>Lazareva</surname> <given-names>B</given-names></name><name><surname>Hatton</surname> <given-names>T</given-names></name><name><surname>Narechania</surname> <given-names>A</given-names></name><name><surname>Diemer</surname> <given-names>K</given-names></name><name><surname>Muruganujan</surname> <given-names>A</given-names></name><name><surname>Guo</surname> <given-names>N</given-names></name><name><surname>Sato</surname> <given-names>S</given-names></name><name><surname>Bafna</surname> <given-names>V</given-names></name><name><surname>Istrail</surname> <given-names>S</given-names></name><name><surname>Lippert</surname> <given-names>R</given-names></name><name><surname>Schwartz</surname> <given-names>R</given-names></name><name><surname>Walenz</surname> <given-names>B</given-names></name><name><surname>Yooseph</surname> <given-names>S</given-names></name><name><surname>Allen</surname> <given-names>D</given-names></name><name><surname>Basu</surname> <given-names>A</given-names></name><name><surname>Baxendale</surname> <given-names>J</given-names></name><name><surname>Blick</surname> <given-names>L</given-names></name><name><surname>Caminha</surname> <given-names>M</given-names></name><name><surname>Carnes-Stine</surname> <given-names>J</given-names></name><name><surname>Caulk</surname> <given-names>P</given-names></name><name><surname>Chiang</surname> <given-names>YH</given-names></name><name><surname>Coyne</surname> <given-names>M</given-names></name><name><surname>Dahlke</surname> <given-names>C</given-names></name><name><surname>Mays</surname> <given-names>A</given-names></name><name><surname>Dombroski</surname> <given-names>M</given-names></name><name><surname>Donnelly</surname> <given-names>M</given-names></name><name><surname>Ely</surname> <given-names>D</given-names></name><name><surname>Esparham</surname> <given-names>S</given-names></name><name><surname>Fosler</surname> <given-names>C</given-names></name><name><surname>Gire</surname> <given-names>H</given-names></name><name><surname>Glanowski</surname> <given-names>S</given-names></name><name><surname>Glasser</surname> <given-names>K</given-names></name><name><surname>Glodek</surname> <given-names>A</given-names></name><name><surname>Gorokhov</surname> <given-names>M</given-names></name><name><surname>Graham</surname> <given-names>K</given-names></name><name><surname>Gropman</surname> <given-names>B</given-names></name><name><surname>Harris</surname> <given-names>M</given-names></name><name><surname>Heil</surname> <given-names>J</given-names></name><name><surname>Henderson</surname> <given-names>S</given-names></name><name><surname>Hoover</surname> <given-names>J</given-names></name><name><surname>Jennings</surname> <given-names>D</given-names></name><name><surname>Jordan</surname> <given-names>C</given-names></name><name><surname>Jordan</surname> <given-names>J</given-names></name><name><surname>Kasha</surname> <given-names>J</given-names></name><name><surname>Kagan</surname> <given-names>L</given-names></name><name><surname>Kraft</surname> <given-names>C</given-names></name><name><surname>Levitsky</surname> <given-names>A</given-names></name><name><surname>Lewis</surname> <given-names>M</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Lopez</surname> <given-names>J</given-names></name><name><surname>Ma</surname> <given-names>D</given-names></name><name><surname>Majoros</surname> <given-names>W</given-names></name><name><surname>McDaniel</surname> <given-names>J</given-names></name><name><surname>Murphy</surname> <given-names>S</given-names></name><name><surname>Newman</surname> <given-names>M</given-names></name><name><surname>Nguyen</surname> <given-names>T</given-names></name><name><surname>Nguyen</surname> <given-names>N</given-names></name><name><surname>Nodell</surname> <given-names>M</given-names></name><name><surname>Pan</surname> <given-names>S</given-names></name><name><surname>Peck</surname> <given-names>J</given-names></name><name><surname>Peterson</surname> <given-names>M</given-names></name><name><surname>Rowe</surname> <given-names>W</given-names></name><name><surname>Sanders</surname> <given-names>R</given-names></name><name><surname>Scott</surname> <given-names>J</given-names></name><name><surname>Simpson</surname> <given-names>M</given-names></name><name><surname>Smith</surname> <given-names>T</given-names></name><name><surname>Sprague</surname> <given-names>A</given-names></name><name><surname>Stockwell</surname> <given-names>T</given-names></name><name><surname>Turner</surname> <given-names>R</given-names></name><name><surname>Venter</surname> <given-names>E</given-names></name><name><surname>Wang</surname> <given-names>M</given-names></name><name><surname>Wen</surname> <given-names>M</given-names></name><name><surname>Wu</surname> <given-names>D</given-names></name><name><surname>Wu</surname> <given-names>M</given-names></name><name><surname>Xia</surname> <given-names>A</given-names></name><name><surname>Zandieh</surname> <given-names>A</given-names></name><name><surname>Zhu</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The sequence of the human genome</article-title><source>Science</source><volume>291</volume><fpage>1304</fpage><lpage>1351</lpage><pub-id pub-id-type="doi">10.1126/science.1058040</pub-id><pub-id pub-id-type="pmid">11181995</pub-id></element-citation></ref><ref id="bib618"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Vera</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><chapter-title>A Translational Medicine Context Envisioning the Application of Systems Biology in Cancer Immunology</chapter-title><person-group person-group-type="editor"><name><surname>Rezaei</surname> <given-names>N</given-names></name></person-group><source>Cancer Immunology</source><publisher-name>Springer Berlin Heidelberg</publisher-name><fpage>429</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1007/978-3-662-44006-3</pub-id></element-citation></ref><ref id="bib619"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vetizou</surname> <given-names>M</given-names></name><name><surname>Pitt</surname> <given-names>JM</given-names></name><name><surname>Daillere</surname> <given-names>R</given-names></name><name><surname>Lepage</surname> <given-names>P</given-names></name><name><surname>Waldschmitt</surname> <given-names>N</given-names></name><name><surname>Flament</surname> <given-names>C</given-names></name><name><surname>Rusakiewicz</surname> <given-names>S</given-names></name><name><surname>Routy</surname> <given-names>B</given-names></name><name><surname>Roberti</surname> <given-names>MP</given-names></name><name><surname>Duong</surname> <given-names>CPM</given-names></name><name><surname>Poirier-Colame</surname> <given-names>V</given-names></name><name><surname>Roux</surname> <given-names>A</given-names></name><name><surname>Becharef</surname> <given-names>S</given-names></name><name><surname>Formenti</surname> <given-names>S</given-names></name><name><surname>Golden</surname> <given-names>E</given-names></name><name><surname>Cording</surname> <given-names>S</given-names></name><name><surname>Eberl</surname> <given-names>G</given-names></name><name><surname>Schlitzer</surname> <given-names>A</given-names></name><name><surname>Ginhoux</surname> <given-names>F</given-names></name><name><surname>Mani</surname> <given-names>S</given-names></name><name><surname>Yamazaki</surname> <given-names>T</given-names></name><name><surname>Jacquelot</surname> <given-names>N</given-names></name><name><surname>Enot</surname> <given-names>DP</given-names></name><name><surname>Berard</surname> <given-names>M</given-names></name><name><surname>Nigou</surname> <given-names>J</given-names></name><name><surname>Opolon</surname> <given-names>P</given-names></name><name><surname>Eggermont</surname> <given-names>A</given-names></name><name><surname>Woerther</surname> <given-names>P-L</given-names></name><name><surname>Chachaty</surname> <given-names>E</given-names></name><name><surname>Chaput</surname> <given-names>N</given-names></name><name><surname>Robert</surname> <given-names>C</given-names></name><name><surname>Mateus</surname> <given-names>C</given-names></name><name><surname>Kroemer</surname> <given-names>G</given-names></name><name><surname>Raoult</surname> <given-names>D</given-names></name><name><surname>Boneca</surname> <given-names>IG</given-names></name><name><surname>Carbonnel</surname> <given-names>F</given-names></name><name><surname>Chamaillard</surname> <given-names>M</given-names></name><name><surname>Zitvogel</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Anticancer immunotherapy by CTLA-4 blockade relies on the gut Microbiota</article-title><source>Science</source><volume>350</volume><fpage>1079</fpage><lpage>1084</lpage><pub-id pub-id-type="doi">10.1126/science.aad1329</pub-id></element-citation></ref><ref id="bib620"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viaud</surname> <given-names>S</given-names></name><name><surname>Saccheri</surname> <given-names>F</given-names></name><name><surname>Mignot</surname> <given-names>G</given-names></name><name><surname>Yamazaki</surname> <given-names>T</given-names></name><name><surname>Daillère</surname> <given-names>R</given-names></name><name><surname>Hannani</surname> <given-names>D</given-names></name><name><surname>Enot</surname> <given-names>DP</given-names></name><name><surname>Pfirschke</surname> <given-names>C</given-names></name><name><surname>Engblom</surname> <given-names>C</given-names></name><name><surname>Pittet</surname> <given-names>MJ</given-names></name><name><surname>Schlitzer</surname> <given-names>A</given-names></name><name><surname>Ginhoux</surname> <given-names>F</given-names></name><name><surname>Apetoh</surname> <given-names>L</given-names></name><name><surname>Chachaty</surname> <given-names>E</given-names></name><name><surname>Woerther</surname> <given-names>PL</given-names></name><name><surname>Eberl</surname> <given-names>G</given-names></name><name><surname>Bérard</surname> <given-names>M</given-names></name><name><surname>Ecobichon</surname> <given-names>C</given-names></name><name><surname>Clermont</surname> <given-names>D</given-names></name><name><surname>Bizet</surname> <given-names>C</given-names></name><name><surname>Gaboriau-Routhiau</surname> <given-names>V</given-names></name><name><surname>Cerf-Bensussan</surname> <given-names>N</given-names></name><name><surname>Opolon</surname> <given-names>P</given-names></name><name><surname>Yessaad</surname> <given-names>N</given-names></name><name><surname>Vivier</surname> <given-names>E</given-names></name><name><surname>Ryffel</surname> <given-names>B</given-names></name><name><surname>Elson</surname> <given-names>CO</given-names></name><name><surname>Doré</surname> <given-names>J</given-names></name><name><surname>Kroemer</surname> <given-names>G</given-names></name><name><surname>Lepage</surname> <given-names>P</given-names></name><name><surname>Boneca</surname> <given-names>IG</given-names></name><name><surname>Ghiringhelli</surname> <given-names>F</given-names></name><name><surname>Zitvogel</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The intestinal Microbiota modulates the anticancer immune effects of cyclophosphamide</article-title><source>Science</source><volume>342</volume><fpage>971</fpage><lpage>976</lpage><pub-id pub-id-type="doi">10.1126/science.1240537</pub-id><pub-id pub-id-type="pmid">24264990</pub-id></element-citation></ref><ref id="bib621"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Vieira</surname> <given-names>LS</given-names></name><name><surname>Vera-Licona</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Computing signal transduction in signaling networks modeled as boolean networks, petri nets and Hypergraphs</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/272344</pub-id></element-citation></ref><ref id="bib622"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villani</surname> <given-names>AC</given-names></name><name><surname>Satija</surname> <given-names>R</given-names></name><name><surname>Reynolds</surname> <given-names>G</given-names></name><name><surname>Sarkizova</surname> <given-names>S</given-names></name><name><surname>Shekhar</surname> <given-names>K</given-names></name><name><surname>Fletcher</surname> <given-names>J</given-names></name><name><surname>Griesbeck</surname> <given-names>M</given-names></name><name><surname>Butler</surname> <given-names>A</given-names></name><name><surname>Zheng</surname> <given-names>S</given-names></name><name><surname>Lazo</surname> <given-names>S</given-names></name><name><surname>Jardine</surname> <given-names>L</given-names></name><name><surname>Dixon</surname> <given-names>D</given-names></name><name><surname>Stephenson</surname> <given-names>E</given-names></name><name><surname>Nilsson</surname> <given-names>E</given-names></name><name><surname>Grundberg</surname> <given-names>I</given-names></name><name><surname>McDonald</surname> <given-names>D</given-names></name><name><surname>Filby</surname> <given-names>A</given-names></name><name><surname>Li</surname> <given-names>W</given-names></name><name><surname>De Jager</surname> <given-names>PL</given-names></name><name><surname>Rozenblatt-Rosen</surname> <given-names>O</given-names></name><name><surname>Lane</surname> <given-names>AA</given-names></name><name><surname>Haniffa</surname> <given-names>M</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name><name><surname>Hacohen</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors</article-title><source>Science</source><volume>356</volume><elocation-id>eaah4573</elocation-id><pub-id pub-id-type="doi">10.1126/science.aah4573</pub-id><pub-id pub-id-type="pmid">28428369</pub-id></element-citation></ref><ref id="bib623"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virchow</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="1858">1858</year><article-title>Die cellularpathologie in ihrer begrundung auf physiologische und pathologische gewebelehre</article-title><source>Zwanzig Vorlesungen Gehalten Wahrend Der Monate Februar, Marz Und</source></element-citation></ref><ref id="bib624"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virchow</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="1863">1863</year><article-title>Cellular pathology as based upon physiological and pathological histology</article-title><source>JB Lippincott</source><volume>383</volume><elocation-id>32770</elocation-id><pub-id pub-id-type="doi">10.5962/bhl.title.32770</pub-id></element-citation></ref><ref id="bib625"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wählby</surname> <given-names>C</given-names></name><name><surname>Erlandsson</surname> <given-names>F</given-names></name><name><surname>Bengtsson</surname> <given-names>E</given-names></name><name><surname>Zetterberg</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Sequential immunofluorescence staining and image analysis for detection of large numbers of antigens in individual cell nuclei</article-title><source>Cytometry</source><volume>47</volume><fpage>32</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1002/cyto.10026</pub-id><pub-id pub-id-type="pmid">11774347</pub-id></element-citation></ref><ref id="bib626"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Waters</surname> <given-names>J</given-names></name><name><surname>Leung</surname> <given-names>ML</given-names></name><name><surname>Unruh</surname> <given-names>A</given-names></name><name><surname>Roh</surname> <given-names>W</given-names></name><name><surname>Shi</surname> <given-names>X</given-names></name><name><surname>Chen</surname> <given-names>K</given-names></name><name><surname>Scheet</surname> <given-names>P</given-names></name><name><surname>Vattathil</surname> <given-names>S</given-names></name><name><surname>Liang</surname> <given-names>H</given-names></name><name><surname>Multani</surname> <given-names>A</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Zhao</surname> <given-names>R</given-names></name><name><surname>Michor</surname> <given-names>F</given-names></name><name><surname>Meric-Bernstam</surname> <given-names>F</given-names></name><name><surname>Navin</surname> <given-names>NE</given-names></name></person-group><year iso-8601-date="2014">2014a</year><article-title>Clonal evolution in breast Cancer revealed by single nucleus genome sequencing</article-title><source>Nature</source><volume>512</volume><fpage>155</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1038/nature13600</pub-id><pub-id pub-id-type="pmid">25079324</pub-id></element-citation></ref><ref id="bib627"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>T</given-names></name><name><surname>Wei</surname> <given-names>JJ</given-names></name><name><surname>Sabatini</surname> <given-names>DM</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name></person-group><year iso-8601-date="2014">2014b</year><article-title>Genetic screens in human cells using the CRISPR-Cas9 system</article-title><source>Science</source><volume>343</volume><fpage>80</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1126/science.1246981</pub-id><pub-id pub-id-type="pmid">24336569</pub-id></element-citation></ref><ref id="bib628"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>G</given-names></name><name><surname>Chow</surname> <given-names>RD</given-names></name><name><surname>Bai</surname> <given-names>Z</given-names></name><name><surname>Zhu</surname> <given-names>L</given-names></name><name><surname>Errami</surname> <given-names>Y</given-names></name><name><surname>Dai</surname> <given-names>X</given-names></name><name><surname>Dong</surname> <given-names>MB</given-names></name><name><surname>Ye</surname> <given-names>L</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Renauer</surname> <given-names>PA</given-names></name><name><surname>Park</surname> <given-names>JJ</given-names></name><name><surname>Shen</surname> <given-names>L</given-names></name><name><surname>Ye</surname> <given-names>H</given-names></name><name><surname>Fuchs</surname> <given-names>CS</given-names></name><name><surname>Chen</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity</article-title><source>Nature Immunology</source><volume>20</volume><fpage>1494</fpage><lpage>1505</lpage><pub-id pub-id-type="doi">10.1038/s41590-019-0500-4</pub-id><pub-id pub-id-type="pmid">31611701</pub-id></element-citation></ref><ref id="bib629"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warburg</surname> <given-names>O</given-names></name><name><surname>Wind</surname> <given-names>F</given-names></name><name><surname>Negelein</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="1927">1927</year><article-title>The metabolism of tumors in the body</article-title><source>The Journal of General Physiology</source><volume>8</volume><fpage>519</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1085/jgp.8.6.519</pub-id><pub-id pub-id-type="pmid">19872213</pub-id></element-citation></ref><ref id="bib630"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname> <given-names>PS</given-names></name><name><surname>Thompson</surname> <given-names>CB</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Metabolic reprogramming: a Cancer hallmark even warburg did not anticipate</article-title><source>Cancer Cell</source><volume>21</volume><fpage>297</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2012.02.014</pub-id><pub-id pub-id-type="pmid">22439925</pub-id></element-citation></ref><ref id="bib631"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Waterman</surname> <given-names>TH</given-names></name><name><surname>Theory</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1968">1968</year><source>Biology—View of a Biologist</source><publisher-loc>Berlin, Heidelberg</publisher-loc><publisher-name>Springer Berlin Heidelberg</publisher-name></element-citation></ref><ref id="bib632"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname> <given-names>DK</given-names></name><name><surname>Chuang</surname> <given-names>Y</given-names></name><name><surname>Knapp</surname> <given-names>LM</given-names></name><name><surname>Brockmann</surname> <given-names>D</given-names></name><name><surname>Kath</surname> <given-names>WL</given-names></name><name><surname>Leonard</surname> <given-names>JN</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Spatial and functional heterogeneities shape collective behavior of tumor-immune networks</article-title><source>PLOS Computational Biology</source><volume>11</volume><elocation-id>e1004181</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1004181</pub-id><pub-id pub-id-type="pmid">25905470</pub-id></element-citation></ref><ref id="bib633"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werner</surname> <given-names>HM</given-names></name><name><surname>Mills</surname> <given-names>GB</given-names></name><name><surname>Ram</surname> <given-names>PT</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cancer systems biology: a peek into the future of patient care?</article-title><source>Nature Reviews Clinical Oncology</source><volume>11</volume><fpage>167</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1038/nrclinonc.2014.6</pub-id><pub-id pub-id-type="pmid">24492837</pub-id></element-citation></ref><ref id="bib634"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wherry</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>T cell exhaustion</article-title><source>Nature Immunology</source><volume>12</volume><fpage>492</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1038/ni.2035</pub-id><pub-id pub-id-type="pmid">21739672</pub-id></element-citation></ref><ref id="bib635"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willimsky</surname> <given-names>G</given-names></name><name><surname>Blankenstein</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance</article-title><source>Nature</source><volume>437</volume><fpage>141</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1038/nature03954</pub-id><pub-id pub-id-type="pmid">16136144</pub-id></element-citation></ref><ref id="bib636"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wishart</surname> <given-names>DS</given-names></name><name><surname>Tzur</surname> <given-names>D</given-names></name><name><surname>Knox</surname> <given-names>C</given-names></name><name><surname>Eisner</surname> <given-names>R</given-names></name><name><surname>Guo</surname> <given-names>AC</given-names></name><name><surname>Young</surname> <given-names>N</given-names></name><name><surname>Cheng</surname> <given-names>D</given-names></name><name><surname>Jewell</surname> <given-names>K</given-names></name><name><surname>Arndt</surname> <given-names>D</given-names></name><name><surname>Sawhney</surname> <given-names>S</given-names></name><name><surname>Fung</surname> <given-names>C</given-names></name><name><surname>Nikolai</surname> <given-names>L</given-names></name><name><surname>Lewis</surname> <given-names>M</given-names></name><name><surname>Coutouly</surname> <given-names>M-A</given-names></name><name><surname>Forsythe</surname> <given-names>I</given-names></name><name><surname>Tang</surname> <given-names>P</given-names></name><name><surname>Shrivastava</surname> <given-names>S</given-names></name><name><surname>Jeroncic</surname> <given-names>K</given-names></name><name><surname>Stothard</surname> <given-names>P</given-names></name><name><surname>Amegbey</surname> <given-names>G</given-names></name><name><surname>Block</surname> <given-names>D</given-names></name><name><surname>Hau</surname> <given-names>DD</given-names></name><name><surname>Wagner</surname> <given-names>J</given-names></name><name><surname>Miniaci</surname> <given-names>J</given-names></name><name><surname>Clements</surname> <given-names>M</given-names></name><name><surname>Gebremedhin</surname> <given-names>M</given-names></name><name><surname>Guo</surname> <given-names>N</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Duggan</surname> <given-names>GE</given-names></name><name><surname>MacInnis</surname> <given-names>GD</given-names></name><name><surname>Weljie</surname> <given-names>AM</given-names></name><name><surname>Dowlatabadi</surname> <given-names>R</given-names></name><name><surname>Bamforth</surname> <given-names>F</given-names></name><name><surname>Clive</surname> <given-names>D</given-names></name><name><surname>Greiner</surname> <given-names>R</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Marrie</surname> <given-names>T</given-names></name><name><surname>Sykes</surname> <given-names>BD</given-names></name><name><surname>Vogel</surname> <given-names>HJ</given-names></name><name><surname>Querengesser</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>HMDB: the human metabolome database</article-title><source>Nucleic Acids Research</source><volume>35</volume><fpage>D521</fpage><lpage>D526</lpage><pub-id pub-id-type="doi">10.1093/nar/gkl923</pub-id></element-citation></ref><ref id="bib637"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wistuba-Hamprecht</surname> <given-names>K</given-names></name><name><surname>Martens</surname> <given-names>A</given-names></name><name><surname>Weide</surname> <given-names>B</given-names></name><name><surname>Teng</surname> <given-names>KW</given-names></name><name><surname>Zelba</surname> <given-names>H</given-names></name><name><surname>Guffart</surname> <given-names>E</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Garbe</surname> <given-names>C</given-names></name><name><surname>Newell</surname> <given-names>EW</given-names></name><name><surname>Larbi</surname> <given-names>A</given-names></name><name><surname>Pawelec</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Establishing high dimensional immune signatures from peripheral blood via mass cytometry in a discovery cohort of stage IV melanoma patients</article-title><source>The Journal of Immunology</source><volume>198</volume><fpage>927</fpage><lpage>936</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1600875</pub-id><pub-id pub-id-type="pmid">27986910</pub-id></element-citation></ref><ref id="bib638"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woelke</surname> <given-names>AL</given-names></name><name><surname>Murgueitio</surname> <given-names>MS</given-names></name><name><surname>Preissner</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Theoretical modeling techniques and their impact on tumor immunology</article-title><source>Clinical and Developmental Immunology</source><volume>2010</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1155/2010/271794</pub-id></element-citation></ref><ref id="bib639"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>SC</given-names></name><name><surname>Puaux</surname> <given-names>AL</given-names></name><name><surname>Chittezhath</surname> <given-names>M</given-names></name><name><surname>Shalova</surname> <given-names>I</given-names></name><name><surname>Kajiji</surname> <given-names>TS</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Abastado</surname> <given-names>JP</given-names></name><name><surname>Lam</surname> <given-names>KP</given-names></name><name><surname>Biswas</surname> <given-names>SK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Macrophage polarization to a unique phenotype driven by B cells</article-title><source>European Journal of Immunology</source><volume>40</volume><fpage>2296</fpage><lpage>2307</lpage><pub-id pub-id-type="doi">10.1002/eji.200940288</pub-id><pub-id pub-id-type="pmid">20468007</pub-id></element-citation></ref><ref id="bib640"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodsworth</surname> <given-names>DJ</given-names></name><name><surname>Castellarin</surname> <given-names>M</given-names></name><name><surname>Holt</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Sequence analysis of T-cell repertoires in health and disease</article-title><source>Genome Medicine</source><volume>5</volume><elocation-id>98</elocation-id><pub-id pub-id-type="doi">10.1186/gm502</pub-id><pub-id pub-id-type="pmid">24172704</pub-id></element-citation></ref><ref id="bib641"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>AR</given-names></name><name><surname>Neff</surname> <given-names>NF</given-names></name><name><surname>Kalisky</surname> <given-names>T</given-names></name><name><surname>Dalerba</surname> <given-names>P</given-names></name><name><surname>Treutlein</surname> <given-names>B</given-names></name><name><surname>Rothenberg</surname> <given-names>ME</given-names></name><name><surname>Mburu</surname> <given-names>FM</given-names></name><name><surname>Mantalas</surname> <given-names>GL</given-names></name><name><surname>Sim</surname> <given-names>S</given-names></name><name><surname>Clarke</surname> <given-names>MF</given-names></name><name><surname>Quake</surname> <given-names>SR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Quantitative assessment of single-cell RNA-sequencing methods</article-title><source>Nature Methods</source><volume>11</volume><fpage>41</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2694</pub-id><pub-id pub-id-type="pmid">24141493</pub-id></element-citation></ref><ref id="bib642"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>T</given-names></name><name><surname>Ji</surname> <given-names>Y</given-names></name><name><surname>Moseman</surname> <given-names>EA</given-names></name><name><surname>Xu</surname> <given-names>HC</given-names></name><name><surname>Manglani</surname> <given-names>M</given-names></name><name><surname>Kirby</surname> <given-names>M</given-names></name><name><surname>Anderson</surname> <given-names>SM</given-names></name><name><surname>Handon</surname> <given-names>R</given-names></name><name><surname>Kenyon</surname> <given-names>E</given-names></name><name><surname>Elkahloun</surname> <given-names>A</given-names></name><name><surname>Wu</surname> <given-names>W</given-names></name><name><surname>Lang</surname> <given-names>PA</given-names></name><name><surname>Gattinoni</surname> <given-names>L</given-names></name><name><surname>McGavern</surname> <given-names>DB</given-names></name><name><surname>Schwartzberg</surname> <given-names>PL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The TCF1-Bcl6 Axis counteracts type I interferon to repress exhaustion and maintain T cell stemness</article-title><source>Science Immunology</source><volume>1</volume><elocation-id>eaai8593</elocation-id><pub-id pub-id-type="doi">10.1126/sciimmunol.aai8593</pub-id></element-citation></ref><ref id="bib643"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>J</given-names></name><name><surname>Lanier</surname> <given-names>LL</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Natural killer cells and Cancer</article-title><source>Advances in Cancer Research</source><volume>90</volume><fpage>127</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1016/s0065-230x(03)90004-2</pub-id><pub-id pub-id-type="pmid">14710949</pub-id></element-citation></ref><ref id="bib644"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Hou</surname> <given-names>Y</given-names></name><name><surname>Yin</surname> <given-names>X</given-names></name><name><surname>Bao</surname> <given-names>L</given-names></name><name><surname>Tang</surname> <given-names>A</given-names></name><name><surname>Song</surname> <given-names>L</given-names></name><name><surname>Li</surname> <given-names>F</given-names></name><name><surname>Tsang</surname> <given-names>S</given-names></name><name><surname>Wu</surname> <given-names>K</given-names></name><name><surname>Wu</surname> <given-names>H</given-names></name><name><surname>He</surname> <given-names>W</given-names></name><name><surname>Zeng</surname> <given-names>L</given-names></name><name><surname>Xing</surname> <given-names>M</given-names></name><name><surname>Wu</surname> <given-names>R</given-names></name><name><surname>Jiang</surname> <given-names>H</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Cao</surname> <given-names>D</given-names></name><name><surname>Guo</surname> <given-names>G</given-names></name><name><surname>Hu</surname> <given-names>X</given-names></name><name><surname>Gui</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>Z</given-names></name><name><surname>Xie</surname> <given-names>W</given-names></name><name><surname>Sun</surname> <given-names>X</given-names></name><name><surname>Shi</surname> <given-names>M</given-names></name><name><surname>Cai</surname> <given-names>Z</given-names></name><name><surname>Wang</surname> <given-names>B</given-names></name><name><surname>Zhong</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Lu</surname> <given-names>Z</given-names></name><name><surname>Gu</surname> <given-names>N</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Goodman</surname> <given-names>L</given-names></name><name><surname>Bolund</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Yang</surname> <given-names>H</given-names></name><name><surname>Kristiansen</surname> <given-names>K</given-names></name><name><surname>Dean</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor</article-title><source>Cell</source><volume>148</volume><fpage>886</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.02.025</pub-id><pub-id pub-id-type="pmid">22385958</pub-id></element-citation></ref><ref id="bib645"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>C</given-names></name><name><surname>Su</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Identification of cell types from single-cell transcriptomes using a novel clustering method</article-title><source>Bioinformatics</source><volume>31</volume><fpage>1974</fpage><lpage>1980</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv088</pub-id></element-citation></ref><ref id="bib646"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname> <given-names>J</given-names></name><name><surname>Schmidt</surname> <given-names>SV</given-names></name><name><surname>Sander</surname> <given-names>J</given-names></name><name><surname>Draffehn</surname> <given-names>A</given-names></name><name><surname>Krebs</surname> <given-names>W</given-names></name><name><surname>Quester</surname> <given-names>I</given-names></name><name><surname>De Nardo</surname> <given-names>D</given-names></name><name><surname>Gohel</surname> <given-names>TD</given-names></name><name><surname>Emde</surname> <given-names>M</given-names></name><name><surname>Schmidleithner</surname> <given-names>L</given-names></name><name><surname>Ganesan</surname> <given-names>H</given-names></name><name><surname>Nino-Castro</surname> <given-names>A</given-names></name><name><surname>Mallmann</surname> <given-names>MR</given-names></name><name><surname>Labzin</surname> <given-names>L</given-names></name><name><surname>Theis</surname> <given-names>H</given-names></name><name><surname>Kraut</surname> <given-names>M</given-names></name><name><surname>Beyer</surname> <given-names>M</given-names></name><name><surname>Latz</surname> <given-names>E</given-names></name><name><surname>Freeman</surname> <given-names>TC</given-names></name><name><surname>Ulas</surname> <given-names>T</given-names></name><name><surname>Schultze</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Transcriptome-based network analysis reveals a spectrum model of human macrophage activation</article-title><source>Immunity</source><volume>40</volume><fpage>274</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.01.006</pub-id><pub-id pub-id-type="pmid">24530056</pub-id></element-citation></ref><ref id="bib647"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanaba</surname> <given-names>K</given-names></name><name><surname>Bouaziz</surname> <given-names>JD</given-names></name><name><surname>Haas</surname> <given-names>KM</given-names></name><name><surname>Poe</surname> <given-names>JC</given-names></name><name><surname>Fujimoto</surname> <given-names>M</given-names></name><name><surname>Tedder</surname> <given-names>TF</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses</article-title><source>Immunity</source><volume>28</volume><fpage>639</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2008.03.017</pub-id><pub-id pub-id-type="pmid">18482568</pub-id></element-citation></ref><ref id="bib648"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>K</given-names></name><name><surname>Han</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences</article-title><source>Trends in Biochemical Sciences</source><volume>41</volume><fpage>954</fpage><lpage>969</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2016.08.010</pub-id></element-citation></ref><ref id="bib649"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname> <given-names>C</given-names></name><name><surname>Sun</surname> <given-names>HW</given-names></name><name><surname>Lacey</surname> <given-names>NE</given-names></name><name><surname>Ji</surname> <given-names>Y</given-names></name><name><surname>Moseman</surname> <given-names>EA</given-names></name><name><surname>Shih</surname> <given-names>HY</given-names></name><name><surname>Heuston</surname> <given-names>EF</given-names></name><name><surname>Kirby</surname> <given-names>M</given-names></name><name><surname>Anderson</surname> <given-names>S</given-names></name><name><surname>Cheng</surname> <given-names>J</given-names></name><name><surname>Khan</surname> <given-names>O</given-names></name><name><surname>Handon</surname> <given-names>R</given-names></name><name><surname>Reilley</surname> <given-names>J</given-names></name><name><surname>Fioravanti</surname> <given-names>J</given-names></name><name><surname>Hu</surname> <given-names>J</given-names></name><name><surname>Gossa</surname> <given-names>S</given-names></name><name><surname>Wherry</surname> <given-names>EJ</given-names></name><name><surname>Gattinoni</surname> <given-names>L</given-names></name><name><surname>McGavern</surname> <given-names>DB</given-names></name><name><surname>O'Shea</surname> <given-names>JJ</given-names></name><name><surname>Schwartzberg</surname> <given-names>PL</given-names></name><name><surname>Wu</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-cell RNA-seq reveals TOX as a key regulator of CD8<sup>+</sup> T cell persistence in chronic infection</article-title><source>Nature Immunology</source><volume>20</volume><fpage>890</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1038/s41590-019-0403-4</pub-id><pub-id pub-id-type="pmid">31209400</pub-id></element-citation></ref><ref id="bib650"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yarchoan</surname> <given-names>M</given-names></name><name><surname>Hopkins</surname> <given-names>A</given-names></name><name><surname>Jaffee</surname> <given-names>EM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Tumor Mutational Burden and Response Rate to PD-1 Inhibition</article-title><source>New England Journal of Medicine</source><volume>377</volume><fpage>2500</fpage><lpage>2501</lpage><pub-id pub-id-type="doi">10.1056/NEJMc1713444</pub-id></element-citation></ref><ref id="bib651"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yona</surname> <given-names>S</given-names></name><name><surname>Kim</surname> <given-names>KW</given-names></name><name><surname>Wolf</surname> <given-names>Y</given-names></name><name><surname>Mildner</surname> <given-names>A</given-names></name><name><surname>Varol</surname> <given-names>D</given-names></name><name><surname>Breker</surname> <given-names>M</given-names></name><name><surname>Strauss-Ayali</surname> <given-names>D</given-names></name><name><surname>Viukov</surname> <given-names>S</given-names></name><name><surname>Guilliams</surname> <given-names>M</given-names></name><name><surname>Misharin</surname> <given-names>A</given-names></name><name><surname>Hume</surname> <given-names>DA</given-names></name><name><surname>Perlman</surname> <given-names>H</given-names></name><name><surname>Malissen</surname> <given-names>B</given-names></name><name><surname>Zelzer</surname> <given-names>E</given-names></name><name><surname>Jung</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis</article-title><source>Immunity</source><volume>38</volume><fpage>79</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2012.12.001</pub-id><pub-id pub-id-type="pmid">23273845</pub-id></element-citation></ref><ref id="bib652"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshihara</surname> <given-names>K</given-names></name><name><surname>Shahmoradgoli</surname> <given-names>M</given-names></name><name><surname>Martínez</surname> <given-names>E</given-names></name><name><surname>Vegesna</surname> <given-names>R</given-names></name><name><surname>Kim</surname> <given-names>H</given-names></name><name><surname>Torres-Garcia</surname> <given-names>W</given-names></name><name><surname>Treviño</surname> <given-names>V</given-names></name><name><surname>Shen</surname> <given-names>H</given-names></name><name><surname>Laird</surname> <given-names>PW</given-names></name><name><surname>Levine</surname> <given-names>DA</given-names></name><name><surname>Carter</surname> <given-names>SL</given-names></name><name><surname>Getz</surname> <given-names>G</given-names></name><name><surname>Stemke-Hale</surname> <given-names>K</given-names></name><name><surname>Mills</surname> <given-names>GB</given-names></name><name><surname>Verhaak</surname> <given-names>RG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Inferring tumour purity and stromal and immune cell admixture from expression data</article-title><source>Nature Communications</source><volume>4</volume><elocation-id>2612</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms3612</pub-id><pub-id pub-id-type="pmid">24113773</pub-id></element-citation></ref><ref id="bib653"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yost</surname> <given-names>KE</given-names></name><name><surname>Satpathy</surname> <given-names>AT</given-names></name><name><surname>Wells</surname> <given-names>DK</given-names></name><name><surname>Qi</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name><name><surname>Kageyama</surname> <given-names>R</given-names></name><name><surname>McNamara</surname> <given-names>KL</given-names></name><name><surname>Granja</surname> <given-names>JM</given-names></name><name><surname>Sarin</surname> <given-names>KY</given-names></name><name><surname>Brown</surname> <given-names>RA</given-names></name><name><surname>Gupta</surname> <given-names>RK</given-names></name><name><surname>Curtis</surname> <given-names>C</given-names></name><name><surname>Bucktrout</surname> <given-names>SL</given-names></name><name><surname>Davis</surname> <given-names>MM</given-names></name><name><surname>Chang</surname> <given-names>ALS</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Clonal replacement of tumor-specific T cells following PD-1 blockade</article-title><source>Nature Medicine</source><volume>25</volume><fpage>1251</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.1038/s41591-019-0522-3</pub-id><pub-id pub-id-type="pmid">31359002</pub-id></element-citation></ref><ref id="bib654"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Youn</surname> <given-names>JI</given-names></name><name><surname>Nagaraj</surname> <given-names>S</given-names></name><name><surname>Collazo</surname> <given-names>M</given-names></name><name><surname>Gabrilovich</surname> <given-names>DI</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Subsets of myeloid-derived suppressor cells in tumor-bearing mice</article-title><source>The Journal of Immunology</source><volume>181</volume><fpage>5791</fpage><lpage>5802</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.181.8.5791</pub-id><pub-id pub-id-type="pmid">18832739</pub-id></element-citation></ref><ref id="bib655"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>M</given-names></name><name><surname>Hon</surname> <given-names>GC</given-names></name><name><surname>Szulwach</surname> <given-names>KE</given-names></name><name><surname>Song</surname> <given-names>CX</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Kim</surname> <given-names>A</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Dai</surname> <given-names>Q</given-names></name><name><surname>Shen</surname> <given-names>Y</given-names></name><name><surname>Park</surname> <given-names>B</given-names></name><name><surname>Min</surname> <given-names>JH</given-names></name><name><surname>Jin</surname> <given-names>P</given-names></name><name><surname>Ren</surname> <given-names>B</given-names></name><name><surname>He</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome</article-title><source>Cell</source><volume>149</volume><fpage>1368</fpage><lpage>1380</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.04.027</pub-id><pub-id pub-id-type="pmid">22608086</pub-id></element-citation></ref><ref id="bib656"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>B</given-names></name><name><surname>Zhang</surname> <given-names>K</given-names></name><name><surname>Milner</surname> <given-names>JJ</given-names></name><name><surname>Toma</surname> <given-names>C</given-names></name><name><surname>Chen</surname> <given-names>R</given-names></name><name><surname>Scott-Browne</surname> <given-names>JP</given-names></name><name><surname>Pereira</surname> <given-names>RM</given-names></name><name><surname>Crotty</surname> <given-names>S</given-names></name><name><surname>Chang</surname> <given-names>JT</given-names></name><name><surname>Pipkin</surname> <given-names>ME</given-names></name><name><surname>Wang</surname> <given-names>W</given-names></name><name><surname>Goldrath</surname> <given-names>AW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Epigenetic landscapes reveal transcription factors that regulate CD8<sup>+</sup> T cell differentiation</article-title><source>Nature Immunology</source><volume>18</volume><fpage>573</fpage><lpage>582</lpage><pub-id pub-id-type="doi">10.1038/ni.3706</pub-id><pub-id pub-id-type="pmid">28288100</pub-id></element-citation></ref><ref id="bib657"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zacharakis</surname> <given-names>N</given-names></name><name><surname>Chinnasamy</surname> <given-names>H</given-names></name><name><surname>Black</surname> <given-names>M</given-names></name><name><surname>Xu</surname> <given-names>H</given-names></name><name><surname>Lu</surname> <given-names>YC</given-names></name><name><surname>Zheng</surname> <given-names>Z</given-names></name><name><surname>Pasetto</surname> <given-names>A</given-names></name><name><surname>Langhan</surname> <given-names>M</given-names></name><name><surname>Shelton</surname> <given-names>T</given-names></name><name><surname>Prickett</surname> <given-names>T</given-names></name><name><surname>Gartner</surname> <given-names>J</given-names></name><name><surname>Jia</surname> <given-names>L</given-names></name><name><surname>Trebska-McGowan</surname> <given-names>K</given-names></name><name><surname>Somerville</surname> <given-names>RP</given-names></name><name><surname>Robbins</surname> <given-names>PF</given-names></name><name><surname>Rosenberg</surname> <given-names>SA</given-names></name><name><surname>Goff</surname> <given-names>SL</given-names></name><name><surname>Feldman</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Immune recognition of somatic mutations leading to complete durable regression in metastatic breast Cancer</article-title><source>Nature Medicine</source><volume>24</volume><fpage>724</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1038/s41591-018-0040-8</pub-id><pub-id pub-id-type="pmid">29867227</pub-id></element-citation></ref><ref id="bib658"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zajac</surname> <given-names>AJ</given-names></name><name><surname>Blattman</surname> <given-names>JN</given-names></name><name><surname>Murali-Krishna</surname> <given-names>K</given-names></name><name><surname>Sourdive</surname> <given-names>DJ</given-names></name><name><surname>Suresh</surname> <given-names>M</given-names></name><name><surname>Altman</surname> <given-names>JD</given-names></name><name><surname>Ahmed</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Viral immune evasion due to persistence of activated T cells without effector function</article-title><source>Journal of Experimental Medicine</source><volume>188</volume><fpage>2205</fpage><lpage>2213</lpage><pub-id pub-id-type="doi">10.1084/jem.188.12.2205</pub-id><pub-id pub-id-type="pmid">9858507</pub-id></element-citation></ref><ref id="bib659"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zappasodi</surname> <given-names>R</given-names></name><name><surname>Merghoub</surname> <given-names>T</given-names></name><name><surname>Wolchok</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Emerging concepts for immune checkpoint Blockade-Based combination therapies</article-title><source>Cancer Cell</source><volume>33</volume><fpage>581</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2018.03.005</pub-id><pub-id pub-id-type="pmid">29634946</pub-id></element-citation></ref><ref id="bib660"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaretsky</surname> <given-names>JM</given-names></name><name><surname>Garcia-Diaz</surname> <given-names>A</given-names></name><name><surname>Shin</surname> <given-names>DS</given-names></name><name><surname>Escuin-Ordinas</surname> <given-names>H</given-names></name><name><surname>Hugo</surname> <given-names>W</given-names></name><name><surname>Hu-Lieskovan</surname> <given-names>S</given-names></name><name><surname>Torrejon</surname> <given-names>DY</given-names></name><name><surname>Abril-Rodriguez</surname> <given-names>G</given-names></name><name><surname>Sandoval</surname> <given-names>S</given-names></name><name><surname>Barthly</surname> <given-names>L</given-names></name><name><surname>Saco</surname> <given-names>J</given-names></name><name><surname>Homet Moreno</surname> <given-names>B</given-names></name><name><surname>Mezzadra</surname> <given-names>R</given-names></name><name><surname>Chmielowski</surname> <given-names>B</given-names></name><name><surname>Ruchalski</surname> <given-names>K</given-names></name><name><surname>Shintaku</surname> <given-names>IP</given-names></name><name><surname>Sanchez</surname> <given-names>PJ</given-names></name><name><surname>Puig-Saus</surname> <given-names>C</given-names></name><name><surname>Cherry</surname> <given-names>G</given-names></name><name><surname>Seja</surname> <given-names>E</given-names></name><name><surname>Kong</surname> <given-names>X</given-names></name><name><surname>Pang</surname> <given-names>J</given-names></name><name><surname>Berent-Maoz</surname> <given-names>B</given-names></name><name><surname>Comin-Anduix</surname> <given-names>B</given-names></name><name><surname>Graeber</surname> <given-names>TG</given-names></name><name><surname>Tumeh</surname> <given-names>PC</given-names></name><name><surname>Schumacher</surname> <given-names>TN</given-names></name><name><surname>Lo</surname> <given-names>RS</given-names></name><name><surname>Ribas</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mutations associated with acquired resistance to PD-1 blockade in melanoma</article-title><source>New England Journal of Medicine</source><volume>375</volume><fpage>819</fpage><lpage>829</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1604958</pub-id><pub-id pub-id-type="pmid">27433843</pub-id></element-citation></ref><ref id="bib661"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarling</surname> <given-names>AL</given-names></name><name><surname>Polefrone</surname> <given-names>JM</given-names></name><name><surname>Evans</surname> <given-names>AM</given-names></name><name><surname>Mikesh</surname> <given-names>LM</given-names></name><name><surname>Shabanowitz</surname> <given-names>J</given-names></name><name><surname>Lewis</surname> <given-names>ST</given-names></name><name><surname>Engelhard</surname> <given-names>VH</given-names></name><name><surname>Hunt</surname> <given-names>DF</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Identification of class I MHC-associated phosphopeptides as targets for Cancer immunotherapy</article-title><source>PNAS</source><volume>103</volume><fpage>14889</fpage><lpage>14894</lpage><pub-id pub-id-type="doi">10.1073/pnas.0604045103</pub-id><pub-id pub-id-type="pmid">17001009</pub-id></element-citation></ref><ref id="bib662"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Conejo-Garcia</surname> <given-names>JR</given-names></name><name><surname>Katsaros</surname> <given-names>D</given-names></name><name><surname>Gimotty</surname> <given-names>PA</given-names></name><name><surname>Massobrio</surname> <given-names>M</given-names></name><name><surname>Regnani</surname> <given-names>G</given-names></name><name><surname>Makrigiannakis</surname> <given-names>A</given-names></name><name><surname>Gray</surname> <given-names>H</given-names></name><name><surname>Schlienger</surname> <given-names>K</given-names></name><name><surname>Liebman</surname> <given-names>MN</given-names></name><name><surname>Rubin</surname> <given-names>SC</given-names></name><name><surname>Coukos</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Intratumoral T cells, recurrence, and survival in epithelial ovarian Cancer</article-title><source>New England Journal of Medicine</source><volume>348</volume><fpage>203</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa020177</pub-id><pub-id pub-id-type="pmid">12529460</pub-id></element-citation></ref><ref id="bib663"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>JA</given-names></name><name><surname>Mortazavi</surname> <given-names>A</given-names></name><name><surname>Williams</surname> <given-names>BA</given-names></name><name><surname>Wold</surname> <given-names>BJ</given-names></name><name><surname>Rothenberg</surname> <given-names>EV</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Dynamic transformations of genome-wide epigenetic marking and transcriptional control establish T cell identity</article-title><source>Cell</source><volume>149</volume><fpage>467</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.01.056</pub-id><pub-id pub-id-type="pmid">22500808</pub-id></element-citation></ref><ref id="bib664"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Choksi</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>K</given-names></name><name><surname>Pobezinskaya</surname> <given-names>Y</given-names></name><name><surname>Linnoila</surname> <given-names>I</given-names></name><name><surname>Liu</surname> <given-names>ZG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages</article-title><source>Cell Research</source><volume>23</volume><fpage>898</fpage><lpage>914</lpage><pub-id pub-id-type="doi">10.1038/cr.2013.75</pub-id><pub-id pub-id-type="pmid">23752925</pub-id></element-citation></ref><ref id="bib665"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Cunningham</surname> <given-names>JJ</given-names></name><name><surname>Brown</surname> <given-names>JS</given-names></name><name><surname>Gatenby</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2017">2017a</year><article-title>Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate Cancer</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>5</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-01968-5</pub-id></element-citation></ref><ref id="bib666"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Feng</surname> <given-names>Q</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name><name><surname>Zeng</surname> <given-names>X</given-names></name><name><surname>Du</surname> <given-names>Y</given-names></name><name><surname>Lin</surname> <given-names>L</given-names></name><name><surname>Wu</surname> <given-names>J</given-names></name><name><surname>Fu</surname> <given-names>L</given-names></name><name><surname>Yang</surname> <given-names>K</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Xu</surname> <given-names>H</given-names></name><name><surname>Zhao</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Schoenauer</surname> <given-names>UH</given-names></name><name><surname>Stadlmayr</surname> <given-names>A</given-names></name><name><surname>Saksena</surname> <given-names>NK</given-names></name><name><surname>Tilg</surname> <given-names>H</given-names></name><name><surname>Datz</surname> <given-names>C</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2017">2017b</year><article-title>Characterization of the B cell receptor repertoire in the intestinal mucosa and of Tumor-Infiltrating lymphocytes in colorectal adenoma and carcinoma</article-title><source>The Journal of Immunology</source><volume>198</volume><fpage>3719</fpage><lpage>3728</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1602039</pub-id><pub-id pub-id-type="pmid">28348270</pub-id></element-citation></ref><ref id="bib667"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Gregorio</surname> <given-names>JD</given-names></name><name><surname>Iwahori</surname> <given-names>T</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Choi</surname> <given-names>O</given-names></name><name><surname>Tolentino</surname> <given-names>LL</given-names></name><name><surname>Prestwood</surname> <given-names>T</given-names></name><name><surname>Carmi</surname> <given-names>Y</given-names></name><name><surname>Engleman</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2017">2017c</year><article-title>A distinct subset of plasmacytoid dendritic cells induces activation and differentiation of B and T lymphocytes</article-title><source>PNAS</source><volume>114</volume><fpage>1988</fpage><lpage>1993</lpage><pub-id pub-id-type="doi">10.1073/pnas.1610630114</pub-id><pub-id pub-id-type="pmid">28167780</pub-id></element-citation></ref><ref id="bib668"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Yu</surname> <given-names>X</given-names></name><name><surname>Zheng</surname> <given-names>L</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Fang</surname> <given-names>Q</given-names></name><name><surname>Gao</surname> <given-names>R</given-names></name><name><surname>Kang</surname> <given-names>B</given-names></name><name><surname>Zhang</surname> <given-names>Q</given-names></name><name><surname>Huang</surname> <given-names>JY</given-names></name><name><surname>Konno</surname> <given-names>H</given-names></name><name><surname>Guo</surname> <given-names>X</given-names></name><name><surname>Ye</surname> <given-names>Y</given-names></name><name><surname>Gao</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Hu</surname> <given-names>X</given-names></name><name><surname>Ren</surname> <given-names>X</given-names></name><name><surname>Shen</surname> <given-names>Z</given-names></name><name><surname>Ouyang</surname> <given-names>W</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Lineage tracking reveals dynamic relationships of T cells in colorectal Cancer</article-title><source>Nature</source><volume>564</volume><fpage>268</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0694-x</pub-id><pub-id pub-id-type="pmid">30479382</pub-id></element-citation></ref><ref id="bib669"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Q</given-names></name><name><surname>He</surname> <given-names>Y</given-names></name><name><surname>Luo</surname> <given-names>N</given-names></name><name><surname>Patel</surname> <given-names>SJ</given-names></name><name><surname>Han</surname> <given-names>Y</given-names></name><name><surname>Gao</surname> <given-names>R</given-names></name><name><surname>Modak</surname> <given-names>M</given-names></name><name><surname>Carotta</surname> <given-names>S</given-names></name><name><surname>Haslinger</surname> <given-names>C</given-names></name><name><surname>Kind</surname> <given-names>D</given-names></name><name><surname>Peet</surname> <given-names>GW</given-names></name><name><surname>Zhong</surname> <given-names>G</given-names></name><name><surname>Lu</surname> <given-names>S</given-names></name><name><surname>Zhu</surname> <given-names>W</given-names></name><name><surname>Mao</surname> <given-names>Y</given-names></name><name><surname>Xiao</surname> <given-names>M</given-names></name><name><surname>Bergmann</surname> <given-names>M</given-names></name><name><surname>Hu</surname> <given-names>X</given-names></name><name><surname>Kerkar</surname> <given-names>SP</given-names></name><name><surname>Vogt</surname> <given-names>AB</given-names></name><name><surname>Pflanz</surname> <given-names>S</given-names></name><name><surname>Liu</surname> <given-names>K</given-names></name><name><surname>Peng</surname> <given-names>J</given-names></name><name><surname>Ren</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Landscape and dynamics of single immune cells in hepatocellular carcinoma</article-title><source>Cell</source><volume>179</volume><fpage>829</fpage><lpage>845</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.10.003</pub-id><pub-id pub-id-type="pmid">31675496</pub-id></element-citation></ref><ref id="bib670"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>Z</given-names></name><name><surname>Tavoosidana</surname> <given-names>G</given-names></name><name><surname>Sjölinder</surname> <given-names>M</given-names></name><name><surname>Göndör</surname> <given-names>A</given-names></name><name><surname>Mariano</surname> <given-names>P</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Kanduri</surname> <given-names>C</given-names></name><name><surname>Lezcano</surname> <given-names>M</given-names></name><name><surname>Sandhu</surname> <given-names>KS</given-names></name><name><surname>Singh</surname> <given-names>U</given-names></name><name><surname>Pant</surname> <given-names>V</given-names></name><name><surname>Tiwari</surname> <given-names>V</given-names></name><name><surname>Kurukuti</surname> <given-names>S</given-names></name><name><surname>Ohlsson</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Circular chromosome conformation capture (4C) uncovers extensive networks of epigenetically regulated intra- and interchromosomal interactions</article-title><source>Nature Genetics</source><volume>38</volume><fpage>1341</fpage><lpage>1347</lpage><pub-id pub-id-type="doi">10.1038/ng1891</pub-id><pub-id pub-id-type="pmid">17033624</pub-id></element-citation></ref><ref id="bib671"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>C</given-names></name><name><surname>Zheng</surname> <given-names>L</given-names></name><name><surname>Yoo</surname> <given-names>J-K</given-names></name><name><surname>Guo</surname> <given-names>H</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Guo</surname> <given-names>X</given-names></name><name><surname>Kang</surname> <given-names>B</given-names></name><name><surname>Hu</surname> <given-names>R</given-names></name><name><surname>Huang</surname> <given-names>JY</given-names></name><name><surname>Zhang</surname> <given-names>Q</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Dong</surname> <given-names>M</given-names></name><name><surname>Hu</surname> <given-names>X</given-names></name><name><surname>Ouyang</surname> <given-names>W</given-names></name><name><surname>Peng</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing</article-title><source>Cell</source><volume>169</volume><fpage>1342</fpage><lpage>1356</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.05.035</pub-id></element-citation></ref><ref id="bib672"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>M</given-names></name><name><surname>Tian</surname> <given-names>SZ</given-names></name><name><surname>Capurso</surname> <given-names>D</given-names></name><name><surname>Kim</surname> <given-names>M</given-names></name><name><surname>Maurya</surname> <given-names>R</given-names></name><name><surname>Lee</surname> <given-names>B</given-names></name><name><surname>Piecuch</surname> <given-names>E</given-names></name><name><surname>Gong</surname> <given-names>L</given-names></name><name><surname>Zhu</surname> <given-names>JJ</given-names></name><name><surname>Li</surname> <given-names>Z</given-names></name><name><surname>Wong</surname> <given-names>CH</given-names></name><name><surname>Ngan</surname> <given-names>CY</given-names></name><name><surname>Wang</surname> <given-names>P</given-names></name><name><surname>Ruan</surname> <given-names>X</given-names></name><name><surname>Wei</surname> <given-names>C-L</given-names></name><name><surname>Ruan</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Multiplex chromatin interactions with single-molecule precision</article-title><source>Nature</source><volume>566</volume><fpage>558</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-0949-1</pub-id></element-citation></ref><ref id="bib673"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname> <given-names>Y</given-names></name><name><surname>Wan</surname> <given-names>Y-W</given-names></name><name><surname>Pang</surname> <given-names>K</given-names></name><name><surname>Chow</surname> <given-names>LML</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Digital sorting of complex tissues for cell type-specific gene expression profiles</article-title><source>BMC Bioinformatics</source><volume>14</volume><elocation-id>89</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-14-89</pub-id></element-citation></ref><ref id="bib674"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>P</given-names></name><name><surname>Shaffer</surname> <given-names>DR</given-names></name><name><surname>Alvarez Arias</surname> <given-names>DA</given-names></name><name><surname>Nakazaki</surname> <given-names>Y</given-names></name><name><surname>Pos</surname> <given-names>W</given-names></name><name><surname>Torres</surname> <given-names>AJ</given-names></name><name><surname>Cremasco</surname> <given-names>V</given-names></name><name><surname>Dougan</surname> <given-names>SK</given-names></name><name><surname>Cowley</surname> <given-names>GS</given-names></name><name><surname>Elpek</surname> <given-names>K</given-names></name><name><surname>Brogdon</surname> <given-names>J</given-names></name><name><surname>Lamb</surname> <given-names>J</given-names></name><name><surname>Turley</surname> <given-names>SJ</given-names></name><name><surname>Ploegh</surname> <given-names>HL</given-names></name><name><surname>Root</surname> <given-names>DE</given-names></name><name><surname>Love</surname> <given-names>JC</given-names></name><name><surname>Dranoff</surname> <given-names>G</given-names></name><name><surname>Hacohen</surname> <given-names>N</given-names></name><name><surname>Cantor</surname> <given-names>H</given-names></name><name><surname>Wucherpfennig</surname> <given-names>KW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>In vivo discovery of immunotherapy targets in the tumour microenvironment</article-title><source>Nature</source><volume>506</volume><fpage>52</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/nature12988</pub-id><pub-id pub-id-type="pmid">24476824</pub-id></element-citation></ref><ref id="bib675"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>Y</given-names></name><name><surname>Herndon</surname> <given-names>JM</given-names></name><name><surname>Sojka</surname> <given-names>DK</given-names></name><name><surname>Kim</surname> <given-names>KW</given-names></name><name><surname>Knolhoff</surname> <given-names>BL</given-names></name><name><surname>Zuo</surname> <given-names>C</given-names></name><name><surname>Cullinan</surname> <given-names>DR</given-names></name><name><surname>Luo</surname> <given-names>J</given-names></name><name><surname>Bearden</surname> <given-names>AR</given-names></name><name><surname>Lavine</surname> <given-names>KJ</given-names></name><name><surname>Yokoyama</surname> <given-names>WM</given-names></name><name><surname>Hawkins</surname> <given-names>WG</given-names></name><name><surname>Fields</surname> <given-names>RC</given-names></name><name><surname>Randolph</surname> <given-names>GJ</given-names></name><name><surname>DeNardo</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Tissue-Resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor progression</article-title><source>Immunity</source><volume>47</volume><fpage>323</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2017.07.014</pub-id><pub-id pub-id-type="pmid">28813661</pub-id></element-citation></ref><ref id="bib676"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziegenhain</surname> <given-names>C</given-names></name><name><surname>Vieth</surname> <given-names>B</given-names></name><name><surname>Parekh</surname> <given-names>S</given-names></name><name><surname>Reinius</surname> <given-names>B</given-names></name><name><surname>Guillaumet-Adkins</surname> <given-names>A</given-names></name><name><surname>Smets</surname> <given-names>M</given-names></name><name><surname>Leonhardt</surname> <given-names>H</given-names></name><name><surname>Heyn</surname> <given-names>H</given-names></name><name><surname>Hellmann</surname> <given-names>I</given-names></name><name><surname>Enard</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Comparative analysis of Single-Cell RNA sequencing methods</article-title><source>Molecular Cell</source><volume>65</volume><fpage>631</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.01.023</pub-id><pub-id pub-id-type="pmid">28212749</pub-id></element-citation></ref><ref id="bib677"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zilionis</surname> <given-names>R</given-names></name><name><surname>Engblom</surname> <given-names>C</given-names></name><name><surname>Pfirschke</surname> <given-names>C</given-names></name><name><surname>Savova</surname> <given-names>V</given-names></name><name><surname>Zemmour</surname> <given-names>D</given-names></name><name><surname>Saatcioglu</surname> <given-names>HD</given-names></name><name><surname>Krishnan</surname> <given-names>I</given-names></name><name><surname>Maroni</surname> <given-names>G</given-names></name><name><surname>Meyerovitz</surname> <given-names>CV</given-names></name><name><surname>Kerwin</surname> <given-names>CM</given-names></name><name><surname>Choi</surname> <given-names>S</given-names></name><name><surname>Richards</surname> <given-names>WG</given-names></name><name><surname>De Rienzo</surname> <given-names>A</given-names></name><name><surname>Tenen</surname> <given-names>DG</given-names></name><name><surname>Bueno</surname> <given-names>R</given-names></name><name><surname>Levantini</surname> <given-names>E</given-names></name><name><surname>Pittet</surname> <given-names>MJ</given-names></name><name><surname>Klein</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-Cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species</article-title><source>Immunity</source><volume>50</volume><fpage>1317</fpage><lpage>1334</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.03.009</pub-id><pub-id pub-id-type="pmid">30979687</pub-id></element-citation></ref><ref id="bib678"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Žurauskienė</surname> <given-names>J</given-names></name><name><surname>Yau</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>pcaReduce: hierarchical clustering of single cell transcriptional profiles</article-title><source>BMC Bioinformatics</source><volume>17</volume><elocation-id>140</elocation-id><pub-id pub-id-type="doi">10.1186/s12859-016-0984-y</pub-id><pub-id pub-id-type="pmid">27005807</pub-id></element-citation></ref></ref-list></back></article>